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Over the past 30 years, catalytic asymmetric hydroboration (CAHB) of alkenes has 
emerged as a leading methodology to access chiral primary and secondary boronic esters. 
However, it wasn’t until 2015 that directed-CAHB was for the first time shown to 
efficiently access chiral tertiary boronic esters. The latter are excellent precursors to 
synthetically challenging structural motifs such as chiral tertiary alcohols, carbinamines 
and all-carbon quaternary stereocenters via stereospecific C-B bond substitutions. This 
dissertation focuses on phosphonate-directed CAHB of diverse alkene substrates, including 
challenging stereodefined trisubstituted alkenes, to efficiently access multifunctional chiral 
secondary and tertiary boronic esters. Mechanistic insights obtained via deuterium 
labelling experiments indicate that CAHB reactions proceed via tertiary-alkyl rhodium 
intermediates for substrates that lead to chiral tertiary boronic esters. The applications of 
phosphonate-functionalized chiral secondary and tertiary boronic ester products are 
discussed in the context of stereospecific C-B bond transformations, through phosphonate 
unmasking methodologies via thiophosphonate and oxophosphonate intermediates, and 
through synthesis of the cytotoxic natural product bakuchiol.  
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PREFACE 
 This dissertation comprises of five chapters: (1) Introduction; (2) Phosphonate-
Directed Catalytic Asymmetric Hydroboration of Disubstituted Vinyl Arenes; (3) 
Phosphonate-Directed Catalytic Asymmetric Hydroboration of Trisubstituted Alkenes; (4) 
Stereospecific Transformations of Phosphonate-Functionalized Chiral Secondary and 
Tertiary Boronic Esters; (5) Experimental Procedures and Characterization Data.   
 The first chapter is an introduction to chiral boronic esters-their synthetic, 
biological and medicinal relevance. In addition, the first chapter entails a comprehensive 
coverage of the reported methods of enantioselective synthesis of chiral tertiary boronic 
esters and their stereospecific transformations. The first chapter ends with a section on the 
introduction to the phosphonate-functionality-their biological relevance and directing 
properties and the initial goals behind the development of phosphonate-directed catalytic 
asymmetric hydroboration.  
 The second chapter details the phosphonate-directed catalytic asymmetric 
hydroboration results with 1,1- and 1,2-disubstituted vinyl arenes and the mechanistic 
insights obtained in each case. This chapter includes comparisons of directing groups, 
effect of distance between the directing group and the alkene, effect of alkene geometry 
and substrate scope for the two substrate types studied. The second chapter also includes 
mechanistic investigations via deuterium labelling experiments with pinBD. The results 
presented in Chapter 2, Sections 2.2, 2.3 and 2.5 are published in the journal ACS Catalysis 
(ACS Catal., 2018, 8, 10530) and sections 2.6-2.10 are published in the journal Chemical 
Science (Chem. Sci., 2019, 10, 4854). 
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 The third chapter begins with a review of the reported methods of efficient CAHB 
of trisubstituted alkenes in the literature. This chapter covers the phosphonate-directed 
catalytic asymmetric hydroboration results with all-alkyl, aryl-alkyl and bisaryl 
trisubstituted alkenes to access chiral tertiary boronic esters. Substrate scope and 
mechanistic insights via deuterium labelling experiments are included. The results 
presented in Chapter 3, Sections 3.2, parts of 3.3 and 3.4 are published in the Journal of the 
American Chemical Society (J. Am. Chem. Soc., 2017, 139, 6066), sections 3.5 and 3.7 are 
published in the journal ACS Catalysis (ACS Catal., 2018, 8, 10530).  
 The fourth chapter is dedicated to the stereospecific transformations carried out 
with the phosphonate-functionalized chiral boronic esters that are generated using the 
chemistry. This chapter includes stereospecific C-B bond transformations with chiral 
secondary benzylic boronic esters, chiral tertiary benzylic boronic esters and chiral tertiary 
all-alkyl boronic esters. This chapter also covers phosphonate-unmasking via 
oxophosphonate intermediates and total synthesis of the cytotoxic natural product 
bakuchiol using Corey’s thiophosphonate olefination chemistry. The results presented in 
Chapter 4, sections 4.2 and 4.3 are published in the journal ACS Catalysis (ACS Catal., 
2018, 8, 10530), section 4.4 is published in Chemical Science (Chem. Sci., 2019, 10, 4854) 
and sections 4.5 and 4.6 are published in Journal of the American Chemical Society (J. Am. 
Chem. Soc., 2017, 139, 6066).  
 The last chapter provides experimental procedures for substrate synthesis, for 
catalytic asymmetric hydroboration and transformations of the derived products. 
Characterization data for new molecules and absolute configuration assignments are 
included. Most of the data compiled in chapter 5 is published in the supporting information 
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sections of the following published journal articles: (i) Chem. Sci., 2019, 10, 4854; (ii) ACS 
Catal., 2018, 8, 10530; (iii) J. Am. Chem. Soc., 2017, 139, 6066.   
viii 
 
TABLE OF CONTENTS 
 
CHAPTER ONE: INTRODUCTION ..................................................................................1 
1.1. Introduction to Chiral Boronic Esters: Synthetic, Biological and Medicinal Relevance ...... 1 
1.2. Chiral tertiary boronic esters: Introduction and enantioselective synthesis .......................... 7 
1.3. Overview of the Fifth Approach: Development of Catalytic Asymmetric Hydroboration 
(CAHB) and it’s utility in the synthesis of chiral tertiary boronic esters ................................... 16 
1.4. Stereospecific transformations of chiral tertiary boronic esters .......................................... 21 
1.5. Introduction to the phosphonate-functionality: biological relevance and directing properties
 ................................................................................................................................................... 33 
1.6. Summary ............................................................................................................................. 37 
1.7. References ........................................................................................................................... 38 
CHAPTER TWO: PHOSPHONATE-DIRECTED CATALYTIC ASYMMETRIC 
HYDROBORATION OF DISUBSTITUTED VINYL ARENES ....................................48 
2.1. Metal-catalyzed CAHB of 1,1-disubstituted (methylidene) vinyl arenes: results with iridium, 
cobalt and copper catalysts ........................................................................................................ 48 
2.2. Development of Rh-catalyzed, directed-CAHB of methylidene vinyl arenes: comparison of 
amide, oxime and phosphonate-directing groups ...................................................................... 50 
2.3. Experimental data probing into the origin of unusual regioselectivity observed ................ 53 
2.4. Mechanistic insights into phosphonate-directed CAHB of 1,1-disubstituted vinyl arenes . 55 
2.5. Substrate-scope of phosphonate-directed CAHB of methylidene vinyl arenes .................. 62 
2.6. Phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes ......................................... 64 
ix 
 
2.7. Experimental data explaining the origin of E/Z-stereoconvergence ................................... 69 
2.8. Mechanistic insights in the CAHB of 1,2-disubstituted alkenes obtained from deuterium 
labeling experiments .................................................................................................................. 71 
2.9. Substrate-scope of phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes ........... 81 
2.10. Stereochemical assignments via kinetic resolution ........................................................... 87 
2.11. Summary ........................................................................................................................... 90 
2.12. References ......................................................................................................................... 91 
CHAPTER THREE: PHOSPHONATE-DIRECTED CATALYTIC ASYMMETRIC 
HYDROBORATION OF TRISUBSTITUTED ALKENES .............................................95 
3.1. Review of reported examples of CAHB with trisubstituted alkenes .................................. 95 
3.2. Phosphonate-directed CAHB of all-alkyl trisubstituted alkenes: access to all-alkyl 
substituted chiral tertiary boronic esters .................................................................................... 99 
3.3. Mechanistic insights into phosphonate directed CAHB of all-alkyl trisubstituted alkenes
 ................................................................................................................................................. 101 
3.4. Substrate scope of phosphonate directed CAHB of all-alkyl trisubstituted alkenes ......... 106 
3.5. Phosphonate-directed CAHB of aryl-substituted (i.e., styrenyl) trisubstituted alkenes: facile 
access to chiral tertiary benzylic boronic esters ....................................................................... 109 
3.6. Mechanistic insights into phosphonate directed CAHB of styrenyl trisubstituted alkenes
 ................................................................................................................................................. 111 
3.7. Substrate scope of phosphonate-directed CAHB of styrenyl trisubstituted alkenes ......... 114 
3.8. Summary and conclusions from the studies of phosphonate-directed CAHB .................. 119 
3.9. References ......................................................................................................................... 124 
x 
 
CHAPTER FOUR: STEREOSPECIFIC TRANSFORMATIONS OF PHOSPHONATE-
FUNCTIONALIZED CHIRAL SECONDARY AND TERTIARY BORONIC ESTERS
..........................................................................................................................................126 
4.1. Stereospecific transformations of multifunctional chiral boronic esters ........................... 126 
4.2. Stereospecific transformations of phosphonate-functionalized chiral tertiary benzylic 
boronic esters ........................................................................................................................... 129 
4.3. Phosphonate-unmasking via oxophosphonate intermediates ............................................ 132 
4.4. Stereoretentive and stereoinvertive transformations of phosphonate-functionalized chiral 
secondary benzylic boronic esters ........................................................................................... 134 
4.5. Stereospecific transformations of phosphonate-functionalized chiral alkyl substituted 
tertiary boronic esters ............................................................................................................... 140 
4.6. Formal total synthesis of the cytotoxic natural product (S)-(+)-bakuchiol ....................... 143 
4.7. Summary and outlook ....................................................................................................... 146 
4.8. References ......................................................................................................................... 149 
CHAPTER FIVE: EXPERIMENTAL DETAILS AND CHARACTERIZATION DATA
..........................................................................................................................................159 
5.1. General Information .......................................................................................................... 159 
5.2. Synthesis of substrates ...................................................................................................... 162 
5.3. Ligand synthesis................................................................................................................ 221 
5.4. Ligand Screening Data ...................................................................................................... 223 
5.5. General Procedure for Catalytic Asymmetric HydroBoration (CAHB) & Synthesis of 
Phosphonate-Functionalized Chiral Boronic Esters ................................................................ 228 
xi 
 
5.6. Oxidation Of Phosphonate-Functionalized Chiral Boronic Esters To Form Chiral Hydroxy 
Phosphonates ........................................................................................................................... 275 
5.7. Stereospecific Functionalizations of Phosphonate-Functionalized Chiral Boronic Esters 350 
5.8. Miscellaneous transformations of phosphonate-functionalized chiral tertiary boronic esters 
without chromophores to determine enantiomer ratios ............................................................ 379 
5.9. Oxidations leading to α-hydroxy and oxophosphonates and their synthetic utility .......... 389 
5.10. Total synthesis of (S)-(+)-Bakuchiol Methyl Ether ........................................................ 401 
5.11. Absolute Configuration Assignments ............................................................................. 410 
5.12. References ....................................................................................................................... 444 
 
  
xii 
 
LIST OF FIGURES 
Figure 1.1. Selected Stereospecific transformations of chiral boronic esters. 
Figure 1.2. Mechanisms of oxidation and metal-free cross-couplings of chiral boronic 
esters.  
Figure 1.3: Selected examples of utility of chiral boronic esters in asymmetric total 
synthesis. 
Figure 1.4: Selected examples of boron-containing natural products found in nature. 
Figure 1.5: Genetically programmed chiral organoborane synthesis: Enzyme-catalyzed 
construction of C-B bonds. 
Figure 1.6: Selected examples of boron-based pharmaceuticals.  
Figure 1.7: Matteson’s stereocontrolled synthesis of chiral tertiary boronic esters via 
stereospecific homologation from pinanediol boronic esters followed by nucleophilic 
substitution. 
Figure 1.8: Lithiation-borylation strategy to access chiral tertiary boronic esters from 
carbamates derived from chiral secondary alcohols. 
Figure 1.9: Mechanistic rationale for conjugate borylation of Michael acceptors to access 
chiral tertiary boronic esters. 
Figure 1.10: Early reports of conjugate boration methodology to access chiral tertiary 
boronic esters from α,β-unsaturated esters, ketones, thioesters and nitriles 
Figure 1.11: Hoveyda’s report on metal-free conjugate borylation of acyclic/cyclic enones 
.  
xiii 
 
Figure 1.12: A: Conjugate borylation to access quaternary stereocenter bearing a -CF3 and 
a boronic ester functionality. B. Conjugate borylation to access phosphonate-
functionalized chiral tertiary boronic esters.   
Figure 1.13: Hoveyda’s allylic substitution methodology to access chiral tertiary boronic 
esters 
Figure 1.14: Morken’s conjunctive cross-coupling methodology to access chiral tertiary 
boronic esters.   
Figure 1.15: Tang’s rhodium-catalyzed asymmetric hydroboration of α-aryl enamides and 
its mechanism.  
Figure 1.16: Takacs' oxime-directed catalytic asymmetric hydroboration to form chiral 
tertiary boronic esters.  
Figure 1.17: Oxidation of chiral tertiary boronic esters to form chiral tertiary alcohols.  
Figure 1.18: Amination of chiral tertiary boronic esters to form chiral tertiary 
carbinamines.  
Figure 1.19: Stereospecific proto/deutero-deboronation of chiral tertiary boronic esters. 
Figure 1.20: Stereospecific vinylation of chiral tertiary boronic esters. 
Figure 1.21: Stereospecific transformation of chiral tertiary boronic esters to methyl 
ketones. 
Figure 1.22: Stereospecific alkynylation of chiral tertiary boronic esters. 
Figure 1.23: Homologation reactions of chiral tertiary boronic esters 
xiv 
 
Figure 1.24: Stereospecific addition of tertiary trifluoroborate salts to aldehydes 
Figure 1.25: Stereospecific coupling of chiral tertiary boronic esters with 5- and 6-
membered electron rich aromatic rings.  
Figure 1.26: Stereospecific coupling of chiral tertiary boronic esters with N-
heteroaromatic compounds and with phenyl acetylenes.  
Figure 1.27: Stereospecific coupling of chiral tertiary boronic esters with dilithio-
phenolates and lithiated aryl hydrazines to phenols or anilines.  
Figure 1.28: Selected examples of bioactive phosphonates  
Figure 1.29: Utility of the phosphonate-functionality in organic synthesis.   
Figure 1.30: Phosphonate-directed aryl C-H functionalizations.  
Figure 2.1. Selected examples of transition-metal catalyzed CAHB of methylidene vinyl 
arenes 
Figure 2.2. Directed CAHB of methylidene vinyl arenes: Comparison of amide, oxime and 
phosphonate-directing groups 
Figure 2.3. Variations in regioselectivity observed for some methylidene substrates 
Figure 2.4: Deuterium incorporation seen in substrate under standard CAHB conditions 
Figure 2.5: Different levels of deuterium incorporation observed in the major (tertiary) 
alcohol product obtained via CAHB of 5a with pinBD followed by oxidation 
Figure 2.6: Different levels of deuterium incorporation observed in the minor (primary) 
alcohol product obtained via CAHB of 5a with pinBD followed by oxidation 
xv 
 
Figure 2.7: Proposed mechanism explaining formation of chiral tertiary boronic esters via 
phosphonate directed CAHB of methylidene vinyl arenes 
Figure 2.8: Competition CAHB reaction between methylidene substrates bearing donor 
(5d) vs. acceptor (5e) groups appended to the arene in the β-position of the substrate with 
sub-stoichiometric pinBH.  
Figure 2.9. Substrate scope of phosphonate-directed CAHB of β-aryl methylidenes. 
Figure 2.10. Previously reported examples of CAHB of 1,2-disubstituted vinyl arenes 
Figure 2.11. Phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes 
Figure 2.12. Amide-directed CAHB of (E)- or (Z)-trisubstituted alkenes affords 
diastereomeric products showing B-H addition is independent of alkene stereochemistry. 
Figure 2.13. (E/Z)-Substrate stereoconvergence observed in the CAHB of phosphonate-
functionalized 1,2-disubstituted vinyl arenes: same major enantiomer of product is formed 
from diastereomeric substrates.   
Figure 2.14. Z- to E- substrate isomerization is seen under standard CAHB conditions.    
Figure 2.15. Different distributions of deuterated products are obtained when isomeric (E)- 
or (Z)-18a react with PinBD under standard CAHB conditions.  
Figure 2.16. “Top-face” addition of pinBH and pinBD in the CAHB of (E)-18a. 
Figure 2.17. 31P NMR of (3S)-22a (Spectrum A) and enriched 2-d-(2S,3S)-22a (Spectrum 
B). 
xvi 
 
Figure 2.18. 13C NMR spectra (zoomed in for β-carbon) of (3S)-22a (Spectrum A) and 
enriched 2-d-(2S,3S)-22a (Spectrum B). 
Figure 2.19. Top and bottom-face addition of pinBD in CAHB of (Z)-18a 
Figure 2.20. 1H and 2H NMR's showing formation of (E)-18a and 2-d-(E)-18a from (Z)-
18a with pinBD under standard CAHB conditions. 
Figure 2.21. 13C NMR zoomed in for the region of β-carbon: (a) CAHB of (E)-18a with 
pinBH, then oxidation to yield (3S)-22a. (b) CAHB of (E)-18a with pinBD, then oxidation 
to yield mixtures of hydro- and deutero incorporated 22a. (c) CAHB of (Z)-18a with 
pinBD, then oxidation to yield diastereomeric monodeuterated 22a in addition to hydro-
incorporated 22a. 
Figure 2.22. HRMS analysis of the mixture of proteo/mono-deutero alcohols 22a obtained 
via CAHB of (E)-18a with pinBD. 
Figure 2.23. HRMS analysis of mixture of proteo/mono deutero and dideutero alcohols 
22a obtained via CAHB of (Z)-18a with pinBD. 
Figure 2.24. Scope of allyl phosphonate substrates bearing substituted benzene derivatives 
at the γ-position. 
Figure 2.25. Scope of allyl phosphonate substrates bearing heterocyclic aromatic 
derivatives at the γ-position. 
Figure 2.26. Additional substrate scope and some limitations of the methodology using the 
(R)-B2/Rh-catalyst system.  
Figure 2.27. Stereochemical assignments based on kinetic resolution.  
xvii 
 
Figure 3.1. Reported examples of CAHB with trisubstituted alkenes. 
Figure 3.2. Phosphonate-directed CAHB of all-alkyl trisubstituted alkenes. 
Figure 3.3. A. 1H NMR of (Z)-37a. B. 2H NMR (zoomed in to 4-7 ppm) after incomplete 
CAHB reaction with pinBD showing vinyl deuterium peak inferring the presence of 3-d-
(Z)-37a. C. Deuterium incorporation in the vinyl position of (E)-37a seen during CAHB. 
D. HRMS data of CAHB mixture indicating presence of 3-d-(Z)-37a.  
Figure 3.4. Different levels of deuterium incorporation seen in the CAHB of (E)-37a with 
pinBD (100% D purity) followed by oxidation. 
Figure 3.5. Key mechanistic considerations: Graph A compares the yield of 38a over time 
for catalysts prepared using 1:1 (blue line) versus 2:1 (red line) T2:Rh ratios; Graph B plots 
percent ee of the product versus percent ee of the chiral catalyst. 
Figure 3.6. Plausible mechanism of deuterium incorporation in substrate (E)-37a under 
standard conditions with pinBD. 
Figure 3.7. Substrate scope of phosphonate-directed CAHB of trialkyl substituted alkenes. 
Figure 3.8. Limitations of the methodology: Unsuccessful trisubstituted substrates.  
Figure 3.9. Disparity in π-facial selectivity in CAHB for substrates differing in the nature 
of the alkene substituent at the β-position. 
Figure 3.10. A. 1H NMR of (E)-41a. B. 2H NMR (zoomed in to 4-7 ppm) after incomplete 
CAHB reaction with pinBD showing vinyl deuterium peak inferring the presence of 3-d-
(Z)-41a. C. Deuterium incorporation in the vinyl position of (E)-41a seen during CAHB. 
D. HRMS data of CAHB mixture indicating presence of 3-d-(Z)-41a.  
xviii 
 
Figure 3.11. Different levels of deuterium incorporation seen in the CAHB of (E)-41a with 
pinBD (100% D purity) followed by oxidation. 
Figure 3.12. Phosphonate-directed CAHB of styrenyl trisubstituted alkenes: effect of ring 
size, alkene stereochemistry and the presence of aryl substituents in both carbon atoms of 
the alkene.  
Figure 3.13. Substrate scope of phosphonate-directed CAHB of styrenyl trisubstituted 
alkenes. 
Figure 3.14. Summary of phosphonate-directed CAHB. 
Figure 4.1. Transformations of multifunctional chiral boronic esters to obtain medicinally 
relevant synthetic targets. 
Figure 4.2. Synthetic utility of phosphonate-functionalized, chiral tertiary benzylic boronic 
esters is illustrated by selected transformations of 6a. 
Figure 4.3. Oxidations leading to α-hydroxy- and oxophosphonates and their synthetic 
utility. 
Figure 4.4. Synthetic utility of chiral secondary benzylic boronic esters illustrated by 
stereoretentive and stereoinvertive C-B bond transformations. 
Figure 4.5: Stereochemical course of Suzuki-Miaura cross-coupling reactions of chiral 
secondary organoboron derivatives. A: Stereoinvertive cross-coupling of chiral secondary 
boronic esters. B: Stereoretentive cross-coupling of chiral secondary boronic esters. 
Figure 4.6. Utility of phosphonate functionalized chiral alkyl-substituted tertiary boronic 
esters is illustrated by selected transformations of (R)-38a. 
xix 
 
Figure 4.7. Formal total synthesis of (S)-(+)-Bakuchiol. 
  
xx 
 
LIST OF ABBREVIATIONS 
 
Ac    Acetate 
acac    Acetylacetonate 
aq    Aqueous 
Ar    Aryl 
BE    Boronic ester 
BINAP   2,2’-Bis(diphenylphosphino)-1,1’-binaphthyl 
BINOL   2,2’-Dihydroxy-1,1’-binaphthyl 
Bn    Benzyl 
Boc    tert-Butyloxycarbonyl 
br s    Broad singlet 
Bz    Benzoyl 
c    Concentration 
CAHB   Catalytic asymmetric hydroboration 
catBH    Catecholborane 
c-Hex or Cy   Cyclohexyl 
cod    Cyclooctadiene 
d    Doublet 
dba    Dibenzylideneacetone 
DBU    1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCM    Dichloromethane 
dd    Doublet of doublets 
dr    Diastereomer ratio 
xxi 
 
DFT    Density functional theory 
DG    Directing group 
DIBAL-H   Diisobutylaluminum hydride 
DMF    N,N-Dimethylformamide 
DMP    Dess–Martin periodinane 
DMSO   Dimethyl sulfoxide 
ee    Enantiomer excess 
Equiv    Equivalent 
er    Enantiomer ratio 
h or hr   Hour 
HIV    Human immunodeficiency virus 
HPLC    High-performance liquid chromatography 
HRMS   High-resolution mass spectrometry 
IR    Infrared 
J    Coupling constant 
LDA    Lithium diisopropylamide 
m    Multiplet 
min    Minutes 
ml or mL  Milliliter 
ND    Not determined 
nbd    Norbornadiene 
NBS    N-Bromosuccinimide 
NLE    Non-linear effect 
xxii 
 
NMR    Nuclear magnetic resonance 
Nu    Nucleophile 
pinBH   Pinacolborane 
ppm    Parts per million 
rac    Racemic 
Rf    Retention factor 
s    Singlet 
sr   % stereoretention 
T    Temperature 
t    Triplet or time 
TADDOL   α,α,α’,α’-Tetraaryl-1,3-dioxolan-4,5-dimethanol 
TBAF    Tetra-butyl ammonium fluoride 
TCCA   Trichloroisocyanuric acid 
TEMPO  2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
THF    Tetrahydrofuran 
TLC    Thin-layer chromatography 
tmdBH   4,5,6-Trimethyl-1,3,2-dioxaborinane 
UV-Vis   Ultraviolet-visible spectroscopy 
 
1 
 
CHAPTER ONE: INTRODUCTION 
1.1. Introduction to Chiral Boronic Esters: Synthetic, Biological and Medicinal 
Relevance  
Chiral boronic esters, in the context of this dissertation, are derivatives of boronic acids 
where the C-B bond is attached to the stereogenic carbon atom. These are versatile reagents 
for diversity-oriented synthesis because they possess a unique blend of bench stability and 
the potential to undergo a myriad of diverse stereospecific transformations.1 The C-B bond 
can be stereospecifically transformed to a C-H, C-C, C-O, C-N and C-X (X = halogen) 
bonds as shown in the transformation wheel in Figure 1.1.2  
 
Figure 1.1. Selected Stereospecific transformations of chiral boronic esters. 
The unique reactivity of the chiral boronic esters stems from the presence of an 
empty 2p-orbital on boron, rendering it Lewis acidic and therefore susceptible to undergo 
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addition reactions with nucleophiles which with suitable substituents provides pathways 
for rearrangement or substitution. For example, oxidation of chiral boronic esters occurs 
via the initial addition of a peroxide anion into the empty p-orbital of boron resulting in a 
boron “ate” complex possessing a weak O-O bond adjacent (Figure 1.2A). The boron-ate 
complex spontaneously undergoes 1,2-migration with the loss of hydroxide (or more 
generally a leaving group attached to the initial nucleophilic atom). The final hydrolysis of 
the O-B bond results in the formation of the alcohol product.  
 
Figure 1.2. Mechanisms of oxidation and metal-free cross-couplings of chiral boronic 
esters.  
 
A transition metal-free cross-coupling of chiral boronic esters with electron rich 
aromatics also features a very similar mechanistic pathway (Figure 1.2B).3 The initial 
addition of a lithiated aromatic ring to the chiral boronic ester generates an “ate” complex, 
which undergoes the desired 1,2-migration/rearrangement when activated by an 
electrophile. The intermediate rearomatizes upon subsequent nucleophilic addition to 
boron with the eventual loss of the electrophile to afford the cross-coupled product. The 
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1,2-migration (also known as Matteson Rearrangement) from boronate complexes occurs 
with complete stereospecificity, with the configuration of the carbon atom initially attached 
to boron retained , a feature common to several boron-based stereospecific transformations.  
Chiral boronic esters have been strategically utilized in diversity-oriented synthesis 
by several groups. Selected examples include the development of an iterative, reagent-
controlled homologation of chiral boronic esters in an assembly line-type synthesis to 
generate complex organic molecules that contain several contiguous methyl bearing 
stereocenters (Figure 1.3A).4 This strategy is versatile and has been used to synthesize 
various diastereomers for molecules bearing multiple chiral centers. This methodology was 
carried out essentially in a single pot, using continuous homologation processes to 
synthesize molecules such as (+)-kalkitoxin and (+)-hydroxyphthioceranic acid (Figure 
1.3B).5  
 
Figure 1.3: Selected examples of utility of chiral boronic esters in asymmetric total 
synthesis. 
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Organoboron compounds have found much use in the past few decades such as 
components in the powerful palladium-catalyzed Suzuki-Miyaura cross-coupling reaction; 
the latter is one of the widely used reactions in the pharmaceutical industry for constructing 
C-C bonds.1,6 The Crudden group developed an efficient method for the enantioselective 
construction of chiral unsymmetrical triaryl methane derivatives via enantiospecific Suzuki 
cross-coupling of chiral bisbenzylic boronic esters (Figure 1.3C).1d The chiral 
unsymmetrical triaryl compounds possess potent biological activity and are difficult to 
prepare via other methods. Yet another example of the utility of chiral boronic esters is in 
the gram scale synthesis of Herboxidiene/GEX1A developed by the Hoveyda group 
(Figure 1.4D).6 A crucial step in the synthesis involves the construction of a C-C bond 
using palladium-catalyzed cross-coupling between a vinyl boronic ester and a vinyl iodide.  
Recent advances in enzyme engineering has expanded nature’s catalytic repertoire 
that are not typically found in biological systems. For example, Frances Arnold’s research 
team has recently disclosed the discovery, evolution and generalization of a fully 
genetically encoded platform for producing chiral organoboranes in bacteria (Figure 1.5).7 
The team showed that E. Coli cells harboring wild-type cytochrome c from Rhodothermus 
marinus (Rma cyt c) could form C-B bonds via carbene insertion into B-H bonds. Directed 
evolution of Rma cyt c resulted in the optimization of the reaction for gram-scale 
biosynthesis of chiral organoboron compounds with a staggeringly high turnover number 
of 15,300 and a turnover frequency of 6100/h with 100% chemoselectivity and an 
enantiomer ratio of 99:1 er. The R/S-enantiopreference of the enzyme could be tuned as 
well. Arnold’s work is the first ever report of catalyzing C-B bond formation using 
enzymes.  
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Figure 1.5: Genetically programmed chiral organoborane synthesis: Enzyme-catalyzed 
construction of C-B bonds. 
 
Boron is less commonly found in nature than carbon, nitrogen, oxygen or even 
halogens. Although compounds bearing C-B bonds have become extremely useful in 
synthesis, their presence in nature is unknown. Where present, boron exists in the form of 
borates (boric acid derivatives) and serves mainly a structural role as a tetrahedral linker 
between four alkoxide units.8 Thus, to incorporate boron into biomolecules, 
microorganisms produce small molecules that spontaneously react with boric acid present 
in nature. Selected examples of such structures in nature include the boric-acid based 
macrolide antibiotics boromycin, borophycin, aplasomycins, and tartolons. The antibiotic 
boromycin was isolated from Streptomyces antibioticus in 1967 and it is the first boron-
containing natural product that was ever isolated. Boromycin is effective against gram 
positive bacteria and it does so by negatively affecting the cytosol leading to loss of 
potassium ions from the cell.9 Boromycin has also shown anti-HIV activity.10 Borophycin 
is a potent cytotoxin isolated from the marine strain of the blue-green algae Nostoc 
linckia.11 The Tartrolons are boron containing antibiotics from a myxobacterium, 
Sorangium cellulosum.12 The boron binding region of the Tartrolons are similar to that of 
boromycin and borophycin. The aplasmomycins were isolated in 1975 from the strain of 
Streptomyces griseus and these showed antibiotic activity against gram positive bacteria 
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and their structures were related to boromycin. AI-2 is a bacterial signaling molecule 
containing boron that has been involved in intracellular communication through quorum 
sensing.13 The structures of boromycin, borophycin, aplasmomycin A, tartrolon B and are 
shown in Figure 1.4.  
 
Figure 1.4: Selected examples of boron-containing natural products found in nature. 
 
While considerably less attention was given to boron containing organic 
compounds for the longest time mainly due to lack of efficient methods to access them, use 
of boron in the design of pharmaceuticals has a high potential for discovery of new 
biological activities. Chiral boronic acids and esters are now attracting significant interest 
as potential therapeutic agents (Figure 1.6).14 This is mainly due to the specific physical 
and physiological properties of boron. For instance, the pKa of a boronic acid is about 10 
and hence it essentially stays protonated under physiological conditions. Furthermore, the 
propensity of boronic acids to form hydrogen bonds as well as B-N bonds can enhance 
protein-ligand interactions. Furthermore, the presence of a vacant p-orbital in boron allows 
for the interconversion between the neutral sp2 and anionic sp3 hybridized states, which 
allows for interconversion between two possible structural states and gives a new platform 
for drug design. In addition, organoboron compounds are generally air-stable and are of 
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low toxicity and hence boron has significant potential in the design of therapeutic agents. 
Selected examples of boron-based pharmaceuticals (as shown in Figure 1.6) are the 
anticoagulant TRI50c, the anticancer agent Bortezomib15 used for the treatment of multiple 
myeloma and non-Hodgkin’s lymphoma, the DPP4 inhibitor dutogliptin which has been 
investigated as an antidiabetic agent, the antiviral drugs based on the template of Bocepvir, 
the antibacterial agent Benzo[b]thiophene-2-boronic acid was found to have an affinity for 
E. coli and the antifungal cyclic boronic ester AN2690 (tavaborole).16  
 
Figure 1.6: Selected examples of boron-based pharmaceuticals.  
 
1.2. Chiral tertiary boronic esters: Introduction and enantioselective synthesis 
The discussion above is intended to give a broad, but brief, overview of modern aspects of 
organoborane research. The dissertation focuses on developing methods to prepare a 
particular subclass of structures. Chiral structures in which boronic ester functionality is 
directly attached to a quaternary carbon stereocenter are known as chiral tertiary boronic 
esters. Nonracemic chiral tertiary boronic esters are excellent precursors to chiral tertiary 
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alcohols, carbinamines and all-carbon quaternary stereocenters via stereospecific C-B bond 
substitution.2 All-carbon quaternary stereocenters are important structural motifs 
commonly encountered in bioactive natural products and pharmaceutical drugs.17 The 
steric encumbrance around a quaternary carbon stereocenter often renders the 
stereoselective assembly of such molecules a challenging undertaking. Furthermore, the 
challenge of quaternary  carbon stereocenters also results from the lack of hydrogen 
handles, which limits approaches via reduction or reductive transpositions or via chiral 
protonation methods. Therefore, development of processes for the enantioselective 
synthesis of fully substituted carbon stereocenters continues to be one of the major 
challenges in the field of asymmetric catalysis. Several groups have contributed to the 
development of methods towards the efficient construction of chiral tertiary boronic esters. 
These are summarized below. 
Matteson reported the first ever synthesis of chiral tertiary boronic esters in 1990.18 
The methodology relied on homologation of a pinanediol-derived chiral boronic ester using 
(1,1-dichloroethyl)lithium and ZnCl2 to afford the corresponding α-chloro chiral tertiary 
boronic ester (Figure 1.7).  
 
Figure 1.7: Matteson’s stereocontrolled synthesis of chiral tertiary boronic esters via 
stereospecific homologation from pinanediol boronic esters followed by nucleophilic 
substitution.  
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Stereospecific substitution from the α-chloro chiral tertiary boronic ester gave the 
corresponding all-alkyl tertiary boronic ester. The stereochemistry of the formed α-chloro 
chiral tertiary boronic was found to be dependent on the structure of the starting boronic 
ester. For example, the phenylboronate leads to the formation of α-(S)-α-chloro boronic 
ester in a diastereomer ratio (dr) of 25:1 upon homologation with lithiodichloromethane. 
The ethylboronate leads to the formation of α-(R)-α-chloro boronic ester in a more modest 
diastereoselectivity of 9:1 dr. The transformation of α-chloro-phenylboronate to the tertiary 
all-alkyl boronic ester occurred with only modest loss of diastereopurity, the dr of the final 
product being 92:8. On the other hand, similar treatment of the α-chloro-ethylboronate with 
phenylmagnesium bromide occurred with significant loss of enantiopurity.  
Several new strategies have been developed for the enantioselective construction 
of chiral tertiary boronic esters.19 In contrast to the Matteson approach, most of these 
involve asymmetric catalysis. In a broad context, there are five unique approaches to access 
these compounds: (i) lithiation-borylation methodology developed by Aggarwal, 20 (ii) 
conjugate borylation approaches developed by Shibasaki,21 Hoveyda,22 Yun23,24 and 
Zhang,25 (iii) allylic substitution developed by Hoveyda,26 (iv) conjunctive cross-coupling 
protocol developed by Morken27 and (v) asymmetric hydroboration approaches developed 
by Tang28 and Takacs.29,30  
Aggarwal reported the 1,2-metallate rearrangement of boron-ate complexes to 
assemble chiral tertiary boronic esters in 2008. The 1,2-metallate rearrangement of boron 
“ate” complexes is essentially a 1,2-B-to-C migration (also referred to as the Matteson 
rearrangement) and this rearrangement forms the basis for several of the stereoretentive 
transformations of chiral boronic esters.31 Hoppe’s lithiated carbamates derived from chiral 
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secondary alcohols (carbamate formation followed by treatment with alkyl-lithium bases) 
were shown to undergo 1,2-B-to-C migration to form chiral tertiary boronic esters in 
excellent yields and in very high levels of enantioinduction (up to 99:1 er or higher). The 
Aggarwal group has since reported the synthesis of chiral tertiary all-alkyl,32 allyl,33 
benzyl,3 dibenzyl,34 propargyl35 and silyl36 boronic esters via stereospecific 1,2-B-to-C 
migration protocol (Figure 1.8).  
 
Figure 1.8: Lithiation-borylation strategy to access chiral tertiary boronic esters from 
carbamates derived from chiral secondary alcohols. A: General scheme of lithiation-
borylation methodology. B: Different classes of chiral tertiary boronic esters accessed via 
lithiation-borylation 
 
 As noted above, the second approach to prepare chiral tertiary boronic esters, the 
conjugate borylation of Michael acceptors, has been developed by several researchers. It is 
perhaps the most common methodology used to access chiral tertiary boronic esters. 
Conjugate borylation approaches result in a net boron-hydrogen addition across a C–C 
double bond. These processes are appropriately referred to as protoboration, because the 
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mechanism involves initial addition of a nucleophilic boryl species (borometallation of the 
alkene) followed by protonolysis of the formed C-Metal (usually Cu) bond. A ligated 
boryl-copper intermediate generated via transmetallation of a diboron species (e.g. 
bispinacolatodiboron B2(pin)2) with a copper alkoxide acts as the nucleophilic boron 
species in these reactions (Figure 1.9).37 Borometallation (often proceeding via a 
stereospecific and syn addition) adds boron to the more electrophilic β-position of the 
Michael acceptor substrates leading to the initial formation of a C-Cu bond α-to the 
electron-withdrawing group, which, depending upon the nature of the substrate undergoing 
reaction, may further isomerize. Direct protonolysis of the α-C-Cu bond introduces the α-
C-H bond, or alternatively the copper enolate (formed in case of enone substrates) can 
undergo transmetallation with another diboron species to yield the 1,4-diborylated product, 
which upon aqueous workup hydrolyzes to the observed β-borated product.  
 
Figure 1.9: Mechanistic rationale for conjugate borylation of Michael acceptors to access 
chiral tertiary boronic esters.37  
 
12 
 
The net protoboration of Michael acceptors such α,β-unsaturated (i.e., vinyl) 
ketones, esters, thioesters, nitriles and phosphonates have been carried out using conjugate 
borylation methodology to allow facile access to the corresponding β-borated chiral tertiary 
boronic ester products (Figure 1.10).  
 
Figure 1.10: Early reports of conjugate boration methodology to access chiral tertiary 
boronic esters from α,β-unsaturated esters, ketones, thioesters and nitriles.  
  
 The groups of Shibasaki,21 Yun23 and Hoveyda22 pioneered the 
development of copper-catalysts for the conjugate borylation of a variety of substrates 
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including acyclic/cyclic enones, α,β-unsaturated esters, nitriles and thioesters. The catalyst 
systems and the reaction conditions for specific substrate types reported by the three groups 
are significantly different. Chiral bisphosphines, diamines and N-heterocyclic carbenes 
were used to generate the active catalyst in-situ from appropriate copper precatalysts. Polar 
aprotic solvents such as DME, DMSO and THF were commonly used along with protic 
additives in these reactions. It is worth noting, however, that Shibasaki’s first report on 
conjugate borylation does not use any protic additives and adventitious moisture could 
account for the protonolysis step in the mechanistic cycle.21  
In 2014, a subsequent report from Hoveyda’s group in 2014 disclosed the Lewis-
base (N-heterocyclic carbene) catalyzed enantioselective boryl conjugate additions to 
enones forming chiral tertiary boronic esters.38 In this protocol, there was no metal catalyst 
involved and the N-heterocyclic carbene (1-5 mol%) was the only catalyst used. In some 
cases, this method afforded the desired products with higher selectivity profiles as 
compared to the corresponding metal-catalyzed variants (Figure 1.11).  
  
Figure 1.11: Hoveyda’s report on metal-free conjugate borylation of acyclic/cyclic enones. 
38  
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An extension of the conjugate borylation methodology was reported by Wu and 
Zhang in 2018 to incorporate substrates bearing trifluoromethyl groups in the β-position of 
vinyl esters and enones.25 A ferrocene-derived P,N-bidentate ligand (i.e., iPr-FOXAP) was 
used in conjugation with CuNO3.5H2O to generate the active borylation catalyst. In the 
event chiral tertiary boronic esters bearing a trifluoromethyl group at the chiral carbon were 
formed in excellent yields and high levels of enantioselectivity (Figure 1.12).  
 
Figure 1.12: A: Conjugate borylation to access quaternary stereocenter bearing a -CF3 and 
a boronic ester functionality. B. Conjugate borylation to access phosphonate-
functionalized chiral tertiary boronic esters.24,25   
 
 Recently, Yun reported an yet another extension of this methodology to incorporate 
vinyl phosphonates, generating β-chiral tertiary boronic esters.24 Copper thiophene-2-
carboxylate was employed as the precatalyst in combination with the chiral bisphosphine 
bidentate ligand MeDuphos to generate the active catalyst in-situ. The products generated 
using Yun’s methodology are the same products we have initially reported via 
phosphonate-directed catalytic asymmetric hydroboration of allylic (i.e., β,γ-unsaturated) 
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phosphonate-substrates and the synthesis of phosphonate-functionalized chiral boronic 
esters is discussed in length in this dissertation in Chapters 2 and 3.  
The third approach to the preparation of chiral tertiary boronic esters, the allylic 
substitution of trisubstituted allylic carbonates bearing an alkyl or aryl group, was 
introduced in 2010 by Hoveyda. This approach proves especially useful for the efficient 
construction of tertiary allyl boronic esters.26 Cis- or trans- trisubstituted alkenes were 
employed and a Cu-NHC complex is used for efficient catalysis. Mechanistically, allylic 
substitution reactions are similar to conjugate borylation reactions. The initial addition of 
a nucleophilic boryl species occurs at the more substituted position of the alkene leading 
to concerted or stepwise loss of the carbonate functionality (Figure 1.13).  
 
Figure 1.13: Hoveyda’s allylic substitution methodology to access chiral tertiary boronic 
esters.   
  
The fourth approach to the preparation of chiral tertiary boronic esters, catalytic 
conjunctive cross-coupling reactions, was reported by Morken in 2018.27 Conjunctive 
cross-coupling involves three different chemical components: an alkyl or vinyl lithium, a 
complementary alkyl or vinyl boronic ester and an appropriate aryl halide or pseudo-halide 
(Figure 1.14). A three-component palladium-catalyzed conjunctive cross-coupling 
reactions is proposed to occur via a 1,2-metallate shift of vinyl boron-ate complexes in the 
presence of a palladium or a nickel catalyst. The vinyl boron-ate complex can be prepared 
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using two different ways: (a) Addition of an alkyl lithium to a vinyl boronic ester, or (b) 
Addition of a vinyl lithium to an alkyl boronic ester. The oxidative addition complex of a 
palladium-catalyst with an aryl electrophile undergoes coordination with the alkene in the 
boron-ate complex which triggers a 1,2-metallate rearrangement resulting in the 
construction of the chiral tertiary boronic ester. Subsequent reductive elimination of the C-
C bond from the Pd-intermediate completes the catalytic cycle. 
 
Figure 1.14: Morken’s conjunctive cross-coupling methodology to access chiral tertiary 
boronic esters.27   
 
1.3. Overview of the Fifth Approach: Development of Catalytic Asymmetric 
Hydroboration (CAHB) and it’s utility in the synthesis of chiral tertiary boronic 
esters 
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In 1956, Dr. B. C. Subba Rao working in the laboratory of Dr. H. C. Brown discovered 
hydroboration of alkenes. Rao was examining the reducing characteristics of borane by 
treating sodium borohydride in diglyme in the presence of aluminum chloride and observed 
the reduction of ethyl oleate under standard conditions. It was soon established that the 
C=C bond in ethyl oleate was undergoing B-H addition resulting in the formation of the 
corresponding organoborane.39 This discovery led to a new era of boron chemistry and 
soon several groups were interested in the utility of organoboranes and this eventually led 
to Prof. H. C. Brown receiving the 1979 Nobel Prize in Chemistry jointly with Prof. Georg 
Wittig for "their development of the use of boron- and phosphorus-containing compounds, 
respectively, into important reagents in organic synthesis".40 
 The first report of metal-catalyzed hydroboration was reported in 1981 by 
Wilczynski and Sneddon in which a dicobalthexacarbonyl complex was shown to be 
effective in catalyzing hydroboration of dimethylacetylene by pentaborane.41 
Subsequently, in 1985, Mannig and Nöth (1985) reported the chemoselective 
hydroboration of hex-5-en-2-one.42 The enone was shown to undergo rhodium-catalyzed 
hydroboration with catecholborane at the alkene but in the absence of a rhodium catalyst, 
the ketone underwent selective hydroboration. Hayashi (1989) reported the first Rh-
catalyzed asymmetric hydroboration of styrenes: the selectivity attained giving 96% ee is 
among the highest obtained in asymmetric reactions by means of a transition-metal 
catalyst.43 
 The next three decades or so saw an active development in the field of catalytic 
asymmetric hydroboration (CAHB) of several different types of substrates leading to new 
routes to chiral organoboranes.44 Several initial reports were restricted to simple 
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monosubstituted styrene derivatives.  Building on the work of Evans and coworkers, 
Takacs and coworkers published in 2008 the first report on the amide-directed CAHB of 
non-styrenyl disubstituted internal alkenes.45 From that point onward, the field of CAHB 
saw a renewed growth with numerous groups around the world contributing to new 
chemistries. Most importantly, however, the development of catalysts for efficient 
hydroboration (i.e., boron-hydride addition) of different classes of alkenes effectively 
resulted in the contruction of chiral primary and secondary boronic esters only.  
As discussed earlier in this chapter, chiral tertiary boronic esters are important 
classes of compounds, but their access via asymmetric hydroboration wasn’t reported until 
recently. In 2015, Tang and workers published the first report to efficiently access α-amino 
chiral tertiary boronic esters via formal asymmetric hydroboration.28 α-Aryl enamides were 
shown to undergo directed hydroboration with bispinacolatodiboron (B2(pin)2) in the 
presence of a rhodium-catalyst with BI-DIME as the chiral ligand (Figure 1.15). A single 
chiral phosphine ligand coordinated to the rhodium precatalyst Rh(nbd)2BF4 was proposed 
to be the active hydroboration catalyst. Mechanistically, this transformation was proposed 
to occur via a tertiary alkyl rhodium intermediate in the catalytic cycle. Oxidative addition 
of B2(pin)2 to the Rh(I)-complex leads to the formation of bis-boryl rhodium (III) 
intermediate which subsequently reacts with the acidic N-H of an enamide substrate to 
afford boryl rhodium (III) hydride intermediate. Migratory insertion of the alkene C=C 
bond to the Rh-H bond generates the putative tertiary alkyl-rhodium intermediate and 
reductive elimination of the C-B bond from this complex forms the tertiary boronic ester 
product and regenerates the active catalyst. The presence of protic N-H is said to be 
important in this reaction to generate the Rh-H (rhodium-hydride) in-situ.   
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Figure 1.15: Tang’s rhodium-catalyzed asymmetric hydroboration of α-aryl enamides and 
its mechanism.28  
 
Shortly after Tang’s publication, Takacs and coworkers reported in 2016 the 
rhodium-catalyzed CAHB of allyl-oxime substrates resulting in a facile entry to chiral all-
alkyl tertiary boronic esters (Figure 1.16).29 A chiral rhodium complex generated in-situ 
from a commercially available precatalyst, Rh(nbd)2BF4, in conjugation with a TADDOL-
derived chiral cyclic phosphite, was shown to efficiently catalyze hydroboration of alkyl-
substituted methylidenes and trisubstituted alkenes with the formation of chiral tertiary 
boronic esters. The oxime-functionality was important for this reaction as prior work on 
the corresponding amide-directed reactions afforded boration at the less substituted 
terminus of the alkene. The oxime-directed reactions were shown to be highly site- and 
regioselective; the presence of multiple alkenes could be accommodated with the alkene 
proximal to the directing group undergoing preferential reaction. Furthermore, the 
reactions were also shown to be highly diastereoselective in case of chiral substrates. 
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Depending on the choice of the chiral catalyst used, either diastereomer of the product from 
a given chiral substrate could be prepared.  
In 2019 Bochat, Shoba and Takacs reported a regiodivergent enantioselective 
oxime-directed CAHB of aryl-substituted methylidenes to access regioisomeric chiral 
primary and tertiary boronic ester products.30 Simple changes in the TADDOL-ligand were 
shown to effect regiodivergent behavior under the standard reaction conditions. In this 
work, chiral tertiary benzylic boronic esters were generated from the corresponding vinyl 
arene substrates. At the same time, the work described in Chapters 2-5 of this dissertation 
were also in progress (vide infra).  
 
Figure 1.16: Takacs' oxime-directed catalytic asymmetric hydroboration (Adapted with 
permission from Ref. 30. Copyright 2019 Wiley-VCH Verlag GmbH & Co. KGaA, 
Weinheim).20,30 
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1.4. Stereospecific transformations of chiral tertiary boronic esters 
As discussed earlier in this chapter, the  development of methods for the enantioselective 
synthesis of chiral tertiary boronic esters has received considerable attention over the past 
decade. Section 1.2 and 1.3 of this chapter summarized the different catalytic methods 
available for the enantioselective construction of chiral tertiary boronic esters. Alongside 
the development of methods for efficient synthesis of chiral tertiary boronic esters, 
significant research has been also devoted to the development of methods for their 
stereospecific functionalization to prepare other useful molecules. This section reviews the 
transformations that are currently available for stereospecific functionalization of chiral 
tertiary boronic esters.  
 Chiral tertiary alcohols are important molecules in medicinal chemistry. The 
presence of a tertiary alcohol functionality adds polarity to a molecule and hence increases 
water solubility. Moreover, the steric hindrance around the tertiary alcohol functionality 
makes them essentially non-nucleophilic and non-oxidizable; hence, non-reactive in 
biological systems. The stereospecific oxidation of a chiral tertiary boronic ester efficiently 
yields the corresponding alcohol. Common oxidation conditions often employed are a 
combination of H2O2 and NaOH, generating the hydroperoxide anion in-situ, or use of 
NaBO3.4H2O; the latter is considered to be milder oxidation conditions. The mechanism 
of oxidation involves formation of the boron-ate complex with the hydroperoxide anion 
which undergoes a 1,2-migration to form the C-O bond and the subsequent hydrolysis of 
the O-B to an O-H bond completes the reaction (Figure 1.17). Oxidation of chiral tertiary 
boronic esters to the corresponding chiral tertiary alcohols is perhaps the most widely used 
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transformation and generally occurs with complete retention of configuration at the 
migrating carbon.  
 
Figure 1.17: Oxidation of chiral tertiary boronic esters to form chiral tertiary alcohols.  
 
Chiral tertiary amines have found important applications in asymmetric catalysis 
either as chiral bases for enantioselective deprotonation reactions or for forming 
diastereomeric complexes for resolving mixtures of chiral acids.46 Chiral amines are also 
highly prevalent in several bioactive molecules including many pharmaceutical drugs and 
drug candidates. The first report of converting chiral tertiary boronic esters into chiral 
tertiary carbinamines via stereospecific C-B to C-N transformation was reported by 
Aggarwal and co-workers in 2011 (Figure 1.18).47  In Aggarwal’s methodology, a chiral 
tertiary boronic ester was first transformed into a chiral tertiary trifluoroborate salt. The 
salt reacts with SiCl4 to generate the highly electrophilic alkyl dichloroborane in-situ. 
Subsequent reaction with an alkyl-azide forms the boron-ate complex which undergoes 
facile 1,2-B-to-N migration; aqueous workup generally affords the chiral tertiary 
carbinamine in excellent yield with high levels of stereoretention. Generation of the chiral 
dichloro-organoborane intermediate is required because boronic esters are not electrophilic 
enough to undergo ate-complex formation with alkyl azides. This reaction has been carried 
out in an intramolecular fashion and can be applied to non-benzylic chiral tertiary boronic 
esters as well. However, the utility of this transformation can be limited by the harsh 
conditions required.  
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Figure 1.18: Amination of chiral tertiary boronic esters to form chiral tertiary 
carbinamines.  
  
Morken reported in 2018 a direct stereospecific transformation of chiral boronic 
esters to carbinamines via treatment with methoxyamine and potassium tert-butoxide 
(Figure 1.18).48 Mechanistically, methoxyamine is proposed to add to a tertiary boronic 
ester to form a boron-ate complex and the potassium tert-butoxide deprotonates the 
amination reagent once the nitrogen is acidified via coordination to the boron center. The 
boron-ate complex then undergoes 1,2-B-to-N migration with the loss of methoxide with 
subsequent workup to form the tertiary carbinamines. A few challenging substrates 
including a chiral tertiary boronic ester bearing tertiary substituent such as an isopropyl 
group can be efficiently converted to the corresponding amine using this methodology. The 
major limitation of this methodology is the formation of high degree of non-stereospecific 
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protodeboronation side products which are obtained with chiral tertiary benzylic boronic 
esters.  
 Stereospecific C-B to C-H (or C-D) bond substitution can be used with chiral 
tertiary boronic esters to enable facile access to chiral tertiary stereogenic centers.49 
Aggarwal’s group showed that bis-benzylic boronic esters undergo protodeboronation 
using CsF and H2O in dioxane at 30 
oC (Figure 1.19). Mechanistically, the TBAF.3H2O 
mediated protodeboronation reaction is proposed to occur via a hydrogen-bonded boron-
ate intermediate which delivers the proton from the same side as that of the boron atom. 
The main driving force for this transformation is the formation of stronger B-F bonds. 
Monoaryl tertiary boronic esters required more activated conditions for protodeboronation, 
however, TBAF.3H2O has been used for their efficient protodeboronation. Unfortunately, 
non-benzylic boronic esters have thus far not been found to efficiently undergo 
protodeboronation in the presence of a F- source; forcing conditions instead lead to 
homolytic cleavage of the C-B bond and loss of stereochemistry.  
 
Figure 1.19: Stereospecific proto/deutero-deboronation of chiral tertiary boronic esters. 
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Zweifel and coworkers reported the formation of a single alkene isomer from a 
borane starting material via addition of iodine to alkenyl dialkylborane in 1967.50 Building 
upon Zweifel’s work, Aggarwal investigated the use of iodine promoted 1,2-migration to 
achieve stereoselective synthesis of chiral centers attached to alkenes. Upon subjecting 
chiral tertiary boronic esters to Zweifel’s olefination conditions, Aggarwal’s group found 
that vinylmagnesium bromide adds three times to the boronic ester to form the 
corresponding boron-ate complex. Subsequent treatment of this boron-ate intermediate 
with I2 and MeONa/MeOH results in the overall substitution of the boronic ester with a 
vinyl group (Figure 1.20).51  
 
Figure 1.20: Stereospecific vinylation of chiral tertiary boronic esters. 
 
 An extension of the vinylation conditions described above was reported for the 
transformation of a chiral tertiary boronic ester into the corresponding methyl-ketone 
(Figure 1.21).52 In this transformation, ethoxyvinyl lithium (generated via treatment of 
ethyl-vinyl ether with tBuLi) adds to the boronic ester to form a boron-ate complex which 
upon subsequent treatment of I2 forms the iodonium ion intermediate facilitating the 1,2-
metallate rearrangement. Subsequent treatment with MeONa and MeOH leads to the 
26 
 
overall substitution of the tertiary boronic ester to the ethoxy-vinyl intermediate. 
Subsequent hydrolysis of the ethyl-vinyl ether leads to the formation of the methyl ketone.  
 
Figure 1.21: Stereospecific transformation of chiral tertiary boronic esters to methyl 
ketones. 
 
Direct extension of the olefination protocol for stereospecific transformation of 
chiral boronic esters to alkynes is challenging. The challenge results in part due to the 
reversible reaction of the lithiated alkyne with the boronic ester. Under such circumstances, 
competing addition of a subsequently added electrophile (e.g., I2) results in addition of the 
iodine across the alkyne instead of inducing the desired 1,2-metallate rearrangement.53 The 
Aggarwal group reported a two-step protocol for the stereospecific transformation of a 
chiral tertiary boronic ester into an alkyne functionality via the following sequence: 
stereospecific olefination with a lithiated vinyl carbamate followed by subsequent 1,2-
elimination from the intermediate using tert-butyl lithium to afford the alkene product 
(Figure 1.22).54 Their reported stereospecific alkynylation of chiral tertiary boronic esters 
is highly efficient; products can be obtained in excellent yields and with essentially 
complete enantiospecificity.  
 
Figure 1.22: Stereospecific alkynylation of chiral tertiary boronic esters. 
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 Homologation of a chiral tertiary boronic ester by one or more carbon units allow 
facile chain extension while retaining the boronic ester functionality for further reactions. 
The Aggarwal group developed several procedures for stereospecific homologation of 
chiral tertiary boronic esters (Figure 1.23).52 Treatment of a chiral tertiary boronic ester 
with dichloromethyl lithium followed by oxidation is frequently used to transform a 
boronic ester to an aldehyde functionality (Figure 1.23A).52 A similar reaction with 
bromomethyl lithium leads to the homologation to a boronic ester extended by one carbon 
atom. The product after homologation is a quaternary all-carbon stereocenter bearing a 
primary boronic ester unit (Figure 1.23B).52  
 
Figure 1.23: Homologation reactions of chiral tertiary boronic esters 
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 Aggarwal’s group a developed two-carbon homologations using chiral lithiated 
reagents to form a new chiral secondary boronic ester with two contiguous chiral centers 
in one molecule (Figure 1.23C).55 The homologation methodology has been extended for 
three-carbon homologations using lithiated allyl chlorides.56 The secondary allyl-boronic 
ester products are formed in excellent yields and enantiospecificity (Figure 1.23D). These 
methodologies have been extended to the synthesis of molecules bearing contiguous 
quaternary carbon stereocenters as well (Figure 1.23E).57 Although the 1,2-B-to-C 
migration did not occur with the tertiary boronic ester, the reaction proceeds with the mixed 
borane (derived after treatment of the neopentyl glycol boronic ester with methyl 
magnesium bromide) to afford the tertiary alcohol after oxidation. 
 Cross-couplings reactions of chiral tertiary boronic esters have also received 
significant attention in recent years.  Several of these methods lead to the formation of 
quaternary carbon stereocenters. Chiral tertiary trifluoroborate salts undergo facile addition 
reactions with electron-deficient aldehydes (e.g. 4-nitrobenzaldehyde) in the presence of 
[Rh(cod)Cl]2 through a stereoretentive pathway.
58 The retention of configuration is 
explained by assuming rhodium acting as a Lewis-acid to simultaneously coordinate both 
the aldehyde and the boronic ester and facilitate the C-C bond formation (Figure 1.24). 
Initial addition leads to the formation of a 1:1 mixture of the secondary alcohol product, 
oxidation of which generates the aryl ketone in excellent yield and high degree of 
enantiospecificity. 
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Figure 1.24: Stereospecific addition of tertiary trifluoroborate salts to aldehydes 
 
In 2014, Aggarwal published the transition metal-free cross-coupling of chiral 
tertiary boronic esters with electron-rich 5- and 6-membered aromatic rings (Figure 1.25).3 
Mechanistically, a lithiated aromatic ring (generated via lithium-halogen exchange or via 
C-H lithiation) is added to a chiral tertiary boronic ester to form the corresponding boron-
ate complex. The latter subsequently undergoes electrophilic aromatic substitution (EAS) 
with an appropriate electrophile to generate a stabilized cation. The cation then triggers the 
1,2-B-to-C migration and after elimination gives the corresponding cross-coupled product. 
This transformation can be carried out using 5-membered or 6-membered electron-rich 
aromatic rings in excellent yields and enantiospecificity, but thus far has been limited to 
electron rich aromatics.  
Modifications of the Aggarwal transition metal-free cross-coupling methodology 
continue to expand its scope for certain desirable cross-coupling partners. For example, 
coupling with common nitrogen heterocycles (e.g. pyridines) was recently been shown to 
be possible. An initial boron-ate-complex is formed by the addition of lithiated pyridines. 
Acylation of the nitrogen using Troc-Cl then facilitates the 1,2-metallate rearrangement.59 
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Oxidation of the resulting boronic ester enables rearomatization affording the coupled 
product (Figure 1.26A).  
 
Figure 1.25: Stereospecific coupling of chiral tertiary boronic esters with 5- and 6-
membered electron rich aromatic rings.  
 
Figure 1.26: Stereospecific coupling of chiral tertiary boronic esters with N-
heteroaromatic compounds and with phenyl acetylenes.  
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 A conceptually similar approach was developed for the cross-coupling with 
lithiated phenylacetylenes.60 In this transformation, the alkyne functionality of the 
intermediate boron-ate complex reacts with NBS (similar to the strategy used for electron 
rich aromatics) triggering the 1,2-migration to form a dearomatized bromoallene 
intermediate. With neopentyl glycol-derived boronic esters, subsequent elimination and 
rearomatization occurs giving rise to the cross-coupled products. With pinacol-boronates, 
however, the boron migrates to the adjacent carbon resulting in the formation of ortho-
boron incorporated products.  
Very recently Aggarwal’s group published reports on stereospecific cross-
couplings of chiral tertiary boronic esters with dilithio-phenolate species and lithiated aryl 
hydrazines for stereospecific transformation of a boronic ester to a phenol or aniline 
functionality (Figure 1.27).61,62 In case of the cross-coupling with a dilithiophenolates, a 
tertiary boronic ester after undergoing ate-complex formation undergoes reaction with 
Martin’s sulfurane or Ph3BiF2 which triggers the 1,2-B-to-C migration resulting in the 
formation of the cross-coupled products with high levels of stereospecificity.61 In a 
conceptually similar transformation with lithiated aryl hydrazines, the intermediate boron-
ate complex undergoes acylation at the terminal nitrogen which triggers a N-N bond 
cleavage along with a 1,2-metallate rearrangement.62 Subsequent workup results in the 
cross-coupled aniline product.  
This section summarized the stereospecific transformations known for chiral 
tertiary boronic esters in the present literature (as of June 2019). Several of these 
stereospecific transformations are based on variations of the original Matteson’s 1,2-
metallate rearrangement. Efficient utility of the latter has been used on a variety of contexts 
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particularly for the stereospecific cross-coupling reactions with chiral tertiary boronic 
esters. As stereospecific transformations continue to evolve, the subsequent synthetic 
utility of chiral tertiary boronic esters is on the rise.  
 
Figure 1.27: Stereospecific coupling of chiral tertiary boronic esters with dilithio-
phenolates and lithiated aryl hydrazines to phenols or anilines.  
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1.5. Introduction to the phosphonate-functionality: biological relevance and directing 
properties 
Phosphonates and their corresponding phosphonic acids are organophosphorus compounds 
containing a C-P(OR)2 in which R can be alkyl, aryl or H. These closely approximate the 
structures of the corresponding phosphates, yet include a hydrolysis resistant C-P linkage.63 
Figure 1.28 shows the selected examples of important bioactive phosphonates or 
phosphonic acids of high relevance in human health and in agriculture. Fosfomycin 
(Monurol) is a broad spectrum antibiotic that concentrates in kidney and bladder and is 
used to treated urinary tract infections. It was initially isolated from the broth cultures of 
Streptomyces fradiae in 1969, however, it is presently accessed predominantly via 
chemical synthesis. Glyphosate (N-phosphonomethylglycine) is a broad spectrum 
herbicide and a crop desiccant which was brought into market for agricultural use in 1974 
by Monsanto under the trade name Roundup. Zoledornate and phosphonoformate 
(Foscarnet) are analogs of pyrophosphate and are used to treat osteroporosis and herpes, 
respectively. Zoledornate also exhibits anticancer activity. Perzinfotel is an analog of N-
methyl-D-aspartate (NMDA) and thus acts as an antagonist towards NMDA receptors. 
Tenofivir is sold under the drug name Viread and is marketed by the biotech company 
Gilead Sciences and was approved by the U.S. FDA for treatment of HIV on October 26, 
2001 and on August 11, 2008 for chronic hepatitis B.64 Upon dephosphorylation in the cell, 
Tenofovir acts as an inhibitor of viral reverse transcriptase by mimicking deoxynucleotide 
triphosphates. It is listed by the World Health Organization (WHO) as an essential 
medication for the treatment of HIV and Hepatitis B.  
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Figure 1.28: Selected examples of bioactive phosphonates  
 
The 2019 ACS National meeting in Orlando FL had a session named "First-time 
Disclosure of Clinical Candidates" by the Division of Medicinal Chemistry which showed 
glimpses of drug-candidate structures not previously made public.65 C&EN made a cover 
story on this topic; two of the eight structures made public at ACS Orlando contained 
phosphonic acid functionality. AB680 is a derivative of methylene diphosphonic acid is a 
checkpoint inhibitor developed by Arcus Biosciences for the treatment of cancer. 
Checkpoint inhibitors successfully disrupt the binding interaction between a protein and a 
checkpoint protein that stops immune T-cells from killing cancer cells. This results in 
checkpoint inhibitors turning immune cells loose to attack tumor cells. LHC165 features a 
difluorophosphonate and it has been developed by Novartis Research Foundation for the 
treatment of solid tumors. LHC165 is developed as a vaccine adjuvant, molecules that 
switch on the immune system to enhance a vaccine’s effect. It activates toll-like receptor 
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(TLR7) and triggers the release of infection-clearing proteins. It was subsequently tested 
for its effectiveness in immuno-oncology.   
In organic synthesis, phosphonates are routinely employed as components of 
Horner-Wadsworth-Emmons olefination for the synthesis of stereodefined alkenes (Figure 
1.29A). In addition, although used less frequently, thiophosphonates can also be used for 
carrying out olefination.66 While β-hydroxyphosphonates are stable isolable molecules, the 
corresponding β-hydroxy thiophosphonates readily undergo elimination to afford alkenes 
(Figure 1.29B) . Yet another common utility of the phosphonate-functionality is in the 
context of active esters in α-oxophosphonates.67 Acylphosphonates are considered analogs 
of acid chlorides and active esters. These are excellent electrophiles that react with a variety 
of nucleophiles resulting in the formation of various substitution products. For example, 
substitution reactions with alcohols and amines with α-oxophosphonates result in 
formation of esters and amides (Figure 1.29C). These are some of the key reactions that 
will be discussed later in this dissertation.  
Recently, phosphonates have been elegantly utilized as directing groups in aryl C-
H functionalization reactions (Figure 1.30). For example, Kim and others have explored 
the utility of benzylic phosphonic monoesters for the selective ortho C-H functionalizations 
using a Pd(II)-catalyst (Figure 1.29A). The directing group positions the metal to the ortho-
position and subsequently a Heck-type reaction leads to the formation of a C-C bond. A 
similar transformation has also been reported with aryl phosphonates in a rhodium-
catalyzed reaction (Figure 1.29B).68,69 Maiti and coworkers developed meta C-H 
functionalization reactions using a cyanophenol-based directing group linked with a benzyl 
phosphonate (Figure 1.29C).70 The reaction is proposed to go through a 11-membered 
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palladacycle stabilized by the cyanide functionality. Subsequent reductive elimination and 
C-C bond formation results in the meta C-H functionalization of such systems.  
 
Figure 1.29: Utility of the phosphonate-functionality in organic synthesis.   
 
   
Figure 1.30: Phosphonate-directed aryl C-H functionalizations.  
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  As discussed briefly above, the Takacs research group is actively engaged in 
preparing multifunctional chiral boronic esters via rhodium-catalyzed, directed catalytic 
asymmetric hydroboration (CAHB) of functionalized alkene substrates capable of two-
point binding (i.e., chelation). For example, efficient amide directed CAHB resulted in the 
highly selective synthesis of chiral β-,γ- and δ-borated amide derivatives. Replacing the 
amide-functionality with an oxime-directing group led to the unprecedented, ligand-
controlled regiodivergent access to chiral boronic esters by CAHB.  
Encouraged by the success of the amide- and oxime-directing groups, and the 
literature precedents set by other groups for the efficient utility of phosphonates as directing 
groups for novel modes of C-H activation, we set out to explore the potential effectiveness 
of the phosphonate-functionality as a directing group in CAHB. We envisioned that a 
successful phosphonate directed CAHB would result in access to a new class of chiral 
molecules, chiral borylated phosphonates, which would enable new possibilities as chiral 
synthons. We further imagined that chiral borated phosphonates would be easily converted 
to chiral hydroxyphosphonates. Hydroxyphosphonates are known in drug candidates and 
enzyme inhibitors and in particular, β-hydroxyphosphonates mimic the corresponding β-
hydroxy carboxylic acids and amino acids.71 Our research into phosphonate-directed 
CAHB, as well as the chemistry of the functionalized phosphonate products will be 
discussed in Chapters 2-4.  
 
1.6. Summary 
In summary, this chapter covered a brief introduction to chiral boronic esters: their 
synthetic, biological and medicinal relevance. In addition, this chapter entailed a 
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comprehensive coverage of the reported methods of enantioselective synthesis of chiral 
tertiary boronic esters and their stereospecific transformations known in the literature to 
date (June 2019). Several of these stereospecific transformations are based on the 
Matteson’s 1,2-metallate rearrangement. Efficient utility of the latter has been used on a 
variety of contexts particularly for the stereospecific cross-coupling reactions with chiral 
tertiary boronic esters. An introduction to the phosphonate functionality highlighting their 
biological relevance and directing properties, and the initial goals behind the development 
of phosphonate-directed catalytic asymmetric hydroboration were covered in this chapter 
as well.  
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CHAPTER TWO: PHOSPHONATE-DIRECTED CATALYTIC ASYMMETRIC 
HYDROBORATION OF DISUBSTITUTED VINYL ARENES 
2.1. Metal-catalyzed CAHB of 1,1-disubstituted (methylidene) vinyl arenes: results 
with iridium, cobalt and copper catalysts 
The substrate class of 1,1-disubstituted (methylidenes) alkenes has been widely explored 
in the field of CAHB. However, achieving high levels of enantioinduction in this substrate 
class has been historically challenging owing to the inability of a chiral reagent or catalyst 
to effectively discriminate between the enantiotopic faces of such barely prochiral 
substrates. Recent catalyst developments for efficient CAHB of 1,1-disubstituted vinyl 
arenes have focused on using iridium, cobalt or copper with pinacolborane (pinBH) or 
pinacol diborane (B2pin2). Boron delivery occur at the less substituted carbon atom of the 
alkene (Figure 2.1). For example, the Hoveyda group developed a NHC(L1)-Cu catalyzed 
enantioselective net protoboration of α-methyl styrene derivatives (Fig. 2.1 A).1 This 
transformation is proposed to occur via an initial borocupration of the alkene which results 
in boron delivery to the less substituted terminus of the alkene and that of copper delivery 
to the more substituted benzylic site. The benzyl-copper intermediate eventually undergoes 
protonolysis to form the final product and the copper-catalyst re-enters the catalytic cycle. 
The Mazet group developed an iridium-catalyzed CAHB of similar substrates using 
pinacolborane (Fig. 2.1 B).2 The active catalyst is formed in situ via the combination of the 
iridium-precatalyst [Ir(OMe)(cod)]2 and the P,N-bidentate ligand L2. Terminal 
regioselectivity leading to β-chiral primary boronic esters were formed. Similar 
regioselectivity is also observed under conditions developed by Huang group (Fig. 2.1 C) 
wherein the cobalt complex C1 bearing bulky chiral oxazoline pyridine mediates the  
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Figure 2.1. Selected examples of transition-metal catalyzed CAHB of methylidene vinyl 
arenes. 
 
reaction.3 In yet another case of cobalt catalyzed CAHB of α-methyl styrene derivatives, 
Lu disclosed the possibilities of forming enantiomers of the product by simply changing 
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the nature of the chiral oxazoline ligand moiety (Figure 2.1 D).4 Depending on whether the 
active catalyst is formed via the more flexible amine group (L3) or the rigid imino group 
(C2), catalysis occurs under mechanistically distinct pathways affording the enantiomeric 
products. Yet another remarkable example of copper-catalyzed CAHB of 1,1-disubstituted 
vinyl/bisvinyl arenes was developed by the Xiong group (Figure 2.1 E).5 The bidentate 
ligand L4 with a smaller bite angle in conjugation with a copper precatalyst was used for 
efficient net protoboration in this case.  
 
2.2. Development of Rh-catalyzed, directed-CAHB of methylidene vinyl arenes: 
comparison of amide, oxime and phosphonate-directing groups6 
The Takacs group has been exploring the rhodium-catalyzed, directed CAHB of 
functionalized alkene substrates with the goal of obtaining multifunctional, chiral boronic 
ester synthons. Several factors influence the regio and stereochemical outcomes of these 
reactions. For instance, the nature of the directing group, the alkene substitution pattern, 
the alkene substituent and the chiral ligand all play pivotal roles. The directed-CAHB of 
functionalized alkenes is catalyzed by a chiral rhodium catalyst prepared in-situ from a 
combination of a commercially available rhodium precatalyst such as Rh(nbd)2BF4 and a 
TADDOL- or BINOL-derived chiral cyclic phosphite or phosphoramidite. Alternatively, 
the rhodium-precatalyst can be generated in-situ using a combination of [Rh(cod)Cl]2 and 
AgBF4 in a 1:2 ratio; this precatalyst can be effectively used as a substitute for the 
commercially available precatalyst Rh(nbd)2BF4. The latter method is more economical. 
Furthermore, we also find that the TADDOL- and BINOL-derived chiral ligands are highly 
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complementary in their effectiveness, their efficiency hinges, in part, on the substrate’s 
alkene substitution pattern.  
Using the TADDOL-derived phosphite (R,R)-T1 in combination with a Rh-
precatalyst, the amide and oxime-directed CAHB of β-aryl, β,γ-unsaturated vinyl arene 
substrates 1 and 3 results in boration at the less substituted terminus of the alkene, affording 
functionalized γ-borated products (S)-2 (71%, 96.5:3.5 er) and (R)-4 (70%, 95:5 er), 
respectively (Fig. 2.2).7 The regiochemical outcomes for amide- and oxime-directed 
CAHB are similar to those obtained using iridium, cobalt or copper catalysts (Sec. 2.1), 
that is, boron addition occurs at the less substituted terminus of the alkene for methylidene 
substrates bearing at least one aryl substituent.  
Incorporating a phosphonate-functionality in otherwise similar β-aryl (or 
heteroaryl) substituted methylidene substrates leads to boron delivery predominantly to the 
more substituted carbon of the alkene undergoing reaction.6 For example, substrate 5a 
undergoes efficient CAHB using the TADDOL-derived chiral cyclic phosphite (R,R)-T1 
to yield chiral tertiary benzylic boronic ester (R)-6a (80%, 95:5 er) as the major product. 
This result constitutes the first reported example of boron delivery to the more substituted 
carbon atom of an aryl substituted methylidene in the literature. Although the 
regioselectivity is opposite to that for the amide- and oxime-directed CAHB reactions, the 
sense of stereochemistry remains the same, that is, B-H adds to the si-face (top-face in the 
perspective shown in Figure 2.2) of the alkene.  
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Figure 2.2. Directed CAHB of methylidene vinyl arenes: Comparison of amide, oxime and 
phosphonate-directing groups. (Adapted with permission from Ref. 6. Copyright 2018 
American Chemical Society) 
 
While 6a is the major product obtained in the CAHB of phosphonate-functionalized 
substrate 5a, the reaction leads to a distribution of products. The minor regioisomer 6a' 
(13%, 92:8 er) and the alkene reduction product 6a" (3-5%, racemate) are also formed 
under the reaction conditions. The minor regioisomer 6a' is formed with the same sense of 
π-facial selectivity as that of the major regioisomer 6a. This outcome contrasts results with 
what was observed from our previous studies where we found that a change in 
regioselectivity is usually coupled with a change in π-facial selectivity under the typical 
CAHB conditions.8 The alkene reduction product 6a" is formed in trace quantities under 
CAHB conditions and its formation is a subject of ongoing studies.9 Its formation as a 
racemate implies its origin from a competing catalytic cycle and is believed to occur in the 
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presence of adventitious moisture. From our studies, we have found that the amount of 
alkene reduction product also varies between different substrate classes and is significantly 
dependent on the nature of borane as well (See Chapter 5: Ligand screening data). For 
instance, using tmdBH for the phosphonate-functionalized substrate 5a, significant 
amounts (ca. >40%) of the reduction side product is obtained. 
 
2.3. Experimental data probing into the origin of unusual regioselectivity observed6 
The contrasting regiochemical results obtained with the phosphonate-functionalized 
methylidene vinyl arene substrate 5a naturally raises the question as to whether the 
phosphonate-directing group is solely responsible for the observed β-boration 
regiochemistry leading to chiral tertiary boronic esters. This does not appear to be the case. 
We have carried out CAHB reactions on several analogs of 5a to obtain information 
regarding the influence of the directing group, the nature of the alkene substituent and that 
of the distance between the directing group and the alkene in the overall regiochemistry 
observed. Substrates bearing ortho- substituted phenyl groups (e.g. 5b and 5c) lead to a 
complete reversal of regioselectivity (Figure 2.3).  
 In these cases, CAHB occurs with predominant γ-boration leading to chiral 
primary boronic esters 6b (82%, 78:22 er) and 6c (80%, 74:26 er) in exclusive 
regioselectivity but poor levels of enantioinduction under the reaction conditions. The 
alkene reduction product accounts for the majority of the mass balance in these two cases. 
While the regioselectivity changes, the sense of π-facial selectivity obtained from 
substrates 5b and 5c (i.e., top-face) is similar to that obtained from the phenyl substituted 
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parent substrate 5a. We speculate that ortho substitution results in regioselectivity reversal 
because of the increased steric hindrance for boration at the β-position.  
 
Figure 2.3. Variations in regioselectivity observed for some methylidene substrates. 
Standard CAHB conditions: 1 mol% Rh(nbd)2BF4, 1 mol% (R,R)-T2, pinBH, rt. 3-12 h. 
Note: Yields and er’s were determined after oxidation to the corresponding alcohols. 
(Adapted with permission from Ref. 6. Copyright 2018 American Chemical Society) 
  
Substrate 7 is similar to 5 except that the substituent at the β-position is an alkyl 
rather than an aryl group (i.e., benzyl vs. phenyl). Under standard CAHB conditions, 
substrate 7 leads to the formation of the γ-borated product (R)-8 (71%, 88:12 er) as the 
major product. Formation of the chiral primary boronic ester 8 occurs via predominant si-
face (top-face in the perspective shown). The minor regioisomer 9 (12%) along with traces 
of the alkene reduction product accounts for majority of the mass balance in the CAHB of 
alkyl-substituted substrate 7.  
The CAHB results obtained from substrate 7 indicates the need for an aryl 
substituent at the β-position for the observed regiochemistry in 5a. To probe into the role 
of proximity of the phosphonate-functionality in directing the course of the reaction, we 
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subjected substrate 10, the one carbon homologue of 5a to standard reaction conditions. 
Unlike the high levels of regioselectivity (5:1) obtained for substrate 5a, the homologous 
substrate 10 affords a 1:1 mixture of the two possible regioisomers with neither regioisomer 
exhibiting high levels of enantioselectivity. Therefore, the results compiled in figure 2.4 
indicate that the phosphonate group, as well as its disposition relative to the alkene and the 
nature of the alkene substituent (i.e., the need for conjugation) combine to control the regio 
and enantioselectivity observed in phosphonate-directed CAHB of 1,1-disubstituted vinyl 
arenes.  
It can be noted, that for most of the chiral borated phosphonates, the overall polarity 
of the molecule is due to the phosphonate functionality. Therefore, separation of 
regioisomeric boronic esters prove difficult in several cases. The isolation of the chiral 
boronic esters from the minor regioisomers or the alkene reduction products were difficult 
for examples shown in Figure 2.3. Oxidation of the purified hydroboration mixture results 
in a mixture of regioisomeric alcohols and the alkene reduction side product which are 
easily separable from each other. The yields and the corresponding enantiomer ratios for 
the compounds in Figure 2.3 were obtained after oxidation to the corresponding alcohols. 
 
2.4. Mechanistic insights into phosphonate-directed CAHB of 1,1-disubstituted vinyl 
arenes 
The results presented in section 2.3 revealed the crucial role of several structural 
components of the allyl phosphonate substrate 5a that leads to the observed β-boration 
regiochemistry in CAHB. The identified factors that results in the observed regiochemistry 
forming chiral tertiary boronic esters are (1) the unique directing ability of the phosphonate 
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functionality, (2) the need for conjugation at the β-position of the methylidene substrate 
undergoing reaction, (3) lack of substitution at the ortho-position of the aromatic ring 
attached to the alkene, and (4) the appropriate positioning of the directing group with 
respect to the alkene for efficient chelation to the chiral rhodium catalyst. If any of these 
factors is not satisfied in the substrate, then boron is not delivered to the more substituted 
position of the alkene in the event of CAHB. We carried out deuterium labelling 
experiments using pinBD for CAHB of 5a to systematically probe into the mechanism of 
the reaction.  
Deuterium incorporation into substrate was found when a CAHB mixture of 5a and 
pinBD was quenched before complete reaction (ca. after 5 minutes into the reaction) with 
methanol (Figure 2.4). 2H-NMR and HRMS analyses of the crude CAHB mixture helped 
identify the monodeuterated species (Z)-3-d-5a and (E)-3-d-5a that were formed in roughly 
a 1:1 ratio. The dideuterated species 3,3-d2-5a was not observed. We have considered two 
mechanistic scenarios for the incorporation of deuterium in substrate (Figure 2.4). Pathway 
1 considers migratory insertion of the alkene to Rh-D forming a 3o-benzyl rhodium 
intermediate Im-1. The latter subsequently undergoes β-H elimination to form (Z)-3-d-5a 
and (E)-3-d-5a. Pathway 2 is another mechanistic possibility suggested by our colleague 
Moraiah Locklear. Pathway 2 considers the possibility of a directed C-H insertion of the 
rhodium complex at the γ-position to form Im-2.10 Subsequent C-D reductive elimination 
from Im-2 should lead to the formation of (Z)-3-d-5a. This pathway, however, cannot 
explain the formation of (E)-3-d-5a. Since we get a 1:1 mixture of the isomeric deuterium 
incorporated products (Z)-3-d-5a and (E)-3-d-5a, the dominant pathway for incorporation 
of deuterium in the substrate is most likely pathway 1. Deuterium incorporation data 
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implies that (1) the alkene coordination and borane oxidative addition to the chiral rhodium 
catalyst are reversible, and (2) deuterium incorporation into the substrate followed by 
substrate decomplexation and the reductive elimination of borane from the rhodium 
catalyst  generates pinBH. The in-situ generated pinBH in the event of deuterium 
incorporation into substrate further is confirmed by the identification of products formed 
from pinBH incorporation to substrate.  
 
Figure 2.4: Deuterium incorporation seen in substrate under standard CAHB conditions. 
  
Deuterium incorporation into substrate was further verified when the products 
obtained from the CAHB/oxidation of 5a with pinBD (a 2:1 ratio of the regioisomeric 
alcohols 13a and 13a' was obtained) were analyzed using a combination of 1H, 2H, 13C, 
13C-DEPT135 NMRs and HRMS techniques (Figure 2.5). Analysis of the chiral tertiary 
alcohol product 13a (obtained via oxidation of the tertiary boronic ester 6a) enabled 
identification of three different species with varying levels of deuterium incorporation: (1) 
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the non-deuterated product 13a (18%), (2) the mono-deuterated product 3-d-13a (74%), 
and (3) the dideuterated product 3,3-d2-13a (8%). The non-deuterated product 13a is 
thought to form via CAHB of 5a with pinBH followed by oxidation (the latter generated 
in-situ from reversible pinBD addition to the alkene followed by substrate decomplexation 
and reductive elimination of pinBH). The mono-deuterated product 3-d-13a is expected to 
form via CAHB of 5a with pinBD followed by oxidation, or via CAHB of (E/Z)-3-d-5a 
with pinBH (generated in-situ) followed by oxidation. The dideuterated product 3,3-d2-
presumably arises from the CAHB of (E/Z)-3-d-5a with pinBD followed by oxidation.  
 
Figure 2.5: Different levels of deuterium incorporation observed in the major (tertiary) 
alcohol product obtained via CAHB of 5a with pinBD followed by oxidation 
 
Analysis of the minor regioisomeric primary alcohol product formed via 
CAHB/oxidation of 5a with pinBD also shows varying levels of deuterium incorporation 
(Figure 2.6). A total of four species were identified: (1) the non-deuterated product 13a' 
(21%), (2) the mono-deuterated product 2-d-13a' (60%), (3) the mono-deuterated product 
3-d-13a' (9%), and (4) the dideuterated product 2,3-d2-13a' (10%). The non-deuterated 
product 13a' arises via CAHB of 5a with pinBH (generated in-situ from H/D exchange of 
the substrate) followed by oxidation. The monodeuterated product 2-d-13a' is presumably 
formed via CAHB of 5a with pinBD followed by oxidation. However, the monodeuterated 
product 3-d-13a' is formed via CAHB of (E/Z)-3-d-5a with pinBH (generated in-situ) 
followed by oxidation. The dideuterated product arises via CAHB of (E/Z)-3-d-5a with 
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pinBD followed by oxidation. The different levels of deuterium incorporation in the minor 
(primary) alcohol product formed via CAHB of 5a with pinBD followed by oxidation 
further confirm the initial incorporation of deuterium in the starting material and thus 
support the reversibility of initial Rh-(H/D) addition to the substrate as well as reversibility 
of pinB(H/D) oxidative addition to the chiral rhodium catalyst.  
 
Figure 2.6: Different levels of deuterium incorporation observed in the minor (primary) 
alcohol product obtained via CAHB of 5a with pinBD followed by oxidation 
 
The results of double labelling experiments11 carried out by our former colleague 
Dr. Sean M. Smith also support a mechanism of Rh-catalyzed CAHB consistent with 
oxidative addition of borane the metal center. Oxidative addition of B-H bonds to Rh-
complexes have been experimentally supported and the complexes resulting from oxidative 
addition have been isolated and characterized.12 Based on this data and the results obtained 
using deuterium labelling experiments, a mechanism explaining the formation of chiral 
tertiary boronic esters via phosphonate-directed CAHB of methylidene vinyl arene 
substrates such as 5a is proposed in Figure 2.7. The proposed mechanism begins with the 
cationic TADDOL-ligated rhodium complex undergoing oxidative addition with pinBH to 
form Im-1. This step is expected to be reversible based on the data obtained from deuterium 
labelling experiments. Im-1 undergoes substrate coordination via a two-point binding (i.e., 
chelation) with the phosphonate as well as the alkene undergoing reaction to form Im-2. 
Im-2 undergoes migratory insertion into the Rh-H bond to form Im-3 which features a 3o-
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alkyl rhodium intermediate (η1 σ-benzyl complex). Im-3 is expected to be in equilibrium 
with its corresponding η3 π-benzyl complex, the formation of which explains the 
regioselectivity observed with vinyl arenes.20 Im-3 can undergo β-H elimination to go back 
to Im-2 or it can undergo reductive elimination of C-B bond to form the chiral tertiary 
boronic ester product and the catalyst re-enters the catalytic cycle. The reductive 
elimination step is expected to be rate-determining as other steps in the catalytic cycle are 
reversible. 
 
Figure 2.7: Proposed mechanism explaining formation of chiral tertiary boronic esters via 
phosphonate directed CAHB of methylidene vinyl arenes.  
  
The mechanism proposed in Figure 2.7 is consistent with the deuterium labelling 
experiments and suggests that migratory insertion of the C=C bond to a Rh-H/D bond 
occurs first in the catalytic cycle. This can explain the insertion of deuterium into a 
substrate via initial addition to a Rh-D bond followed by β-H elimination to form a Rh-H 
intermediate. However, this mechanism requires invoking a sterically congested tertiary-
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alkyl rhodium intermediate. An alternative mechanistic proposal was along the lines of 
alkene insertion into a Rh-B occurring first to construct the tertiary boronic ester, followed 
by reductive elimination to construct the C-H bond at the γ-position. However, deuterium 
labelling experiments suggested this is not in fact the case and insertion into Rh-H occurs 
first.  
 Yet another experimental evidence for the existence of tertiary-alkyl-rhodium 
intermediates in the catalytic cycle came from the results of competition CAHB 
experiments between substrates bearing donor and acceptor groups appended to the arene 
at the β-position with sub stoichiometric amount of borane (Figure 2.8). When a 1:1 
mixture of substrates 5d and 5e bearing 4-methylphenyl and 4-trifluoromethylphenyl 
substituents at the β-position are subjected to standard CAHB conditions with 1 equivalents 
of pinBH, the substrate 5e undergoes reaction twice as fast as compared to 5d. This 
indicates that in case of 5e, the tertiary alkyl rhodium intermediate is formed faster and 
undergoes rapid reductive elimination as compared to 5d. This data provides an indirect 
evidence about the existence of a tertiary alkyl rhodium intermediate in the catalytic cycle. 
Figure 2.7A shows the 31P NMR of a 1:1 mixture of 5d and 5e prior to undergoing CAHB. 
Figure 2.7B shows the 31P NMR (zoomed in at the area where recovered substrates 
resonate) after standard CAHB of a 1:1 mixture of 5d and 5e with 1 equivalents of pinBH, 
showing a 2:1 ratio of 5d and 5e, showing faster consumption of 5e as compared 5d.  
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Figure 2.8: Competition CAHB reaction between methylidene substrates bearing donor 
(5d) vs. acceptor (5e) groups appended to the arene in the β-position of the substrate with 
sub-stoichiometric pinBH. A. 31P NMR of the mixture of 5d and 5e prior to CAHB. B. 31P 
NMR of the mixture of 5d and 5e after CAHB.  
 
2.5. Substrate-scope of phosphonate-directed CAHB of methylidene vinyl arenes6 
We subsequently turned our attention to the scope of substrates similar to 5a varying in the 
electronic/steric characters of the aromatic ring appended to the alkene undergoing CAHB. 
Figure 2.9 summarizes the yields of chiral tertiary boronic esters obtained for a series of 
such substrates. For all documented cases, the major byproduct is the regioisomeric 
terminal boronic ester and traces of the alkene reduction product. The relative abundance 
of minor regioisomer and the reduced by-product are not easily determined by NMR in 
most of the cases. The enantiomer ratios are determined after oxidation to the 
corresponding chiral tertiary benzylic alcohols via chiral HPLC analysis.  
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The electronic character of the aryl group appended to the aromatic ring does not 
significantly affect the final outcome of CAHB. For instance, substrates bearing 4-
methylphenyl (5d) and 4-trifluoromethylphenyl (5e) groups undergo CAHB with  high 
efficiency, yielding chiral tertiary boronic esters 6d (81%, 96:4 er) and 6e (77%, 96:4 er), 
respectively. However, as demonstrated in Figure 2.8, the electronic nature of the aromatic 
ring does affect the relative turnover frequency. Substrates bearing 3-methoxyphenyl (5f) 
and 4-methoxyphenyl (5g) groups undergo efficient β-boration to yield the corresponding 
chiral tertiary benzylic boronic esters 6f (76%, 97:3 er) and 6g (70%, 94:6 er), respectively. 
Similarly, the catechol derivative 5h and 3,5-dimethylphenyl bearing substrate 5i undergo 
CAHB in good yield and with high levels of enantioinduction to afford the products 6h 
(77%, 94:6 er) and 6i (76%, 96:4 er), respectively. 
 
Figure 2.9. Substrate scope of phosphonate-directed CAHB of β-aryl methylidenes. 
Standard CAHB conditions: 1 mol% Rh(nbd)2BF4, 1 mol% (R,R)-T2, pinBH, rt. 3 h. Note: 
Yields and er’s were determined after oxidation to the corresponding alcohols. (Adapted 
with permission from Ref. 6. Copyright 2018 American Chemical Society) 
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Aryl halides are versatile intermediates which can be subsequently refunctionalized 
via palladium-catalyzed cross-coupling protocols. We find that substrates bearing meta- or 
para- substituted phenyl substituents react smoothly under the standard conditions, albeit 
with some unusual variations in their regioselectivity. The corresponding β-borated 
products 6j-m are obtained with high levels enantioselectivity (94:6 to 97:3 er) and in 
moderate to very good yields (62-82%). It is pleasing to note that the 4-bromophenyl 
derivative 5m underwent CAHB without any apparent protodebromination, a competing 
transformation which is reported to occur under similar reaction conditions.13  
Substrates derived from the heterocyclic thienyl ring system undergo highly 
regioselective β-boration in good yield. However, the enantioselectivity is dependent on 
the substitution at the thienyl moiety. For instance, the 2-thienyl derivative (5n) exhibits 
higher enantioselectivity than the corresponding 3-thienyl derivative (5o); the tertiary 
boronic ester products  6n (85%, 97:3 er) and 6o (80%, 88:12 er) are obtained, respectively. 
The reason behind the observed differences in the enantioselectivities obtained from the 
two thienyl substrates is unclear. One might reasonably expect the 3-thienyl derivative to 
perform better because the sulfur is positioned away from the site of unsaturation in the 
molecule as compared to the 2-thienyl derivative. However, similar observations were also 
noted in our work on CAHB of 1,2-disubstituted vinyl arenes (vide infra). The Hoveyda 
group also reported similar differences in the enantioselective addition of MEMO-
substituted allyl-boron compounds catalyzed by organoboron-ammonium complexes to 
furan-derived aldimines differing in the substitution at the 2- or 3- position.14  
 
2.6. Phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes 
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As described above, the efforts of multiple groups have combined to achieve the 
development of effective catalysts for asymmetric protoboration or hydroboration of 
simple terminal and 1,1-disubstituted vinyl arenes (α-substituted styrene derivatives). 
However, the CAHB of the more functionalized 1,2-disubstituted vinyl arenes (β-
substituted styrene derivatives) continues to be challenging as evidenced by a scarcity of 
literature reports. Therefore, there are few reports on the direct CAHB of 1,2-disubstituted 
vinyl arenes in the literature. In 2011, Prof. Yun's group reported an efficient copper-
catalyzed CAHB of β-substituted styrene derivatives in which exclusive benzylic 
regioselectivity was observed (Figure 2.10).15 The axially chiral ligand DTBM-SEGPHOS 
in conjugation with CuCl was used for efficient catalysis. In 2018, the Takacs group 
reported the amide-directed CAHB of δ-aryl-γ,δ-unsaturated substrates with 
pinacolborane, leading to direct access to chiral secondary benzylic δ-borated  amide 
derivatives.8 A simple BINOL-derived chiral cyclic phosphoramidite B1 in conjugation 
with a commercially available rhodium precatalyst (Rh(nbd)2BF4) was used for efficient 
catalysis. The distal amide-functionality was shown to be crucial for achieving high levels 
of enantioselectivity.  
 
Figure 2.10. Previously reported examples of CAHB of 1,2-disubstituted vinyl arenes 
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In an effort to expand the substrate scope of phosphonate-directed CAHB of 
disubstituted alkenes, we envisioned the possibility of utilizing 1,2-disubstituted vinyl 
arenes bearing a directing group at the γ-position. Substrates of these types (e.g. 18a) are 
structural isomers of the methylidene substrates bearing an aryl substitution at the β-
position (e.g. 5a). While the substrates of the latter type undergo rhodium-catalyzed CAHB 
with pinacolborane giving chiral tertiary boronic esters via regioselective β-boration, the 
isomeric γ-aryl substrates undergo highly regio and enantioselective γ-boration to afford 
new chiral, secondary benzylic boronic esters (Figure 2.11).16 The choice of the chiral 
ligand is highly critical to the success of CAHB. Our studies consistently find that 
TADDOL-derived chiral phosphites and BINOL-derived chiral  phosphoramidites tend to 
be complementary in their effectiveness; in part, the choice of the chiral ligand hinges on 
the substrate’s alkene substitution pattern. While the rhodium catalyst systems 
incorporating TADDOL-derived phosphites were successful for efficient enantioinduction 
for β-aryl methylidene substrates such as 5a, their use with the isomeric 1,2-disubstituted 
vinyl arenes such as 18a gives the desired product in good yields (~80-82%) but with poor 
levels of enantioinduction (e.g. T1: 48:52 er, T2: 64:36 er). In contrast, the BINOL-derived 
phosphoramidites afford high levels of regiocontrol, yield and enantioselectivity with such 
substrates. For example, the ligand (R)- B1 affords (S)-19a in good levels of enantiocontrol 
(90:10 er). From further ligand optimization, we identified the 3,3'-diphenyl derivative (R)-
B2 as the optimal ligand for this system. Its use with (E)-18a affords (S)-19a in excellent 
levels of enantiocontrol (96:4 er).  
In the CAHB of 1,2-disubstituted vinyl arene (E)-18a, apart from the major 
regioisomeric secondary benzylic boronic ester 19a, the minor regioisomer 19a' (3-5%) 
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and the alkene reduction product 19a" (10-15%) typically comprise the remaining mass 
balance. The regioisomeric ratio (rr) is the ratio of the major regioisomer (19a) and the 
minor regioisomer (19a'). Formation of the alkene reduction product is highly dependent 
on the nature of the substrate. For example, in case of the 1,1-disubstituted vinyl arene 
substrate 5a, the alkene reduction product was formed in about 3-5% under the CAHB 
conditions. However, in case of the isomeric substrate (E)-18a, the alkene reduction 
product comprised 10-15% of the total reaction mass. The origin of the alkene reduction 
product under CAHB conditions is a subject of ongoing studies. Presence of adventitious 
moisture can lead to formation of the reduction side product.9  
 
Figure 2.11. Phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes. (Adapted with 
permission from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
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Our previous studies on amide-directed hydroboration of diastereomeric E- or Z- 
β,γ-unsaturated trisubstituted alkenes showed that B-H addition in CAHB is independent 
of alkene stereochemistry (Figure 2.12).17 Diastereomeric products were obtained from 
stereoisomeric substrates. For example, CAHB of (E)-20 with pinacolborane yields 
(3R,4S)-21 and that of (Z)-20 yields (3R,4R)-21. 
 
Figure 2.12. Amide-directed CAHB of (E)- or (Z)-trisubstituted alkenes affords 
diastereomeric products showing B-H addition is independent of alkene stereochemistry. 
(Adapted with permission from Ref. 17. Copyright 2010 American Chemical Society) 
 
Based on the results obtained with the amide-directed CAHB of stereoisomeric (E)- 
and (Z)-trisubstituted alkene substrates 20, we expected formation of enantiomeric 
products from phosphonate-functionalized 1,2-disubstituted vinyl arene substrates (E)- and 
(Z)-18a assuming B-H addition occurring to the same face irrespective of the alkene 
stereochemistry. However, we were surprised to find that the alkene stereochemistry did 
not impact the overall yield and stereochemistry in the CAHB of 18a. The same major 
enantiomer of product (S)-19a is formed from either diastereomer of the substrate (Figure 
2.13). Similar results were also obtained from the corresponding homologous vinyl arene 
substrates (E)- and (Z)-23.15 
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Figure 2.13. (E/Z)-Substrate stereoconvergence observed in the CAHB of phosphonate-
functionalized 1,2-disubstituted vinyl arenes: same major enantiomer of product is formed 
from diastereomeric substrates.  (Adapted with permission from Ref. 16. Copyright 2019 
The Royal Society of Chemistry) 
 
2.7. Experimental data explaining the origin of E/Z-stereoconvergence16 
The discovery of (E/Z)-stereoconvergence in the CAHB of 1,2-disubstituted vinyl arenes 
adds an element of practical significance to the methodology since the product 
enantiopurity is independent of the substrate’s alkene stereochemistry. The ability to arrive 
at the same major enantiomer of the product boronic ester starting with pure E or pure Z or 
any combination of an E/Z-mixture is highly practical but raises mechanistic questions. We 
speculated two possible scenarios that could explain the observed stereoconvergence: (1) 
Z- to E- substrate isomerization occurrs faster under the reaction conditions than the 
formation of B-H addition products. Hence essentially all product would arise from the E 
isomer only. (2) B-H addition occurs with opposite π-facial selectivity for the Z substrate 
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as compared to the E variant. The second possibility would be counterintuitive to the results 
obtained from trisubstituted amide substrates shown in Figure 2.12.  
The origin of (E/Z)-isomer stereoconvergence is easily resolved based on the results 
of CAHB using a sub-stoichiometric quantity of pinBH (Figure 2.14) and results of 
deuterium labelling experiments, that is, CAHB of (E)- and (Z)-18a with pinBD (Figure 
2.15). With respect to the first test, a sample enriched in (Z)-isomer of 18a (9:1 Z:E) is 
subjected to the otherwise standard CAHB conditions, but using a limiting amount of 
pinBH (0.4 equiv.); the reaction, under such conditions leads to partial boration and 
recovered alkene. The 1H spectral windows for the starting and recovered E/Z mixtures of 
18a shown in Figure 2.13 indicate that (Z)-18a is essentially completely converted to the 
(E)-isomer under the reaction conditions, thus suggesting a mechanistic pathway by which 
the two isomers lead to the same product.18   
 
Figure 2.14. Z- to E- substrate isomerization is seen under standard CAHB conditions.    
(Adapted with permission from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
 
Figure 2.15 shows the results of deuterium labelling which support the results 
obtained using a limiting amount of pinBH. Independently carried out CAHBs of (E)- and 
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(Z)-18a using pinBD results in different distributions of non-, isomeric mono- and di-
deuterated products for the isomeric alkenes. CAHB/oxidation of (E)-18a using pinBD 
essentially forms a single monodeuterated product, tentatively assigned as 2-d-(2S,3S)-22a 
(83%) accompanied by the all proteo product (3S)-22a (17%); we find no evidence for 
dideuteration by mass spectral analysis. In contrast, CAHB/oxidation of (Z)-18a using 
pinBD yields about 30% of the non-deuterated product (3S)-22a, 47% of a mixture of 
diastereomeric monodeuterated products 2-d-(2S,3S)-22a and 2-d-(2R,3R)-22a and 21% of 
the dideuterated product 2,2-d2-(3S)-22a. The dideuterated product presumably arises by 
the reaction of 2-d-(E)-18a with pinBD. 
 
Figure 2.15. Different distributions of deuterated products are obtained when isomeric (E)- 
or (Z)-18a react with PinBD under standard CAHB conditions. (Adapted with permission 
from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
 
2.8. Mechanistic insights in the CAHB of 1,2-disubstituted alkenes obtained from 
deuterium labeling experiments16 
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Rhodium-catalyzed pinBH addition to (E)-18a occurs from the “top-face” in the 
perspective drawn to form (3S)-22a (Figure 2.16; For absolute configuration assignments, 
see chapter 5). To systematically probe the origin of their stereoconvergent CAHB, we 
separately carried out deuterium labelling experiments via CAHB using pinBD followed 
by oxidation to analyze deuterated alcohol products for each stereoisomer of the substrate 
18a (Sec. 2.7).  In this section, the mechanistic implications indicated by the results of 
deuterium labeling experiments is analyzed. In analogy to reaction with pinBH, CAHB of 
(E)-18a with pinBD proceeding via addition to the “top face” is assumed to give the 2-d-
(2S,3S)-22a diastereomer. The site and extent of deuterium incorporated in 18a were 
analyzed via 1H, 2H, 13C, 13C-DEPT 135 NMR and HRMS techniques.  
 
Figure 2.16. “Top-face” addition of pinBH and pinBD in the CAHB of (E)-18a. (Adapted 
with permission from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
 
The 31P NMR spectrum of (3S)-22a shows a single peak at 32.83 ppm (Spectrum 
A, Figure 2.16). However, the 31P NMR spectrum of 22a obtained from (E)-18a after 
CAHB with pinBD followed by oxidation shows two peaks at 32.85 ppm and 32.83 ppm 
in about 83:17 ratio (Spectrum B, Figure 2.17). The 32.85 ppm peak is assigned to 2-d-
(2S,3S)-22a and that of 32.83 ppm for (3S)-22a. The formation of (3S)-22a must arise from 
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pinBH addition to (E)-18a; although completely deuterated pinBD is used, we speculate 
that some pinBH is formed under the reaction conditions. The mechanism of pinBH 
formation under the conditions described is unclear.  
 
                                 Spectrum A: 
 
                                               
        Spectrum B: 
 
 
Figure 2.17. 31P NMR of (3S)-22a (Spectrum A) and enriched 2-d-(2S,3S)-22a (Spectrum 
B). (Adapted with permission from Ref. 16. Copyright 2019 The Royal Society of 
Chemistry) 
 
The peak for the β-carbon of (3S)-22a appears as a doublet at δ 32.02 (2JC-P = 5.0 
Hz; Spectra A, Figure 2.18) in the 13C NMR spectrum. The 13C NMR spectrum of 22a 
obtained from (E)-18a after CAHB with pinBD followed by oxidation shows two peaks as 
shown in Spectra B (Figure 2.18). The β-carbon atom assigned to 2-d-(2S,3S)-22a bonded 
to deuterium and being two bonds away from phosphorus is identified at δ 31.66 in the 13C 
NMR spectrum with a characteristic splitting pattern of a triplet of doublets (1JC-D coupling 
~ 20 Hz, 2JC-P coupling ~ 4.25 Hz): 31.66 (td, 
1JC-D = 20 Hz, 
2JC-P = 4.25 Hz) ppm. The 
peak at d 32.02 (d, 2JC-P = 5.0 Hz) is assigned to the non-deuterated product (3S)-22a. The 
ratio of deuterium to hydrogen in the β-carbon of 22a obtained via CAHB of (E)-18a 
followed by oxidation is about 80:20 based on the 13C and 31P NMR spectra obtained.  
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                                          Spectrum A 
 
 
 
      Spectrum B 
 
 
Figure 2.18. 13C NMR spectra (zoomed in for β-carbon) of (3S)-22a (Spectrum A) and 
enriched 2-d-(2S,3S)-22a (Spectrum B). (Adapted with permission from Ref. 16. 
Copyright 2019 The Royal Society of Chemistry) 
 
In Figure 2.19, we consider the mechanistic consequences of “top face” and 
“bottom face” addition of pinBD to the isomeric (Z)-18a in light of the fact that it must 
ultimately produce deuterated (S)-22a, not deuterated (R)-22a. Addition of pinBD to the 
“top-face” of (Z)-18a would give rise to Im-3. Alternatively, addition of pinBD to the 
“bottom face” of (Z)-18a would give rise to Im-4. If subsequent steps in the mechanism 
leading to C–B bond formation were fast, Im-3 would lead to deuterated (R)-22a, while 
Im-4 would lead to the observed product, deuterated (S)-22a. However, as discussed in sec. 
2.7, the (E/Z)-alkene isomerization occurring under the CAHB conditions can explain this 
(E/Z)-alkene geometry induced change in the sense of π-facial discrimination.  
The formation of either Im-3 or Im-4 followed by rapid β-hydride elimination 
would lead to the formation of 2-d-(E)-18a which has been identified via 1H and 2H NMR 
analysis (Figure 2.20) from a reaction of (Z)-18a with pinBD that is quenched early with 
methanol. We find that isomerization of (Z)-18a is very rapid in the beginning of the 
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reaction; a nearly 1:1 ratio of E:Z substrates is identified in the first 5 minutes of the 
reaction time and then increases more slowly reaching a 2:1 ratio after about 30 minutes.  
 
Figure 2.19. Top and bottom-face addition of pinBD in CAHB of (Z)-18a (Adapted with 
permission from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
   
 
Figure 2.20. 1H and 2H NMR's showing formation of (E)-18a and 2-d-(E)-18a from (Z)-
18a with pinBD under standard CAHB conditions. (Adapted with permission from Ref. 
16. Copyright 2019 The Royal Society of Chemistry) 
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As shown in Figure 2.19, CAHB of 2-d-(E)-18a with pinBD from the expected 
“top-face” should result in the formation of 2,2-d2-(3S)-22a, and the latter has been 
identified via HRMS analysis (vide infra). However, β-hydride elimination from Im-3 or 
Im-4 not only forms 2-d-(E)-18a but generates an equivalent amount of pinBH from 
pinBD. Therefore, we also find products resulting from this in situ generated pinBH; its 
expected addition to the “top-face” of 2-d-(E)-18a should afford 2-d-(2R,3S)-22a as 
illustrated in Figure 2.19. In addition, isomerization of (Z)-18a to (E)-18a via the with the 
initial addition of pinBH and then followed by pinBD addition, after oxidation, should 
generate the diastereomeric alcohol 2-d-(2S,3S)-22a. Finally, the addition of pinBH to in 
situ generated (E)-18a should generate a small amount of (3S)-22a. Thus, CAHB of (Z)-
18a with pinBD should potentially lead to the formation of four possible products: (3S)-
22a, 2-d-(2R,3S)-22a, 2-d-(2S,3S)-22a and 2,2-d2-(3S)-22a. The 
13C NMR data shown in 
Figure 2.21 highlight the characteristic signatures for: a. (3S)-22a; b. 2-d-(2S,3S)-22a (as 
formed from (E)-18a with pinBD); and c. the mixture of 2-d-(2S,3S)-22a and 2-d-(2R,3S)-
22a formed from (Z)-18a with pinBD in which the presence of 2-d-(2R,3S)-22a is inferred 
from the overlapping sets of ddd signals for the β-carbon bearing one deuterium from each 
of the two diastereomers.   
The mixture of proteo/mono-deutero alcohols 22a obtained via CAHB of (E)-18a 
with pinBD followed oxidation is subjected to HRMS (Figure 2.22). (i) The molecular ion 
peak for (3S)-18a (Calculated for C13H21O4P+Na
+ = 295.1075) corresponds to a m/z peak 
at 295.1079 and that of 2-d-(2S,3S)-18a (Calculated for C13H20DO4P+Na
+ = 296.1138) 
corresponds to a m/z peak at 296.1140. (ii) Since 18a contains 13 C-atoms and the relative 
abundance of 13C is 1.1% in nature, 14.3% of the area under the peak corresponding to m/z 
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295.1079 is subtracted from the area under the peak corresponding to m/z of 296.1140 to 
account for the 13C correction. This gives a corrected area of 557640 under the peak 
corresponding to m/z of 296.1140 (molecular ion peak for 2-d-(2S,3S)-22a). The 13C 
correction for area under the peak corresponding to m/z of 297.1180 would give a corrected 
area of 14808. This peak is mainly due to 13C and not due to 2H (See the elemental analysis). 
(iii) The ratio of (3S)-22a to 2-d-(2S,3S)-22a as obtained from the above HRMS analysis 
(Sample obtained from CAHB/Oxidation of (E)-18a with pinBD) is 17:83. 
 
Figure 2.21. 13C NMR zoomed in for the region of β-carbon: (a) CAHB of (E)-18a with 
pinBH, then oxidation to yield (3S)-22a. (b) CAHB of (E)-18a with pinBD, then oxidation 
to yield mixtures of hydro- and deutero incorporated 22a. (c) CAHB of (Z)-18a with 
pinBD, then oxidation to yield diastereomeric monodeuterated 22a in addition to hydro-
incorporated 22a. (Adapted with permission from Ref. 16. Copyright 2019 The Royal 
Society of Chemistry)  
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Figure 2.22. HRMS analysis of the mixture of proteo/mono-deutero alcohols 22a obtained 
via CAHB of (E)-18a with pinBD. (Adapted with permission from Ref. 16. Copyright 2019 
The Royal Society of Chemistry)   
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Figure 2.23. HRMS analysis of mixture of proteo/mono deutero and dideutero alcohols 
22a obtained via CAHB of (Z)-18a with pinBD. (Adapted with permission from Ref. 16. 
Copyright 2019 The Royal Society of Chemistry) 
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The mixture of proteo/mono deutero and dideutero alcohols 22a obtained via 
CAHB of (Z)-18a with pinBD following CAHB/oxidation is subjected to HRMS (Figure 
2.23). (i) The molecular ion peak for (3S)-22a (Calculated for C13H21O4P+Na
+ = 295.1075) 
corresponds to a m/z peak at 295.1098, that of 2-d-(2S,3S)-22a (Calculated for 
C13H20DO4P+Na
+ = 296.1138) corresponds to a m/z peak at 296.1147 and that of 2,2-d2-
(3S)-22a (Calculated for C13H19D2O4P+Na
+ = 297.1201) corresponds to a m/z peak at 
297.1218. (ii) Since 22a contains 13 C atoms and the relative abundance of 13C is 1.1% in 
nature, 14.3% of the area under the peak corresponding to m/z 295.1098 is subtracted from 
the area under the peak corresponding to m/z of 296.1147 to account for the 13C correction. 
This gives a corrected area of 393871 under the peak corresponding to m/z of 296.1147 
(molecular ion peak for 2-d-(2S,3S)-22a). 14.3% of the corrected area under the peak 
corresponding to m/z 296.1147 is to be subtracted from the peak corresponding to m/z of 
297.1218 to account for 13C correction. Thus, the corrected area under m/z 297.1218 is 
186671. (iii) Thus, the ratio of (3S)-22a: 2-d-(2S,3S)-22a: 2,2-d2-(3S)-22a determined from 
HRMS analysis (Sample obtained from CAHB/Oxidation of (Z)-18a with pinBD) is 30: 
47: 23. 
Summary of deuterium-labeling experiments. 
Following is the distribution of products that is obtained from (E)-18a and (Z)-18a when 
reacted with pinBD under standard CAHB conditions:  
Substrate 
Percentages inferred from NMR and HRMS analysis 
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17 83 -- -- 
 
30 47 21 
 
In conclusion, the same major enantiomer of chiral secondary benzyl alcohol 22a 
is obtained from both (E)- and (Z)-18a. This (E/Z)-stereoconvergence during CAHB can 
be simply explained by the rapid isomerization of (Z)-18a to (E)-18a via initial addition of 
borane followed by β-hydride elimination under reaction conditions; this isomerization has 
been verified by deuterium labelling studies. However, it should be noted that the question 
of whether the (E/Z)-alkene geometry induces a change in the sense π-facial discrimination 
is not answered definitively by our experimental data. We can only conclude it is not 
necessary to invoke such a change to account for the observed experimental results. 
 
2.9. Substrate-scope of phosphonate-directed CAHB of 1,2-disubstituted vinyl 
arenes16 
Figure 2.24 summarizes results obtained for a series of 1,2-disubstituted vinyl arene 
substrates differing in the nature of the aromatic ring appended at the γ-position. In addition 
to the γ-borated product 19 and the minor regioisomeric β-borated product 19', alkene 
reduction (i.e., 19") typically comprises the remaining 5-15% of the product mixture. The 
three products formed in the CAHB have distinct peaks in the 31P NMR spectrum and the 
regioisomeric ratio (rr) of γ:β borated products is determined via 31P NMR analysis of the 
crude CAHB mixture. The isolation of the major regioisomeric boronic ester (19) from the 
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minor regioisomeric boronic ester (19') and the alkene reduction product (19") is typically 
difficult as these have very similar Rf  values. However, the isolation of the major 
regioisomeric alcohol (22) after oxidation of the mixture of CAHB products is quite 
feasible. Therefore, yields and enantiomer ratios are determined after oxidation. Alkene 
reduction under standard CAHB conditions arises from a competing catalytic cycle and is 
the subject of ongoing studies;9 it will not be discussed further here. Herein, we focus on 
the regio- and enantioselectivity of the rhodium-catalyzed hydroboration mode.  
 
Figure 2.24. Scope of allyl phosphonate substrates bearing substituted benzene derivatives 
at the γ-position. Note: Yields and er determined after oxidation to the corresponding 
alcohols. (Adapted with permission from Ref. 16. Copyright 2019 The Royal Society of 
Chemistry) 
 
A range of donor and acceptor substituents appended to the γ-phenyl group are well 
tolerated with minor fluctuations in regio and/or enantioselectivity. For example, the 4-
methylphenyl derivative 18b and the 4-trifluoromethylphenyl derivative 18c undergo γ-
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boration with high regioselectivity (>20:1 rr) yielding 22b (84%, 97:3 er) and 22c (78%, 
97:3 er) after oxidation of the corresponding secondary benzylic boronic esters (i.e., 19b 
and 19c). The 4-fluorophenyl (18d) and 4-methyoxyphenyl (18e) derivatives exhibit 
comparatively lower levels of γ:β regioselectivity (19d–e, 10-11:1 rr) and 
enantioselectivity affording 22d (71%, 94:6 er) and 22e (77%, 94:6 er), respectively. In 
contrast, the 3-methoxyphenyl derived substrate 18f and 3,4-methylenedioxyphenyl 
derivative 18g again exhibit higher regioselectivity (19f-g: >20:1 rr) and a range of 
enantioselectivity leading to 22f (83%, 98:2 er) and 22g (70%, 94:6 er), after oxidation. 
Substrates bearing ortho-substituted phenyl groups (e.g. 18h-i) undergo good 
conversion albeit with comparatively reduced regioselectivity (19h: 9:1 rr, 19i: 13:1 rr) 
leading to 22h (72%, 94:6 er) and 22i (74%, 91:9 er). It is worth noting that unlike the 
results obtained with 1,1-disubstituted alkenes in which presence of an ortho substituent 
on the β-aryl group (e.g. 5n-o) lead to a change in regioselectivity, substrates bearing 2-
substituted arenes in this series of 1,2-disubstituted internal vinylarenes (e.g. 18h-i) do not 
significantly impact the regioselectivity. 
 Substrates bearing basic nitrogen functionality appended to the aromatic ring at the 
γ-position undergo efficient reaction. For example, the substrates bearing 4-
dimethylamino, morpholine, and pyrazine substituents 18i–k demonstrate the viability of 
substrates bearing basic nitrogen functionality; 22i–k are obtained in moderate to good 
yields (55-68%) and up to 94:6 er. The indole derivative 18l exhibits high γ-regioselectivity 
(19l: >20:1 rr) in the event of CAHB and forms 22l (78%, 96:4 er) in good yield and 
enantioselectivity.   
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 In addition to demonstrating tolerance for basic nitrogen in several of the substrates 
described in Figure 2.24, it is important to note that CAHB is successful for substrates 
incorporating some common heterocyclic ring systems of high relevance in medicinal and 
pharmaceutical chemistry, albeit with some unusual variations in regio- and/or 
enantioselectivity (Figure 2.25). For example, the 3-substituted N-Boc-protected pyrrole 
derived substrate 18n is both highly regioselective (19n: >20:1 rr) and highly 
enantioselective; the er obtained for 22n (86%, 99:1 er) is the highest obtained among the 
set of substrates tested. However, the results obtained for CAHB of the 2-substituted N-
Boc protected pyrrole derivative 18o differ significantly. The regioselectivity of boronic 
ester 19o (>20:1 rr) is excellent. However, the level of enantioselectivity for 22o (85%, 
80:20 er) is not only much lower but results from hydroboration with the opposite sense of 
π-facial selectivity compared to most other substrates (vide infra); (R)-22o is the major 
product. Other five-membered ring heteroaryl substituents also lead to surprising results. 
Compared to the results obtained for 3- and 2- substituted pyrrole derivatives, the 3- and 
2-substituted thiophene substrates (i.e., 18p and 18q) exhibit high regioselectivity leading 
to 19p and 19q (>20:1 rr), respectively. However, the 3-substituted thiophene 18p affords 
22p (83%, 85:15 er) with only modest levels of stereocontrol while the 2-substituted 
thiophene derivative 18q gives 22q (80%, 95:5 er) with good stereocontrol. The 
enantioselectivity disparity from isomeric thiophene substrates is seen in case of the 
conjugated methylidene systems as well (e.g. 5l vs. 5m). The 2-substituted benzothiophene 
18r gives both lower levels of regiocontrol (19r, 5:1 rr) and enantioselectivity for 22r 
(65%, 89:11 er).  
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Figure 2.25. Scope of allyl phosphonate substrates bearing heterocyclic aromatic 
derivatives at the γ-position. Note: Yields and er determined after oxidation to the 
corresponding alcohols. (Adapted with permission from Ref. 16. Copyright 2019 The 
Royal Society of Chemistry) 
 
The series of furan derivatives 18s–u undergo CAHB with moderate levels of 
enantioinduction. Unlike the 2-substituted thiophene derivative 18q, the corresponding 2-
substituted furan derivative 18t exhibits poor levels of enantioinduction. A similar 
observation was made in the asymmetric hydroboration of 2-vinyl furan by Brown and co-
workers where the enantioselectivity of the product was surprisingly low as compared to 
the vinyl arenes derived from 6-membered aromatic rings.19 Brown and co-workers 
proposed that the lower steric influence exerted by the smaller 2-furyl group resulted in the 
inability of the chiral catalyst to efficiently discriminate between the prochiral faces of the 
alkene leading to lower enantioselectivity. However, our results on the CAHB of 
benzofuran substrate 18u leading to 19u (55%, 79:21), again with moderate levels of 
enantioinduction shows that the steric effect may not be the primary cause for lower 
enantioselectivity. The lower levels of enantioselectivity could potentially stem from the 
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lower stability of the η3 π-benzyl rhodium intermediates formed with these significantly 
electron rich furan derived substrates.20  
One might reasonably question as to whether the phosphonate directing group is 
unique in promoting the γ-boration with these vinyl arene substrates. This, in fact, appears 
not to be the case. The corresponding benzylamide substrate (E)-18v undergoes 
regioselective γ-boration with (R)-B1 to afford the analogous amide-functionalized, γ-
borated benzylic boronic ester (S)-19v (7:1 rr) (Figure 2.25). Oxidation yields the chiral 
benzyl alcohol (S)-22v (78%, 94:6 er). In case of this amide substrate, we were surprised 
to find a unique ligand-dependent regioselection. The 3,3'-bisphenyl substituents in ligand 
B1 play a significant role in determining regioselectivity. B2, the analogous BINOL-
derived phosphoramidite derived from the parent BINOL ring system, gives a slight 
preference for β-boration (ca. 2:1 rr) with (E)-18v. However, with B2, the corresponding 
γ,δ-unsaturated amides such as (E)-16 afford δ-borated benzylic boronic esters ((R)-17) in 
excellent yields and enantioselectivities.  
The attempted CAHB of several other related phosphonates reveal some current 
limitations of the [Rh(nbd)2BF4/B1] catalyst system (Figure 2.26). In contrast to the 
vinylarene substrate (E)-18a, similar internal alkenes bearing an alkyl rather aryl/heteroaryl 
γ-substituent (e.g. (E)-18w), undergo predominantly β-boration, albeit with modest regio- 
and enantioselectivity with the standard catalyst system. The chiral secondary alkyl boronic 
ester (S)-19w (3:1 rr) is oxidized to yield the alcohol (S)-22w (60%, 75:25 er). The isomeric 
δ,ε-unsaturated vinyl arene (E)-18x affords the corresponding benzylic boronic ester (S)-
19x upon CAHB, but again, with only modest regioselectivity (3:1 rr), yield, and 
enantiopurity (obtained after oxidation to (S)-22x: 47%, 88:12 er). The vinyl (i.e., α,β-
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unsaturated) phosphonate (E)-18y is largely recovered unreacted when subjected to the 
standard CAHB conditions. The trisubstituted variants (E)-18z and (E)-18aa only react 
sluggishly under the standard conditions. The benzylic regioisomer is preferred for these 
trisubstituted substrates. It should be noted that these results may reflect only the 
limitations of the [Rh(nbd)2BF4/(R)-B2] catalyst system; systematic catalyst optimizations 
have not been carried out for these substrates.  
Substrate (E)-18w, however, reacts with pinBH using the catalyst formed from 
[Rh(nbd)2BF4/(R,R)-T3] with a similar regioselectivity as that obtained using 
[Rh(nbd)2BF4/(R)-B2], but with an improved enantioselectivity to form 22w (60%, 94:6 
er) after oxidation. The substrate (E)-18aa was also found to undergo reaction with 
[Rh(nbd)2BF4/(R,R)-T2] to form the corresponding benzylic regioisomer in a moderate 
enantioselectivity (65:35 er).  
 
Figure 2.26. Additional substrate scope and some limitations of the methodology using the 
(R)-B2/Rh-catalyst system. (Adapted with permission from Ref. 16. Copyright 2019 The 
Royal Society of Chemistry) 
 
2.10. Stereochemical assignments via kinetic resolution16 
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The variable regio- and stereochemical results obtained with several substrates bearing 
heteroaromatic ring systems in the CAHB of γ-aryl 1,2-disubstituted vinyl arenes illustrate 
a potential caveat for substrates bearing multiple donor groups in proximity of the alkene 
or those bearing relatively bulky extended aromatic ring systems. We used Birman’s chiral 
cyclic thiourea  (benzotetramisole (BTM))21 acylation catalyst to employ a kinetic 
resolution (KR) strategy for confirming the absolute configuration assignments for several 
of the previously unreported chiral secondary benzylic alcohols 22 prepared via CAHB. 
As presented in Figure 2.27, the (S)-BTM catalyzed acylation of a racemic sample of 22a 
with 0.5 equivalents of isobutyric anhydride results in the rapid acylation of (S)-22a to (S)-
26a and recovery of the known (R)-22a unreacted alcohol.22  
 Alcohol 22 and the corresponding isopropyl-ester 26 are readily differentiated by 
31P NMR spectroscopy providing a convenient protocol for the rapid determination of 
absolute configuration of some of these previously unreported chemical entities (Fig. 
2.27B). As demonstrated by the 31P NMR stack plot, (S)-22a (96:4 er) is more rapidly 
acylated using (S)-BTM than with (R)-BTM. Using this method, we were able to assign 
absolute configurations for the α-hydroxy heteroaryl products obtained via 
CAHB/oxidation (Figure 2.27C). For example, the 3-substituted pyrrole derivative 22n 
(99:1 er), synthesized via CAHB/oxidation using (R)-B2, undergoes more rapid (S)-BTM 
catalyzed acylation to yield 26n (27% conversion in 12 h) compared to (R)-BTM catalyzed 
acylation (2% conversion in 12 h). The relative rates are consistent with predominant (S)-
configuration of 22n.  
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Figure 2.27. Stereochemical assignments based on kinetic resolution. (Adapted with 
permission from Ref. 16. Copyright 2019 The Royal Society of Chemistry) 
 
In contrast to 22n, the 2-pyrrole derivative 22o (80:20 er), also prepared via 
CAHB/oxidation, undergoes relatively sluggish (S)-BTM catalyzed acylation to 26o 
compared to (R)-BTM catalyzed acylation. The results indicate that predominantly (R)-22o 
is formed from 2-substituted pyrrole by CAHB with (R)-B1. We can only speculate that 
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the N-Boc moiety acts as an alternate directing group in the rhodium-catalyzed 
hydroboration thereby switching the sense of alkene π-facial selectivity. Although one 
might reasonably expect that 2-substituted thiophene and furan derivatives behave 
similarly, however, the data summarized in Figure 2.26 indicate that (S)-22p-q and (S)-
22s-t are major stereoisomers formed via CAHB/oxidation. Thus, the sense of pi-facial 
selectivity is independent of the substitution nature of the substrates bearing heteroaromatic 
ring systems.  
 
2.11. Summary 
In this chapter, directed CAHB of allyl phosphonates bearing 1,1- and 1,2-disubstituted 
vinyl arenes was discussed. In case of the 1,1-disubstituted alkenes, CAHB leads to the 
formation of chiral tertiary boronic esters via regioselective β-boration. This result 
constitutes the first reported example of boron delivery to the more substituted carbon atom 
of an aryl substituted methylidene in the literature. Systematic studies of individual 
components of methylidene substrate 5a suggested that the appropriate positioning of the 
phosphonate functionality and alkene conjugation are essential elements required for the 
observed regiochemistry. Mechanistic studies carried out using deuterium labelling 
experiments (CAHB using pinBD) suggested the migratory insertion of the C=C bond to a 
Rh-H/D bond forms a 3o-alkyl rhodium intermediate which subsequently undergoes 
reductive elimination to form the tertiary boronic ester product. Substrates bearing meta 
and para substituents including halogen atoms undergo this reaction efficiently, yielding 
the corresponding tertiary boronic esters. Heteroaromatic substituents such as thienyl 
derivatives can be tolerated as well. The only limitation in the substrate scope is with ortho-
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substituted aromatics where regioselective γ-boration leads to the formation of primary 
boronic esters.  
 The isomeric allyl phosphonates bearing 1,2-disubstituted vinyl arenes (e.g. 18a) 
undergo efficient CAHB with regioselective γ-boration to form chiral secondary benzylic 
boronic esters. In these cases, isomeric E and Z substrates lead to the same major 
enantiomer of the chiral product formed. Mechanistic studies indicated rapid Z to E 
substrate isomerization occurring under reaction conditions leading to product 
stereoconvergence from any mixture of stereoisomeric substrates. A variety of substrates 
similar to 18a were shown to undergo efficient CAHB, affording the corresponding γ-
borated chiral secondary benzylic boronic ester products. Substrates bearing ortho-
substituted aromatics did not change regiochemistry unlike in case of the 1,1-disubstituted 
vinyl arenes. Substrates bearing basic nitrogen functionality such as derivatives of aniline 
and substrates bearing common heteroaromatic ring systems of relevance in medicinal 
chemistry underwent efficient reaction, albeit with some unusual variations in regio- and 
enantioselectivity. Birman’s chiral cyclic thiourea (benzotetramisole (BTM)) acylation 
catalyst was used to employ a kinetic resolution strategy for confirming the absolute 
configuration assignments for several of the chiral benzyl alcohol products derived from 
substrates bearing heteroaromatic ring systems.  
 
2.12. References 
(1) Corberán, R.; Mszar, N. W.; Hoveyda, A. H. "NHC-Cu-catalyzed enantioselective 
hydroboration of acyclic and exocyclic 1,1-disubstituted aryl alkenes" Angew. Chem., Int. 
Ed., 2011, 50, 7079.  
 
92 
 
 
(2) Mazet, C.; Ge´rard, D. " Highly regio- and enantioselective catalytic asymmetric 
hydroboration of α-substituted styrenyl derivatives" Chem. Commun., 2011, 47, 298.  
(3) Zhang, L.; Zuo, Z.; Wan, X.; Huang, Z. "Cobalt-Catalyzed Enantioselective 
Hydroboration of 1,1-Disubstituted Aryl Alkenes" J. Am. Chem. Soc. 2014, 136, 15501.  
(4) Zhang, H.; Lu, Z. "Dual-Stereocontrol Asymmetric Cobalt-Catalyzed Hydroboration 
of Sterically Hindered Styrenes" ACS Catal., 2016, 6, 6596.  
(5) Wang, Z.; He, X.; Zhang, R.; Zhang, G.; Xu, G.; Zhang, Q.; Xiong, T.; Zhang, Q. 
"Copper-Catalyzed Asymmetric Hydroboration of 1,1-Disubstituted Alkenes" Org. Lett. 
2017, 19, 3067.  
(6) Chakrabarty, S.; Takacs, J. M. "Phosphonate-Directed Catalytic Asymmetric 
Hydroboration: Delivery of Boron to the More Substituted Carbon, Leading to Chiral 
Tertiary Benzylic Boronic Esters" ACS Catal., 2018, 8, 10530.  
(7) Smith, S. M.; Hoang, G. L.; Pal, R.; Khaled, M. O. B.; Pelter, L. S. W.; Zeng, X. C.; 
Takacs, J. M. "γ-Selective directed catalytic asymmetric hydroboration of 1,1-disubstituted 
alkenes" Chem. Commun., 2012, 48, 12180.  
(8) Hoang, G. L.; Zhang, S.; Takacs, J. M. "Rhodium-catalyzed asymmetric hydroboration 
of γ,δ-unsaturated amide derivatives: δ-borylated amides" Chem. Commun., 2018, 54, 
4838.  
(9) Shoba, V.; Takacs, J. M. "Remarkably Facile Borane-Promoted, Rhodium-Catalyzed 
Asymmetric Hydrogenation of Tri- and Tetrasubstituted Alkenes" J. Am. Chem. Soc., 
2017, 139, 5740.  
93 
 
 
(10) Thacker, N. C.; Shoba, V. M.; Geis, A. E.; Takacs, J. M. "Surprisingly facile C–H 
activation in the course of oxime-directed catalytic asymmetric hydroboration" Tet. Lett., 
2015, 56, 3306.  
(11) Smith, S. M., "Directed Catalytic Asymmetric Hydroboration (CAHB): An Effective 
Method For The Enantioselective Preparation Of Chiral Organoboronates" dissertation, 
Ph.D. 2012, University of Nebraska-Lincoln.  
(12) Fritschi, C. B.; Wernitz, S. M.; Vogels, C. M.; Shaver, M. P.; Decken, A.; Bell, A.; 
Westcott, S. A. "4,4,5,5‐Tetraphenyl‐1,3,2‐dioxaborolane: A Bulky Borane for the 
Transition Metal Catalysed Hydroboration of Alkenes" Eur. J. Inorg. Chem. 2008, 5, 779.  
(13) Wu, Z., Laffoon, S. D.; Nguyen, T. T.; McAlpin, J. D.; Hull, K. L. "Rhodium-
Catalyzed Asymmetric Synthesis of β-Branched Amides" Angew. Chem., Int. Ed., 2017, 
56, 1371.  
(14) Morrison, R. J.; Hoveyda, A. H. "γ-, Diastereo-, and Enantioselective Addition of 
MEMO-Substituted Allylboron Compounds to Aldimines Catalyzed by Organoboron-
Ammonium Complexes" Angew. Chem. Int. Ed. 2018, 57, 11654.  
(15) Noh, D.; Yoon, S. K.; Won, J.; Lee, J. Y.; Yun, J. "An Efficient Copper(I)‐Catalyst 
System for the Asymmetric Hydroboration of β‐Substituted Vinylarenes with 
Pinacolborane" Chem.-Asian J., 2011, 6, 1967.  
(16) Chakrabarty, S.; Palencia, H.; Morton, M. D.; Carr, R. O.; Takacs, J. M. "Facile access 
to functionalized chiral secondary benzylic boronic esters via catalytic asymmetric 
hydroboration" Chem. Sci., 2019, 10, 4854. 
(17) Smith, S. M.; Takacs, J. M. "Amide-Directed Catalytic Asymmetric Hydroboration of 
Trisubstituted Alkenes" J. Am. Chem. Soc., 2010, 132, 1740.  
94 
 
 
(18) Rhodium and iridium complexes are known to isomerize alkenes. For example, see 
(a) Morrill, T. C.; D’Souza, C. A. "Efficient Hydride-Assisted Isomerization of Alkenes 
via Rhodium Catalysis" Organometallics, 2003, 22, 1626; (b) Knapp, S. M. M.; Shaner, S. 
E.; Kim, D.; Shopov, D. Y.; Tendler, J. A.; Pudalov, D. M.; Chianese, A. R. "Mechanistic 
Studies of Alkene Isomerization Catalyzed by CCC-Pincer Complexes of Iridium" 
Organometallics, 2014, 33, 473; and the references cited therein.  
(19) Douchet, H.; Fernandez, E.; Layzell, T. P.; Brown, J. M. " The Scope of Catalytic 
Asymmetric Hydroboration/Oxidation with Rhodium Complexes of 1,1′‐(2‐
Diarylphosphino‐1‐naphthyl)isoquinolines" Chem. Eur. J. 1999, 5, 1320.  
(20)  Edwards, D. R.; Hleba, Y. B.; Lata, C. J.; Calhoun, L. A.; Crudden, C. M. 
"Regioselectivity of the rhodium-catalyzed hydroboration of vinyl arenes: electronic twists 
and mechanistic shifts" Angew. Chem., Int. Ed. 2007, 46, 7799.  
(21) Birman, V. B.; Li, X. "Benzotetramisole:  A Remarkably Enantioselective Acyl 
Transfer Catalyst" Org. Lett., 2006, 8, 1351.  
(22) Zhang, Y. H.; Xu, C. F.; Li, J. F.; Yuan, C. Y. "Candida rugosa Lipase‐catalyzed 
Kinetic Resolution of Hydroxy‐alkanephosphonates" Chin. J. Chem., 2003, 21, 883.  
95 
 
CHAPTER THREE: PHOSPHONATE-DIRECTED CATALYTIC ASYMMETRIC 
HYDROBORATION OF TRISUBSTITUTED ALKENES 
3.1. Review of reported examples of CAHB with trisubstituted alkenes 
The use of trisubstituted alkenes as substrates for CAHB has historically proven 
challenging; few successful reports appear in the literature. In 2010, Smith and Takacs 
published the first successful report of efficient amide-directed CAHB of stereodefined 
trisubstituted alkenes (Figure 3.1A).1 In the reported transformation, E- or Z- β,γ-
unsaturated β,γ,γ-trisubstituted (which, giving numbering priority to the directing group, 
we sometimes refer to as a 1,2,2-trisubstituted) alkene substrates underwent efficient 
rhodium-catalyzed β-selective CAHB with pinacolborane to afford chiral secondary 
boronic esters. The highlight of this chemistry is the formation of two vicinal chiral centers 
assembled in a single step in a highly enantioselective reaction. For example, substrate (Z)-
27 underwent CAHB forming the chiral secondary boronic ester in excellent yield and high 
levels of stereoinduction to form (3R,4R)-28 (83%, 97.5:2.5 er). The TADDOL-derived 
chiral cyclic phosphite (R,R)-T1 was used as the ligand in this transformation.  
 In 2015, Tang and workers reported the CAHB of α-aryl enamides to afford α-
amino chiral tertiary boronic esters (Figure 3.1B). Simple trisubstituted substrates such as. 
(E)-29 were shown to undergo CAHB with the formation of the corresponding tertiary 
boronic ester product (S)-30 (57%, 96.5:3.5 er) in high levels of enantioinduction. The 
monodentate phosphine ligand BI-DIME was used in a 1:1 ratio with a rhodium-precatalyst 
to generate the active catalyst in-situ.  
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Figure 3.1. Reported examples of CAHB with trisubstituted alkenes. 
 
In 2016, the Takacs group published a second report of efficient CAHB of 
stereodefined trisubstituted alkenes (Figure 3.1C).2 In this report, an oxime-ether 
functionality was used as the directing group instead of the amide functionality used 
previously. A new alkene substitution pattern was also used in this study as compared to 
ones previously reported. E- or Z- β,γ-unsaturated β,β,γ-trisubstituted (or 1,1,2-
trisubstituted) alkenes such as (E)-31 underwent efficient oxime-directed β-selective 
CAHB with pinacolborane to afford novel chiral all-alkyl tertiary boronic ester (R)-32 
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(84%, 95:5 er) in excellent yield and high levels of enantioinduction. This work was the 
first example of a methodology to access chiral tertiary all-alkyl boronic esters via CAHB 
of trisubstituted alkenes. This methodology was also shown to be highly site-selective; in 
case of substrates bearing multiple alkenes, the alkene proximal to the directing group 
underwent selective reaction leaving the distal alkene untouched. The TADDOL-derived 
chiral cyclic phosphite (R,R)-T1 was also used as the ligand in this transformation.  
Subsequent examples of enantioselective B-H addition to alkenes appeared in the 
literature in the recent years. Some of these transformations (Figure 3.1 C-E) could be 
appropriately described as protoboration instead of hydroboration as no hydride source is 
involved in the processes. The postulated mechanism involve a copper-catalyst and 
diborane (B2Pin2) in the presence of an alkoxide base to generate a copper-boryl 
intermediate; the nucleophilic boron undergoes addition to an alkene resulting in an 
organo-copper intermediate bearing a boronic ester.3 The organocopper intermediate 
subsequently undergoes protonolysis to release the copper catalyst and forms the C-H bond 
in the product. This mechanism is significantly different as compared to that generally 
postulated for a rhodium catalyst and a borane. A rhodium catalyst can undergo oxidative 
addition of a X2B–H bond resulting in a boryl-rhodium-hydride (X2B–Rh–H) species 
which is assumed to be the active catalyst. Migratory insertion of the alkene into the Rh-H 
bond followed by reductive elimination of the C-B bond completes the catalytic cycle in 
rhodium catalysis.4  
In 2017 Qian Zhang and coworkers reported examples of efficient protoboration of 
cyclic bisaryl trisubstituted alkenes via a copper-catalyzed transformation to afford chiral 
secondary boronic esters (Figure 3.1C).5 For example, the substrate (Z)-33 undergoes 
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efficient protoboration with boron-delivery at the less substituted terminus of the alkene to 
afford the chiral secondary benzylic boronic ester (1R,2S)-34 (73%, 95.5:4.5 er). The 
bisphosphine ligand (S,S)-BDPP, which features a relatively small bite angle, was used in 
combination with a copper-precatalyst for optimal catalysis. Similar to Takacs' amide-
directed CAHB of trisubstituted alkenes (Figure 3.1A), the key highlight of this work is 
the formation of two vicinal chiral centers generated in a single step with high levels 
oregio- and enantioselectivity. More examples of protoboration of trisubstituted alkenes to 
access chiral tertiary boronic esters are documented in Chapter 1 of this dissertation.  
 Recently, Bie-Jie Li and coworkers reported a β-selective CAHB of trisubstituted 
vinyl (i.e., α,β-unsaturated) amide substrates (Figure 3.1E).6 Li’s work presents an unusual 
regiochemical outcome for such substrates. Vinyl amides have a strong substrate-
controlled electronic bias towards formation α-boryl amides under rhodium-catalyzed 
CAHB conditions. This is typically explained by initial hydride addition at the β-position 
leading to a stable carbanion at the α-position of the amide. The formed α-boryl amide 
undergoes facile protodeboronation resulting in a net reduction of such substrates. The 
novelty of Li's work is in the identification of the highly electron rich bidentate ferrocene-
based JoSPO ligand which results in switching the regioselectivity of the initial Rh-H 
addition to such substrates; the catalyst formed with the optimized ligand now leads to the 
initial hydride addition at the α-position of vinyl amide substrate leading to the formation 
of a β-Rh intermediate stabilized by the amide coordination. Subsequent C-B reductive 
elimination leads to boron delivery at the β-position. For example, the trisubstituted vinyl 
amide substrate (E)-35 containing a trisubstituted alkene undergoes efficient protoboration 
with the delivery of boron at the β-position to afford chiral secondary boronic ester 
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(2R,3R)-36 (84%, 98.5:1.5 er, >20:1 dr) in excellent yield and high levels of enantio- and 
diastereoselectivity. β-Borated products such as 36 are similar to ones obtained using 
Takacs' amide-directed β-selective CAHB of β,γ-di/trisubstituted alkene substrates. Apart 
from the unusual regiochemistry presented, Li's work also assembles two vicinal chiral 
centers in a single step and shows the possibility of accessing all 4-stereoisomers of 
products such as 36 using the methodology. 
 
3.2. Phosphonate-directed CAHB of all-alkyl trisubstituted alkenes: access to all-alkyl 
substituted chiral tertiary boronic esters 
In summer 2014 we started exploring the potential effectiveness of the phosphonate-
functionality as a directing group for the CAHB of several classes of alkene substrates. 
This was at a time when there was a single reference1 in the literature for the efficient 
CAHB of trisubstituted alkenes and the development of oxime-directed2 CAHB of 
trisubstituted alkenes was just taking shape in the Takacs lab. Encouraged by the success 
of the amide- and oxime-ether directing groups and as part of the Takacs' group strategy to 
compare and contrast the results obtained using very different directing groups, we started 
exploring phosphonate-directed CAHB of stereodefined trisubstituted alkenes.  
 Allylic phosphonates bearing all-alkyl 1,1,2-trisubstituted alkenes were found to 
undergo highly efficient β-boration under standard CAHB conditions affording chiral 
tertiary boronic esters.7 For example, substrate (E)-37a underwent efficient CAHB 
affording the chiral all-alkyl substituted tertiary boronic ester (R)-38a (82%, 99:1 er; Figure 
3.2) in excellent yield and very high levels of enantioinduction. Substrate (E)-37a is similar 
to (E)-29, differing only in the nature of the directing group present (phosphonate vs. oxime 
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ether). Unlike the results obtained with conjugated methylidene substrates (e.g. substrates 
3 vs. 5a; see Chapter 2), the oxime- and phosphonate-functionalized trisubstituted alkene 
substrates (i.e., 29 and 37) undergo efficient CAHB with pinacolborane with similar regio 
and π-facial selectivity. For the phosphonate-directed reaction, the ligand (R,R)-T2 bearing 
a 2-methylphenyl group at the terminus was found empirically to be superior to (R,R)-T1. 
Yields for phosphonate-directed CAHB are typically slightly higher (ca. 4-5%) using T2 
than those obtained using T1; the er of (R)-38a obtained using T1 is 98.5:1.5.  
 
Figure 3.2. Phosphonate-directed CAHB of all-alkyl trisubstituted alkenes. (Adapted with 
permission from Ref. 7. Copyright 2017 American Chemical Society) 
  
 The formation of chiral, tertiary all-alkyl boronic esters is one of the novel features 
of this transformation. We estimate based on 31P NMR analysis of the crude CAHB mixture 
that greater than >90% of the crude product is due to the major tertiary boronic ester. The 
remaining mass balance is accounted by 4-5 minor products. While we did not analyze any 
of the trace minor products, based on the results obtained with other substrates, we 
speculate the formation of alkene reduction product and the minor regioisomeric secondary 
boronic ester accounts for the majority of the remaining mass balance. 
 While the regioselectivity of the phosphonate-directed CAHB of all-alkyl 
trisubstituted alkenes (e.g. 38a) is similar to those obtained with methylidene vinyl arene 
substrates (e.g. 5a; See Chapter 2), an obvious question as to the origin of the unusual 
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regioselectivity remains. In the case of 5a, we inferred that intermediacy of a tertiary 
benzyl-rhodium intermediate may be important in the catalytic cycle with methylidene 
vinyl arenes. The importance of the phosphonate-functionality in the CAHB of all-alkyl 
trisubstituted alkenes such as 38a is obvious, given the lack of additional activation  (e.g. 
presence of conjugation) and the unusual regioselectivity for generation of chiral tertiary 
boronic esters. As a result, we decided to check the reactivity of a one carbon homologue 
(39) under the standard conditions. In the event of CAHB, the substrate 39 is essentially 
unreactive, providing a direct evidence of the importance of the effective positioning of the 
phosphonate-functionality and the trisubstituted alkene for efficient catalysis.  
 
3.3. Mechanistic insights into phosphonate directed CAHB of all-alkyl trisubstituted 
alkenes  
As discussed in Chapter 2, deuterium labelling experiments can help shed significant light 
into the mechanism of a catalytic transformation. Deuterium labelling for substrate (E)-37a 
was carried out under standard CAHB conditions except for use of pinBD and the reaction 
quenched with methanol prior to completion to look for deuterium incorporation in 
substrate. The reaction of (E)-37a with pinBD using 2 mol% catalyst loading was quenched 
with methanol after 30 minutes and the reaction mixture was analyzed using 2H NMR and 
HRMS. Deuterium incorporation was identified in the substrate as evidenced from 2H 
NMR and the presence of the molecular ion peak corresponding to 3-d-(Z)-37a via ESI-
HRMS (Figure 3.3).  
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Figure 3.3. A. 1H NMR of (Z)-37a. B. 2H NMR (zoomed in to 4-7 ppm) after incomplete 
CAHB reaction with pinBD showing vinyl deuterium peak inferring the presence of 3-d-
(Z)-37a. C. Deuterium incorporation in the vinyl position of (E)-37a seen during CAHB. 
D. HRMS data of CAHB mixture indicating presence of 3-d-(Z)-37a (highlighted in 
yellow). 
 
The formation of 3-d-(Z)-37a is further indicated by the analysis of different levels 
of deuterium incorporation in (2S)-40a obtained via the CAHB of (E)-37a (obtained in a 
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separate experiment after complete substrate consumption) followed by oxidation (Figure 
3.4). Formation of 3-d-(Z)-37a from (E)-37a under CAHB conditions generates an 
equivalent amount of pinBH (vide infra). The pinBH generated in-situ from substrate 
isomerization can react with (E)-37a followed by oxidation to afford the unlabeled proteo 
product (S)-40a after oxidation. The monodeuterated alcohol product 3-d-(2S)-40a can 
presumably arise via the CAHB of (E)-37a with pinBD followed by oxidation. 
Alternatively, a small amount of the diastereomeric 3-d-(2S)-40a product is also possible 
from the CAHB of 3-d-(Z)-37a with the pinBH generated in-situ from substrate 
isomerization followed by oxidation. The dideuterated product 3,3-d2-(2S)-40a is also 
inferred in the product mixture. Its formation is possible via CAHB of (E)-37a with pinBD 
followed by oxidation.  
 
Figure 3.4. Different levels of deuterium incorporation seen in the CAHB of (E)-37a with 
pinBD (100% D purity) followed by oxidation. Note: Percentages inferred from 13C NMR 
and HRMS.   
 
The reaction between a Rh(I)-precursor (Rh(nbd)2BF4 or [Rh(cod)Cl]2/AgBF4) 
with the TADDOL derived chiral cyclic phosphite (R,R)-T2 is used to generate the active 
CAHB catalyst in-situ. Figure 3.5 summarizes data obtained probing aspects of the nature 
of chiral rhodium catalyst used for the phosphonate-directed CAHB. The ligand-to-metal 
ratio (i.e., T2:Rh) strongly influences the activity of the chiral catalyst. Graph A (Figure 
3.5) compares the yield of 38a over time for catalysts prepared with a 1:1 T2:Rh ratio (blue 
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line) and 2:1 T2:Rh ratio (red line). The catalyst formed using a 1:1 T2:Rh yields 38a in 
about 80% yield after roughly an hour. The catalyst formed using a 2:1 T2:Rh ratio 
produces 38a but in only 60% after roughly 4 hours. While the reaction is much slower, 
the enantiomer ratio of 38a (99:1 er) is unchanged by the change in T2:Rh ratio. Graph B 
(Figure 3.5) shows the linear dependence of percentage enantiomeric excess (ee) of product 
38a on the enantiomeric purity of T2. The lack of a non-linear effect in this case is 
consistent with a 1:1 T2:Rh complex in the active catalyst. The results of this study indicate 
that a 1:1 ratio of ligand-to-metal combination is optimal for efficient catalysis. For the 
phosphonate-directed CAHB reactions, we routinely use a 1:1 L:Rh complex as the active 
catalyst.   
 
Figure 3.5. Key mechanistic considerations: Graph A compares the yield of 38a over time 
for catalysts prepared using 1:1 (blue line) versus 2:1 (red line) T2:Rh ratios; Graph B plots 
percent ee of the product versus percent ee of the chiral catalyst. (Adapted with permission 
from Ref. 7. Copyright 2017 American Chemical Society).  
 
The complexed rhodium catalyst is expected to undergo oxidative addition with 
pinBD, followed by migratory insertion of the alkene in substrate (E)-37a to the Rh-D bond 
resulting in Im-1 (Figure 3.6) featuring a tertiary (3o)-alkyl rhodium intermediate in the 
catalytic cycle. If this intermediate undergoes rapid rotation followed by β-H elimination, 
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then deuterium incorporation in the vinyl position is possible leading to 3-d-(Z)-37a. If the 
migratory insertion of the alkene into a Rh-B bond were to occur first, then it would lead 
to the formation of the CAHB product after C-D reductive elimination, and that wouldn’t 
explain the formation of 3-d-(Z)-37a.  
Therefore, formation of 3-d-(Z)-37a highlights several important aspects of the 
catalytic cycle that underlies the CAHB of (E)-37a (Figure 3.6): (i) alkene coordination to 
the rhodium complex is reversible. (ii) migratory insertion of the alkene into the Rh-H/D 
bond occurs first in a reversible fashion to form Im-1. (iii) rapid rotation followed by β-H 
elimination would lead to the formation of 3-d-(Z)-37a and the generation of an equivalent 
amount of pinBH in the reaction mixture which is available to react with (E)- or 3-d-(Z)- 
37a (vide infra). (iv) reductive elimination of the C-B bond completes the catalytic cycle. 
Essentially the mechanistic features are similar to those inferred for the methylidene vinyl 
arene substrate 5a. However, while in case of 5a there was additional stabilization because 
of the β-phenyl group (leading to the formation of a π-benzyl complex), the seemingly 
facile formation of a 3o alkyl rhodium intermediate from (E)-37a is unusual and is not 
easily rationalized. 
 
Figure 3.6. Plausible mechanism of deuterium incorporation in substrate (E)-37a under 
standard conditions with pinBD. 
 
106 
 
3.4. Substrate scope of phosphonate directed CAHB of all-alkyl trisubstituted 
alkenes7  
The results obtained for a series of trialkyl substituted alkenes differing in the nature of the 
alkyl group at the γ-position (position labelled RE) is summarized in Figure 3.7. Substrates 
similar to 37a bearing substituted aromatics and heteroaromatics (i.e., 37b-e) undergo 
efficient β-selective CAHB, forming the corresponding chiral tertiary boronic esters. For 
example, the substrate bearing a 4-trifluoromethylphenyl unit  (i.e., 37b) affords chiral 
tertiary boronic ester 38b (78%, >99:1 er). The 4-chlorophenyl derivative 38c (76%, 99:1 
er), could in principle be used in subsequent cross-coupling chemistry,8 further highlighting 
the potential of CAHB for generation of multifunctional synthons via CAHB. Furthermore, 
substrates 37d and 37e demonstrate that simple heteroaromatic ring systems can be carried 
through the CAHB sequence; chiral tertiary boronic esters 38d (77%, 98.5:1.5 er) and 38e 
(71%, 97:3 er) are obtained in good yields and high enantioselectivities.  
 Substrates bearing saturated alkyl substituents at the γ-position (i.e., 37f and 37g) 
give tertiary boronic esters 38f (83%, 97:3 er) and 38g (80%, 98:2 er), respectively. The 
structurally related chiral substrate (2E,5S)-37h undergoes highly diastereoselective 
CAHB (>20:1 dr) with catalyst control; (R,R)-T2 affords (2R,5S)-38h (83%), and (S,S)-T2 
affords the diastereomeric (2S,5S)-38h (82%). β-Borated products bearing a Boc-protected 
nitrogen substituent (38i) or hydroxy substituents protected as the benzoate (38j), benzyl 
ether (38k), or benzyloxymethyl ether (38l), are obtained with high levels of asymmetric 
induction. The chiral acetal substrate (2E,5S)-37m undergoes efficient CAHB, again with 
good catalyst control over diastereoselectivity. Depending on the configuration of the 
ligand T2 used, either (2R,5S)-38m or (2S,5S)-38m is obtained in high yield (81-82%) and 
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in high levels of diastereoselectivity, 97:3 dr and 98:2 dr, respectively. The one carbon 
shorter analogue (2E,4S)-37n affords (2R,4S)-38n (51%, 91:9 dr) using (R,R)-T2 but forms 
a rather complex mixture with (S,S)-T2. Substrates related to 37n, bearing bulkier vinyl 
substituent at the γ-position such as in 37o and 37p, tend to react more sluggishly and give 
more side products; for example, lower yields are obtained for 38o (52%, 90:10 er) and 
38p (53%, 98:2 er).  
 
Figure 3.7. Substrate scope of phosphonate-directed CAHB of trialkyl substituted alkenes. 
CAHB conditions: 0.5 mol% Rh-precatalyst ([Rh(cod)Cl]2/2AgBF4), 0.5 mol% (R,R)-T2 
(unless otherwise indicated). In each case, the er is determined after oxidation to the 
corresponding tertiary alcohol or to other derivatives (See Chapter 5 for details). (Adapted 
with permission from Ref. 7. Copyright 2017 American Chemical Society).  
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  The alkene geometry also plays a critical role in the reaction. For example, while 
(E)-37a undergoes CAHB/oxidation in high yield, (Z)-37a yields (R)-38a (40%, 99:1 er) 
in much lower yield but with high levels of enantioselectivity. The re/si-sense π-facial 
selectivity for CAHB of (Z)-37a is the same as that obtained from (E)-38a. Alkene 
reduction is a significant side reaction for substrate (Z)-37a accounting for the much lower 
yield obtained for the desired hydroboration product.  
Figure 3.8 shows several substrates related to (E)-37a that gave poor results under 
the standard CAHB conditions. Attempted CAHB of substrate related to (E)-37a with a 
1,2,2- substitution pattern (e.g. (E)-37q) results in essentially no reaction under the 
standard conditions. At this stage, we can only conclude this to be a limitation of the 
catalyst system generated using (R,R)-T1, because rigorous catalyst optimizations have not 
been carried out for this substrate. The substrate (2E,5S)-37r derived from (S)-citronellal 
was prepared to check for diastereoselective and site-selective reaction of the proximal 
alkene under standard CAHB conditions. In the event, however, the distal alkene partially 
undergoes competing reaction(s), and we were not successful in carrying out selective 
CAHB of just the proximal alkene. If the terminal alkene in (S)-citronellal was reduced 
using H2/Pd-C prior to incorporation in substrate, for example in case of substrate (2E,5S)-
37h; the latter undergoes efficient diastereoselective CAHB under standard conditions 
(Figure 3.7). The skipped diene substrate (E)-37s was prepared as part of our initial plan 
towards the synthesis of the natural product bakuchiol (See Chapter 4). Similar to the case 
of 37r, the substrate 37s did not undergo selective CAHB at the proximal alkene. The 
skipped distal alkene also underwent partial reaction under the standard CAHB conditions. 
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The substrate (E)-37t bearing a conjugated diene resulted in a complicated reaction mixture 
under the reaction conditions.  
Another current limitation is found for bulkier analogs of substrates related to (E)-
37a, wherein the methyl substituent on the alkene is replaced by bulkier substitutes. Such 
substrates tend to react sluggishly and resulted in complex reaction mixtures. For example, 
substitution of the vinyl methyl group in (E)-37a by an ethyl group as in (E)-37u, a benzyl 
group as in (E)-37v or the dimethyl allyl group as in (E)-37w did not result in clean 
transformations. A further complication arises in attempted isolation of the major product 
either at the boronate stage or post-oxidation to the corresponding alcohols for some of 
these substrates. In our hands, clean separation by chromatography on silica was not 
possible because the overall polarity of the molecules is dominated by the phosphonate 
functionality and changes in the hydrocarbon backbone did not provide sufficient 
differentiation for efficient separation of regioisomeric mixtures.  
 
Figure 3.8. Limitations of the methodology: Unsuccessful trisubstituted substrates.  
  
3.5. Phosphonate-directed CAHB of aryl-substituted (i.e., styrenyl) trisubstituted 
alkenes: facile access to chiral tertiary benzylic boronic esters9 
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Figure 3.8 showed some limitations in substrate scope we uncovered for substrates related 
to (E)-37a under the standard CAHB conditions. Substitution of the β-vinyl methyl group 
to other bulkier substituents such as an ethyl group, benzyl group or a 3,3-dimethylallyl 
group resulted in substrates that were unsuccessful under the standard conditions. 
However, the substitution of the β-vinyl methyl group to a β-vinyl phenyl or aryl group 
resulted in substrates that underwent efficient β-selective CAHB. For example, substrate 
(E)-41 undergoes efficient CAHB with pinacolborane using (R,R)-T2, generating the 
highly hindered chiral tertiary benzylic boronic ester (R)-42 via delivery of boron to the 
more substituted carbon atom of the alkene undergoing the reaction (Figure 3.9). 
Comparison of the CAHB result of (E)-41 with other substrates (5a and (E)-37a) that 
undergo conversion to tertiary boronic esters revealed an interesting disparity in the re/si 
sense of π-facial selectivity (Figure 3.9).  
 
Figure 3.9. Disparity in π-facial selectivity in CAHB for substrates differing in the nature 
of the alkene substituent at the β-position.9 
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Using the same configuration of the ligand T2, substrates 5a, (E)-37a and (E)-41a 
result in β-boration; however, the facial selectivity in the addition of pinBH across the π-
system is dependent on the nature of the substituent appended at the β-position of the 
substrate. As illustrated in Figure 3.9, pinBH is added at the β-position from the "top-face" 
(of the perspective shown) for substrates 5a and (E)-41a (bearing an aryl substituent at the 
β-position), whereas pinBH is added at the β-position from the "bottom-face" for substrate 
(E)-37a (bearing an alkyl substituent at the β-position) using (R,R)-T2. This reversal in π-
facial selectivity may stem from π-stacking interactions between the substrate and the 
ligand for vinyl arene substrates or via involvement of the aromatic ring stabilizing a Rh-
C intermediate. The latter argument has been long used to explain the regioselective 
hydroboration of simple vinyl arenes.10 As a practical matter, however, the top/bottom 
sense of π-facial selectivity is of no consequence; either configuration of ligand T2 is 
equally accessible, and hence either enantiomeric/diastereomeric products (in case of chiral 
substrates) can be prepared with equal facility.  
 
3.6. Mechanistic insights into phosphonate directed CAHB of styrenyl trisubstituted 
alkenes 
The CAHB results obtained from styrenyl trisubstituted alkenes (e.g. (E)-41a) are similar 
to those results obtained from all-alkyl trisubstituted alkenes (e.g. (E)-37a) and 
methylidene vinyl arene substrates (e.g. 5a) in terms of the regiochemical outcome 
obtained. The only apparent difference is noted in terms of π-facial selectivity. We 
questioned whether the mechanism of CAHB with styrenyl trisubstituted alkenes is similar 
in terms of the sequence of elementary steps in the mechanistic cycle with the other two  
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Figure 3.10. A. 1H NMR of (E)-41a. B. 2H NMR (zoomed in to 4-7 ppm) after incomplete 
CAHB reaction with pinBD showing vinyl deuterium peak inferring the presence of 3-d-
(Z)-41a. C. Deuterium incorporation in the vinyl position of (E)-41a seen during CAHB. 
D. HRMS data of CAHB mixture indicating presence of 3-d-(Z)-41a (highlighted in 
yellow).   
 
substrate types, or if it is any different. Deuterium labelling experiments carried out using 
pinBD under standard CAHB reaction conditions for substrate (E)-41a shows deuterium 
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incorporation in substrate under reaction conditions, a result similar to that observed for 
other substrates affording tertiary boronic esters (Figure 3.10).  
 Furthermore, the analysis of the tertiary alcohol product formed from (E)-41a via 
CAHB with pinBD followed by oxidation shows different levels of deuterium 
incorporation; the three different products identified are non-deuterated 43a, the 
monodeuterated product 3-d-43a and the dideuterated product 3,3-d2-43a (Figure 3.11). 
These results together indicate that the mechanism of CAHB of styrenyl trisubstituted 
alkenes (e.g. (E)-41a) is similar to that inferred for the other two classes of substrates. After 
oxidative addition of the Rh-complex with B–H/D bond, the substrate undergoes migratory 
insertion to the Rh–H/D bond forming a tertiary benzyl rhodium intermediate stabilized by 
chelation to the phosphonate. This intermediate could undergo C-B reductive elimination 
to form the mono-deutero product 3-d-43a and regenerate the catalyst, or it can undergo β-
H elimination to incorporate deuterium in the alkene and form 3-d-(Z)-41a. In the event, a 
Rh–H intermediate is formed, interception of which by a substrate can explain the 
formation of the proteo product 43a after oxidation. Similarly, migratory insertion of 3-d-
(Z)-41a to the Rh-D bond followed by C-B reductive elimination can explain the formation 
of 3,3-d2-43a.  
 
Figure 3.11. Different levels of deuterium incorporation seen in the CAHB of (E)-41a with 
pinBD (100% D purity) followed by oxidation. Note: Percentages inferred from 13C NMR 
and HRMS.   
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3.7. Substrate scope of phosphonate-directed CAHB of styrenyl trisubstituted 
alkenes9 
Figure 3.12 summarizes the effects of variations in several structural features of 
trisubstituted styrenyl substrates similar to (E)-41a on the overall outcome of CAHB: (1) 
the effect of ring size (5 vs. 6 membered ring) of the arene appended at the β-position, (2) 
the stereochemistry of the alkene (E vs. Z substrates), and (3) the presence of aryl 
substituents on both the carbon atoms of the alkene undergoing reaction. Substrate 41b 
bears a 5-membered thiophene ring at the β-position and an alkyl chain bearing a chiral 
dioxolane at the γ-position. Catalyst controlled diastereoselective CAHB of both (E)- and 
(Z)-41b occurs with similar efficiency: β-boration leads to the formation of chiral tertiary 
benzylic boronic ester 42b in excellent yield and high levels of stereoinduction. Use of 
(R,R)-T2 results in (2S,5S)-42b (structure shown in Figure 3.10) and use of (S,S)-T2 leads 
to the diastereomeric boronic ester (2R,5S)-42b from either diastereomer of 41b. Thus, 
depending on the choice of the ligand used, either diastereomer of the boronic ester 42b 
can be accessed with ease and the alkene stereochemistry does not impact overall yield or 
product diastereoselectivity. The chiral dioxolane unit appended at the γ-position is not a 
requirement for the reaction, however, its presence allows for the ease of diastereomer 
differentiation via 31P NMR analysis of the crude CAHB mixture.  
Substrates similar to 41b, but bearing a 6-membered phenyl ring at the β-position 
(e.g. 41c) in place of the five membered thiophene ring, exhibit more pronounced 
differences in CAHB results when diastereomeric (E)- and (Z)- stereoisomers were used. 
The trans-isomer (E)-41c undergoes CAHB with (R,R)-T1 forming the tertiary benzylic 
boronic ester (2R,5S)-42c (80%, 91:9 dr) in excellent yield but in moderate levels of 
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diastereoselectivity as compared to the cis-isomer (Z)-41b. CAHB of (E)-41c with (S,S)-
T1 leads to formation of (2S,5S)-42c (78%, 85:15 dr) in high yields but with reduced levels 
of diastereoselectivity. However, the corresponding cis isomer (Z)-41c undergoes CAHB 
with much higher efficiency in terms of yield and diastereoinduction. CAHB using (R,R)-
T1 results in the formation of (2R,5S)-42c (83%, 96:4 dr) in excellent yield and 
diastereoselectivity. CAHB of (Z)-41c with (S,S)-T1 leads to the formation of 
diastereomeric boronic ester (2S,5S)-42c (84%, 97:3 dr) in excellent efficiency as well. 
Thus, as compared to substrate 41b (bearing a 5-membered thiophene ring at the β-
position), the substrate 41c bearing a 6-membered phenyl ring shows slight 
match/mismatched effect in the event of CAHB with enantiomeric chiral ligands used. 
Furthermore, while the alkene stereochemistry did not impact the overall yield and 
stereochemistry in case of substrate 41b, the alkene stereochemistry in case of 41c plays a 
crucial role in CAHB: the (Z)-substrate has superior performance as compared to the (E)-
isomer.  
In contrast to 41c, substrate 41d bears phenyl groups in both the β- and γ-positions, 
presenting a potential competition for regiocontrol. CAHB of β-aryl methylidene substrate 
5a results in preferential β-boration leading to chiral tertiary boronic esters such as 6a, and 
CAHB of γ-aryl 1,2-disubstituted substrate 18a results in preferential γ-boration leading to 
chiral secondary benzylic boronic esters such as 19a (Chapter 2). The case of 41d naturally 
raises the question as to which one of the two phenyl groups will determine the 
regiochemistry? In the event of CAHB with (R,R)-T2, (E)-41d yields the β-borated product 
(R)-42d (60%, 3:1 β:γ, 97:3 er) in moderate yield and regioselectivity yet in high levels of 
enantiocontrol. However, unlike the improved enantioselectivity seen for the (Z)- isomer 
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of 41c, CAHB of diastereomeric (Z)-41d affords (R)-42d (71%, ~4:1 β:γ, 70:30 er) with a 
slightly improved yield but in much lower degree of enantioinduction. The presence of γ-
phenyl group in (Z)-41d exerts a deleterious steric effect resulting in much lower levels of 
enantioinduction.  
 
Figure 3.12. Phosphonate-directed CAHB of styrenyl trisubstituted alkenes: effect of ring 
size, alkene stereochemistry and the presence of aryl substituents in both carbon atoms of 
the alkene. (Adapted with permission from Ref. 9. Copyright 2018 American Chemical 
Society) 
  
Substrates bearing a 2-thienyl moiety in the β-position as in 41b, but with a simple 
alkyl substituent in the γ-position (e.g. 41e), also undergo β-boration, yielding the 
corresponding tertiary benzylic boronic ester product (S)-42e (85%, 93:7 er) (Figure 3.13). 
The chiral substrate derived from citronellal (i.e., 41f) bears a pendant alkene as well a 
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remote stereocenter. It undergoes catalyst-controlled diastereo- and site-selective β-
boration, leaving the distal alkene intact. CAHB of 41f with (R,R)-T2 affords (2S,5S)-42f 
(55%, 92:8 dr), and (S,S)-T2 affords (2R,5S)-42f (58%, 92:8 dr). For substrate 41f, a higher 
catalyst loading (2 mole percent) is used. However, even using the higher catalyst loading, 
the reaction of this substrate did not proceed to completion, perhaps due to the presence of 
multiple chelating sites in the substrate leading to catalyst deactivation. It is worth noting 
that while 41f undergoes site selective CAHB of the proximal trisubstituted vinyl arene 
leaving the distal trialkyl substituted alkene untouched under the reaction conditions, the 
corresponding substrate bearing a methyl group at the β-position (compound 37r shown in 
Figure 3.8) did not undergo selective CAHB. In case of 37r, the distal alkene was also 
found to undergo competitive reaction, albeit not cleanly to a single product, even when 
using a limiting amount of pinBH. We speculate that the reactivity of the trisubstituted 
vinyl arene in case of 41f is significantly higher and the directed CAHB leads to site-
selective CAHB. However, in case of 37r, while there is activation for the proximal alkene 
from that of the directing group, the distal alkene also underwent partial consumption 
because of the similar substitution pattern.  
While substrates bearing a simple thiophene ring (e.g. 41b) undergoes β-selective 
CAHB affording tertiary benzylic boronic esters in high yields and high levels of 
diastereoinduction, the corresponding substrates bearing extended ring aromatics such as 
the benzothiophene derivative (41g) undergoe CAHB with lesser efficiency. 
Diastereoselective CAHB of 41g with (R,R)-T2 leads to the formation of (2S,5S)-42g 
(68%, 92:8 dr), and CAHB with (S,S)-T2 leads to the formation of (2R,5S)-42g (69%, 92:8 
dr). The corresponding benzofuran derivative 41h gives comparable results using (R,R)-
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T2, affording (2R,5S)-42h (76%, 93:7 dr), but exhibits an unusual mismatched effect with 
(S,S)-T2 to give (2S,5S)-42h (72%, 80:20 dr) with a much reduced level of 
diastereoselectivity.  
 
Figure 3.13. Substrate scope of phosphonate-directed CAHB of styrenyl trisubstituted 
alkenes. Note: Trans substrates were used. The E/Z descriptor of the substrate and the R/S 
descriptor of the chiral products is dependent on the nature of the β-substituent. Results 
highlighted in yellow are obtained using (R,R)-T2; nonhighlighted data are from reactions 
carried out using (S,S)-T2. (Adapted with permission from Ref. 9. Copyright 2018 
American Chemical Society) 
 
Finally, we find that allylic phosphonates bearing β-phenyl substituents, for 
example, (E)-41i-k, tend to undergo highly regioselective β-boration albeit with somewhat 
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lower diastereoselectivity. A significant electronic effect is also observed in this class of 
substituents. The 4-methoxyphenyl substrate 41i behaves like the phenyl substituted 
substrate (E)-41c; either diastereomer of 42i is formed with catalyst control in 75% yield 
but with modest diastereoselectivity (90:10 dr). However, presence of an electron-
withdrawing substituent lowers the yield and diastereoselectivity. For example, substrates 
41j (4-chlorophenyl derivative) and 41k (4-trifluoromethyl derivative) afford much lower 
yields (56-63%) of the corresponding chiral tertiary benzylic boronic esters 42j (83:17 dr) 
and 42k (ca. 85:15 dr), respectively.  
 
3.8. Summary and conclusions from the studies of phosphonate-directed CAHB 
In summary, enabling efficient access to chiral tertiary boronic esters via 
phosphonate-directed CAHB of several different alkene substrates including challenging 
trisubstituted alkenes, represents the key highlight of this dissertation work (Figure 3.14). 
Formation of chiral tertiary boronic esters via CAHB of trisubstituted alkenes was 
unprecedented in the literature until our group reported the first examples of oxime-2 and 
phosphonate-directed7,9 boration. Several new substrate types were also explored in the 
process such as trisubstituted styrenyl derivatives and bisaryl trisubstituted alkenes which 
underwent phosphonate-directed boron delivery at the more substituted carbon atom of the 
alkene undergoing reaction.  
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Figure 3.14. Summary of phosphonate-directed CAHB. 
 
The mechanism of rhodium-catalyzed CAHB leading to formation of tertiary 
boronic esters is a subject of intellectual curiosity. Migratory insertion of the alkene to a 
Rh-H bond is generally accepted to be the first step in the mechanistic cycle.11 However, 
we initially speculated that most likely our substrates were undergoing migratory insertion 
into a Rh-B bond first followed by reductive elimination of the C-H bond to form the 
tertiary boronic esters. While this speculation was not in lines with what is generally 
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accepted in the mechanistic cycle, we thought of the same to avoid invoking tertiary alkyl-
rhodium intermediates in the mechanistic cycle. However, our deuterium labelling 
experiments for several of the substrates showed the reversibility of elementary steps in the 
mechanistic cycle, incorporation of deuterium in the vinyl position of the substrate and 
formation of dideuterated products. The data put together supports a mechanism consistent 
with migratory insertion of the alkene to the Rh-H bond occurring first to form a tertiary 
alkyl-rhodium intermediate, which undergoes C-B bond reductive elimination to form the 
chiral tertiary boronic ester product and complete the catalytic cycle. Deuterium labelling 
data also suggests that reductive elimination is likely the irreversible step in the catalytic 
cycle.   
The outcomes from phosphonate-directed CAHB of different classes of alkene 
substrates is summarized in Figure 3.14. Tertiary boronic ester products such as 6l, 38m, 
42f and 42d are obtained from the phosphonate-directed CAHB of β-aryl methylidene, β,γ-
bisalkyl trisubstituted, β-aryl, γ-alkyl trisubstituted and β,γ-bisaryl trisubstituted alkene 
substrates respectively. The selectivity for the formation of chiral tertiary boronic esters 
from these substrate classes varied significantly. For example, the regioselectivity in 
CAHB of β-aryl methylidene substrates (e.g. 5l) was at best about 4:1, however, very high 
levels of enantioinduction were generally achieved irrespective of the nature of the aryl 
group appended at the β-position. The only exception was in case of the substrate bearing 
a 3-thienyl group at the β-position (5m). CAHB of 5m resulted in the tertiary boronic ester 
product 6m (80%, 88:12 er) with a much-reduced level of enantioinduction. Several 
substrates in the class of all-alkyl trisubstituted alkenes (e.g. 37m) underwent CAHB with 
high efficiency providing excellent yields and enantioinductions of the chiral boronic esters 
122 
 
formed. The major limitation in this class of substrates was the high levels of steric 
sensitivity. Replacement of the vinyl methyl group with larger alkyl groups resulted in non-
selective reactions leading to mixtures of products that were not easily separated from each 
other.  
The substrate class of β-aryl, γ-alkyl trisubstituted (i.e.,styrenyl trisubstituted 
alkenes, e.g. 41f) underwent CAHB with high levels of selectivity yielding the 
corresponding tertiary boronic esters in high yields, however, the levels of 
enantioinductions were comparatively lower as compared to other substrate classes. The 
efficiency of enantioinduction was found to be dependent on (1) the alkene geometry for 
substrates bearing 6-membered aromatic ring at the β-position, with the Z-substrate 
resulting in higher levels of enantioinduction, (2) steric hindrance of extended ring systems 
such as benzothiophene/benzofuran resulted in lower levels of enantioinduction.  
The substrate class of β,γ-bisaryl trisubstituted alkenes (e.g. 41d) was a curious 
case. In the event of CAHB, boron is delivered to the carbon atom of the alkene proximal 
to the phosphonate-directing group resulting in the formation of tertiary boronic ester 
products. However, the regioisomeric ratio was much lower; about 3:1 ratio of 
regioisomers was obtained. The alkene geometry had a significant effect on the 
enantioinduction in this case with very low levels of enantioinduction obtained for the Z-
substrate as compared to the E-counterpart.  
1,2-disubstituted vinyl arene substrates (e.g. 18n) are isomeric to the corresponding 
1,1-disubstituted vinyl arene substrates (e.g. 5l) and these result in the formation of chiral 
secondary benzylic boronic esters via regioselective γ-boration. High levels of selectivity 
were obtained in this substrate class and the limitations were seen with some common 
123 
 
heterocyclic ring systems of high relevance in medicinal chemistry. The allyl phosphonate 
substrates (i.e., β,γ-unsaturated) substrates are generally more efficient as compared to the 
homoallyl phosphonate (i.e., γ,δ-unsaturated) substrates. However, in case of the 1,2-
disubstituted vinyl arene substrates, the corresponding homoallyl substrates also underwent 
CAHB with similar efficiency.    
Several other permutations were tested which did not lead to successful results. 
Although, in principle, several of these systems could be further improved via ligand and 
borane optimizations. For example, the β-alkyl methylidene substrates (e.g. 7) undergo 
CAHB with boron delivery to the less-substituted carbon atom of the alkene undergoing 
reaction leading to β-chiral primary boronic esters (e.g. 8). β-alkyl, γ-aryl trisubstituted 
alkenes (e.g. 18aa) undergo γ-selective CAHB resulting in chiral secondary benzylic 
boronic ester (19aa) with the formation of two vicinal chiral centers in a single step. 
However, with the common ligand systems used, we were at best able to get a very modest 
level of enantioinduction for 19aa (T2: 75%, 65:35 er).  
Phosphonate-directed CAHB of a variety of alkene substrates is presented in this 
dissertation. The reactions are carried out under ambient conditions, demonstrate a broad 
substrate scope and can be performed on multigram quantities. Because of the generality 
and practical significance of this methodology, we expect this work to add to a growing 
repertoire of methods to access functionized chiral secondary and tertiary boronic esters 
with high fidelity. 
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CHAPTER FOUR: STEREOSPECIFIC TRANSFORMATIONS OF PHOSPHONATE-
FUNCTIONALIZED CHIRAL SECONDARY AND TERTIARY BORONIC ESTERS 
4.1. Stereospecific transformations of multifunctional chiral boronic esters 
Chiral boronic esters are versatile intermediates in asymmetric synthesis because of the 
relative ease with which the C-B bond can be transformed into a myriad of rapidly evolving 
diverse stereospecific transformations.1 In addition, chiral boronic esters and the 
corresponding chiral boronic acids are being increasingly seen as important therapeutic 
candidates as developments in efficient construction of chiral organoboronates continue to 
evolve.2 Chiral boronic esters are highly bench stable and are stable to air and moisture, 
yet they undergo a variety of C-B bond substitutions upon appropriate activation via either 
(1) electrophile induced 1,2-migration from a boron-ate complex for stereoretentive 
transformations, or (2) SE2 reaction between a boron-ate complex and an appropriate 
electrophile for stereoinvertive transformations.3  
 The Takacs group focuses on the synthesis of functionalized chiral boronic esters 
via directed CAHB of appropriately functionalized alkene substrates.4 These 
multifunctional boronic esters can be converted to a variety of different targets of interest 
in medicinal chemistry by sequentially exploiting the chemistries of the boronic esters and 
that of the additional functionality present in the molecule (usually the directing group). 
For example, the tert-butyl carboxylic ester functionalized chiral primary boronic ester (R)-
45 (synthesized via ester-directed CAHB of methylidene substrate 44) undergoes 
spontaneous lactonization under typical conditions employed for the oxidation of chiral 
boronic esters (H2O2/NaOH) to form β-benzyl substituted γ-lactone (R)-46 (Figure 4.1).4a 
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β-Substituted butyrolactones such as compound 46 undergo diastereoselective alkylation 
and have been used in the synthesis of lignan natural products such as (+)-arctigenin.5  
 
Figure 4.1. Transformations of multifunctional chiral boronic esters to obtain medicinally 
relevant synthetic targets. Reagents and conditions: (a) Rh(nbd)2BF4 (1 mol%), (R,R)-T1 
(2 mol%), tmdBH (2 equiv.), THF, 40 oC; (b) H2O2/NaOH; (c) Rh(nbd)2BF4 (1 mol%), 
(R,R)-T1 (2 mol%), pinBH, THF, 40 oC; (d) i. LiC(OEt)=CH2, -78 
oC, THF. ii. I2. iii. 
NaOMe, MeOH; (e) HCl, H2O/MeOH, 40 
oC; (f) BCl3, DCM; (g) Raney Ni, H2, 
MeOH/THF.   
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 Other examples of using functionalized chiral boronic esters obtained via directed 
CAHB include transformations of oxime-ether functionalized chiral boronic esters to 
access unique structural motifs such as 4,4,5-trisubstituted isoxazoline, 5,6-dihydro-1,2-
oxazine and oxaborolane derivatives (Figure 4.1B).4c Oxime-directed CAHB of 
trisubstituted alkene substrate (E)-47 yields the chiral tertiary boronic ester (R)-48 (78%, 
97:3 er). Using conditions reported by Aggarwal et. al, Shoba and Takacs converted the 
chiral boronic ester (R)-48 to the methyl ketone derivative (S)-49 (40%, 97:3 er). 
Subsequent hydrolysis of the oxime-ether functionality generated the hydroxylamine 
intermediate which spontaneously undergoes condensation with the methyl ketone to 
generate the 3,4,4-trisubstituted isoxazoline derivative (S)-50 (88%, 97:3 er). Chiral 
isoxazoline derivatives are found in several natural products and these exhibit diverse 
biological properties, however, the 3,4,4-trisubstituted chiral isoxazoline derivatives are 
not known in the literature. The synthesis of (S)-50 by Shoba and Takacs constitutes the 
first report of enantioselective synthesis of a 3,4,4-trisubstituted isoxazoline.  
 The regioselective γ-boration of oxime-functionalized vinyl arene substrate 3 
affords (R)-4 (64%, 96:4 er).4c Using a similar strategy to that employed for the chiral 
tertiary boronic ester (R)-48 en-route to the synthesis of 3,4,4-trisubstituted isoxazoline 
derivative (S)-50, the chiral primary boronic ester (R)-4 was transformed to the methyl-
ketone derivative (R)-51 (57%) and its subsequent acid-catalyzed cyclization affords the 
chiral 5,6-dihydro-1,2-oxazine derivative (R)-52 (39%).  
 Boron is fairly ubiquitous in earth’s crust (8.6 x 10-4 %), occurring mainly as 
borates that serve structural roles as tetrahedral linker between four alkoxide units.6 
However, while organoboranes are versatile intermediates in asymmetric synthesis, they 
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are not found in nature. Recent developments in synthetic chemistry has allowed access to 
unique organoboron derivatives, some of which have promising activity in biological 
systems. For example, the oxaborolane Tavaborole (AN2690) is a topical drug for the 
treatment of onychomycosis.7 However, chiral cyclic oxaborolane derivatives are not 
known in the present literature. The oxime-functionalized chiral primary boronic ester (R)-
4 was transformed to the chiral oxaborolane (R)-54 by Bochat, Shoba and Takacs.4e 
Hydrolysis of the boronic ester in (R)-4 using BCl3 in dichloromethane gives the boronic 
acid (R)-53 which upon treatment with Raney nickel results in N-O bond cleavage of the 
oxime-functionality and subsequent cyclization affords the chiral borocycle (R)-54 (57%).  
 The syntheses of chiral heterocyclic compounds (S)-50, (R)-52 and (R)-54 highlight 
the potential utility of multifunctional chiral boronic esters for exploring unique chemical 
spaces in the context of medicinal chemistry, new molecular architectures and in the 
potential development of new drug candidates.  
 
4.2. Stereospecific transformations of phosphonate-functionalized chiral tertiary 
benzylic boronic esters 
Phosphonates and their corresponding phosphonic acids are often used as stable phosphate 
surrogates. The carbon-phosphorus bond (C-P) that defines these molecules is key to their 
potent bioactivity as well as their stability against enzymatic degradation.8 Chiral 
phosphonates, particularly hydroxy- and amino-phosphonates are bioisosteres of the 
corresponding amino acids and are key structural elements found in antibiotics, antiviral 
and anticancer drugs.9 However, the toolbox for introducing chirality via functionalization 
of phosphonates is largely limited to catalytic asymmetric hydrogenation of phosphonate-
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functionalized alkenes.10,11 The main goal towards exploration of the phosphonate-
functionality as a directing group in CAHB of alkenes was to access phosphonate-
functionalized chiral boronic esters and use these chiral synthons to access diverse chiral 
phosphonates via stereospecific C-B bond substitutions.  
Phosphonate-directed CAHB of methylidene vinyl arenes such as 5a and β-aryl 
trisubstituted alkenes such as 41a result in preferential β-boration leading to formation of 
chiral tertiary benzylic boronic esters.12 The reactivities of tertiary benzylic boronic esters 
(e.g. 6a) are significantly different from those of tertiary alkyl-substituted boronic esters 
(e.g. 38a). This is mainly because the presence of an aromatic ring appended to the chiral 
carbon significantly enhances the electrophilicity of the boron atom. As a result, while 
certain transformations such as protodeboronation,13 occur readily with tertiary benzylic 
boronic esters, the corresponding reaction of trialkyl substituted boronic esters occurs only 
under forcing conditions and lead to non-stereospecific protodeboronation.14 
Several common transformations of boronic esters were carried out using (R)-6a to 
demonstrate the potential utility of phosphonate-functionalized, chiral tertiary benzylic 
boronic esters (Figure 4.2). The chiral tertiary boronic ester is easily converted to the 
corresponding trifluoroborate salt (R)-55 (87%) using KHF2 in methanol;
15 trifluoroborate 
salts are generally more stable than the corresponding pinacol boronates and are of 
significant interest for metal-catalyzed cross coupling chemistry.16 While there are several 
reports for efficient stereospecific-cross coupling reactions of chiral secondary 
trifluoroborate salts, there are no reports in the present literature for the stereospecific 
cross-couplings of chiral tertiary trifluoroborate salts. Morken’s report on cross-coupling 
of tertiary trifluoroborate salts via radical mediated alkyl transfer17 and Londregan’s report 
131 
 
on construction of 1-heteroaryl-3-azabicyclo[3.1.0]hexanes by sp3-sp2 Suzuki-Miayura 
and Chan-Evans-Lam coupling reactions of tertiary trifluoroborates18 are the only two 
reports of efficient cross-coupling of tertiary trifluoroborate salts in the present literature; 
but neither is stereospecific.  
 
Figure 4.2. Synthetic utility of phosphonate-functionalized, chiral tertiary benzylic boronic 
esters is illustrated by selected transformations of 6a. Reagents and conditions: (a) KHF2, 
MeOH; (b) NaBO3.4H2O; (c) TBAF.H2O; (d) (i) nBuLi, furan, -78 
oC, THF; (ii) NBS; (iii) 
aq. Na2S2O3; (e) (i) CH2=CHMgBr; (ii) I2; (iii) MeONa, MeOH. (Adapted with permission 
from Ref. 12. Copyright 2018 American Chemical Society) 
 
Oxidation of (R)-6a by NaBO3.4H2O affords the chiral tertiary benzyl alcohol (S)-
13a (90%, 97:3 er). Protodeboronation28 of 6a using TBAF/H2O yields the known chiral 
phosphonate (R)-6a" (85%, 96:4 er).19 Cross-coupling of 6a with 2-lithiofuran is highly 
efficient under the conditions reported by Aggarwal14 to yield the furan derivative 56 (91%, 
97:3 er) in high yield and essentially complete stereospecificity; the latter contains a 
quaternary carbon stereocenter bearing two aryl groups, a structural motif attracting recent 
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interest in medicinal chemistry.20 Cross-coupling with vinylmagnesium bromide under 
similar conditions affords the vinyl derivative 57 (70%, 97:3 er).15 These stereospecific C-
B bond transformations construct chiral phosphonates bearing a quaternary chiral 
stereocenter. The Aggarwal cross-coupling procedures are successful in our system for 
coupling with 5-membered electron-rich furan and vinylation (synthesis of 56 and 57); 
however, attempted cross-coupling with 6-membered ring aromatics using Aggarwal’s 
procedure was not successful for the phosphonate-functionalized, chiral tertiary benzylic 
boronic ester 6a.  
 
4.3. Phosphonate-unmasking via oxophosphonate intermediates  
As mentioned above, phosphonates and phosphonic acids are important constituents of 
bioactive compounds principally due to their capacity to act as stable phosphate surrogates 
by resisting hydrolysis.8 In this section, the synthetic utility of the phosphonate moiety is 
highlighted by the chemistry of α-oxophosphonates (i.e., acylphosphonates) (Figure 4.3). 
The common methods of preparing acylphosphonates are via the reaction of 
trialkylphosphite with an acid chloride,21 a modification of the Michaelis-Arbuzov 
reaction, or via addition of a dialkylphosphite anion to an aldehyde followed by oxidation. 
The direct α-oxidation of phosphonates is not commonly employed in the literature, 
however, Weimer reported the oxidation of benzylic phosphonates to chiral α-
hydroxyphosphonates by treatment of the phosphonate α-carbanion with camphorsulfonyl 
oxaziridine.22 We used a similar strategy to oxidize phosphonate intermediates using 2-
(phenylsulfonyl)-3-phenyloxaziridine (Davis' oxaziridine),23 although our initial attempts 
to α-oxidize the boronic ester functionalized phosphonate 6a were unsuccessful. Catalytic 
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hydrogenation of 57 gives 58, which when treated with nBuLi and Davis' oxaziridine yields 
α-hydroxyphosphonate 59 (83%, 2:1 dr) in excellent yield but with minimal 
diastereoselectivity. However, the configuration of the α-chiral center is inconsequential 
because it is essentially lost in the subsequent steps.  
 
Figure 4.3. Oxidations leading to α-hydroxy- and oxophosphonates and their synthetic 
utility. Reagents and conditions: (a) nBuLi, –78 oC, THF; Davis' oxaziridine; (b) aq. 
NaHCO3 reflux; (c) Dess-Martin Periodinane, CH2Cl2; (d) LiAlH4, THF; (e) EtOH, DBU; 
(f) aq. NH3, THF; cat. (nBu)4NBr; (g) aq. NaOH; (h) (i) PhMgBr, –78 oC, THF; (ii) aq. 
NH4Cl; (iii) aq. NaOH. (Adapted with permission from Ref. 12. Copyright 2018 American 
Chemical Society) 
 
α-Hydroxyphosphonates such as 59 are aldehyde equivalents and these easily 
undergo elimination.24 Thus, treating 59 with aqueous NaHCO3 affords the chiral aldehyde 
(S)-60 (88%, 95:5 er). Alternatively, oxidation of α-hydroxyphosphonate 59 with Dess-
Martin periodinane affords acylphosphonate 61 (92%). Reduction of 61 with LiAlH4 yields 
the known chiral alcohol (S)-62 (89%, 95:5 er), confirming the absolute configuration 
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assigned to 6a.15,25 Acylphosphonates have also recently attracted interest as surrogates for 
esters and amides in asymmetric organocatalysis by serving the role of an active ester.26 
Thus, treatment of 61 with with (i) ethanol/DBU converts 61 to the chiral ester 63 (95%, 
96:4 er), or (ii) aqueous ammonia affords the chiral amide (S)-64 (85%, 97:3 er),27 or (iii) 
aqueous sodium hydroxide forms the known chiral carboxylic acid28 (S)-65 (91%, 96:4 
er).29 Treatment of 61 with phenylmagnesium bromide gives after aqueous workup the 
stable α-hydroxyphosphonate as a mixture of diastereomers, the latter when treated with 
aqueous base liberates the known chiral phenyl ketone30 (S)-66 (78% overall yield).31 
 
4.4. Stereoretentive and stereoinvertive transformations of phosphonate-
functionalized chiral secondary benzylic boronic esters 
While there are significant limitations, chiral tertiary boronic esters can be precursors to 
quaternary carbon stereocenters using the Aggarwal protocol for electrophile induced 
stereoretentive 1,2-B-to-C migration from an intermediate boron “ate” complex resulting 
in the net C-B to C-C bond substitution.1 Chiral secondary boronic esters, on the other 
hand, are somewhat more versatile in terms of their utility. Chiral secondary boronic esters 
can also be elaborated via stereoretentive electrophile promoted 1,2-B-to-C migrations, 
stereoretentive palladium- and rhodium-catalyzed cross-coupling protocols and by 
stereoinvertive SE2 reactions of boron-ate complexes with electrophiles.
1,3 For example, 
phosphonate-directed CAHB of 1,2-disubstituted vinyl arenes (e.g. (E/Z)-18a) affords 
functionalized chiral secondary benzylic boronic esters (e.g. (S)-19a). We demonstrated 
the synthetic utility of these phosphonate-functionalized, chiral secondary benzylic boronic 
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esters via stereoretentive and stereoinvertive C-B bond transformations of the boron-ate 
complex derived from (S)-19a (Figure 4.4).32   
 Stereoretentive cross-coupling with carbanions derived from electron rich vinyl and 
aromatic derivatives via electrophile-promoted 1,2-B-to-C migration of a boron-ate 
complex is generally quite facile under conditions reported by Aggarwal.14,15 For instance, 
treatment of (S)-19a with excess vinyl magnesium bromide followed by I2 and sodium 
methoxide affords the vinyl derivative (R)-67 (79%, 95:5 er) in high levels of 
stereospecificity.15 Similarly, reaction of (S)-19a with 2-lithiobenzofuran followed by NBS 
affords the gem-bisaryl product (S)-68 (68%, 96:4 er) with essentially complete 
enantiospecificity.14 While cross-coupling with 2-lithiobenzofuran is facile with the 
secondary benzylic boronic ester (S)-19a, the analogous transformation does not work with 
the tertiary benzylic boronic ester (R)-6a. Attempted cross- coupling of (R)-6a with 2-
lithiobenzofuran results essentially in complete protodeboronation resulting in the 
formation of 6a", however, the reaction with 2-lithiofuran works efficiently (Figure 4.2). 
This was a common problem encountered in several attempted C-B bond transformations 
with phosphonate-functionalized chiral tertiary benzylic boronic esters. If the electrophile 
induced 1,2-B-to-C migration is not fast enough (For mechanism, see Figure 1.25), 
protodeboronation of the ate-complex perhaps due to adventitious moisture or during 
aqueous workup leads to the reduced product.  
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Figure 4.4. Synthetic utility of chiral secondary benzylic boronic esters illustrated by 
stereoretentive and stereoinvertive C-B bond transformations. Reagents and conditions: (a) 
(i) Excess CH2=CHMgBr, THF, -78 
oC to rt; (ii) I2/MeOH, -78 
oC; (iii) NaOMe/MeOH; 
(iv) Na2S2O3 (aq.); (b) (i) benzofuran-2-yllithium, THF, -78 
oC; (ii) NBS, THF, -78 oC; 
(iii) Na2S2SO3 (aq.); (c) 2-iodobenzofuran, Ag2O, Pd2(dba)3/PPh3, THF, 60 
oC; (d) 4-
iodoanisole, Ag2O, Pd2(dba)3/PPh3, THF, 60 
oC; (e) (i) 4-nitrobenzaldehyde, [Rh(cod)Cl]2, 
KHF2, dioxane/H2O ; (ii) TEMPO, TCCA, CH2Cl2; (f) (i) (3,5-
bis(trifluoromethyl)phenyl)lithium, THF, -78 oC to -40 oC; (ii) Cycloheptatrienyl 
tetrafluoroborate, rt.; (iii) NaHCO3 (aq); (g) (i) (3,5-bis(trifluoromethyl)phenyl)lithium, 
THF, -78 oC to -40 oC; (ii) 4-Methoxybenzenediazonium tetrafluoroborate, 0 oC; (iii) 
NaHCO3 (aq.). (Adapted with permission from Ref. 32. Copyright 2019 The Royal Society 
of Chemistry).  
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 The stereoselective palladium-catalyzed cross-coupling of chiral boronic esters has 
attracted recent interest both due to its synthetic utility and the interesting mechanistic 
issues raised by the potential for either stereoretention33 or stereoinversion34; the outcome 
is often found to be dependent upon the participation or non-participation of polar 
substituents present in the substrate.35,36 For example, Hall (110a),34a,34c Biscoe (110b),34b 
Suginome (110c)34d,34f and Molander (110d)34e independently reported functionalized 
chiral secondary boronic esters that underwent palladium-catalyzed cross coupling 
reactions with stereoinversion (Figure 4.5A). The inversion in stereochemistry is usually 
rationalized by the intramolecular coordination of the polar substituents to the boron atom; 
this intramolecular coordination leads to invertive transmetallation resulting in overall 
inversion of stereochemistry of the cross-coupling product. Several other examples are 
reported by Morken (110e),33a Suginome (110f)33b and Takacs (110g-h)4b,4d wherein cross-
coupling proceeds with stereoretention. Morken reported that 110e undergoes hydroxyl-
directed inner-sphere stereoretentive transmetallation in the course of palladium-catalyzed 
cross-coupling reaction. Suginome’s cyclic aminoboronate 110f also undergoes an overall 
stereoretentive cross-coupling reaction with palladium. In the examples published by 
Takacs, stereoretention occurs presumably because the coordinating functionality is not 
present in proximity to the organoboron derivative undergoing the reaction (Figure 4.5B).  
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Figure 4.5: Stereochemical course of Suzuki-Miaura cross-coupling reactions of chiral 
secondary organoboron derivatives. A: Stereoinvertive cross-coupling of chiral secondary 
boronic esters. B: Stereoretentive cross-coupling of chiral secondary boronic esters. 
(Adapted from Ref. 4d Copyright 2017 The Royal Society of Chemistry).  
 
Chiral secondary benzylic boronic esters are rather unique in the context of 
palladium-catalyzed cross-coupling because of their high propensity to undergo 
protodeboronation. Only the protocol recently introduced by Crudden is reportedly 
effective in favoring C-C coupling versus protodeboronation.37 The degree of 
stereoretention (sr; See definition in Figure 4.4) varies, but in favorable constructs, 
Crudden reports that it proceeds with 84-94% sr. While Crudden’s protocol is highly cited 
in the literature, few applications of the method have thus far been reported. The outcome 
for the bifunctional substrate (S)-19a (96:4 er) was, therefore, uncertain. Cross-coupling of 
(S)-19a with 2-iodobenzofuran under Crudden’s conditions [Pd2(dba)3/PPh3/Ag2O] gives 
(S)-68 (55%, 70:30 er, 73% sr); cross-coupling proceeds with predominant stereoretention 
(as evidenced by matching the HPLC traces of 68 obtained using Aggarwal’s electrophile-
induced stereoretentive 1,2-B-to-C migration; See chapter 5 for experimental details and 
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HPLC traces). However, the reaction proceeds with significant erosion of enantiopurity. 
Similarly, cross coupling of (S)-19a with 4-iodoanisole yields (S)-69 (60%, 77:23 er, 80% 
sr). In spite of the moderate level of stereochemical integrity, the result is useful. We were 
unable to prepare 69 via the 1,2-B-to-C migration protocol. This again illustrates a 
limitation of Aggarwal’s 1,2-B-to-C migration; the transformation works well for 5-
membered aromatic rings, but fails with 6-membered aromatic rings in our functionalized 
chiral boronic esters.  
An alternative rhodium-catalyzed cross-coupling procedure also developed by 
Aggarwal effects the stereoretentive addition of chiral trifluoroborate salts to electron-
deficient aromatic aldehydes or other non-enolizable aldehydes (For mechanism, see 
Figure 1.24).38 A modification of this original procedure developed by Aggarwal was 
reported by Tang and co-workers wherein the trifluoroborate salt is generated in-situ by 
addition of aqueous KHF2 solution.
39 Following Tang’s modification of Aggarwal’s 
original procedure, (S)-19a underwent efficient Rh-catalyzed stereoretentive addition to 4-
nitrobenzaldehyde to afford the aryl ketone (S)-70 (74%, 94:6 er) after oxidation; the latter 
cross-coupling proceeds with only slight erosion of enantiopurity over two steps. 
 Chiral secondary boronic esters are known to undergo several stereoinvertive C-B 
bond transformations with strong electrophiles via an SE2 mechanism.
3,48 For example, the 
intermediate boron-ate complex formed by addition of (3,5-bis(trifluoromethylphenyl) 
lithium to (S)-19a (96:4 er) readily reacts with cycloheptatrienyl tetrafluoroborate to effect 
the net C-B to C-C bond substitution to give (S)-71 (95%, 95:5 er) in excellent yield and 
stereochemical purity. Similarly, the net stereoinvertive C-B to C-N bond substitution is 
accomplished by treating the in-situ generated boron-ate complex with 4-
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methoxybenzenediazonium tetrafluoroborate to give the diazo compound (R)-72 (55%, 
94:6 er). The diazo compound 72 is highly light and heat sensitive. It undergoes 
spontaneous decomposition in chloroform within minutes, however, proved stable in 
dichloromethane, methanol and isopropanol. 
 
4.5. Stereospecific transformations of phosphonate-functionalized chiral alkyl 
substituted tertiary boronic esters 
Phosphonate-directed CAHB of trialkyl substituted alkenes (e.g. 37a) results in efficient 
access to chiral alkyl-substituted tertiary boronic esters (e.g. 38a).40 The reactivities of 
chiral all-alkyl tertiary boronic esters are significantly different from chiral benzylic 
boronic esters. The latter are more reactive as the electrophilicity of the boron is 
significantly enhanced by the presence of an aromatic ring. Figure 4.6 illustrates the 
stereospecific transformations we have carried out for the chiral tertiary all-alkyl 
substituted boronic ester (R)-38a; these include its conversion to β- and γ- 
hydroxyphosphonates and aminophosphonates and to phosphonates bearing a quaternary 
all-carbon stereocenter. The latter are common structural motifs found in bioactive natural 
products and pharmaceutical drugs and yet often pose a significant challenge for their 
synthesis.41 
The CAHB reaction of (E)-37a has been carried out on a gram scale using 0.5% 
catalyst loading using the ligand (R,R)-T2 and pinacolborane to afford (R)-38a (82%, 99:1 
er). Oxidation of (R)-38a using NaBO3.4H2O yields the chiral, tertiary β-
hydroxyphosphonate (S)-40a (95%, 99:1 er). Cross-coupling reactions of (R)-38a under 
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conditions reported by Aggarwal and coworkers are facile and afford the furan derivative 
(R)-73a (71%)42 and the vinylated derivative (R)-74a (93%).43 Attempts to convert 4a  
 
Figure 4.6. Utility of phosphonate functionalized chiral alkyl-substituted tertiary boronic 
esters is illustrated by selected transformations of (R)-38a. Reagents and conditions: (a) 
NaBO3.4H2O;  (b) (i) nBuLi, furan, -78 
oC, THF; (ii) NBS; (iii) aq. Na2S2O3; (c) (i) 
CH2=CHMgBr, THF; (ii) I2, MeOH; (iii) MeONa, MeOH; (d) (i) O3, CH2Cl2, 0 
oC; (ii) 
Et3N, rt; (e) Et3SiH, [Ru(p-cymene)Cl2]2, toluene, 50 
oC; (f) (i) O3, CH2Cl2, 0
 oC; (ii) Et3N; 
(iii) NaH2PO4, NaClO2, 2-methyl-2-butene, tBuOH, rt; (g) (i) DPPA, toluene reflux; (ii) 
EtOH; (h) (i) (R)-(+)-α-methylbenzylamine, AcOH, NaCNBH3; (ii) (CF3CO)2O, Et3N, 
THF, rt. (Adapted with permission from Ref. 40. Copyright 2017 American Chemical 
Society) 
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directly to the latent aldehyde or carboxylic acid moieties using the typical conditions 
employed for boronic esters were not successful.15 Such transformations require in-situ 
generation of either dichloromethyllithium or bromomethyllithium by treatment of the 
mixture of boronic ester and dichloromethane/dibromomethane with nBuLi. Since the α-
hydrogens of phosphonates are somewhat acidic (pKa ~ 30-35), competing deprotonation 
results in competing side reactions leading to complex reaction mixtures. We devised an 
indirect way to carry out the one-carbon homologation to the corresponding aldehyde.  
Ozonolysis of the vinyl derivative (R)-74a followed by a mild reductive workup44 
yields the chiral phosphonoaldehyde (R)-75a (86%). With the aldehyde in hand, 
ruthenium-catalyzed reductive silylation affords the silyl protected chiral γ-
hydroxyphosphonate (R)-76a (72%).45 Reductive amination46 of (R)-75a with (R)-(+)-α-
methylbenzylamine followed by acylation affords the chiral γ-aminophosphonate (R)-79a 
(76% over two steps, 98:2 dr). Acylation using trifluoroacetic anhydride was crucial as the 
acylated derivative allowed for the determination of diastereomeric excess via 31P as well 
as 19F NMRs. The diastereomers of γ-aminophosphonate without acylation (93a; see 
Chapter 5) did not resolve in 31P NMR.  
Attempts to convert 38a directly to chiral, tertiary β-aminophosphonate10 using 
several commonly employed methods47 for the direct C-B to C-N bond transformation 
were unsuccessful. This is mainly because direct C-B to C-N bond transformation usually 
requires transformation of a boronic ester to a strongly electrophilic dichloro-organoboron 
intermediate which undergoes ate-complex formation with an azide prior to undergoing the 
1,2-migration. However, generation of the electrophilic dichloro-organoboron species is 
carried out via either (1) treatment of pinacolboronates with excess BCl3,
4b or (2) treatment 
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of a trifluoroborate salt with excess SiCl4 to effect R-BCl2 formation via σ-bond 
metathesis.19 The usage of such strong Lewis acids lead to functional group incompatibility 
issues, and phosphonates are not stable under these reaction conditions. Morken’s 
amination protocol involving lithiated methoxyamine as the nucleophile was known to be 
unsuccessful for tertiary boronic esters.19b We, therefore, developed an alternate way to 
transform the C-B bond of our phosphonate-functionalized, chiral tertiary boronic ester to 
a C-N bond. Ozonolysis of vinylated intermediate (R)-74a followed by Lindgren/Pinnick 
oxidation48 affords the chiral carboxylic acid (R)-77a (80%). Its conversion to the chiral β-
aminophosphonate (S)-78a (76%, 98:2 er) via Curtius rearrangement49 occurred smoothly 
under the standard conditions. 
 
4.6. Formal total synthesis of the cytotoxic natural product (S)-(+)-bakuchiol 
In addition to their potential as pharmacophores for medicinal chemistry, phosphonates 
enable other useful synthetic transformations. For example, the Horner-Wadsworth-
Emmons olefination involves stable α-carbanions derived from phosphonates 
functionalized with electron-withdrawing groups appended at the α-position (e.g. -COOR, 
-CN etc.). While C-B bond functionalization from phosphonate-functionalized chiral 
boronic esters allows for the synthesis of diverse chiral phosphonates, sequential utilization 
of the boronic ester functionality and the phosphonate functionality in the formal total 
synthesis of the cytotoxic natural product (S)-(+)-bakuchiol50 further illustrates the 
synthetic utility of these chiral phosphonate-functionalized, chiral tertiary boronic esters 
(Figure 4.7).12 (S)-(+)-Bakuchiol possess a remote alkene as well as a challenging skipped 
diene subunit in which the two alkene moieties are separated by a quaternary all-carbon 
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stereocenter. We envisioned utilizing the chemistry of the boronic ester and the 
phosphonate in 38x sequentially to form the skipped diene subunit at a late stage in the 
synthetic sequence.  
 
Figure 4.7. Formal total synthesis of (S)-(+)-Bakuchiol. Reagents and conditions: (a) 
[Rh(cod)Cl]2 (0.25 mol%), AgBF4 (0.50 mol%), (S,S)-T2 (0.50 mol%), pinBH (1.1 equiv.), 
THF (c = 1M), rt, 12 h; (b) (i) CH2=CHMgBr, THF, -78 
oC; (ii) I2, MeOH, -78 
oC; (iii) 
NaOMe, MeOH; (iv) Na2S2O3 (aq.); (c) TBAF, H2O; (d) DMSO, Py.SO3, Hünig's base; 
(e) (CH3)2CH=PPh3; (f) Lawesson’s reagent, toluene reflux; (g) nBuLi, 4-methoxy-
benzaldehyde. (Adapted with permission from Ref. 40. Copyright 2017 American 
Chemical Society) 
 
 CAHB of (E)-37x with (S,S)-T2 affords (S)-38x (80% on a gram scale); the 
enantioselectivity (>99:1) is determined after oxidation to the tertiary alcohol (R)-40x. 
Cross-coupling of (S)-38x with vinylmagnesium bromide15 followed by deprotection of the 
silyl ether yields (S)-80. Oxidation to the terminal alcohol to the corresponding aldehyde 
using a modified Swern oxidation (Parikh-Doering oxidation;51 DMSO, Py.SO3) followed 
by Wittig olefination to (S)-82 sets the stage for exploiting the phosphonate-functionality 
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to complete the synthesis. Direct phosphonate olefination is limited in scope since β-
hydroxy phosphonates lacking electron withdrawing substituents at the α-position do not 
undergo elimination without activation.52 However, Corey found that β-hydroxy 
thiophosphonates readily undergo elimination to form alkenes.53 Treating phosphonate 82 
with Lawesson’s reagent54 affords thiophosphonate 83. Deprotonation of 83 by nBuLi 
followed by the addition of 4-methoxybenzaldehyde smoothly yields (S)-(+)-bakuchiol 
methyl ether (84).55 Conversion of 84 to the natural product was previously reported.22b 
Since either enantiomer of the chiral monophosphite T2 is equally accessible, a sequence 
beginning with (R,R)-T2 was carried out to give the enantiomeric (R)-(-)-Bakuchiol methyl 
ether.22d  
It should be noted that it was critical for us to access the natural product to assign 
absolute configurations for tertiary all-alkyl substituted boronic esters derived from 
substrates 37. Few chiral phosphonates are known in the literature and few other 
straightforward alternate routes are available to assign absolute configurations of 
phosphonate-functionalized chiral tertiary boronic esters. Our initial plans towards the 
formal total synthesis of bakuchiol involved CAHB of the skipped diene substrate (E)-37s 
(Chapter 3), a successful CAHB of which, followed by vinylation of the formed β-boronate 
would have directly afforded intermediate 82 (Figure 4.3) in a much shorter and efficient 
synthetic sequence. However, the synthetic plan was not successful because the distal 
trisubstituted alkene in the substrate (E)-37s underwent competing reaction under the 
standard CAHB conditions. Therefore, we resorted to carrying out CAHB of substrate (E)-
37x with a protected hydroxyl group that was eventually transformed into the terminal 
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trisubstituted alkene in the intermediate 82 in the successful sequence leading to (S)-(+)-
bakuchiol methyl ether (Figure 4.6). 
 
4.7. Summary and outlook  
In this chapter, stereospecific transformations of three different classes of phosphonate-
functionalized chiral boronic esters are documented: (i) tertiary benzylic boronic esters 
(e.g. 6a), (ii) secondary benzylic boronic esters (e.g. 19a), and (iii) all-alkyl substituted 
tertiary boronic esters (e.g. 37a). Utility of these bifunctional molecules was further 
demonstrated by sequential transformation of the boronic ester and/or phosphonate 
functionalities in (i) phosphonate-unmasking via oxophosphonate intermediates (Figure 
4.3), and (ii) construction of the skipped diene subunit in the formal total synthesis of 
bakuchiol using thiophosphonate olefination developed by Corey (Figure 4.6).24 
While efficient stereospecific C-B bond transformations demonstrate the synthetic 
utility of these phosphonate-functionalized, chiral boronic esters, we also identified certain 
limitations with these functionalized systems. Stereospecific C-B bond transformations are 
typically developed for chiral boronic esters that are usually non-functionalized with 
hydrocarbon backbones or are minimally functionalized with inert functional groups such 
as ethers. Application of existing literature procedures on our functionalized chiral boronic 
esters frequently led to functional group tolerance issues. For instance, direct C-B to C-N 
bond substitution was never successful in our system mainly because the common methods 
employed to do so require very strong Lewis acids such as BCl3 and SiCl4 to transform the 
chiral boronic ester or the corresponding trifluoroborate salt to a more reactive 
dichloroborane intermediate.4b,19 Phosphonates are not stable in the presence of such strong 
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Lewis acids and phosphonate-functionalized chiral tertiary boronic esters undergo 
decomposition and hydrolysis leading to a rather messy reaction mixture on attempted C-
B to C-N transformations. However, direct C-B to C-N bond transformation was possible 
for chiral secondary boronic esters (e.g. 19a) via the SE2 reaction with the corresponding 
ate-complex.3 
Acidity of the phosphonate α-H’s (pKa ~ 30-35) presented problems while 
performing direct one-carbon homologations of phosphonate-functionalized chiral boronic 
esters using either dichloromethyl lithium or bromomethyl lithium, both of which are 
generated in-situ via reaction of the corresponding boronic ester with either 
dichloromethane or dibromomethane and butyllithium. Performing these reactions with 
phosphonates bearing α-H’s resulted in deprotonation at the α-position leading to non-
specific reactions and overall complicated reaction mixtures.  
Aggarwal’s vinylation/cross-coupling with electron rich 5-membered ring 
aromatics is among the most successful stereospecific C-B bond transformations carried 
out for these phosphonate-functionalized chiral boronic esters.14,15 This is presumably 
because even though the initial addition of excess vinyl magnesium bromide or the aryl 
lithium results in deprotonation of the phosphonate α-position, the subsequent addition of 
the electrophile in an alcohol solvent results in rapid re-protonation of the phosphonate α-
carbanion and capture of the electrophile by the boron-ate complex leading to 
stereospecific 1,2-B-to-C migration (e.g. synthesis of 56, 57, 67, 68, 73a and 74a). 
Specific classes of phosphonate-functionalized chiral boronic esters presented 
unique challenges towards stereospecific functionalization. Trialkyl substituted chiral 
tertiary boronic esters had significant reactivity issues. For example, transformations such 
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as stereospecific protodeboronation and rhodium-catalyzed addition to aromatic aldehydes 
did not occur under standard conditions. On the other hand, several attempted 
stereospecific transformations with the phosphonate-functionalized chiral tertiary benzylic 
boronic esters resulted in high degrees of protodeboronation side products.  
Phosphonate unmasking via hydroxy and oxophosphonate intermediates was 
carried out to afford a variety of common functionality appended to the quaternary chiral 
stereocenter (Figure 4.3). The chiral boronic ester 6a was transformed to an ethyl group in 
58 (via vinylation followed by reduction) prior to phosphonate α-oxidation. While the 
transformation of the boronic ester to an ethyl group was carried out because several of the 
final unmasked products (e.g. 60, 62, 64, 65 and 66) are known compounds previously 
reported in literature and this helped us reverify absolute configuration assigned to 6a, 
however, in principle the boronic ester could be transformed into any functionality/group 
as long as the substituted functionality survives the conditions employed for α- oxidation. 
In summary, the phosphonate-functionalized chiral boronic esters are highly 
versatile chiral synthons and can be further refunctionalized via stereospecific C-B bond 
transformations as well as via the chemistry of the phosphonate-functionality 
(thiophosphonate olefination and α- oxophosphonates). Diverse chiral phosphonates 
bearing a quaternary all-carbon stereocenter can be accessed and product utility in the 
context of total synthesis of a cytotoxic natural product further illustrates the potential of 
the chemistry. The chemistry developed as part of this dissertation should be of broad 
interest to chemists working in the field of asymmetric catalysis, chiral boron chemistry, 
chiral phosphonate chemistry and medicinal chemistry. 
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CHAPTER FIVE: EXPERIMENTAL DETAILS AND CHARACTERIZATION DATA 
5.1. General Information 
All reactions were carried out under a dry nitrogen atmosphere unless otherwise indicated. 
Tetrahydrofuran (THF) was freshly distilled over sodium and benzophenone prior usage in 
CAHB reactions. Pinacolborane (pinBH) was obtained from Acros Organics MS (97% 
purity, stabilized with triethylamine) and was distilled under nitrogen (760 mm Hg, 150 
oC) prior to use. For long term storage, the distilled pinacolborane was stored in freezer in 
8 mL vials with airtight screw cap under nitrogen. All substrates were subjected to high 
vacuum (ca. 1 mm Hg) at 100 oC for an hour to remove any residual diethyl phosphite, 
triethyl phosphite or triethyl phosphate. The latter are trace contaminants in commercial 
diethyl phosphite, and if present in even trace quantitates in the substrate, can greatly 
diminish the activity of the chiral rhodium catalyst. For convenience, CAHB reactions were 
set up in glovebox under a dry nitrogen atmosphere. Yields reported for the boronic 
esters/derivatives are an average of at least 2 runs. 
Synthesized compounds are purified by flash chromatography using EMD Silica 
Gel 60 Geduran®. Thin Layer Chromatography analyses are performed on Analtech Silica 
Gel HLF (0.25 mm) precoated analytical plates and visualized with the use of either a 
handheld short wavelength UV light, iodine stain (molecular iodine adsorbed on silica gel) 
or KMnO4 stain (KMnO4, K2CO3, NaOH and H2O). Chiral HPLC analyses were performed 
with the use of either (1) An ISCO model 2360 HPLC and Chiral Technologies Inc: 
monitored with US-VIS detector (Shimadzu SPD-10AVP/10AVP; or (2) A 1220 Infinity 
II LC (Agilent Technologies) Model Number G4290C. Typical λ used for HPLC UV 
detectors = 210 nm unless otherwise indicated. Daicel HPLC 250 x 4.6 mm columns are 
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used for chiral separations (specific column used is indicated in the appropriate 
experimental section). OpenLAB CDS ChemStation Edition (Rev. C.01.08(210)) software 
is used for integration/analysis of HPLC results.  
NMR spectra were recorded on 300, 400 or 700 MHz Bruker Advance NMR 
spectrometers in the deuterated solvent specified. The solvent residual peaks were used for 
reference and spectra calibration unless otherwise indicated. Rather complex splitting 
patterns are found in the NMR spectra due to phosphorus-hydrogen coupling (JP-H) and 
phosphorus-carbon coupling (JC-P).  Phosphorus-carbon coupling is seen up to 5 bonds (
5JC-
P); these splitting patterns were resolved, and the corresponding coupling constants 
assigned. The quaternary carbon atoms connected directly to boron in tertiary boronic 
esters or trifluoroborate salts were not seen in the 13C NMR spectra due to quadrupolar 
relaxation of boron. Peaks in the NMR spectra are described as s (singlet), br s (broad 
singlet), d (doublet), t (triplet), q (quartet), quin (quintet), dd (doublet of doublets), m 
(unresolved multiplet), etc. In several cases, C6D6 proved to be a superior NMR solvent for 
resolving the signals for diastereomers in 31P NMR spectra for diastereoenriched chiral 
boronic esters. However, 1H and 13C NMR data are reported only for the major 
diastereomer in this dissertation.  
IR spectra were recorded using an Avatar 360 FT-IR instrument as neat films. 
Optical rotations were typically measured as 1.0 g/100 mL (i.e., c = 1.0) solutions in the 
indicated solvent (usually in CHCl3 used directly from commercial bottles) using an 
Autopol III automatic polarimeter. Specific rotation values are reported in units of deg dm-
1 cm3 g-1. EI/ESI-HRMS analyses were carried out by the Nebraska Center for Mass 
Spectrometry.  
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The Routine Preparation of Synthetic Precursors. The Supporting Information given below 
for the preparation and CAHB of allylic phosphonates starts with the allyl bromide. These 
precursors were obtained either from (1) direct allylic bromination of α-methyl styrene 
using NBS (for substrate 5a),1 or (2) bromination of allylic alcohols using PBr3
2 or 
NBS/PPh3.
3 The allyl alcohols were obtained either via the CuI-catalyzed addition of the 
corresponding aryl Grignard reagent to propargyl alcohol4 or via Suzuki cross-coupling of 
the arylboronic acids with 2-iodoprop-2-en-1-ol (e.g., for thiophene derivatives 5l and 5m; 
Typical Suzuki cross-coupling conditions: 5 mol% Pd(PPh3)4, 2 eq. Cs2CO3, EtOH at 70
oC 
for 12 hours), or via the Horner-Wadsworth-Emmons olefination with the appropriate 
aldehyde. The allyl alcohol precursors for the β-aryl trisubstituted substrates were derived 
from  (1) Suzuki cross-coupling reaction of the corresponding (Z)-β-iodo-γ-(alkyl/aryl)-2-
en-1-ol with the arylboronic acid derivatives (Typical conditions: 5 mol% Pd(PPh3)4, 1.5 
equiv. boronic acid, 2 eq. Cs2CO3, EtOH reflux for 12-24 hours) for substrates in which 
the phosphonate and the γ-alkyl chain are trans to each other; (2) Stille cross coupling of 
the corresponding (E)-β-tributylstannyl-γ-(alkyl)-2-en-1-ol (with corresponding aryl 
bromides; typical conditions: 5 mol% Pd(PPh3)4, 1.5 equiv. aryl bromide, 2 eq. Cs2CO3, 
EtOH reflux for 12-24 hours) for substrates in which the phosphonate and the γ-alkyl chain 
are cis to each other. The vinyl (alkenyl) tin precursors were obtained via Pd-catalyzed 
hydrostannation of the corresponding alkynyl esters.5 The α-vinyl tin allyl esters were 
reduced to the corresponding alcohols using DIBAL-H prior to their use in Stille cross 
coupling. Davis' Oxaziridine was prepared according to reported protocols.6 
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Comment on the Oxidation.  We found that attempted oxidation of the crude CAHB 
reaction mixture led to unexpected side products and lower yields of the alcohol. In some 
cases, the boronic esters could not be cleanly separated by flash chromatography; 
nonetheless, the partially purified mixture of boronic esters and reduced products (if any) 
could be efficiently oxidized using standard conditions.  
Comment on Absolute Configuration. The presence of the 2-thiophene subunit in the beta 
position of the substrates requires that the typical E-substrate substitution pattern is 
correctly described as Z since the 2-thienyl unit is assigned the highest priority. This also 
results in a switch from the expected R-configuration of boronic esters obtained using 
(R,R)-T2 to S for the 2-thienyl products. 
 
5.2. Synthesis of substrates 
Synthesis of methylidene substrates 
 
General procedure for the synthesis of conjugated allyl methylidene phosphonates via 
Michaelis-Arbuzov Rearrangement (GP1). Synthesis of 5a: A mixture of allyl bromide 
85a (1.00 g, 5.07 mmol, 1.00 eq) and triethyl phosphite (0.38 mL, 2.20 mmol, 1.10 eq) is 
heated to reflux for 1 hour. Afterwards, the reaction mixture is cooled down to room 
temperature and flash chromatography on silica gel (ethyl acetate/hexanes 2:1) affords the 
desired phosphonate substrate 5a (1.13 g, 88%) as a colorless viscous oil: TLC analysis 
(ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.47-7.26 (5H, m, aryl), 
5.53 (1H, dd, J = 5.5 (4JP-H), 0.8 (
4JH-H) Hz, He or He'), 5.37 (1H, dd, J = 5.5 (
4JP-H), 0.8 
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(4JH-H) Hz, He or He'), 4.09-3.94 (4H, m, b), 3.08 (2H, dd, J = 22.4 (
2JP-H ), 0.8 (
4JH-H) Hz, 
c), 1.21 (6H, t, J = 7.2 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 140.87 (d, 2JC-P = 4.0 
Hz, d), 138.89 (d, 3JC-P = 10 Hz, f), 128.44 (aryl), 127.88 (aryl), 126.45 (aryl), 117.33 (d, 
3JC-P = 11 Hz, e), 62.14 (d, 
2JC-P = 7.0 Hz, b), 33.18 (d, 
1JC-P = 138 Hz, c), 16.44 (d, 
3JC-P 
= 6.0 Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.53 ppm; IR (neat) 2981 (aromatic C-
H), 2906 (aliphatic C-H), 1624 (C=C), 1250 (P=O), 1052 (C-O), 1020 (C-O), 934 (P-O) 
cm-1; HRMS (EI) calculated for C13H19O3P = 254.1072, found 254.1071 m/z.  
 
Synthesis of phosphonate functionalized alkene 5b: Following GP1, allyl bromide 85b 
(528 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5b (590 mg, 88%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.21-
7.13 (4H, m, aryl), 5.50 (1H, d, J = 5.2 (4JP-H), 1.0 (
4JH-H) Hz, He or He'), 5.13 (1H, d, J = 
5.0 (4JP-H), 1.2 (
4JH-H) Hz, He or He'), 4.05-3.88 (4H, m, b), 2.95 (2H, dd, J = 22 (
2JP-H), 1.0 
(4JH-H) Hz, c), 2.35 (3H, s, j), 1.20 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, CDCl3) 
δ 142.15 (d, 2JC-P = 5 Hz, d), 139.73 (d, 3JC-P = 10 Hz, f), 134.98 (g), 130.34 (aryl), 128.76 
(aryl), 127.41 (aryl), 125.64 (aryl), 119.59 (d, 3JC-P = 11 Hz, e), 61.87 (d, 
2JC-P = 7 Hz, b), 
35.01 (d, 1JC-P = 137 Hz, c), 20.09 (j), 16.40 (d, 
3JC-P = 7 Hz, a) ppm; 
31P NMR (162 MHz, 
CDCl3) δ 26.25 ppm; IR (neat) 2980 (aromatic C-H), 2906 (aliphatic C-H), 1633 (C=C), 
1251 (P=O), 1052 (C-O), 1022 (C-O), 958 (P-O) cm-1; HRMS (EI) calculated for 
C14H21O3P = 268.1228, found 268.1226 m/z. 
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Synthesis of phosphonate functionalized alkene 5c: Following GP1, allyl bromide 85c 
(568 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5c (570 mg, 80%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.50-
7.30 (2H, m, aryl), 6.95-6.87 (1H, m, aryl), 6.86 (1H, d, J = 8.0 Hz, h), 5.38-5.36 (1H, m, 
He or He'), 5.25 (1H, dd, J = 5.0 (
4JP-H), 1.6 (
4JH-H) Hz, He or He'), 3.99-3.87 (4H, m, b), 
3.84 (3H, s, j), 3.18 (2H, dd, J = 21.6 (2JP-H), 1.0 (
4JH-H) Hz, c), 1.70 (6H, t, J = 7.2 Hz, a) 
ppm; 13C NMR (100 MHz, CDCl3) δ 156.53 (g), 139.39 (d, 3JC-P = 10 Hz, f), 131.15 (d, 
2JC-P = 4 Hz, d), 130.75 (aryl), 129.11 (aryl), 120.79 (aryl), 119.45 (d, 
3JC-P = 12 Hz, e), 
110.57 (h), 61.73 (d, 2JC-P = 6 Hz, b), 55.53 (j), 33.48 (d, 
1JC-P = 137 Hz, c), 16.40 (d, 
3JC-
P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.34 ppm; IR (neat) 2980 (aromatic C-
H), 2905 (aliphatic C-H), 1629 (C=C), 1598 (C=C), 1241 (P=O), 1047 (C-O), 1021 (C-O), 
957 (P-O) cm-1; HRMS (EI) calculated for C14H21O4P = 284.1177, found 284.1167 m/z. 
 
Synthesis of phosphonate functionalized alkene 5d: Following GP1, allyl bromide 85d 
(528 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5d (610 mg, 91%) as a colorless 
viscous oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.39 (2H, d, J = 8.0 Hz, g or h), 7.16 (2H, d, J = 8.0 Hz, g or h), 5.52 (1H, d, 4JP-H = 5.2 
Hz, He or He'), 5.33 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.10-3.95 (4H, m, b), 3.07 (2H, d, 
2JP-H = 22.4 Hz, c), 2.36 (3H, s, j), 1.23 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, 
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CDCl3) δ 138.65 (d, 3JC-P = 10 Hz, f), 137.97 (d, 2JC-P = 5 Hz, d), 137.74 (i), 129.16 (g or 
h), 126.34 (g or h), 116.53 (d, 3JC-P = 10 Hz, e), 62.20 (d, 
2JC-P = 7 Hz, b), 33.18 (d, 
1JC-P = 
138 Hz, c), 21.29 (j), 16.50 (d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.72 
ppm; IR (neat) 2980 (aromatic C-H), 2905 (aliphatic C-H), 1621 (C=C), 1514 (aromatic 
C=C), 1391 (aromatic C=C), 1249 (P=O), 1052 (C-O), 1021 (C-O), 939 (P-O) cm-1; HRMS 
(EI) calculated for C14H21O3P = 268.1228, found 268.1230 m/z. 
 
Synthesis of phosphonate functionalized alkene 5e: Following GP1, allyl bromide 85e 
(663 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5e (580 mg, 72%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.60 
(4H, s, aryl), 5.59 (1H, d, 4JP-H = 5.6 Hz, He or He'), 5.45 (1H, d, 
4JP-H = 5.2 Hz, He or He'), 
4.10-3.96 (4H, m, b), 3.07 (2H, d, 2JP-H = 22 Hz, c), 1.22 (6H, t, J = 7.2 Hz, a) ppm; 
13C 
NMR (100 MHz, CDCl3) δ 144.41 (d), 138.09 (d, 3JC-P = 11 Hz, f), 129.89 (q, 2JC-F = 32 
Hz, i), 126.86 (j), 125.42 (q, 3JC-F = 4 Hz, h), 124.31 (q, 
1JC-F = 271 Hz, CF3), 119.27 (d, 
3JC-P = 11 Hz, e), 62.26 (d, 
2JC-P = 6 Hz, b), 33.21 (d, 
1JC-P = 138 Hz, c), 16.45 (d, 
3JC-P = 
6 Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 25.83 ppm; 19F NMR (376 MHz, CDCl3) δ -
62.61 ppm; IR (neat) 2984 (aromatic C-H), 2907 (aliphatic C-H), 1616 (C=C), 1324 (C-
F), 1250 (P=O), 1052 (C-O), 1023 (C-O), 959 (P-O) cm-1; HRMS (EI) calculated for 
C14H18F3O3P = 322.0946, found 322.0950 m/z. 
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Synthesis of phosphonate functionalized alkene 5f: Following GP1, allyl bromide 85f 
(568 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5f (604 mg, 85%) as a colorless 
viscous oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.25 (1H, t, J = 8.0 Hz, aryl), 7.07-7.03 (2H, m, aryl), 6.83 (1H, dd, J = 2.0, 0.6 Hz, aryl), 
5.52 (1H, d, 4JP-H = 5.6 Hz, He or He'), 5.36 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.09-3.94 
(4H, m, b), 3.82 (3H, s, j), 3.05 (2H, d, 2JP-H = 22.0 Hz, c), 1.24 (6H, t, J = 7.0 Hz) ppm; 
13C NMR (100 MHz, CDCl3) δ 159.69 (h), 142.43 (d, 2JC-P = 4 Hz, d), 138.77 (d, 3JC-P = 
10 Hz, f), 129.39 (aryl), 118.96 (aryl), 117.47 (d, 3JC-P = 10 Hz, e), 113.30 (aryl), 112.29 
(aryl), 62.14 (d, 2JC-P = 6 Hz, b), 55.39 (j), 33.19 (d, 
1JC-P = 138 Hz, c), 16.44 (d, 
3JC-P = 6 
Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.50 ppm; IR (neat) 3056 (aromatic C-H), 
2980 (aliphatic C-H), 1687 (C=C), 1665 (C=C), 1249 (P=O), 1022 (C-O), 952 (P-O) cm-1; 
HRMS (EI) calculated for C14H21O4P = 284.1177, found 284.1175 m/z.   
 
Synthesis of phosphonate functionalized alkene 5g: Following GP1, allyl bromide 85g 
(568 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5g (533 mg, 75%) as a colorless 
viscous oil: TLC analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.43 (2H, 
d, J = 8.8 Hz, g), 6.87 (2H, d, J = 8.8 Hz, g), 5.45 (1H, dd, J = 6.4 (4JP-H), 0.8 (
4JH-H) Hz, 
He or He'), 5.26 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.09-3.94 (4H, m, b), 3.81 (3H, s, j), 3.04 
(2H, d, 2JP-H = 22.0 Hz, c), 1.22 (6H, t, J = 7.2 Hz) ppm; 
13C NMR (100 MHz, CDCl3) δ 
159.46 (h), 138.11 (d, 3JC-P = 10 Hz, f), 133.23 (d, 
2JC-P = 4 Hz, d), 127.59 (g), 115.64 (d, 
3JC-P = 10 Hz, e), 113.75 (h), 62.14 (d, 
2JC-P = 6 Hz, b), 55.43 (j), 33.25 (d, 
1JC-P = 137 Hz, 
c), 16.47 (d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.72 ppm; IR (neat) 
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3056 (aromatic C-H), 2980 (aliphatic C-H), 1606 (C=C), 1512 (aromatic C=C), 1246 
(P=O), 1051 (C-O), 1021 (C-O), 958 (P-O) cm-1; HRMS (EI) calculated for C14H21O4P = 
284.1177, found 284.1171 m/z.   
 
Synthesis of phosphonate functionalized alkene 5h: Following GP1, allyl bromide 85h 
(602 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5h (537 mg, 72%) as a colorless 
oil (Note: This substrate is air sensitive and slowly decomposes on exposure to air and 
turns into a dark brown mass. This compound was stored in vial with airtight screw cap 
under nitrogen in the freezer): TLC analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.00 (1H, d, J = 2.4 Hz, aryl), 6.97 (1H, d, J = 1.6 Hz, aryl), 6.78 (1H, d, J = 8.0 
Hz, aryl), 5.96 (2H, s, j), 5.43 (1H, d, 4JP-H = 5.6 Hz, He or He'), 5.27 (1H, d, 
4JP-H = 5.6 Hz, 
He or He'), 4.11-3.97 (4H, m, b), 3.01 (2H, d, 
2JP-H = 22.4 Hz, c), 1.25 (6H, t, J = 7.0 Hz, a) 
ppm; 13C NMR (100 MHz, CDCl3) δ 147.85 (h or i), 147.42 (h or i), 138.34 (d, 3JC-P = 10 
Hz, f), 135.18 (d, 2JC-P = 4 Hz, d), 120.20 (aryl), 116.28 (d, 
3JC-P = 11 Hz, e), 108.11 (aryl), 
107.04 (aryl), 101.28 (j), 62.19 (d, 2JC-P = 7 Hz, b), 33.43 (d, 
1JC-P = 138 Hz, c), 16.51 (d, 
3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.52 ppm; IR (neat) 2980 (aromatic 
C-H), 2903 (aliphatic C-H), 1604 (C=C), 1489 (aromatic C=C), 1441 (aromatic C=C), 
1231 (P=O), 1020 (C-O), 933 (P-O) cm-1; HRMS (EI) calculated for C14H19O5P = 
298.0970, found 298.0974 m/z. 
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Synthesis of phosphonate functionalized alkene 5i: Following GP1, allyl bromide 85i 
(563 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5i (600 mg, 85%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.09 
(2H, s, g), 6.93 (1H, s, i), 5.50 (1H, d, 4JP-H = 5.5 Hz, He or He'), 5.33 (1H, d, 
4JP-H = 5.5 
Hz, He or He'), 4.09-3.95 (4H, m, b), 3.05 (2H, d, 
2JP-H = 22 Hz, c), 2.32 (6H, s, j), 1.23 
(6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 140.92 (d, 2JC-P = 4.5 Hz, d), 
139.00 (d, 3JC-P = 10 Hz, f), 137.82 (h), 129.49 (i), 124.33 (g), 116.89 (d, 
3JC-P = 10.8 Hz, 
e), 62.09 (d, 2JC-P = 6.5 Hz, b), 33.15 (d, 
1JC-P = 138.65, c), 21.49 (j), 16.43 (d, 
3JC-P = 6.5 
Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.74 ppm; IR (neat) 2979 (aromatic C-H), 
2910 (aliphatic C-H), 1599 (C=C), 1252 (P=O), 1053 (C-O), 1022 (C-O), 953 (P-O) cm-1; 
HRMS (EI) calculated for C15H23O3P = 282.1385, found 282.1380 m/z. 
 
Synthesis of phosphonate functionalized alkene 5j: Following GP1, allyl bromide 85j 
(538 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5j (517 mg, 76%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.48-
7.44 (2H, m, g), 7.06-7.00 (2H, m, h), 5.47 (1H, d, 4JP-H = 5.5 Hz, He or He'), 5.33 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.10-3.96 (4H, m, b), 3.04 (2H, d, 
2JP-H = 22 Hz, c), 1.23 (6H, t, 
J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 162.63 (d, 1JC-F = 245 Hz, i), 138.00 
(d, 3JC-P = 10 Hz, f), 136.97 (d, 
2JC-P = 4 Hz, d), 128.21 (d, 
3JC-F = 8 Hz, g), 117.31 (d, 
3JC-
P = 11 Hz, e), 115.27 (d, 
2JC-F = 21 Hz, h), 62.20 (d, 
2JC-P = 6 Hz, b), 33.45 (d, 
1JC-P = 138 
Hz, c), 16.49 (d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.28 ppm; 19F NMR 
(376 MHz, CDCl3) δ -114.75 ppm; IR (neat) 2982 (aromatic C-H), 2907 (aliphatic C-H), 
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1624 (C=C), 1601 (C=C), 1509 (C-F), 1249 (P=O), 1052 (C-O), 1022 (C-O), 902 (P-O) 
cm-1; HRMS (EI) calculated for C13H18FO3P = 272.0978, found 272.0982 m/z. 
 
Synthesis of phosphonate functionalized alkene 5k: Following GP1, allyl bromide 85k 
(579 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5k (577 mg, 80%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.6; 
1H NMR (400 MHz, CDCl3) δ 7.41 
(2H, d, J = 8.8 Hz, g or h), 7.29 (2H, d, J = 8.8 Hz, g or h), 5.50 (1H, d, 4JP-H = 5.5 Hz, He 
or He'), 5.35 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.06-3.96 (4H, m, b), 3.01 (2H, d, 
2JP-H = 
22.4 Hz, c), 1.21 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 139.23 (d, 2JC-
P = 4 Hz, d), 137.87 (d, 
3JC-P = 10 Hz, f), 133.72 (i), 128.52 (g or h), 127.78 (g or h), 117.79 
(d, 3JC-P = 11 Hz, e), 62.17 (d, 
2JC-P = 7 Hz, b), 33.17 (d, 
1JC-P = 138 Hz, c), 16.44 (d, 
3JC-P 
= 6 Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.13 ppm; IR (neat) 2981 (aromatic C-
H), 2905 (aliphatic C-H), 1623 (C=C), 1248 (P=O), 1022 (C-O), 940 (P-O), 835 (C-Cl) 
cm-1; HRMS (EI) calculated for C13H18ClO3P = 288.0682, found 288.0690 m/z. 
 
Synthesis of phosphonate functionalized alkene 5l: Following GP1, allyl bromide 85l 
(579 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5l (584 mg, 81%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.45 
(1H, dd, J = 2.0, 0.8 Hz, aryl), 7.39-7.34 (1H, m, aryl), 7.29-7.25 (2H, m, aryl), 5.53 (1H, 
dd, J = 5.5 (4JP-H), 0.4 (
4JH-H) Hz, He or He'), 5.39 (1H, dd, J = 5.6 (
4JP-H), 0.5 (
4JH-H) Hz, 
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He or He'), 4.10-3.96 (4H, m, b), 3.03 (2H, dd, J = 22 (
2JP-H), 0.8 (
4JH-H) Hz, c), 1.23 (6H, 
t, J = 7.2 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 142.74 (d, 2JC-P = 4 Hz, d), 137.90 
(d, 3JC-P = 10 Hz, f), 134.38 (h), 129.69 (aryl), 127.89 (aryl), 126.72 (aryl), 124.71 (aryl), 
118.47 (d, 3JC-P = 11 Hz, e), 62.21 (d, 
2JC-P = 7 Hz, b), 33.15 (d, 
1JC-P = 139 Hz, c), 16.45 
(d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 25.96 ppm; IR (neat) 2981 
(aromatic C-H), 2906 (aliphatic C-H), 1625 (C=C), 1248 (P=O), 1051 (C-O), 1021 (C-O), 
960 (P-O), 788 (C-Cl) cm-1; HRMS (EI) calculated for C13H18ClO3P = 288.0682, found 
288.0691 m/z.  
 
Synthesis of phosphonate functionalized alkene 5m: Following GP1, allyl bromide 85m 
(690 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5m (616 mg, 74%) as a colorless 
viscous oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.47 (2H, d, J = 8.8 Hz, g or h), 7.36 (2H, d, J = 8.8 Hz, g or h), 5.52 (1H, d, 4JP-H = 5.6 
Hz, He or He'), 5.37 (1H, d, 
4JP-H = 5.6 Hz, He or He'), 4.10-3.96 (4H, m, b), 3.03 (2H, dd, J 
= 22.4 (2JP-H), 0.8 (
4JH-H) Hz, c), 1.23 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, 
CDCl3) δ 139.75 (d, 2JC-P = 4 Hz, d), 137.98 (d, 3JC-P = 10 Hz, f), 131.54 (g or h), 128.15 
(g or h), 121.94 (i), 117.91 (d, 3JC-P = 11 Hz, e), 62.24 (d, 
2JC-P = 7 Hz, b), 33.16 (d, 
1JC-P 
= 139 Hz, c), 16.49 (d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.15 ppm; IR 
(neat) 2980 (aromatic C-H), 2902 (aliphatic C-H), 1620 (C=C), 1248 (P=O), 1052 (C-O), 
1021 (C-O), 955 (P-O), 759 (C-Br) cm-1; HRMS (EI) calculated for C13H18BrO3P = 
332.0177, found 332.0168 m/z. 
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Synthesis of phosphonate functionalized alkene 5n: Following GP1, allyl bromide 85n 
(508 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5n (540 mg, 83%) as a light buff 
colored oil: TLC analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.19 (1H, 
d, J = 5.2 Hz, i), 7.15 (1H, d, J = 3.2 Hz, g), 7.00-6.98 (1H, m, h), 5.61 (1H, d, 4JP-H = 5.5 
Hz, He or He'), 5.23 (1H, d, 
4JP-H = 5.5 Hz, He or He'), 4.14-4.00 (4H, m, b), 3.05 (2H, d, 
2JP-H = 22 Hz, c), 1.26 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, CDCl3) δ 144.60 
(d, 2JC-P = 5 Hz, d), 132.33 (d, 
3JC-P = 10 Hz, f), 127.63 (h), 125.05 (g), 124.98 (i), 115.56 
(d, 3JC-P = 10 Hz, e), 62.38 (d, 
2JC-P = 6 Hz, b), 33.46 (d, 
1JC-P = 139 Hz, c), 16.53 (d, 
3JC-P 
= 6 Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 25.85 ppm; IR (neat) 3091 (aromatic C-
H), 2980 (aliphatic C-H), 1622 (C=C), 1247 (P=O), 1051 (C-O), 1020 (C-O/C=S), 954 (P-
O) cm-1; HRMS (EI) calculated for C11H17O3PS = 260.0636, found 260.0630 m/z. 
 
Synthesis of phosphonate functionalized alkene 5o: Following GP1, allyl bromide 85o 
(508 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 5o (555 mg, 85%) as a light buff 
oil: TLC analysis (ethyl acetate) Rf = 0.6; 
1H NMR (400 MHz, CDCl3) δ 7.37 (1H, s, i), 
7.28-7.25 (2H, m, g+h), 5.57 (1H, d, 4JP-H = 5.5 Hz, He or He'), 5.28 (1H, d, 
4JP-H = 5.5 Hz, 
He or He'), 4.12-4.98 (4H, m, b), 3.02 (2H, d, 
2JP-H = 22 Hz, c), 1.25 (6H, t, J = 7.0 Hz, a) 
ppm; 13C NMR (100 MHz, CDCl3) δ 141.96 (d, 2JC-P = 4 Hz, d), 133.37 (d, 3JC-P = 11 Hz, 
f), 125.94 (g or h), 125.77 (g or h), 121.97 (i), 115.87 (d, 3JC-P = 11 Hz, e), 62.27 (d, 
2JC-P 
= 7 Hz, b), 33.59 (d, 1JC-P = 138 Hz, c), 16.49 (d, 
3JC-P = 7 Hz, a) ppm; 
31P NMR (162 
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MHz, CDCl3) δ 26.63 ppm; IR (neat) 3090 (aromatic C-H), 2978 (aliphatic C-H), 1621 
(C=C), 1250 (P=O), 1052 (C-O), 1020 (C-O/C=S), 955 (P-O) cm-1; HRMS (EI) calculated 
for C11H17O3PS = 260.0636, found 260.0630 m/z. 
 
Synthesis of phosphonate functionalized alkene 7: Following GP1, allyl bromide 85p 
(527 mg, 2.50 mmol, 1.00 eq) yields the alkene substrate 7 (543 mg, 81%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.32-
7.21 (5H, m, aryl), 5.06 (1H, d, 4JP-H = 5.2 Hz, He or He'), 4.98 (1H, d, 
4JP-H = 5.2 Hz, He 
or He'), 4.17-4.08 (4H, m, b), 3.53 (2H, s, f), 2.52 (2H, d, 
2JP-H = 22 Hz, c), 1.33 (6H, t, J = 
7.2 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 139.60 (d, 2JC-P = 11 Hz, d), 138.94 (g), 
129.29 (aryl), 128.51 (aryl), 126.46 (aryl), 116.50 (d, 3JC-P = 11 Hz, e), 62.00 (d, 
2JC-P = 7 
Hz, b), 43.40 (d, 3JC-P = 4 Hz, f), 32.91 (d, 
1JC-P = 137 Hz, c), 16.56 (d, 
3JC-P = 6 Hz, a) 
ppm; 31P NMR (162 MHz, CDCl3) δ 27.02 ppm; IR (neat) 2981 (aromatic C-H), 2904 
(aliphatic C-H), 1645 (C=C), 1247 (P=O), 1052 (C-O), 1023 (C-O), 956 (P-O) cm-1; 
HRMS (EI) calculated for C14H21O3P = 268.1228, found 268.1231 m/z. 
 
Synthesis of homoallylic phosphonate substrate 10: This synthesis was carried out 
according to our previously reported procedure.6 Allyl bromide 85a (492 mg, 2.50 mmol, 
1.10 eq) yields the homoallylic phosphonate 10 (470 mg, 70%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.42-7.28 (5H, 
m, aryl), 5.32 (1H, s, Hf or Hf'), 5.12 (1H, d, 
4JH-H = 1.0 Hz, Hf or Hf'), 4.14-4.07 (4H, m, 
173 
 
b), 2.84-2.78 (2H, m, d), 1.94-1.85 (2H, m, c), 1.34 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR 
(100 MHz, CDCl3) δ 147.45 (d, 3JC-P = 19 Hz, e), 140.27 (g), 128.60 (aryl), 127.84 (aryl), 
126.23 (aryl), 112.76 (f), 61.70 (d, 2JC-P = 7 Hz, b), 28.29 (d, 
2JC-P = 4 Hz, d), 24.96 (d, 
1JC-
P = 140 Hz, c), 16.64 (d, 
3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 31.46 ppm; 
IR (neat) 3082 (aromatic C-H), 2980 (aliphatic C-H), 1629 (C=C), 1243 (P=O), 1054 (C-
O), 1024 (C-O), 958 (P-O) cm-1; HRMS (EI) calculated for C14H21O3P = 268.1228, found 
268.1232 m/z. 
 
Synthesis of 1,2-disubstituted vinyl arene substrates 
Substitution of the corresponding allyl bromides (GP2): Synthesis of allyl 
phosphonates via substitution of the corresponding allyl bromides is carried out as follows. 
A 2.0M solution of NaHMDS (1.1 equiv.) is added drop-wise to a solution of diethyl 
phosphite (1.0 equiv.) in anhydrous THF (0.5 M) at 0 oC. The resultant mixture is stirred 
at room temperature for 10 minutes. A solution of the corresponding allyl bromide (1.1 
equiv.) in THF (0.5 M) is added dropwise to the mixture over 10 minutes (room 
temperature). The completion of the reaction mixture (ca. 1-2 hours) is determined by 
analysis of unworked up reaction samples by 31P NMR spectrum following disappearance 
of HP=O(OEt)2 peak at ~8 ppm and appearance of a new peak in the range of 25-30 ppm 
for the substrate. After complete reaction, the resulting mixture is filtered through a celite 
bed and the bed washed with ethyl acetate. The combined filtrates are concentrated under 
reduced pressure and purification is carried out using silica gel chromatography.    
Synthesis of allyl phosphonates via palladium-catalyzed substitution of the 
corresponding allyl carbonates (GP3): The synthesis of substrates via Palladium-
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catalyzed allylic substitution of the corresponding allyl carbonates is carried out with few 
modifications of the original procedure reported by Zhao7 and co-workers as follows. 
Under a dry nitrogen atmosphere, a mixture of Pd2(dba)3 (2 mol%) and Xantphos (4 mol%) 
in dry THF is stirred for 1 hour. To the resultant palladium-complex solution, a mixture of 
the corresponding allyl carbonate (1 equiv.) and diethyl phosphite (1.2 equiv.) is added and 
the resultant mixture is refluxed for 24 hours. Afterwards, the reaction mixture is cooled 
down to room-temperature and filtered over a bed of celite. The celite bed is washed with 
ethyl-acetate and the combined filtrates are concentrated under reduced pressure. 
Purification is carried out using silica-gel chromatography. Note: GP3 is carried out for 
the preparation of substrates bearing a basic nitrogen or sensitive heterocyclic functional 
groups. In such cases either the preparation of corresponding allyl bromide isn’t 
straightforward, or the corresponding allyl bromides are very unstable. 
 
Synthesis of allylic phosphonate (E)-18a: Following GP2, the allyl bromide (E)-86a (197 
mg, 1.00 mmol) yields alkene substrate (E)-18a (218 mg, 86%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.35 (2H, d, J 
= 7.5 Hz, g), 7.31-7.27 (2H, m, aryl), 7.23-7.19 (1H, m, aryl), 6.52 (1H, dd, J = 15.8, 5.1 
Hz, e), 6.21-6.12 (1H, m, d), 4.18-4.05 (4H, m, b), 2.76 (2H, ddd, J = 22.4, 7.5, 1.3 Hz, c), 
1.31 (6H, t, J = 7.08 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 136.88 (d, 4JC-P = 3.5 Hz, 
f), 134.73 (d, 3JC-P = 14.79 Hz, e), 128.61 (aryl), 127.64 (aryl), 126.28 (d, 
5JC-P = 2.07 Hz, 
g), 118.91 (d, 2JC-P = 12.0 Hz, d), 62.08 (d, 
2JC-P = 6.7 Hz, b), 31.16 (d, 
1JC-P = 139.89 Hz, 
c), 16.55 (d, 3JC-P = 5.89 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.81 ppm; IR (neat) 
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3055 (sp2 C-H), 2979 (sp3 C-H), 1651 (C=C), 1597 (C=C), 1495 (aromatic C=C), 1448 
(aromatic C=C), 1247 (P=O), 1018 (C-O), 955 (P-O) cm-1; HRMS (ESI) calculated for 
C13H19O3P+Na
+ = 277.0972, found 277.0972 m/z. 
 
Synthesis of allylic phosphonate (Z)-18a: Photoisomerization of the allylic phosphonate 
(E)-18a (200 mg, 0.79 mmol; Ref. 5) yields the diastereomeric substrate (Z)-18a (178 mg, 
89%; Z:E ratio = 9:1) as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.6; 
1H NMR (400 MHz, CDCl3) δ 7.35-7.21 (5H, m, aryl), 6.67-6.63 (1H, m, e), 5.76-5.68 
(1H, m, d), 4.13-4.04 (4H, m, b), 2.84 (2H, ddd, J = 22.4, 8.0, 1.5 Hz, c), 1.29 (6H, t, J = 
7 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 136.40 (d, 4JC-P = 3.5 Hz, f), 133.17 (d, 3JC-
P = 14.5 Hz, e), 128.59 (d, 
5JC-P = 2.0 Hz, g), 128.39 (h), 127.21 (i), 120.45 (d, 
2JC-P = 11 
Hz, d), 61.98 (d, 2JC-P = 7.0 Hz, b), 26.93 (d, 
1JC-P = 140 Hz, c), 16.45 (d, 
3JC-P = 6.0 Hz, 
a) ppm; 31P NMR (162 MHz, CDCl3) δ 27.28 ppm; IR (neat) 3025 (sp2 C-H), 2904 (sp3 C-
H), 1599 (C=C), 1495 (aromatic C=C), 1446 (aromatic C=C), 1247 (P=O), 1021 (C-O), 
955 (P-O) cm-1; HRMS (ESI) calculated for C13H19O3P+Na
+ = 277.0970, found 277.0971 
m/z.  
 
Synthesis of allylic phosphonate (E)-18b: Following GP2, the allyl bromide (E)-86b 
(211 mg, 1.00 mmol) yields alkene substrate (E)-18b (244 mg, 91%) as a colorless oil: 
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TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.27 (2H, 
d, J = 8.70 Hz, g), 7.13 (2H, d, J = 7.98 Hz, h), 6.51 (1H, dd, J = 15.79, 5.15 Hz, e), 6.17-
6.08 (1H, m, d), 4.20-4.07 (4H, m, b), 2.76 (2H, ddd, J = 22.7, 7.6, 1.18 Hz, c), 2.34 (3H, 
s, j), 1.33 (6H, t, J = 7.06 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 137.57 (d, 7JC-P = 
1.07 Hz, i), 134.71 (d, 3JC-P = 14.93 Hz, e), 134.23 (d, 
4JC-P = 3.3 Hz, f), 129.41 (h), 126.29 
(d, 5JC-P = 2.05 Hz, g), 117.86 (d, 
2JC-P = 12.09 Hz, d), 62.19 (d, 
2JC-P = 6.65 Hz, b), 31.25 
(d, 1JC-P = 139.92 Hz, c), 21.34 (j), 16.65 (d, 
3JC-P = 5.94 Hz, a) ppm; 
31P NMR (162 MHz, 
CDCl3) δ 27.02 ppm; IR (neat) 2980 (C-H), 1513 (C=C), 1443 (aromatic C=C), 1391 
(aromatic C=C), 1247 (P=O), 1019 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C14H21O3P+Na
+ = 291.1129, found 291.1126 m/z.  
 
Synthesis of allylic phosphonate (E)-18c: Following GP2, the allyl bromide (E)-86c (265 
mg, 1.00 mmol) yields alkene substrate (E)-18c (164 mg, 51%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.57 (2H, d, J 
= 8.25 Hz, g), 7.46 (2H, d, J = 8.15 Hz, h), 6.57 (1H, dd, J = 15.5, 5.10 Hz, e), 6.34-6.24 
(1H, m, d), 4.22-4.08 (4H, m, b), 2.80 (2H, ddd, J = 22.5, 7.6, 1.2 Hz, c), 1.34 (6H, t, J = 
7.05 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 140.38 (f), 133.52 (d, 3JC-P = 14.5 Hz, e), 
129.57 (q, 2JC-F = 32.5 Hz, i), 126.55 (d, J = 2 Hz, g), 125.71 (q, 
3JC-F = 3.5 Hz, h), 124.50 
(q, 1JC-F = 272 Hz, CF3), 122.07 (d, 
2JC-P = 11.93 Hz, d), 62.30 (d, 
2JC-P = 6.70 Hz, b), 31.36 
(d, 1JC-P = 139 Hz, c), 16.65 (d, 
3JC-P = 5.78 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 
26.23 ppm; 19F NMR (376 MHz, CDCl3) δ -62.54 ppm; IR (neat) 2983 (sp2 C-H), 2933 
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(sp3 C-H), 1614 (C=C), 1323 (C-F), 1247 (P=O), 1162 (C-O), 1015 (C-O), 953 (P-O), 789 
cm-1; HRMS (ESI) calculated for C14H18F3O3P+Na
+ = 345.0843, found 345.0849 m/z.    
 
Synthesis of allylic phosphonate (E)-18d: Following GP2, the allyl bromide (E)-86d 
(215 mg, 1.00 mmol) yields alkene substrate (E)-18d (180 mg, 66%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.34-7.28 
(2H, m, g), 7.01-6.97 (2H, m, h), 6.49 (1H, dd, J = 15.0, 5.5 Hz, e), 6.13-6.03 (1H, m, d), 
4.20-4.04 (4H, m, b), 2.75 (2H, ddd, J = 22.25, 7.5, 1.0 Hz, c), 7.06 (6H, t, J = 7.05 Hz, a) 
ppm; 13C NMR (100 MHz, CDCl3) δ 162.45 (d, 1JC-F = 246 Hz, i), 133.62 (d, 3JC-P = 14.9 
Hz, e), 127.89 (dd, 3JC-F = 8.0 Hz, 
6JC-P = 2.0 Hz, g), 118.77 (dd, 
2JC-P = 12 Hz, 
6JC-F = 2.0 
Hz, d), 115.62 (d, 2JC-F = 21.9 Hz, h), 62.20 (d, 
2JC-P = 6.75 Hz, b), 31.18 (d, 
1JC-P = 140 
Hz, c), 16.64 (d, 3JC-P = 5.9 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.77 ppm; 19F 
NMR (376 MHz, CDCl3) δ -114.49 ppm; IR (neat) 2981 (sp2 C-H), 2909 (sp3 C-H), 1600 
(C=C), 1508 (C-F), 1247 (P=O), 1225 (P=O), 1020 (C-O), 957 (P-O) cm-1; HRMS (ESI) 
calculated for C13H18FO3P+Na
+ = 295.0875, found 295.0885 m/z. 
 
Synthesis of allylic phosphonate (E)-18e: Following GP2, the allyl bromide (E)-86e (227 
mg, 1.00 mmol) yields alkene substrate (E)-18e (202 mg, 71%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.30 (2H, d, J 
= 8.5 Hz, g), 6.85 (2H, d, J = 8.5 Hz, h), 6.48 (1H, dd, J = 15.0, 5.5 Hz, e), 6.08-5.98 (1H, 
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m, d), 4.21-4.08 (4H, m, b), 3.81 (3H, s, j), 2.75 (2H, ddd, J = 22.0, 7.5, 1.25 Hz, c), 1.33 
(6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 159.36 (i), 134.22 (d, 3JC-P = 15 
Hz, e), 129.84 (d, 4JC-P = 3.5 Hz, f), 127.55 (d, 
5JC-P = 2.0 Hz, g), 116.59 (d, 
2JC-P = 12 Hz, 
d), 114.12 (h), 62.16 (d, 2JC-P = 6.5 Hz, b), 55.44 (j), 31.20 (d, 
1JC-P = 140 Hz, c), 16.65 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.15 ppm; IR (neat) 2980 (sp2 C-
H), 2905 (sp3 C-H), 1606 (C=C), 1510, 1244 (P=O), 1018 (C-O), 958 (P-O) cm-1; HRMS 
(ESI) calculated for C14H21O4P+Na
+ = 307.1075, found 307.1078 m/z.  
 
Synthesis of allylic phosphonate (E)-18f: Following GP2, the allyl bromide (E)-86f (227 
mg, 1.00 mmol) yields alkene substrate (E)-18f (196 mg, 69%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.22-7.17 (1H, 
m, j), 6.93 (2H, d, J = 7.6 Hz, k), 6.87 (1H, s, g), 6.76 (1H, d, J = 8.2 Hz, i), 6.47 (1H, dd, 
J = 15.75, 4.75 Hz, e), 6.19-6.09 (1H, m, d), 4.16-4.04 (4H, m, b), 3.77 (3H, s, l), 2.73 (2H, 
dd, J = 22.5, 7.5 Hz, c), 1.30 (6H, td, J = 7.0, 2.5 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) 
δ 159.82 (h), 138.28 (d, 4JC-P = 3.5 Hz, f), 134.62 (d, 3JC-P = 15 Hz, e), 129.56 (j), 119.19 
(d, 2JC-P = 12 Hz, d), 118.95 (d, 
5JC-P = 1.65 Hz, k), 113.25 (i), 111.56 (d, 
5JC-P = 2.0 Hz, 
g), 62.08 (d, 2JC-P = 7.0 Hz, b), 55.22 (l), 31.08 (d, 
1JC-P = 139 Hz, c), 16.51 (d, 
3JC-P = 5.9 
Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.75 ppm; IR (neat) 2981 (sp2 C-H), 2905 (sp3 
C-H), 1597 (C=C), 1488 (aromatic C=C), 1463 (aromatic C=C), 1241 (P=O), 1019 (C-O), 
957 (P-O) cm-1; HRMS (ESI) calculated for C14H21O4P+Na
+ = 307.1075, found 307.1077 
m/z.  
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Synthesis of allylic phosphonate (E)-18g: Following GP2, the allyl bromide (E)-86g (240 
mg, 1.00 mmol) yields alkene substrate (E)-18g (206 mg, 69%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 6.91 (1H, s, l), 
6.80-6.74 (2H, m, g+h), 6.44 (1H, dd, J = 15.5, 5.5 Hz, e), 6.04-5.95 (3H, m, d+j), 4.22-
4.04 (4H, m, b), 2.74 (2H, ddd, J = 22.0, 7.5, 1.5 Hz, c), 1.33 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, CDCl3) δ 148.18 (i), 147.37 (d, 6JC-P = 1.0 Hz, k), 134.39 (d, 3JC-P = 
15 Hz, e), 131.51 (d, 4JC-P = 3.5 Hz, f), 121.02 (d, 
5JC-P = 2.25 Hz, g), 117.11 (d, 
2JC-P = 12 
Hz, d), 108.42 (h), 105.74 (d, 5JC-P = 2.0 Hz, l), 101.24 (j), 62.20 (d, 
2JC-P = 6.75 Hz, b), 
31.12 (d, 1JC-P = 140 Hz, c), 16.66 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) 
δ 26.99 ppm; IR (neat) 2980 (sp2 C-H), 2904 (sp3 C-H), 1605 (C=C), 1489 (aromatic C=C), 
1445 (aromatic C=C), 1240 (P=O), 1018 (C-O), 957 (P-O), 781 cm-1; HRMS (ESI) 
calculated for C14H19O5P+Na
+ = 321.0868, found 321.0869 m/z.  
 
Synthesis of allylic phosphonate (E)-18h: Following GP2, the allyl bromide (E)-86h 
(227 mg, 1.00 mmol) yields alkene substrate (E)-18h (169 mg, 63%) as a colorless oil: 
TLC analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.24 (1H, t, J = 8.0 
Hz, aryl), 6.97 (1H, d, J = 7.6 Hz, k), 6.91 (1H, br s, h), 6.81 (1H, dd, J = 8.25, 2.50 Hz, 
aryl), 6.52 (1H, dd, J = 15.0, 5.5 Hz, e), 6.23-6.14 (1H, m, d), 4.19-4.09 (4H, m, b), 3.83 
(3H, s, l), 2.78 (2H, ddd, J = 22, 7.5, 1.5 Hz, c), 1.34 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR 
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(100 MHz, CDCl3) δ 159.98 (g), 138.45 (d, 4JC-P = 3.5 Hz, f), 134.72 (d, 3JC-P = 15 Hz, e), 
129.72 (aryl), 119.38 (d, 2JC-P = 12 Hz, d), 119.13 (d, 
5JC-P = 2.0 Hz, k), 113.41 (aryl), 
111.73 (d, 6JC-P = 2.0 Hz, h), 62.26 (d, 
2JC-P = 6.75 Hz, b), 55.42 (l), 31.28 (d, 
1JC-P = 140 
Hz, c), 16.68 (d, 3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.78 ppm; IR 
(neat) 2980 (sp2 C-H), 2904 (sp3 C-H), 1597 (C=C), 1578 (C=C), 1247 (P=O), 1156 (C-
O), 1019 (C-O), 956 (P-O) cm-1; HRMS (ESI) calculated for C14H21O4P+Na
+ = 307.1075, 
found 307.1078 m/z. 
 
Synthesis of allylic phosphonate (E)-18i: Following GP2, the allyl bromide (E)-86i (211 
mg, 1.00 mmol) yields alkene substrate (E)-18i (177 mg, 66%) as a colorless oil: TLC 
analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.42-7.40 (1H, 
m, aryl), 7.23-7.11 (3H, m, aryl), 6.74 (1H, d, J = 15.5, 5.5 Hz, e), 6.08-5.99 (1H, m, d), 
4.19-4.06 (4H, m, b), 2.79 (2H, dd, J = 22.0, 7.50 Hz, c), 2.33 (3H, s, l), 1.33 (6H, t, J = 
7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 136.06 (d, 4JC-P = 3.5 Hz, f), 135.18 (d, 5JC-
P = 2.0 Hz, g), 132.70 (d, 
3JC-P = 15 Hz, e), 130.26 (aryl), 127.56 (aryl), 126.16 (aryl), 
125.74 (d, 5JC-P = 2.5 Hz, k), 120.22 (d, 
2JC-P = 12 Hz, d), 62.06 (d, 
2JC-P = 6.75 Hz, b), 
31.37 (d, 1JC-P = 140 Hz, c), 19.82 (l), 16.54 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 
MHz, CDCl3) δ 26.88 ppm; IR (neat) 2979 (sp2 C-H), 2906 (sp3 C-H), 1694 (C=C), 1483 
(aromatic C=C), 1391 (aromatic C=C), 1247 (P=O), 1019 (C-O), 958 (P-O), 746 cm-1; 
HRMS (ESI) calculated for C14H21O3P+Na
+ = 291.1126, found 291.1129 m/z. 
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Synthesis of allylic phosphonate (E)-18j: Following GP3, the allyl carbonate (E)-86j 
(249 mg, 1.00 mmol) yields alkene substrate (E)-18j (110 mg, 37%) as a colorless oil: TLC 
analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.27 (2H, d, J = 9 Hz, g), 
6.69 (2H, d, J = 9 Hz, h), 6.45 (1H, dd, J = 15.75, 5.5 Hz, e), 6.01-5.92 (1H, m, d), 4.20-
4.07 (4H, m, b), 2.97 (6H, s, j), 2.76 (2H, ddd, J = 22, 7.5, 1.5 Hz, c), 1.33 (6H, t, J = 7.0 
Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 150.25 (i), 134.70 (d, 3JC-P = 15 Hz, e), 127.36 
(d, 5JC-P = 1.6 Hz, g), 125.62 (d, 
4JC-P = 3.3 Hz, f), 114.19 (d, 
2JC-P = 12 Hz, d), 112.53 (h), 
62.17 (d, 2JC-P = 6.8 Hz, b), 40.67 (j), 31.27 (d, 
1JC-P = 140 Hz, c), 16.68 (d, 
3JC-P = 6.0 Hz, 
a) ppm; 31P NMR (162 MHz, CDCl3) δ 27.50 ppm; IR (neat) 2980 (sp2 C-H), 2902 (sp3 C-
H), 1608 (C=C), 1520, 1352 (C-N), 1246 (P=O), 1019 (C-O), 944 (P-O), 786 cm-1; HRMS 
(ESI) calculated for C15H24NO3P+Na
+ = 320.1391, found 320.1398 m/z.  
 
Synthesis of allylic phosphonate (E)-18k: Following GP3, the allyl carbonate (E)-86k 
(291 mg, 1.00 mmol) yields alkene substrate (E)-18k (139 mg, 41%) as a colorless oil: 
TLC analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.29 (2H, d, J = 8.5 
Hz, g), 6.85 (2H, d, J = 8.5 Hz, h), 6.46 (1H, dd, J = 15.5, 5.5 Hz, e), 6.10-5.93 (1H, m, d), 
4.18-4.06 (4H, m, b), 3.85 (4H, t, J = 4.5 Hz, k), 3.16 (4H, t, J = 4.5 Hz, j), 2.75 (2H, dd, J 
= 22.0, 7.5 Hz, c), 1.32 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 150.79 
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(i), 134.29 (d, 3JC-P = 15 Hz, e), 128.83 (d, 
4JC-P = 3.5, f), 127.28 (d, 
5JC-P = 2.0 Hz, g), 
115.99 (d, 2JC-P = 12 Hz, d), 115.52 (h), 66.95 (k), 62.13 (d, 
2JC-P = 6.7 Hz, b), 49.18 (j), 
31.18 (d, 1JC-P = 140 Hz, c), 16.62 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) 
δ 27.23 ppm; IR (neat) 2976 (sp2 C-H), 2823 (sp3 C-H), 1605 (C=C), 1514, 1449 (aromatic 
C=C), 1379 (aromatic C=C/C-N), 1234 (P=O), 1120 (C-O), 925 (P-O), 787 cm-1; HRMS 
(ESI) calculated for C17H26NO4P+Na
+ = 362.1497, found 362.1498 m/z. 
 
Synthesis of allylic phosphonate (E)-18l: Following GP3, the allyl carbonate (E)-86l 
(195 mg, 0.50 mmol) yields alkene substrate (E)-18l (99 mg, 45%) as a colorless oil: TLC 
analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.26 (2H, d, J = 8.75 Hz, 
g), 6.85 (2H, d, J = 8.75 Hz, h), 6.43 (1H, dd, J = 15.5, 5.5 Hz, e), 6.05-5.93 (1H, m, d), 
4.17-4.04 (4H, m, b), 3.56 (4H, d, J = 5.0 Hz, j or k), 3.13 (4H, d, J = 5.0 Hz, j or k), 2.73 
(2H, ddd, J = 22, 7.5, 1.0 Hz, c), 1.47 (9H, s, n), 1.30 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR 
(100 MHz, CDCl3) δ 154.79 (l), 150.71 (i), 134.25 (d, 3JC-P = 15 Hz, e), 128.96 (d, 4JC-P = 
3.5 Hz, f), 127.25 (d, 5JC-P = 1.8 Hz, g), 116.35 (h), 116.06 (d, 
2JC-P = 12 Hz, d), 80.00 (m), 
62.11 (d, 2JC-P = 6.8 Hz, b), 49.17 (j or k), 43.58 (j or k), 31.14 (d, 
1JC-P = 140 Hz, c), 28.52 
(n), 16.59 (d, 3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.21 ppm; IR (neat) 
2979 (sp2 C-H), 2904 (sp3 C-H), 1691 (C=O), 1606 (C=C), 1514, 1233 (P=O), 1162 (C-
O), 1020 (C-O), 961 (P-O), 751 cm-1; HRMS (ESI) calculated for C22H35N2O5P+Na
+ = 
461.2181, found 461.2180 m/z. 
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Synthesis of allylic phosphonate (E)-18m: Following GP2, the allyl bromide (E)-86m 
(168 mg, 0.50 mmol) yields alkene substrate (E)-18m (153 mg, 80%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 8.18 (1H, 
s, k), 7.58 (1H, d, J = 3.6 Hz, m), 7.49 (1H, d, J = 8.0 Hz, h), 7.30 (1H, d, J = 8.0 Hz, g), 
6.65 (1H, dd, J = 15.5, 5.5 Hz, e), 6.54 (1H, dd, J = 3.6, 0.5 Hz, l), 6.27-6.17 (1H, m, d), 
4.21-4.08 (4H, m, b), 2.81 (2H, ddd, J = 22.0, 7.5, 1.5 Hz, c), 1.69 (9H, s, r), 1.34 (6H, t, J 
= 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 149.87 (o), 135.78 (i or j), 135.66 (d, 3JC-
P = 15 Hz, e), 133.49 (d, 
4JC-P = 3.5 Hz, f), 130.32 (i or j), 126.56 (m), 121.22 (d, 
5JC-P = 
2.0 Hz, g), 121.05 (h), 117.92 (d, 2JC-P = 12 Hz, d), 113.49 (d, 
5JC-P = 2.0 Hz, k), 107.41 
(l), 83.91 (q), 62.22 (d, 2JC-P = 7.0 Hz, b), 31.38 (d, 
1JC-P = 140 Hz, c), 28.37 (r), 16.68 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.05 ppm; IR (neat) 2979 (sp2 C-
H), 2904 (sp3 C-H), 1729 (C=O), 1612 (C=C), 1335 (C-N), 1250 (P=O), 1125 (C-O), 1020 
(C-O), 960 (P-O) cm-1; HRMS (ESI) calculated for C20H28NO5P+Na
+ = 416.1603, found 
416.1607 m/z.   
 
Synthesis of allylic phosphonate (E)-18n: Following GP3, the allyl carbonate (E)-86n 
(295 mg, 1.00 mmol) yields alkene substrate (E)-18n (151 mg, 44%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.17-7.15 
(2H, m, g+i), 6.40-6.35 (2H, m, e+h), 5.94-5.85 (1H, m, d), 4.19-4.06 (4H, m, b), 2.72 (2H, 
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dd, J = 22, 7.5 Hz, c), 1.60 (9H, s, l), 1.33 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, 
CDCl3) δ 148.89 (j), 127.15 (d, 3JC-P = 15 Hz, e), 125.51 (d, 4JC-P = 3.75 Hz, f), 121.17 (i), 
117.88 (d, 5JC-P = 3 Hz, g), 117.29 (d, 
2JC-P = 12 Hz, d), 109.57 (h), 83.93 (k), 62.20 (d, 
2JC-P = 7.0 Hz, b), 31.16 (d, 
1JC-P = 140 Hz, c), 28.17 (l), 16.67 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.13 ppm; IR (neat) 2980 (sp2 C-H), 2802 (sp3 C-H), 1738 
(C=O), 1352 (C-N), 1251 (P=O), 1154 (C-O), 1021 (C-O), 959 (P-O), 769 cm-1; HRMS 
(ESI) calculated for C16H26NO5P+Na
+ = 366.1446, found 366.1446 m/z. 
 
Synthesis of allylic phosphonate (E)-18o: Following GP3, the allyl carbonate (E)-86o 
(295 mg, 1.00 mmol) yields alkene substrate (E)-18o (134 mg, 39%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.20 (1H, 
br s, i), 7.10 (1H, dd, J = 15.5, 5.5 Hz, e), 6.38 (1H, br s, g), 6.12 (1H, dd, J = 3.5, 3.0 Hz, 
h), 5.99-5.90 (1H, m, d), 4.19-4.07 (4H, m, b), 2.76 (2H, dd, J = 22.0, 7.5 Hz, c), 1.60 (9H, 
s, l), 1.33 (6H, t, J = 7.10 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 149.51 (j), 133.58 
(d, 4JC-P = 3.75 Hz, f), 125.98 (d, 
3JC-P = 16 Hz, e), 121.87 (i), 118.70 (d, 
2JC-P = 12.25 Hz, 
d), 111.12 (d, 5JC-P = 3.0 Hz, g), 111.00 (h), 83.96 (k), 62.19 (d, 
2JC-P = 6.75 Hz, b), 31.34 
(d, 1JC-P = 140 Hz, c), 28.18 (l), 16.65 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, 
CDCl3) δ 26.85 ppm; IR (neat) 2979 (sp2 C-H), 2906 (sp3 C-H), 1739 (C=O), 1320 (C-N), 
1246 (P=O), 1122 (C-O), 1022 (C-O), 958 (P-O) cm-1; HRMS (ESI) calculated for 
C16H26NO5P+Na
+ = 366.1446, found 366.1447 m/z. 
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Synthesis of allylic phosphonate (E)-18p: Following GP2, the allyl bromide (E)-85p 
(203 mg, 1.00 mmol) yields alkene substrate (E)-18p (216 mg, 83%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.26 (1H, 
dd, J = 5.0, 3.0 Hz, h), 7.20 (1H, d, J = 5.0 Hz, i), 7.12 (1H, br s, g), 6.54 (1H, dd, J = 
15.75, 5.5 Hz, e), 6.07-5.97 (1H, m, d), 4.19-4.06 (4H, m, b), 2.72 (2H, ddd, J = 22, 7.5, 
1.0 Hz, c), 1.32 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 139.57 (d, 4JC-
P = 3.5 Hz, f), 129.02 (d, 
3JC-P = 15 Hz, e), 126.16 (h), 125.05 (i), 121.98 (d, 
5JC-P = 3.0 Hz, 
g), 118.76 (d, 2JC-P = 12 Hz, d), 62.16 (d, 
2JC-P = 6.7 Hz, b), 31.09 (d, 
1JC-P = 140 Hz, c), 
16.63 (d, 3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.88 ppm; IR (neat) 3078 
(sp2 C-H), 2904 (sp3 C-H), 1477 (aromatic C=C), 1390 (aromatic C=C), 1244 (P=O), 1018 
(C-O), 955 (P-O), 765 cm-1; HRMS (ESI) calculated for C11H17O3PS+Na
+ = 283.0534, 
found 283.0534 m/z.  
 
Synthesis of allylic phosphonate (E)-18q: Following GP2, the allyl bromide (E)-86q 
(203 mg, 1.00 mmol) yields alkene substrate (E)-18q (205 mg, 79%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.14 (1H, 
m, g or h), 6.96-6.93 (2H, m, g or h and i), 6.66 (1H, dd, J = 15.5, 5.5 Hz, e), 6.04-5.94 
(1H, m, d), 4.19-4.06 (4H, m, b), 2.73 (2H, ddd, J = 22, 7.5, 1.5 Hz, c), 1.35-1.31 (6H, m, 
a) ppm; 13C NMR (100 MHz, CDCl3) δ 141.94 (d, 4JC-P = 4.5 Hz, f), 127.90 (d, 3JC-P = 15 
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Hz, e), 127.44 (i), 125.55 (d, 5JC-P = 3.0 Hz, g), 124.31 (d, 
6JC-P = 1.5 Hz), 118.57 (d, 
2JC-P 
= 12 Hz, d), 62.25 (d, 2JC-P = 6.7 Hz, b), 31.06 (d, 
1JC-P = 140 Hz, c), 16.64 (d, 
3JC-P = 6.0 
Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.45 ppm; IR (neat) 3030 (sp2 C-H), 2904 
(sp3 C-H), 1433 (aromatic C=C), 1391 (aromatic C=C), 1246 (P=O), 1018 (C-O), 950 (P-
O) cm-1; HRMS (ESI) calculated for C11H17O3PS+Na
+ = 283.0534, found 283.0533 m/z. 
 
Synthesis of allylic phosphonate (E)-18r: Following GP2, the allyl bromide (E)-86r (127 
mg, 0.50 mmol) yields alkene substrate (E)-18r (127 mg, 82%) as a viscous oil: TLC 
analysis (ethyl acetate/hexanes 4:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.77-7.75 (1H, 
m, aryl), 7.70-7.68 (1H, m, aryl), 7.34-7.27 (2H, m, aryl), 7.13 (1H, s, g), 6.78 (1H, dd, J 
= 15.5, 5.5 Hz, e), 6.15-6.05 (1H, m, e), 4.22-4.09 (4H, m, b), 2.79 (2H, ddd, J = 22, 7.5, 
1.2 Hz, c), 1.35 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 142 (d, 4JC-P = 
4.5 Hz, f), 140.13 (d, 6JC-P = 1.2 Hz, h), 138.99 (m), 128.65 (d, 
3JC-P = 15 Hz, e), 124.88 
(aryl), 124.62 (aryl), 123.62 (aryl), 122.73 (d, 5JC-P = 3.5 Hz, g), 122.36 (aryl), 121.45 (d, 
2JC-P = 12 Hz, d), 62.37 (d, 
2JC-P = 6.7 Hz, b), 31.27 (d, 
1JC-P = 140 Hz, c), 16.67 (d, 
3JC-P 
= 6.0 Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.06 ppm; IR (neat) 2980 (sp2 C-H), 
2904 (sp3 C-H), 1245 (P=O), 1017 (C-O), 951 (P-O) cm-1; HRMS (ESI) calculated for 
C15H19O3PS+Na
+ = 333.0690, found 333.0693 m/z. 
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Synthesis of allylic phosphonate (E)-18s: Following GP3, the allyl carbonate (E)-86s 
(785 mg, 4.00 mmol) yields alkene substrate (E)-18s (288 mg, 30%) as a colorless oil: TLC 
analysis (ethyl acetate) Rf = 0.4; 
1H NMR (400 MHz, CDCl3) δ 7.38 (1H, br s, g), 7.34 
(1H, dd, J = 1.5, 1.0 Hz, h), 6.52 (1H, d, J = 1.7 Hz, h), 6.38 (1Hh, dd, J = 15.75, 5.0 Hz, 
e), 5.93-5.83 (1H, m, d), 4.18-4.05 (4H, m, b), 2.71 (2H, ddd, J = 22.0, 7.50, 1.25 Hz, c), 
1.32 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 143.66 (i), 140.32 (d, 5JC-
P = 3.5 Hz, g), 124.55 (d, 
3JC-P = 15 Hz, e), 123.98 (d, 
4JC-P = 3.5 Hz, f), 118.40 (d, 
2JC-P = 
12 Hz, d), 107.64 (h), 62.18 (d, 2JC-P = 6.7 Hz, b), 31.08 (d, 
1JC-P = 140 Hz, c), 16.62 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.94 ppm; IR (neat) 2981 (C-H), 
1507 (aromatic C=C), 1443 (aromatic C=C), 1391 (aromatic C=C), 1246 (P=O), 1161, 
1017 (C-O), 955 (P-O), 870, 773 cm-1; HRMS (ESI) calculated for C11H17O4P+Na
+ = 
267.0757, found 267.0757 m/z.  
 
Synthesis of allylic phosphonate (E)-18t: Following GP3, the allyl carbonate (E)-86t 
(210 mg, 1.00 mmol) yields alkene substrate (E)-18t (119 mg, 46%) as a buff colored oil: 
TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 6.28 (1H, 
dd, J = 15.75, 5.5 Hz, e), 6.09 (1H, dd, J = 2.5, 2.0 Hz, g), 6.07-5.96 (1H, m, d), 5.96-5.95 
(1H, m, h), 4.19-4.09 (4H, m, b), 2.72 (2H, ddd, J = 22.5, 7.5, 1.2 Hz, c), 2.31 (3H, s, j), 
1.34 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 152.10 (i), 150.95 (d, 4JC-
P = 4.5 Hz, f), 123.24 (d, 
3JC-P = 15 Hz, e), 115.78 (d, 
2JC-P = 12.5 Hz, d), 108.85 (d, 
5JC-P 
= 3.0 Hz, g), 107.38 (h), 62.17 (d, 2JC-P = 6.5 Hz, b), 30.98 (d, 
1JC-P = 140 Hz, c), 16.62 (d, 
3JC-P = 6.0 Hz, a), 13.79 (j) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.78 ppm; IR (neat) 2982 
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(sp2 C-H), 2906 (sp3 C-H), 1592 (C=C), 1534, 1443 (aromatic C=C), 1391 (aromatic C=C), 
1248 (P=O), 1017 (C-O), 954 (P-O), 774 cm-1; HRMS (ESI) calculated for C12H19O4P+Na
+ 
= 281.0919, found 281.0922 m/z.  
 
Synthesis of allylic phosphonate (E)-18u: Following GP2, the allyl bromide (E)-86u 
(118 mg, 0.50 mmol) yields alkene substrate (E)-18u (125 mg, 85%) as a colorless oil: 
TLC analysis (ethyl acetate/hexanes 4:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.52 (1H, 
d, J = 7.5 Hz, i or l), 7.44 (1H, d, J = 7.5 Hz, i or l), 7.29-7.18 (2H, m, j+k), 6.56 (1H, br s, 
g), 6.53-6.37 (2H, m, d+e), 4.23-4.10 (4H, m, b), 2.82 (2H, dd, J = 22, 7.5 Hz, c), 1.36 (6H, 
t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 154.93 (m), 154.21 (d, 4JC-P = 4.5 
Hz, f), 129.00 (d, 6JC-P = 1.35 Hz, h), 124.72 (j or k), 123.29 (d, 
3JC-P = 15 Hz, e), 122.99 
(j or k), 121.44 (d, 2JC-P = 12 Hz, d), 121.06 (i or l), 111.12 (i or l), 104.45 (d, 
5JC-P = 3.5 
Hz, g), 62.36 (d, 2JC-P = 7.0 Hz, b), 31.29 (d, 
1JC-P = 140 Hz, c), 16.67 (d, 
3JC-P = 6.0 Hz, 
a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.05 ppm; IR (neat) 2980 (sp2 C-H), 2904 (sp3 C-
H), 1451 (aromatic C=C), 1391 (aromatic C=C), 1250 (P=O), 1018 (C-O), 944 (P-O), 748 
cm-1; HRMS (ESI) calculated for C15H19O4P+Na
+ = 317.0919, found 317.0920 m/z.    
 
Synthesis of benzylamide substrate (E)-18v: To a solution of styryl acetic acid (486 mg, 
3.00 mmol, 1.00 eq) in dry dichloromethane (15 mL) at 0 oC is added a drop of dry DMF. 
To the resultant mixture is added oxalyl chloride (0.38 mL, 4.50 mmol, 1.50 eq) drop wise 
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and the resultant mixture is stirred at room temperature for ca. 2 hours. Following this, the 
reaction mixture is subjected to rotary evaporation to get rid of unreacted oxalyl chloride. 
The crude mass is redissolved in dry dichloromethane (15 mL) and benzylamine (0.66 mL, 
6.00 mmol, 2.00 eq) is added dropwise and the resultant mixture is stirred for ca. 2 hours. 
The mixture is concentrated via rotary evaporation and flash chromatography over silica 
gel (ethyl-acetate/hexanes/dichloromethane 40:50:10) affords the benzylamide product 
(E)-17 (580 mg, 77%) as yellowish-white flaky solid: Melting point = 122-124 oC; TLC 
analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.40-7.25 
(10H, m, aryl), 6.54 (1H, d, J = 16 Hz, e), 6.33 (1H, dt, J = 15.5, 7.5 Hz, d), 6.17 (1H, br 
s, NH), 4.46 (2H, d, J = 6.0 Hz, a), 3.21 (2H, dd, J = 7.5, 1.1 Hz, c) ppm; 13C NMR (100 
MHz, CDCl3) δ 170.75 (b), 138.35 (aryl), 136.71 (aryl), 134.79 (e), 128.86 (aryl), 128.77 
(aryl), 127.92 (aryl), 127.67 (aryl), 126.47 (aryl), 122.48 (d), 43.82 (a), 40.95 (c) ppm; IR 
(neat) 3235 (N-H), 3035 (C-H), 2160 (C=N), 1630 (C=O), 1539 cm-1.    
  
Preparation of disubstituted allylic phosphonate (E)-87: Following GP2 (with dimethyl 
phosphite) the allyl bromide (E)-86w (225 mg, 1.00 mmol) yields dimethyl phosphonate 
alkene substrate (E)-87 (211 mg, 83%) as a colorless oil: TLC analysis (ethyl 
acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.31-7.17 (5H, m, aryl), 5.76-
5.64 (1H, m, e), 5.50-5.41 (1H, m, d), 3.73 (6H, d, 3JP-H = 11 Hz, a), 2.71 (2H, t, J = 7.75 
Hz, f), 2.58 (2H, dd, 2JC-P = 22 Hz, 
3JH-H = 7.5 Hz, b), 2.42-2.36 (2H, m, e) ppm; 
13C NMR 
(100 MHz, CDCl3) δ 141.76 (g), 135.58 (d, 3JC-P = 15 Hz, c), 128.61 (h or i), 128.49 (h or 
i), 126.03 (j), 119.03 (d, 2JC-P = 11 Hz, c), 52.83 (d, 
2JC-P = 6.8 Hz, a), 35.69 (d, 
5JC-P = 3.5 
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Hz, f), 34.43 (d, 4JC-P = 2.0 Hz, e), 29.64 (d, 
1JC-P = 140 Hz, b) ppm; 
31P NMR (162 MHz, 
CDCl3) δ 30.27 ppm; IR (neat) 2951 (sp2 C-H), 2850 (sp3 C-H), 1603 (C=C), 1496 
(aromatic C=C), 1453 (aromatic C=C), 1400 (aromatic C=C), 1251 (P=O), 1022 (C-O), 
968 (P-O), 850, 805, 747, 698 cm-1.  
 
Preparation of disubstituted allylic phosphonate (E)-18w: Following GP2, the allyl 
bromide (E)-86w (225 mg, 1.00 mmol) yields alkene substrate (E)-18w (217 mg, 77%) as 
a colorless oil: TLC analysis (ethyl acetate/hexanes) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.31-7.18 (5H, m, aryl), 5.71-5.63 (1H, m, e), 5.51-5.42 (1H, m, d), 4.15-4.05 (4H, m, 
b), 2.71 (2H, t, J = 7.8 Hz, g), 2.56 (2H, dd, J = 21.5, 7.5 Hz, c), 2.42-2.37 (2H, m, f), 1.32 
(6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 141.83 (h), 135.29 (d, 3JC-P = 
15 Hz, e), 128.59 (i or j), 128.49 (i or j), 126.03 (k), 119.43 (d, 2JC-P = 11 Hz, d), 62.02 (d, 
2JC-P = 7 Hz, b), 35.76 (d, 
5JC-P = 3.5 Hz, g), 34.49 (d, 
4JC-P = 2 Hz, f), 30.64 (d, 
1JC-P = 140 
Hz, c), 16.64 (d, 3JC-P = 6 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 27.82 ppm; IR (neat) 
2981 (sp2 C-H), 2906 (sp3 C-H), 1603 (C=C), 1496 (aromatic C=C), 1454 (aromatic C=C), 
1391 (aromatic C=C), 1249 (P=O), 1021 (C-O), 957 (P-O), 698 cm-1.       
 
Preparation of disubstituted phosphonate (E)-18x: Following GP1, the allyl bromide 
(E)-86x (225 mg, 1.00 mmol) yields alkene substrate (E)-18x (184 mg, 65%) as a colorless 
oil: TLC analysis (ethyl acetate/hexanes) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.37-
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7.20 (5H, m, aryl), 6.42 (1H, d, J = 15.8 Hz, g), 6.18 (1H, dt, J = 15.8, 7.0 Hz, f), 4.18-4.05 
(4H, m, b), 2.35-2.30 (2H, m, e), 1.89-1.74 (4H, m, c+d), 1.34 (6H, t, J = 7 Hz, a) ppm; 13C 
NMR (100 MHz, CDCl3) δ 137.64 (h), 131.26 (g), 129.34 (f), 128.68 (i or j), 127.23 (k), 
126.16 (i or j), 61.61 (d, 2JC-P = 6.5 Hz, b), 33.79 (d, 
3JC-P = 17 Hz, e), 25.29 (d, 
1JC-P = 141 
Hz, c), 22.35 (d, 2JC-P = 5 Hz, d), 16.67 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, 
CDCl3) δ 32.21 ppm; IR (neat) 3025 (sp2 C-H), 2980 (sp3 C-H), 1701 (C=C), 1493 
(aromatic C=C), 1448 (aromatic C=C), 1390 (aromatic C=C), 1236 (P=O), 1022 (C-O), 
955 (P-O), 693 cm-1.  
 
Synthesis of vinyl phosphonate substrate (E)-18y: To a solution of tetraethyl-methylene-
diphosphonate (288 mg, 1.00 mmol, 1.00 eq) in dry THF (10 mL) at 0 oC is added 
NaHMDS (2M solution in THF; 0.6 mL, 1.2 mmol, 1.2 eq) dropwise, and the resultant 
solution is stirred for 10 minutes. To the resultant mixture is added benzaldehyde (0.11 
mL, 1.10 mmol, 1.10 eq) and the resultant mixture is stirred at room temperature for 3 
hours. Following this, a saturated aqueous solution of NH4Cl (10 mL) is added to the 
reaction mixture and the layers separated. The aqueous layer is extracted with ethyl acetate 
(2 x 20 mL) and the combined organic layers were washed with brine, dried over anhydrous 
Na2SO4 and concentrated in vacuum. Flash chromatography over silica gel (ethyl acetate) 
affords the desired vinyl phosphonate (E)-18y (202 mg, 84%) as a colorless oil: TLC 
analysis (ethyl acetate) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.56-7.37 (6H, m, 
d+f+g+h), 6.27 (1H, dd, J = 17.5 Hz, c), 4.21-4.07 (4H, m, b), 1.36 (6H, t, J = 7 Hz, a) 
ppm; 13C NMR (100 MHz, CDCl3) δ 148.92 (d, 2JC-P = 7.0 Hz, d), 135.02 (d, 3JC-P = 23 
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Hz, e), 130.40 (h), 129.01 (f or g), 127.86 (f or g), 114.12 (d, 1JC-P = 191 Hz, c), 62.04 (d, 
2JC-P = 5.5 Hz, b), 16.57 (d, 
3JC-P = 6.5 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 19.50 
ppm; IR (neat) 2981 (C-H), 1615 (C=C), 1449 (aromatic C=C), 1391 (aromatic C=C), 1242 
(P=O), 1018 (C-O), 954 (P-O), 740 cm-1. 
 
Preparation of trisubstituted allylic phosphonate (E)-18z: Following GP2, the allyl 
bromide (E)-86z (211 mg, 1.00 mmol) yields alkene substrate (E)-18z (228 mg, 85%) as a 
colorless oil: TLC analysis (ethyl acetate/hexanes) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.36-7.21 (5H, m, aryl), 6.43 (1H, d, J = 5.7 Hz, e), 4.21-4.07 (4H, m, b), 2.75 (2H, d, 
2JP-H = 22.5 Hz, c), 2.03 (3H, d, J = 3.75 Hz, j), 1.34 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR 
(100 MHz, CDCl3) δ 137.83 (d, 4JC-P = 3.9 Hz, f), 129.79 (d, 3JC-P = 13 Hz, e), 129.52 (d, 
2JC-P = 12 Hz, d), 128.96 (d, 
6JC-P = 3 Hz, g), 128.27 (h), 126.59 (i), 62.11 (d, 
2JC-P = 7.0 
Hz, b), 38.19 (d, 1JC-P = 137 Hz, c), 19.31 (d, 
3JC-P = 2.75 Hz, j), 16.66 (d, 
3JC-P = 6.0 Hz, 
a) ppm; 31P NMR (162 MHz, CDCl3) δ 27.10 ppm; IR (neat) 2981 (C-H), 1599 (C=C), 
1444 (aromatic C=C), 1391 (aromatic C=C), 1247 (P=O), 1019 (C-O), 955 (P-O) cm-1. 
 
Preparation of trisubstituted allylic phosphonate (E)-18aa: Following GP2, the allyl 
bromide (E)-86aa (211 mg, 1.00 mmol) yields alkene substrate (E)-18aa (209 mg, 78%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.41-7.24 (5H, m, aryl), 5.83-5.76 (1H, m, d), 4.18-4.09 (4H, m, b), 2.79 (2H, 
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ddd, J = 22.5, 8.0, 0.5 Hz, c), 2.09 (3H, dt, J = 4.0, 0.6 Hz, j), 1.34 (6H, t, J = 7 Hz, a) ppm; 
13C NMR (100 MHz, CDCl3) δ 143.28 (d, 4JC-P = 3.6 Hz, f), 139.45 (d, 3JC-P = 15 Hz, e), 
128.41 (h), 127.29 (i), 125.95 (d, 5JC-P = 2.25 Hz, g), 116.36 (d, 
2JC-P = 12 Hz, d), 62.12 (d, 
2JC-P = 7 Hz, b), 27.57 (d, 
1JC-P = 140 Hz, c), 16.67 (d, 
3JC-P = 6.0 Hz, a), 16.35 (d, 
4JC-P = 
2.5 Hz, j) ppm; 31P NMR (162 MHz, CDCl3) δ 27.65 ppm; IR (neat) 2980 (C-H), 1600 
(C=C), 1494 (aromatic C=C), 1444 (aromatic C=C), 1390 (aromatic C=C), 1247 (P=O), 
1019 (C-O), 955 (P-O), 757, 695 cm-1. 
 
Preparation of disubstituted phosphonate (E)-23: This transformation is carried out via 
reaction between allyl bromides and lithiated diethyl methylphosphonate. The allyl 
bromide (E)-86a (197 mg, 1.00 mmol) yields alkene substrate (E)-23 (190 mg, 71%) as a 
colorless oil: TLC analysis (ethyl acetate/hexanes) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) 
δ 7.36-7.19 (5H, m, aryl), 6.44 (1H, d, J = 15.5 Hz, f), 6.23 (1H, dt, J = 15.5, 6.5 Hz, e), 
4.19-4.06 (4H, m, b), 2.57-2.48 (d), 1.96-1.87 (2H, m, c), 1.34 (6H, t, J = 7.0 Hz, a) ppm; 
13C NMR (100 MHz, CDCl3) δ 137.43 (g), 130.79 (f), 129.18 (d, 3JC-P = 17 Hz, e), 128.71 
(h or i), 127.38 (j), 126.23 (h or i), 61.72 (d, 2JC-P = 6 Hz, b), 26.18 (d, 
2JC-P = 4.5 Hz, d), 
25.79 (d, 1JC-P = 140 Hz, c), 16.68 (d, 
3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) 
δ 31.19 ppm; IR (neat) 3025 (sp2 C-H), 2980 (sp3 C-H), 1597 (C=C), 1495 (aromatic C=C), 
1442 (aromatic C=C), 1390 (aromatic C=C), 1240 (P=O), 1023 (C-O), 956 (P-O) cm-1; 
HRMS (ESI) calculated for C14H21O3P+Na
+ = 291.1126, found 291.1129 m/z.   
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Synthesis of allylic phosphonate (Z)-23: Photoisomerization of the allylic phosphonate 
(E)-23 (200 mg, 0.75 mmol; Ref. 5) affords the diastereomeric (Z)-23 (170 mg, 84%; Z:E 
ratio = 4:1) as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.6; 
1H NMR 
(400 MHz, CDCl3) δ 7.36-7.22 (5H, m, aryl), 6.48 (1H, d, J = 12 Hz, f), 5.68 (1H, dt, J = 
12, 7.0 Hz, e), 4.18-4.06 (4H, m, b), 2.68-2.62 (2H, m, d), 1.92-1.86 (2H, m, c), 1.32 (6H, 
t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 137.22 (g), 131.12 (d, 3JC-P = 17 Hz, 
e), 130.11 (f), 128.89 (h or i), 128.45 (h or i), 127.03 (j), 61.76 (d, 2JC-P = 6.5 Hz, b), 26.21 
(d, 1JC-P = 140 Hz, c), 21.91 (d, 
2JC-P = 4.8 Hz, d), 16.65 (d, 
3JC-P = 6.5 Hz, a) ppm; 
31P 
NMR (162 MHz, CDCl3) δ 31.05 ppm; IR (neat) 3026 (sp2 C-H), 2978 (sp3 C-H), 1597 
(C=C), 1496 (aromatic C=C), 1440 (aromatic C=C), 1391 (aromatic C=C), 1237 (P=O), 
1023 (C-O), 958 (P-O) cm-1; HRMS (ESI) calculated for C14H21O3P+Na
+ = 291.1126, 
found 291.1127 m/z.   
Synthesis of trisubstituted substrates.  
 
Synthesis of phosphonate functionalized alkene (E)-38a: Using GP1, allyl bromide (E)-
88a (2.05 g, 8.57 mmol, 1.10 eq) yields substrate (E)-38a (1.65 g, 72%) as a clear, colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 3:2) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) 
δ 7.31-7.16 (5H, m, aryl), 5.37 (1H, dd, J = 6.6, 6.3 Hz, f), 4.07 (4H, doublet of quartets, J 
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= 7.5, 7.2 Hz, b+b’), 2.67 (2H, t, J = 7.5 Hz, h), 2.54 (2H, d, J = 21.6 Hz, c), 2.41-2.32 (2H, 
m, g), 1.74 (3H, d, 3 Hz, e), 1.30 (6H, t, J = 7.3 Hz a+a') ppm; 13C NMR (75 MHz, CDCl3) 
δ 141.99 (i), 129.11 (d, 3JC-P = 12.8 Hz, f), 128.48 (aryl), 128.35 (aryl), 126.50 (d, 2JC-P = 
11.3 Hz, d), 125.86 (aryl), 61.76 (d, 2JC-P = 6.8 Hz, b+b'), 36.88 (d, 
1JC-P = 136.5 Hz, c), 
35.74 (d, 5JC-P = 3.8 Hz, h), 30.17 (d, 
4JC-P = 3 Hz, g), 17.40 (d, 
3JC-P = 3 Hz, e), 16.53 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 27.89 ppm; IR (neat) 2980 
(aromatic C-H), 2909 (aliphatic C-H), 1448.27 (C=C), 1245 (P=O) cm-1; HRMS (ESI) 
calculated for C16H25O3P  296.1541, found 296.1537 m/z.  
 
Synthesis of phosphonate functionalized alkene (Z)-38a: Using GP2, allyl bromide (Z)-
88a (240 mg, 1.00 mmol) yielded (Z)-38a (174 mg, 76%) as a colorless viscous oil; TLC 
analysis (ethyl-acetate/hexanes 3:2) Rf = 0.6; 
1H NMR (400 MHz, CDCl3) δ 7.29-7.25 (2H, 
m, aryl), 7.19-7.16 (3H, m, aryl), 5.38 (1H, dd, J = 6.6, 13.4 Hz, f), 4.12-4.05 (4H, m, b+b'), 
2.66 (2H, t, J = 7.8 Hz, h), 2.53 (2H, d, J = 22.8 Hz, c), 2.39-2.32 (2H, m, g), 1.85 (3H, q, 
J = 3.2, 1.2 Hz, e), 1.30 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 142.08 
(aryl), 128.69 (aryl), 128.54 (aryl), 128.40 (aryl), 126.25 (d, 2JC-P = 12 Hz, d), 61.84 (d, 
2JC-P = 7 Hz, b+b'), 35.80 (d, 
5JC-P = 3 Hz, h), 30.39 (d, 
1JC-P = 137 Hz, c), 30.37 (d, 
4JC-P 
= 3 Hz, g), 24.93 (d, 3JC-P = 2 Hz, e), 16.60 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 
MHz, CDCl3) δ 27.60 ppm; IR (neat) 2978 (aromatic C-H), 2905 (aliphatic C-H), 1447 
(C=C), 1247.90 (P=O) cm-1.  
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Synthesis of homologous phosphonate functionalized alkene substrate (E)-39: A 
solution of diethyl methylphosphonate (0.29 mL, 2.0 mmol) in THF (20 mL) is cooled to 
–78° C using a dry ice-acetone bath and nBuLi (1.3 mL; 1.6 M solution in hexanes, 2.1 eq) 
was added dropwise. The resultant mixture was stirred for 1 hour and then the mixture was 
warmed to –40° C in a dry ice-acetonitrile bath. Copper iodide (400 mg, 2.10 mmol, 1.05 
eq) is added to the mixture and the resultant mixture is stirred at –40° C for 1 hour. The 
mixture is re-cooled to –78oC and a solution of allyl bromide 88a (526 mg, 2.20 mmol, 
1.10 eq) in THF (5 mL) added dropwise. The mixture is allowed to warm up to room 
temperature overnight and stirred for a total of 9 hours. Saturated NH4Cl (aq) is added and 
the mixture extracted with 1:1 ethyl acetate/hexanes (3 x 20 mL). The combined organics 
were washed with brine, dried over Na2SO4 and concentrated in vacuum. Flash 
chromatography on silica gel (ethyl acetate/hexanes 1:1) yielded the desired product as a 
colorless oil: TLC analysis (ethyl-acetate/hexanes 3:2) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.28-7.15 (5H, m, aryl), 5.23 (1H, t, J = 7.1 Hz, g), 4.14-4.04 (4H, m, b+b'), 2.63 
(2H, t, J = 7.65 Hz, i), 2.33-2.20 (4H, m, d+h), 1.86-1.67 (2H, m, c), 1.54 (3H, s, f), 1.32 
(6H, t, J = 7.1 Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 142.05 (aryl), 134.55 (d, 3JC-
P = 18 Hz, e), 128.44 (aryl), 128.22 (aryl), 125.73 (aryl), 124.13 (g), 61.45 (d, 
2JC-P = 6.75 
Hz, b+b'), 35.89 (i), 31.97 (d, 2JC-P = 4.5 Hz, d), 29.86 (h), 16.48 (d, 
3JC-P = 6 Hz, a+a'), 
15.70 (f) ppm; 31P NMR (121 MHz, CDCl3) δ 32.17 ppm; IR (neat) 2979 (aromatic C-H), 
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2860 (aliphatic C-H), 1603 (C=C), 1447, 1390, 1244 (P=O), 1025 (C-O), 954 (P-O), 698 
cm-1.  
 
Synthesis of phosphonate functionalized alkene (E)-37b: Using GP2, the allyl bromide 
(E)-88b (307 mg, 1.00 mmol) yields  substrate (E)-37b (302 mg, 83%) as a colorless, 
viscous oil: TLC analysis (ethyl-acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) 
δ 7.55-1.51 (2H, m, k), 7.32-7.28 (2H, m, j), 5.36-5.33 (1H, m, f), 4.12-4.02 (4H, m, b+b'), 
2.75-2.70 (2H, m, h), 2.53 (2H, d, J = 21.6, c), 2.39-2.37 (2H, m, g), 1.71 (3H, s, e), 1.33-
1.28 (6H, m, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 145.98 (aryl), 128.78 (aryl), 128.38 
(aryl or vinyl), 128.20 (aryl or vinyl), 127.15 (aryl or vinyl), 127.00 (aryl or vinyl), 125.18 
(aryl or vinyl), 125.13 (aryl or vinyl), 61.69 (d, 2JC-P = 6.75 Hz, b+b'), 36.74 (d, 
1JC-P = 
137.25 Hz, c), 35.44 (d, 5JC-P = 3.75 Hz, h), 29.69 (g), 17.35 (e), 16.41 (d, 
3JC-P = 6 Hz, 
a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 27.72 ppm; 19F NMR (282 MHz, CDCl3) δ –
62.33 ppm; IR (neat) 2983.20 (aromatic C-H), 2906.20 (aliphatic C-H), 1617.93 (C=C), 
1443.92, 1323.55 (C-F), 1246.49 (P=O), 1161.18, 1119.47, 1054.30 (C-O), 1018.51 (C-
O), 955.42, 834.85 cm-1; HRMS (ESI) calculated for C17H24F3O3P+Na
+ 387.1307, found 
387.1311 m/z.  
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Synthesis of phosphonate functionalized alkene (E)-37c: Using GP2, allyl bromide (E)-
88c (410 mg, 1.50 mmol) yields the alkene substrate (E)-37c (402 mg, 81%) as a colorless 
oil: TLC analysis (ethyl-acetate/hexanes 3:2) Rf = 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.25 
(2H, d, J = 8.0 Hz, k), 7.13 (2H, d, J = 8.0 Hz, j), 5.39-5.31 (1H, m, f), 4.11-4.04 (4H, m, 
b+b'), 2.65 (2H, t, J = 7.6 Hz, h), 2.53 (2H, d, J = 22.0 Hz, c), 2.38-2.31 (2H, m, g), 1.72 
(3H, d, J = 3.2 Hz, e), 1.31 (6H, t, J = 7.1 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 
140.43 (aryl), 131.63 (aryl), 129.62 (aryl or vinyl), 128.74 (aryl or vinyl), 128.62 (aryl or 
vinyl), 128.52 (aryl or vinyl), 128.46 (aryl or vinyl), 128.40 (aryl or vinyl), 126.94 (d, 2JC-
P = 11.0 Hz, d), 61.82 (d, 
2JC-P = 7.0 Hz, b+b'), 36.89 (d, 
1JC-P = 136 Hz, c), 35.08 (d, 
5JC-P 
= 4 Hz, h), 30.03 (d, 4JC-P = 3 Hz, g), 17.48 (d, 
3JC-P = 3 Hz, e), 16.57 (d, 
3JC-P = 6 Hz, a+a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 27.80 ppm; IR (neat) 2981 (sp2 C-H), 2862 (sp3 C-
H), 1492, 1443, 1390, 1246 (P=O), 1053 (C-O), 1024 (C-O), 955, 802 (C-Cl) cm-1; HRMS 
(ESI) calculated for C16H24ClO3P+Na
+ 353.1044, found 353.1052 m/z. 
 
Synthesis of phosphonate functionalized alkene (E)-37d: Using GP2 the allyl bromide 
(E)-88d (370 mg, 1.50 mmol) yields the alkene substrate (E)-37d (376 mg, 83%): TLC 
analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 7.12-7.10 (1H, 
m, l), 6.92-6.90 (1H, m, k), 6.81-6.79 (1H, m, j), 5.40-5.33 (1H, m, f), 4.12-4.02 (4H, m, 
b+b'), 2.89 (2H, t, J = 7.5 Hz, h), 2.55 (2H, d, J = 21.9 Hz, c), 2.47-2.38 (2H, m, g), 1.77-
1.76 (3H, m, e), 1.34 (6H, t, J = 4.5 Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 144.72 
(i), 128.48 (d, 3JC-P = 12.8 Hz, f), 127.06 (d, 
2JC-P = 11.3 Hz, d), 126.68 (k), 124.22 (j), 
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123.03 (l), 61.73 (d, 2JC-P = 6.8 Hz, b+b'), 36.81 (d, 
1JC-P = 136.5 Hz, c), 30.36 (d, 
4JC-P = 
3 Hz, g), 29.71 (d, 5JC-P = 4.5 Hz, h), 17.43 (d, 
3JC-P = 2.3 Hz, e), 16.46 (d, 
3JC-P = 6 Hz, 
a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 27.76 ppm; IR (neat) 2979.64 (sp2 C-H), 2906.49 
(sp3 C-H), 1441.35 (C=C), 1244.43 (P=O), 1023.49 (C=S), 693.98 (C-S) cm-1; HRMS 
(ESI) calculated for C14H23O3PS = 302.1106, found 302.1111 m/z. 
 
Synthesis of phosphonate functionalized alkene (E)-37e: Using GP2, allyl bromide (E)-
88e (385 mg, 1.50 mmol) yields the alkene substrate (E)-37e (296 mg, 63%): TLC analysis 
(ethyl-acetate) Rf = 0.6; (Note: This molecule is sensitive to air, light and silica gel. For 
purification, the silica gel that was used is deactivated by packing with 3% trimethylamine 
in ethyl acetate and chromatography was performed quickly so that the exposure of this 
molecule to air/light and silica gel is greatly minimized) 1H NMR (300 MHz, CDCl3) δ 
5.77 (2H, s, k), 5.37-5.31 (1H, m, f), 4.16-4.06 (4H, m, b+b'), 3.76-3.71 (2H, m, h), 2.57 
(2H, d, J = 21.9 Hz, c), 2.40-2.31 (2H, m, g), 2.24 (6H, s, j), 1.77 (3H, d, J = 2.4 Hz, e), 
1.33 (6H, t, J = 7.1 Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 128.85 (d, 2JC-P = 11.3 
Hz, d), 127.22 (i), 125.23 (d, 3JC-P = 12.8 Hz, f), 105.17 (k), 61.79 (d, 
2JC-P = 6.8 Hz, d), 
42.95 (d, 5JC-P = 5.3 Hz, h), 36.86 (d, 
1JC-P = 137.3 Hz, c), 29.96 (d, 
4JC-P = 3 Hz, g), 17.29 
(d, 3JC-P = 2.3 Hz, e), 16.47 (d, 
3JC-P = 6 Hz, a+a'), 12.48 (j) ppm; 
31P NMR (121 MHz, 
CDCl3) δ 27.49 ppm; IR (neat) 2977.57 (sp2 C-H), 2905.38 (sp3 C-H), 1630 (C=C), 1407.55 
(C=N), 1244.51 (P=O), 1088.81 (C-N) cm-1; HRMS (ESI) calculated for C16H28NO3P 
313.1807, found 313.1804 m/z. 
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Synthesis of phosphonate functionalized alkene (E)-37f: Using GP2, the allyl bromide 
(E)-88f (329 mg, 1.50 mmol) yields substrate (E)-37f (336 mg, 81%) as a colorless oil: 
TLC analysis (EtOAc:hexanes 2:3) Rf = 0.6; 
1H NMR (400 MHz, CDCl3) δ 5.34-5.27 (1H, 
m, f), 4.11-4.04 (4H, m, b+b'), 2.52 (2H, d, J = 21.6 Hz, c), 2.02-1.99 (2H, m, g), 1.75 (3H, 
s, e), 1.31-1.26 (14H, m, a+a'+h+i+j+k), 0.88-0.85 (3H, m, l) ppm; 13C NMR (100 MHz, 
CDCl3) δ 130.50 (d, 3JC-P = 13 Hz, f), 125.54 (d, 2JC-P = 12 Hz, d), 61.82 (d, 2JC-P = 7 Hz, 
b+b'), 37.03 (d, 1JC-P = 136 Hz, c), 31.92 (j), 29.63 (d, 
4JC-P = 4 Hz, g), 29.10 (i), 28.36 (d, 
5JC-P = 2 Hz, h), 22.80 (k), 17.44 (d, 
3JC-P = 3 Hz, e), 16.60 (d, 
3JC-P = 6 Hz, a+a'), 14.24 (l) 
ppm; 31P NMR (162 MHz, CDCl3) δ 28.12 ppm; IR (neat) 2956 (sp2 C-H), 2856 (sp3 C-
H), 1249 (P=O), 1025 (C-O), 955 (P-O) cm-1; HRMS (ESI) calculated for C14H29O3P+Na
+ 
299.1747, found 299.1751 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37g: Using GP2, the allyl bromide 
(E)-88g (230 mg, 1.50 mmol) yields substrate (E)-37g (323 mg, 83%) as a colorless oil: 
TLC analysis (EtOAc:hexanes 2:3) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 5.30-5.72 (1H, 
broad m, f), 4.09-3.99 (4H, m, b+b'), 2.51 (2H, d, J = 21.6 Hz, c), 1.90-1.84 (2H, m, g), 
1.71 (3H, s, e), 1.62-1.53 (1H, m, h), 1.29-1.24 (6H, m, a+a'), 0.85 (6H, d, J = 6.0 Hz, i) 
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ppm; 13C NMR (75 MHz, CDCl3) δ 129.11 (d, 3JC-P = 12.8 Hz, f), 125.95 (d, 2JC-P = 12 Hz, 
d), 61.63 (d, 2JC-P = 6.8 Hz, b+b'), 36.86 (d, 
1JC-P = 136.5 Hz, c) 37.29 (d, 
4JC-P = 2.3 Hz, 
g), 28.73 (d, 5JC-P = 3.8 Hz, h), 22.28 (i), 17.37 (d, 
3JC-P = 2.3 Hz, e), 16.38 (d, 
3JC-P = 6 
Hz, a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 28.14 ppm; IR (neat) 2955.88 (aliphatic C-
H), 1630 (C=C), 1246.78 (P=O) cm-1; HRMS (ESI) calculated for C12H25O3P 248.1541, 
found 248.1541 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37h: Using GP2, the allyl bromide 
(E)-88h (393 mg, 1.50 mmol) yields the alkene substrate (E)-37h (408 mg, 85%): TLC 
analysis (1:1 EtOAc:Hexanes) Rf = 0.5; [α]D20 = –2.9o (c = 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 5.34-5.29 (1H, m, f), 4.12-4.05 (4H, m, b+b'), 2.55 (2H, d, J = 21.6 Hz, c), 
2.04-1.97 (1H, m, g), 1.90-1.75 (1H, m, g), 1.75 (3H, s, e), 1.58-1.44 (2H, m, h+m), 1.34-
1.00 (12H, m, a+a'+j+k+l), 0.87-0.85 (9H, overlapping doublets, i+n+n') ppm; 13C NMR 
(100 MHz, CDCl3) δ 129.07 (d, 3JC-P = 10.5 Hz, f), 126.01 (d, 2JC-P = 12.25 Hz, d), 61.63 
(d, 2JC-P = 7 Hz, b+b'), 39.29, 36.96 (d, 
1JC-P = 136.5 Hz, c), 36.91, 35.52, 33.54, 27.97, 
24.89, 22.65, 19.55 (i), 17.45 (d, 3JC-P = 2 Hz, e), 16.47 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 28.11 ppm; IR (neat) 2953.39 (sp2 C-H), 2866.96 (sp3 C-H), 
1630 (C=C), 1249.72 (P=O), 1025.58, 955.88 cm-1; HRMS (ESI) calculated for 
C17H35O3P+Na
+ 341.2216, found 341.2227 m/z.  
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Synthesis of phosphonate functionalized alkene (E)-37i: Using GP2, the allyl bromide 
(E)-88i (368 mg, 1.00 mmol) yields the alkene substrate (E)-37i (335 mg, 78%): TLC 
analysis (EtOAc) Rf = 0.6; 
1H NMR (400 MHz, CDCl3, 333K) δ 7.33-7.23 (5H, m, aryl), 
5.29-5.24 (1H, m, f), 4.45 (2H, s, i), 4.12-4.05 (4H, m, b+b'), 3.19 (2H, t, J = 6.8 Hz, h), 
2.52 (2H, d, J = 22.0 Hz, c), 2.28-2.25 (2H, m, g), 1.76 (3H, d, J = 2.8 Hz, e), 1.49 (9H, s, 
k), 1.31 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3, 333K) δ 155.78 
(carbonyl C), 138.79 (aryl), 128.46 (aryl), 128.20 (d, 2JC-P = 12 Hz, d), 127.57 (aryl), 
127.12 (aryl), 126.29 (d, 3JC-P = 13 Hz, f), 79.63 (j), 61.68 (d, 
2JC-P = 6 Hz, b+b'), 50.86 (i), 
46.47 (d, 5JC-P = 5 Hz, h), 37.15 (d, 
1JC-P = 137 Hz, c), 28.53 (k), 27.46 (g), 17.29 (d, 
3JC-P 
= 2 Hz, e), 16.40 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3, 333K) δ 27.39 
ppm; IR (neat) 2976 (aromatic C-H), 2906 (aliphatic C-H), 1689 (carbamate C=O), 1244 
(P=O), 1158 (C-O), 1024 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C22H36NO5P+Na
+ 448.2229, found 448.2239 m/z. 
 
Synthesis of phosphonate containing unsaturated alcohol intermediate (E)-37-OH: 
Substrate (E)-37q (1.19 g, 2.50 mmol, 1.00 eq) is dissolved in 25 mL THF and the mixture 
is cooled to 0oC. TBAF (1.0 M in THF; 5 mL, 5.0 mmol, 2.0 eq) is added dropwise and the 
resultant mixture is stirred at room temperature overnight. Afterwards, the mixture is 
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concentrated under reduced pressure and flash chromatography on silica gel (ethyl-
acetate/methanol 19:1) affords the desired unsaturated phosphonate alcohol intermediate 
(E)-37-OH (562 mg, 95%) as a clear, colorless viscous oil: TLC analysis (ethyl-
acetate/methanol 10:1) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 5.23-5.16 (1H, m, f), 3.94-
3.77 (5H, m, b+b'+OH), 3.40 (2H, t, J = 6.75 Hz, h), 2.37 (2H, d, J = 21.9 Hz, c), 2.14-
2.10 (2H, m, g), 1.60 (3H, s, e), 1.13 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (75 MHz, 
CDCl3) δ 127.44 (d, 2JC-P = 11.25 Hz, d), 126.39 (d, 3JC-P = 12.75 Hz, f), 61.75-61.40 (m, 
b+b'+h), 36.57 (d, 1JC-P = 136.5 Hz, c), 31.74 (d, 
2JC-P = 3 Hz, g), 17.28 (d, 
3JC-P = 2.25 Hz, 
e), 16.22 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 28.00 ppm. IR (neat) 
3392 (O-H), 2981 (sp2 C-H), 2907 (sp3 C-H), 1229 (P=O), 1021 (C-O), 958 (P-O) cm-1.  
 
Synthesis of phosphonate functionalized alkene substrate (E)-37j: The alcohol (E)-37-
OH (354 mg, 1.50 mmol) is dissolved in 15 mL THF and the reaction mixture is cooled to 
0oC. Triethylamine (0.52 mL, 3.7 mmol, 2.5 eq) is added in one portion followed by 
benzoyl chloride (0.26 mL, 2.2 mmol, 1.5 eq) dropwise. The resultant mixture is warmed 
to room temperature and stirred for a total of 2 hours. Saturated NaHCO3 solution is added 
and the mixture is extracted with ethyl-acetate (3 x 20 mL). The combined organics were 
washed with brine, dried over Na2SO4 and concentrated. Flash chromatography on silica 
gel (ethyl-acetate) affords the desired substrate (E)-37j (388 mg, 76%) as a colorless oil: 
TLC analysis (ethyl-acetate) Rf = 0.4; 
1H NMR (400 MHz, CDCl3) δ 8.04-8.02 (2H, m, 
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aryl), 7.57-7.41 (3H, m, aryl), 5.42-5.37 (1H, m, f), 4.32 (2H, t, J = 6.8 Hz, h), 4.11-4.03 
(4H, m, b+b'), 2.58 (2H, d, J = 22.4 Hz, c), 2.55-2.49 (2H, m, g), 1.84 (3H, d, J = 2.8 Hz, 
e), 1.28 (6H, t, J = 7.1 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 166.68 (carbonyl), 
132.99 (aryl), 130.41 (aryl), 130.41 (aryl), 129.64 (aryl), 129.20 (d, 2JC-P = 12 Hz, d), 
128.43 (aryl), 124.83 (d, 3JC-P = 13 Hz, f), 64.28 (d, 
5JC-P = 4 Hz, h), 61.90 (d, 
2JC-P = 7.00 
Hz, b+b'), 37.00 (d, 1JC-P = 136 Hz, c), 28.00 (d, 
4JC-P = 2.00 Hz, g), 17.63 (d, 
3JC-P = 3.00 
Hz, e), 16.52 (d, 3JC-P = 6.00 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 27.44 ppm; IR 
(neat) 2982 (sp2 C-H), 2905 (sp3 C-H), 1716 (C=O), 1602 (C=C), 1269 (P=O), 1053 (C-
O), 1023 (C-O), 956, 711, 583 cm-1. HRMS (ESI) calculated for C17H25O5P+Na
+ 363.1332, 
found 363.1339 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37k: Using GP2, allyl bromide (E)-
88k (336 mg, 1.50 mmol) yields the alkene substrate (E)-37k (321 mg, 76%): TLC analysis 
(ethyl-acetate/hexanes 3:2) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 7.32-7.22 (5H, m, aryl), 
5.37-5.30 (1H, m, f), 4.49 (2H, s, i), 4.10-4.01 (4H, m, b+b'), 3.46 (2H, t, J = 6.9 Hz, h), 
2.54 (2H, d, J = 21.9 Hz, c), 2.40-2.31 (2H, m, g), 1.78 (3H, d, J = 3 Hz, e), 1.27 (6H, t, J 
= 7.1 Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 138.43 (j), 128.32 (aryl), 127.75 (d, 
2JC-P = 11.3 Hz, d), 127.58 (aryl), 127.50 (aryl), 125.96 (d, 
3JC-P = 13.5 Hz, f), 72.87 (i), 
69.66 (d, 5JC-P = 4.5 Hz, h), 61.73 (d, 
2JC-P = 6.8 Hz, b+b'), 36.88 (d, 
1JC-P = 136.5 Hz, c), 
28.94 (d, 4JC-P = 2.3 Hz, g), 17.46 (d, 
3JC-P = 2.3 Hz, e), 16.42 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 27.69 ppm; IR (neat) 2980.94 (C-H), 1453.82 (C=C), 
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1245.73 (P=O), 1097.75 (C-O) cm-1; HRMS (ESI) calculated for C17H27O4P: 326.1647, 
found 326.1631 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37l: Using GP2, the allyl bromide 
(E)-88l (450 mg, 1.50 mmol) yields the alkene substrate (E)-37l (413 mg, 77%): TLC 
analysis (ethyl-acetate) Rf = 0.6; 
1H NMR (300 MHz, CDCl3) δ 7.37-7.32 (5H, m, aryl), 
5.39-5.32 (1H, m, f), 4.77 (2H, s, j), 4.62 (2H, s, i), 4.18-4.00 (4H, m, b+b'), 3.62 (2H, t, J 
= 6.9 Hz, h), 2.57 (2H, d, J = 21.6 Hz, c), 2.42-2.33 (2H, m, g), 1.81 (3H, d, J = 2.7 Hz, e), 
1.32 (6H, t, J = 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 137.93 (k), 128.43 (aryl), 128.03 
(d, 2JC-P = 11.25 Hz, d), 127.85 (aryl), 127.69 (aryl), 125.86 (d, 
3JC-P = 13.5 Hz, f), 94.60 
(i), 69.34 (j), 67.33 (d, 5JC-P = 4.5 Hz, h), 61.76 (d, 
2JC-P = 6.75 Hz, b+b'), 36.92 (d, 
1JC-P = 
136.5 Hz, c), 28.89 (d, 4JC-P = 3 Hz, g), 17.50 (d, 
3JC-P = 2.25 Hz, e), 16.46 (d, 
3JC-P = 6 Hz, 
a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 27.71 ppm; IR (neat) 2978.88 (sp2 C-H), 2903.19 
(sp3 C-H), 1246.33 (P=O), 1022.29 (C-O), 954.90 (C-O) cm-1; HRMS (ESI) calculated for 
C18H29O5P+Na
+ 379.1645, found 379.1651 m/z. 
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Synthesis of phosphonate functionalized alkene (E)-37m: Using GP2, allyl bromide 
(E)-88m (374 mg, 1.50 mmol) yields the alkene substrate (E)-37m (376 mg, 82%): TLC 
analysis (EtOAc) Rf = 0.4; [α]D = +1.4o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
5.34-5.29 (1H, m, f), 4.15-4.00 (6H, m, b+b'+h+i(1H)), 3.55 (1H, dd, J = 6.8, 6 Hz, i), 2.56 
(2H, d, J = 21.6 Hz, c), 2.45-2.24 (2H, m, g), 1.80 (3H, d, J = 2.4 Hz), 1.42 (3H, s, k or k'), 
1.35 (3H, s, k or k'), 1.31 (6H, t, J = 6.8 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 
128.88 (d, 2JC-P = 11 Hz, d), 124.45 (d, 
3JC-P = 13 Hz, f), 109.01 (j), 75.63 (d, 
5JC-P = 4 Hz, 
h), 69.10 (i), 61.86 (d, 2JC-P = 7 Hz, b+b’), 37.06 (d, 1JC-P = 136 Hz, c), 32.61 (d, 4JC-P = 3 
Hz, g), 27.00 (k or k'), 25.75 (k or k'), 17.74 (d, 3JC-P = 2 Hz, e), 16.56 (d, 
3JC-P = 6 Hz, 
a+a'); 31P NMR (162 MHz, CDCl3) δ 27.51 ppm; IR (neat) 2958.99 (sp2 C-H), 2877.73 
(sp3 C-H), 1673.16 (C=C), 1233.36 (P=O), 1054.15 (C-O), 950.27 (P-O) cm-1; HRMS 
(ESI) calculated for C14H27O5P 306.1596, found 306.1600 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37n: Using GP2, allyl bromide (E)-
88n (353 mg, 1.50 mmol) yields the alkene substrate (E)-37n (335 mg, 80%): TLC analysis 
(ethyl-acetate) Rf = 0.4; [α]D = +2.7o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.35-
5.31 (1H, m, f), 4.80-4.74 (1H, m, g), 4.09-4.03 (5H, m, b+b' & h (1H)), 3.50 (1H, t, J = 8 
Hz, h (1H)), 2.64-2.46 (2H, m, c), 1.85 (3H, m, e), 1.38 (3H, s, j or j'), 1.36 (3H, s, j or j'), 
1.28 (6H, t, J = 7.2 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 132.30 (d, 2JC-P = 11 
Hz, d), 127.59 (d, 3JC-P = 12 Hz, f), 109.07 (i), 72.79 (d, 
4JC-P = 3 Hz, g), 69.31 (d, 
5JC-P = 
4 Hz, h), 61.98 (d, 2JC-P = 7 Hz, b+b'), 37.11 (d, 
1JC-P = 137 Hz, c), 26.84 (j or j'), 26.00 (j 
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or j'), 18.04 (d, 3JC-P = 2 Hz, e), 16.54-16.45 (m, a+a') ppm; 
31P NMR (162 MHz, CDCl3) 
δ 26.49 ppm; IR (neat) 2983.21 (sp2 C-H), 2935.94 (sp2 C-H), 1671.36 (C=C), 1245.26 
(P=O), 1051.13 (C-O), 956.40 (P-O) cm-1; HRMS (ESI) calculated for C13H25O5P 
292.1440, found 292.1454 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37o: Using GP2, allyl bromide (E)-
88o (320 mg, 1.50 mmol) yields substrate (E)-37o (306 mg, 76%) as a colorless viscous 
oil: TLC analysis (ethyl-acetate:hexanes 1:1) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 5.14-
5.09 (1H, br m, f), 4.11-4.01 (4H, m, b+b'), 2.50 (2H, d, J = 21.9 Hz, c), 2.22-2.14 (1H, m, 
g), 1.81-0.96 (19H, m, e+a+a'+h+i+j) ppm; 13C NMR (75 MHz, CDCl3) δ 136.24 (d, 3JC-P 
= 12.8 Hz, f), 123.80 (d, 2JC-P = 11.3 Hz, d), 61.73 (d, 
2JC-P = 6.8 Hz, b+b'), 36.87 (d, 
1JC-P 
= 135.8 Hz, f), 37.23 (d, 4JC-P = 2.3 Hz, g), 32.96 (d, 
5JC-P = 4.5 Hz, h), 26.02 (j), 25.92 (i), 
17.38 (d, 3JC-P = 2.3 Hz, e), 16.43 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) 
δ 28.00 ppm; IR (neat) 2922 (C-H), 1625 (C=C), 1246.13 (P=O) cm-1; HRMS (ESI) 
calculated for C14H27O3P 274.1698, found 274.1691 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37p: Using GP2, allyl bromide (E)-
88p (338 mg, 1.50 mmol) yields substrate (E)-37p (288 mg, 68%) as a colorless viscous 
208 
 
oil: TLC analysis (ethyl-acetate/hexanes 3:2) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 7.31-
7.18 (5H, m, aryl), 5.55-5.49 (1H, m, f), 4.12-4.03 (4H, m, J = 7.2 Hz, b+b'), 3.41 (2H, t, 
J = 6.0 Hz, g), 2.60 (2H, d, J = 21.9 Hz, c), 1.90 (3H, d, J = 3 Hz, e), 1.29 (6H, t, J = 7.1 
Hz, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 140.84 (d, 5JC-P = 3.8 Hz, h), 128.53 (aryl), 
128.40 (aryl), 128.36 (aryl), 128.32 (aryl), 126.90 (d, 2JC-P = 11.3 Hz, d), 125.91 (aryl), 
61.81 (d, 2JC-P = 6.8 Hz, b+b'), 36.89 (d, 
1JC-P = 136.5 Hz, c), 34.43 (d, 
4JC-P = 3 Hz, g), 
17.44 (d, 3JC-P = 2.3 Hz, e), 16.41 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) 
δ 27.71 ppm; IR (neat) 3026.05 (sp2 C-H), 2980.86 (sp3 C-H), 1624 (C=C), 1243.85 (P=O) 
cm-1; HRMS (ESI) calculated for C15H23O3P 282.1385, found 282.1373 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-37q: Using GP2, allyl bromide (E)-
88q (626 mg, 1.50 mmol) yielded the alkene substrate (E)-37q (592 mg, 83%): TLC 
analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; 
1H NMR (300 MHz, CDCl3) δ 7.70-7.67 (4H, 
m, aryl), 7.41-7.39 (6H, m, aryl), 5.35-5.33 (1H, m, f), 4.12-4.03 (4H, m, b+b'), 3.68 (2H, 
t, J = 6.9 Hz, h), 2.54 (2H, d, J = 21.6 Hz, c), 2.37-2.29 (2H, m, g), 1.74 (3H, br s, e), 1.29 
(6H, t, J = 7.1 Hz, a+a'), 1.08 (9H, s, j) ppm; 13C NMR (75 MHz, CDCl3) δ 135.55 (aryl), 
134.02 (d), 129.63 (aryl), 129.54 (aryl), 127.79 (aryl), 127.64 (aryl), 127.59 (aryl), 125.96 
(d, 3JC-P = 13.5 Hz, f), 63.44 (d, 
5JC-P = 5.25 Hz, h), 61.67 (d, 
2JC-P = 6.75 Hz, b+b'), 37.03 
(d, 1JC-P = 136.5 Hz, c), 31.85 (d, 
4JC-P = 3 Hz, h), 26.87 (j), 19.17 (i), 17.35 (d, 
3JC-P = 2.25 
Hz, e), 16.40 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 27.18 ppm; IR 
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(neat) 3070.33 (sp2 C-H), 2902.57 (sp3 C-H), 1245.44 (P=O), 1054.07 (C-O), 1024.60 (C-
O) cm-1; HRMS (ESI) calculated for C26H39O4PSi+Na
+ 497.2247, found 497.2272 m/z.    
 
Synthesis of phosphonate functionalized alkene (E)-41a: Following GP2, allyl bromide 
(E)-89a (301 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41a (319 mg, 89%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.38-7.11 (10H, m, aryl), 5.77 (1H, dd, J = 12.5, 7.0 Hz, e), 4.02-3.58 (4H, m, 
b), 2.92 (2H, d, 2JP-H = 21.5 Hz, c), 2.68 (2H, t, J = 7.5 Hz, g), 2.39-2.32 (2H, m, f), 1.18 
(6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) δ 141.76 (h), 140.34 (d, 2JC-P = 
4.0 Hz, d), 131.84 (d, 3JC-P = 12 Hz, e), 131.47 (d, 
3JC-P = 10.5 Hz, l), 128.70 (aryl), 128.63 
(aryl), 128.42 (aryl), 128.18 (aryl), 127.07 (aryl), 125.98 (aryl), 61.79 (d, 2JC-P = 7.0 Hz, 
b), 36.26 (d, 1JC-P = 137 Hz, c), 36.12 (d, 
5JC-P = 4.00 Hz, g), 31.24 (d, 
4JC-P = 2.0 Hz, f), 
16.44 (d, 3JC-P = 6.0 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.98 ppm; IR (neat) 2989 
(aromatic C-H), 2904 (aliphatic C-H), 1601 (C=C), 1494 (aromatic C=C), 1453 (aromatic 
C=C), 1442 (aromatic C=C), 1391 (aromatic C=C), 1249 (P=O), 1048 (C-O), 1023 (C-O), 
956 (P-O) cm-1; HRMS (EI) calculated for C21H27O3P = 358.1698, found 358.1685 m/z.  
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Synthesis of phosphonate functionalized alkene (Z)-41b: Following GP2, allyl bromide 
(E)-89b (317 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41b (326 mg, 87%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; [α]D20 = +25.0o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.29 (1H, dd, J = 5.2, 1.2 Hz, n), 7.07 (1H, dd, 
J = 3.6, 0.8 Hz, l), 7.02 (1H, dd, J = 5.2, 3.6 Hz, m), 5.79 (1H, dd, J = 12.8, 7.0 Hz, e), 
4.21-3.96 (6H, m, b+b'+g+h(1H)), 3.57 (1H, dd, J = 8.0, 7.0 Hz, h(1H)), 2.99 (2H, d, 2JP-H 
= 21.6 Hz, c), 2.64-2.58 (2H, m, f), 1.42 (3H, s, j or j'), 1.36 (3H, s, j or j'), 1.24 (3H, t, J = 
7.0 Hz, a or a'), 1.23 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 141.46 
(d, 2JC-P = 4.0 Hz, d), 128.87 (d, 
3JC-P = 11 Hz, e), 127.06 (l or m), 126.98 (l or m), 126.12 
(d, 3JC-P = 11 Hz, k), 125.35 (n), 109.25 (i), 75.62 (d, 
5JC-P = 3 Hz, g), 69.17 (h), 62.10 (d, 
2JC-P = 6.0 Hz, b+b'), 37.15 (d, 
1JC-P = 138 Hz, c), 34.02 (d, 
4JC-P = 2.0 Hz, f), 27.05 (j or 
j'), 25.84 (j or j'), 16.53 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 26.20 
ppm; Proof of stereochemistry: Strong NOE is observed between vinyl hydrogen (He) and 
the methylene hydrogens adjacent to phosphonate functionality (Hc).  IR (neat) 2983 
(aromatic C-H), 2905 (aliphatic C-H), 1368 (aromatic C=C), 1248 (P=O), 1022 (C-O), 958 
(P-O) cm-1; HRMS (ESI) calculated for C17H27O5PS + Na
+ = 397.1215, found 397.1218 
m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-42b: Following GP2, allyl bromide 
(Z)-89b (158 mg, 0.50 mmol, 1.00 eq) yields the alkene substrate (E)-42b (150 mg, 80%) 
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as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; [α]D20 = +7.0o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.12 (1H, d, J = 5.0 Hz, n), 7.09 (1H, d, J = 3.5 Hz, 
l), 6.96 (1H, dd, J = 5.0, 3.5 Hz, m), 6.12 (1H, dd, J = 13.5, 7.0 Hz, e), 4.29-4.23 (1H, m, 
g), 4.10-3.95 (5H, m, b+b'+h(1H)), 3.65 (1H, dd, J = 8.0, 7.0 Hz, h(1H)), 3.08 (2H, d, 2JP-
H = 22.0 Hz, c), 2.66-2.53 (2H, m, f), 1.45 (3H, s, j or j'), 1.37 (3H, s, j or j'), 1.22 (3H, t, J 
= 7.0 Hz, a or a'), 1.21 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 
145.93 (d, 3JC-P = 3.0 Hz, d), 127.46 (m), 126.29 (d, 
3JC-P = 11.0 Hz, e & k), 124.00 (l), 
123.97 (n), 109.24 (i), 75.34 (d, 5JC-P = 3.0 Hz, g), 69.05 (h), 62.27 (d, 
2JC-P = 6.0 Hz, b or 
b'), 62.23 (d, 2JC-P = 6.0 Hz, b or b'), 33.17 (d, 
4JC-P = 3.0 Hz, f), 29.58 (d, 
1JC-P = 140 Hz, 
c), 27.04 (j or j'), 25.80 (j or j'), 16.48 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, 
CDCl3) δ 25.78 ppm; Proof of stereochemistry: Strong NOE is observed between 
methylene hydrogens Hf and the methylene hydrogens adjacent to phosphonate 
functionality Hc.  IR (neat) 2985 (aromatic C-H), 2903 (aliphatic C-H), 1370 (aromatic 
C=C), 1248 (P=O), 1023 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C17H27O5PS+Na
+ = 397.1215, found 397.1214 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-41c: Following GP2, allyl bromide 
(E)-89c (311 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41c (313 mg, 85%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; [α]D20 = +17.9o (c = 
1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.35-7.24 (5H, m, aryl), 5.75 (1H, dd, J = 13.3, 
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7 Hz, e), 4.12-4.09 (1H, m, g), 4.00-3.89 (5H, m, b+b'+h(1H)), 3.49 (1H, t, J = 7.7 Hz, 
h(1H)), 2.95 (2H, d, 2JP-H = 21.7 Hz, c), 2.20-2.46 (2H, m, f), 1.37 (3H, s, j or j'), 1.34 (3H, 
s, j or j'), 1.21-1.17 (6H, m, a+a') ppm; 13C NMR (175 MHz, CDCl3) δ 140.05 (d, 2JC-P = 
3.5 Hz, d), 133.65 (d, 3JC-P = 10.5 Hz, k), 128.77 (aryl), 128.34 (aryl), 127.28 (d, 
3JC-P = 
10.5 Hz, e), 109.11 (i), 75.67 (d, 5JC-P = 5.25 Hz, g), 69.15 (h), 61.89 (d, 
2JC-P = 6.0 Hz, b 
or b'), 61.85 (d, 2JC-P = 6.0 Hz, b or b'), 36.51 (d, 
1JC-P = 138.5 Hz, c), 33.60 (d, 
4JC-P = 1.75 
Hz, f), 26.99 (j or j'), 25.83 (j or j'), 16.47 (d, 3JC-P = 7 Hz, a or a'), 16.45 (d, 
3JC-P = 7 Hz, 
a or a') ppm; 31P NMR (283 MHz, CDCl3) δ 26.59 ppm; Proof of stereochemistry: Strong 
NOE is observed between vinyl hydrogen (He) and the methylene hydrogens adjacent to 
phosphonate functionality (Hc).   IR (neat) 2982 (aromatic C-H), 2904 (aliphatic C-H), 
1600 (C=C), 1442 (aromatic C=C), 1368 (aromatic C=C), 1249 (P=O), 1048 (C-O), 1023 
(C-O), 957 (P-O) cm-1; HRMS (EI) calculated for C19H29O5P = 368.1753, found 368.1767 
m/z. 
 
Synthesis of phosphonate functionalized alkene (Z)-41c: Following GP2, allyl bromide 
(Z)-89c (311 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41c (321 mg, 87%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; [α]D20 = +7.3o (c = 1.0, 
CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.44-7.25 (5H, m, aryl), 5.94 (1H, dd, J = 13.3, 6.3 
Hz, e), 4.28 (1H, m, g), 4.30-4.09 (1H, m, h(1H)), 4.01-3.95 (2H, m, b or b'), 3.94-3.87 
(2H, m, b or b'), 3.69-3.67 (1H, m, h(1H)), 3.13 (2H, d, 2JP-H = 22.4 Hz, c), 2.67-2.60 (2H, 
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m, f), 1.46 (3H, s, j or j'), 1.38 (3H, s, j or j'), 1.18-1.16 (6H, m, a+a') ppm; 13C NMR (175 
MHz, CDCl3) δ 142.47 (d, 2JC-P = 1.75 Hz, d), 132.74 (d, 3JC-P = 12.25 Hz, k), 128.45 
(aryl), 127.84 (d, 3JC-P = 12.25 Hz, k), 127.42 (aryl), 126.80 (aryl), 109.23 (i), 75.57 (d, 
5JC-P = 1.75 Hz, g), 69.16 (h), 62.06 (d, 
2JC-P = 6.0 Hz, b or b'), 62.02 (d, 
2JC-P = 6.0 Hz, b 
or b'), 33.52 (d, 4JC-P = 3.50 Hz, f), 29.28 (d, 
1JC-P = 138.25 Hz, c), 27.13 (j or j'), 25.84 (j 
or j'), 16.44 (d, 3JC-P = 7 Hz, a+a') ppm; 
31P NMR (283 MHz, CDCl3) δ 26.42 ppm; Proof 
of stereochemistry: Strong NOE is observed between methylene hydrogens Hf and the 
methylene hydrogens adjacent to phosphonate functionality Hc. IR (neat) 2983 (aromatic 
C-H), 2903 (aliphatic C-H), 1599 (C=C), 1444 (aromatic C=C), 1368 (aromatic C=C), 
1248 (P=O), 1052 (C-O), 1023 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C19H29O5P+Na
+ = 391.1650, found 391.1649 m/z. 
 
Synthesis of phosphonate functionalized alkene (E)-41d: Following GP2, allyl bromide 
(E)-89d (273 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41d (281 mg, 85%) 
as a light buff oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.29-7.26 (5H, m, aryl), 7.13-7.11 (3H, m, aryl), 6.99-6.97 (2H, m, aryl), 6.70 
(2H, d, 4JP-H = 6.0 Hz, e), 4.10-3.94 (4H, m, b), 3.09 (2H, d, 
2JC-P = 22 Hz, c), 1.23 (6H, t, 
J = 7.0 Hz) ppm; 13C NMR (100 MHz, CDCl3) δ 140.70 (d, 2JC-P = 4.0 Hz, d), 136.96 (d, 
4JC-P = 4.0 Hz, f), 132.66 (d, 
3JC-P = 12 Hz, j), 131.16 (d, 
3JC-P = 12 Hz, e), 129.29 (aryl), 
129.26 (aryl), 129.11 (aryl), 129.09 (aryl), 128.64 (aryl), 128.06 (aryl), 127.50 (aryl), 
126.86 (aryl), 62.05 (d, 2JC-P = 7.0 Hz, b), 37.56 (d, 
1JC-P = 137 Hz, c), 16.52 (d, 
3JC-P = 6.5 
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Hz, a) ppm; 31P NMR (162 MHz, CDCl3) δ 26.31 ppm; Proof of stereochemistry: Strong 
NOE is observed between vinyl hydrogen (He) and the methylene hydrogens adjacent to 
phosphonate functionality (Hc). IR (neat) 2979 (aromatic C-H), 2905 (aliphatic C-H), 1598 
(C=C), 1493 (aromatic C=C), 1443 (aromatic C=C), 1390 (aromatic C=C), 1248 (P=O), 
1055 (C-O), 1019 (C-O), 957 (P-O) cm-1; HRMS (EI) calculated for C19H23O3P = 
330.1385, found 330.1384 m/z. 
 
Synthesis of phosphonate functionalized alkene (Z)-41d: Following GP2, allyl bromide 
(Z)-89d (273 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41d (274 mg, 83%) 
as a light buff oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.56 (2H, d, J = 8.0 Hz, g or k), 7.51 (2H, d, J = 8.0 Hz, g or k), 7.41-7.35 (4H, 
m, aryl), 7.32-7.26 (2H, m, aryl), 6.90 (1H, d, 4JP-H = 5.25 Hz, e), 3.97-3.75 (4H, m, b), 
3.34 (2H, d, J = 22.4 Hz, c), 1.09 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 MHz, CDCl3) 
δ 142.41 (d, 4JC-P = 2.0 Hz, f), 137.16 (d, 2JC-P = 3.5 Hz, d), 132.77 (d, 3JC-P = 11 Hz, j), 
132.33 (d, 3JC-P = 13 Hz, e), 128.88 (aryl), 128.86 (aryl), 128.37 (aryl), 128.24 (aryl), 
127.49 (aryl), 127.16 (aryl), 126.81 (aryl), 61.63 (d, 2JC-P = 7.0 Hz, b), 29.15 (d, 
1JC-P = 
140.11 Hz, c), 16.09 (d, 3JC-P = 6.4 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.33 ppm; 
Proof of stereochemistry: Strong NOE is observed between vinyl hydrogen (He) and the 
ortho hydrogens of the aromatic ring (Hg and Hk). IR (neat) 2979 (aromatic C-H), 2904 
(aliphatic C-H), 1599 (C=C), 1494 (aromatic C=C), 1444 (aromatic C=C), 1391 (aromatic 
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C=C), 1245 (P=O), 1053 (C-O), 1023 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C19H23O3P+Na
+ = 353.1283, found 353.1285 m/z. 
 
Synthesis of phosphonate functionalized alkene (Z)-41e: Following GP2, allyl bromide 
(E)-89e (307 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41e (295 mg, 81%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
1H NMR (400 MHz, 
CDCl3) δ 7.29-7.26 (3H, m, aryl), 7.22-7.18 (3H, m, aryl), 7.02-7.00 (2H, m, m+n), 5.82 
(1H, dd, J = 12.5, 7.0 Hz, e), 4.08-3.92 (4H, m, b), 2.98 (2H, d, 2JP-H = 21.5 Hz, c), 2.78 
(2H, t, J = 7.5 Hz, g), 2.68-2.61 (2H, m, f), 1.23 (6H, t, J = 7.0 Hz, a) ppm; 13C NMR (100 
MHz, CDCl3) δ 141.75 (d, 2JC-P = 4.0 Hz, d), 141.65 (h), 133.49 (d, 3JC-P = 11.0 Hz, e), 
128.63 (aryl), 128.52 (aryl), 126.85 (aryl), 126.70 (aryl), 126.10 (aryl), 125.07 (aryl), 
124.02 (d, 3JC-P = 11.0 Hz, l), 62.04 (d, 
2JC-P = 7.0 Hz, b), 36.90 (d, 
1JC-P = 139 Hz, c), 
36.00 (d, 5JC-P = 3.5 Hz, g), 31.66 (d, 
4JC-P = 3.0 Hz, f), 16.51 (d, 
3JC-P = 6.5 Hz, a) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.55 ppm; IR (neat) 2983 (aromatic C-H), 2904 (aliphatic 
C-H), 1605 (C=C), 1494 (aromatic C=C), 1368 (aromatic C=C), 1249 (P=O), 1023 (C-O), 
957 (P-O) cm-1; HRMS (EI) calculated for C19H25O3PS = 364.1262, found 364.1253 m/z.   
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Synthesis of phosphonate functionalized alkene (Z)-41f: Following GP2, allyl bromide 
(E)-89f (327 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41f (308 mg, 80%) 
as a light buff oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +24.1o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.28-7.25 (1H, m, q), 7.04-7.00 (2H, m, o+p), 
5.78 (1H, dd, J = 13.0, 7.0 Hz, e), 5.09 (1H, t, J = 7.0 Hz, k), 4.08-3.93 (4H, m, b+b'), 2.98 
(2H, d, 2JP-H = 21.2 Hz, c), 2.35-2.11 (2H, m, f), 2.05-1.89 (2H, m, j), 1.68 (3H, s, m or 
m'), 1.63-1.55 (1H, m, g), 1.60 (3H, s, m or m'), 1.42-1.32 (1H, m, i), 1.23 (6H, t, J = 7.0 
Hz, a+a'), 1.26-1.13 (1H, m, i), 0.92 (3H, d, J = 7.0 Hz, h) ppm; 13C NMR (100 MHz, 
CDCl3) δ 142.12 (d, 2JC-P = 4.0 Hz, d), 133.82 (d, 3JC-P = 11.0 Hz, e), 131.35 (l), 126.75 (o 
or p), 126.64 (o or p), 124.91 (k), 126.64 (d, 4JC-P = 1.0 Hz, o), 123.74 (d, 
3JC-P = 11.0 Hz, 
n), 61.98 (d, 2JC-P = 7.0 Hz, b+b'), 36.98 (d, 
1JC-P = 137 Hz, c), 36.99 (d, 
4JC-P = 3.0 Hz, f), 
36.97 (i), 33.49 (d, 5JC-P = 3.0 Hz, g), 25.89 (m or m'), 25.74 (j), 19.74 (h), 17.81 (m or m'), 
16.51 (d, 3JC-P = 6.0 Hz, d) ppm; 
31P NMR (162 MHz, CDCl3) δ 26.77 ppm; IR (neat) 2963 
(aromatic C-H), 2907 (aliphatic C-H), 1440 (aromatic C=C), 1377 (aromatic C=C), 1252 
(P=O), 1051 (C-O), 1025 (C-O), 957 (P-O) cm-1; HRMS (EI) calculated for C20H33O3PS = 
384.1888, found 384.1897 m/z.  
 
Synthesis of phosphonate functionalized alkene (Z)-41g: Following GP2, allyl bromide 
(E)-89g (367 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (Z)-41g (378 mg, 89%) 
as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +13.8o (c = 1.0, CHCl3); 
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1H NMR (700 MHz, CDCl3) δ 7.81 (1H, d, J =8.8 Hz, q), 7.76 (1H, d, J = 7.7 Hz, l), 7.37-
7.29 (3H, m, n+o+p), 5.93 (1H, dd, J = 12.6, 7.0 Hz, e), 7.23-7.20 (1H, m, g), 4.08-4.00 
(5H, m, b+b'+h(1H)), 3.59 (1H, dd, J = 7.7, 7.0 Hz, h(1H)), 3.05 (2H, d, 2JP-H = 21 Hz, c), 
2.71-2.61 (2H, m, f), 1.43 (3H, s, j or j'), 1.37 (3H, s, j or j'), 1.24-1.21 (6H, m, a+a') ppm; 
13C NMR (175 MHz, CDCl3) δ 141.67 (d, 2JC-P = 3.5 Hz, d), 139.90 (m or r), 139.70 (m or 
r), 130.70 (d, 3JC-P = 10.5 Hz, e), 126.51 (d, 
3JC-P = 10.5 Hz, k), 124.58 (aryl), 123.83 (aryl), 
123.79 (aryl), 122.20 (q), 109.32 (i), 75.55 (d, 5JC-P = 1.72 Hz, g), 69.18 (h), 62.21 (d, 
2JC-
P = 7.0 Hz, b or b'), 62.19 (d, 
2JC-P = 7.0 Hz, b or b'), 36.78 (d, 
1JC-P = 136.5 Hz, c), 34.06 
(d, 4JC-P = 1.75 Hz, f), 27.06 (j or j'), 25.84 (j or j'), 16.55 (d, 
3JC-P = 7.0 Hz, a or a'), 16.53 
(d, 3JC-P = 7.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 25.96 ppm; IR (neat) 2982 
(aromatic C-H), 2904 (aliphatic C-H), 1661 (C=C), 1456 (aromatic C=C), 1437 (aromatic 
C=C), 1248 (P=O), 1052 (C-O), 1022 (C-O), 958 (P-O) cm-1; HRMS (EI) calculated for 
C21H29O5PS = 424.1473, found 424.1453 m/z.     
 
Synthesis of phosphonate functionalized alkene (E)-41h: Following GP2, allyl bromide 
(E)-89h (351 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41h (319 mg, 78%) 
as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.6; [α]D20 = +5.45o (c = 1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.57 (1H, d, J = 7.7 Hz, n), 7.46 (1H, d, J = 8.4 Hz, q), 7.31-
7.28 (1H, m, o or q), 7.24 (1H, dd, J = 7.7, 7.0 Hz, o or q), 6.82 (1H, s, l), 5.90 (1H, dd, J 
= 12.6, 7.0 Hz, e), 4.32-4.28 (1H, m, g), 4.11 (1H, dd, J = 7.7, 6.3 Hz, h(1H)), 4.09-4.00 
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(4H, m, b+b'), 3.67 (1H, t, J = 7.7 Hz, h(1H)), 3.08 (2H, d, 2JP-H = 21.7 Hz, c), 2.94-2.87 
(2H, m, f), 1.46 (3H, s, j or j'), 1.39 (3H, s, j or j'), 1.23-1.20 (6H, m, a+a') ppm; 13C NMR 
(175 MHz, CDCl3) δ 154.63 (d, 2JC-P = 4.50 Hz, d), 154.45 (r), 130.90 (d, 3JC-P = 11.0 Hz, 
e), 128.56 (m), 124.79 (o or p), 123.11 (o or p), 122.27 (d, 3JC-P = 10.5 Hz, k), 121.28 (n), 
111.22 (q), 109.34 (i), 106.50 (l), 75.65 (d, 5JC-P = 3.5 Hz, g), 69.23 (h), 62.22 (d, 
2JC-P = 
7.0 Hz, b+b'), 34.11 (d, 4JC-P = 1.75 Hz, f), 33.24 (d, 
1JC-P = 140 Hz, c), 27.11 (j or j'), 25.89 
(j or j'), 16.54 (d, 3JC-P = 6.50 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 26.35 ppm; 
IR (neat) 2981 (aromatic C-H), 2904 (aliphatic C-H), 1474 (aromatic C=C), 1369 (aromatic 
C=C), 1252 (P=O), 1048 (C-O), 1022 (C-O), 960 (P-O) cm-1; HRMS (EI) calculated for 
C21H29O6P = 408.1702, found 408.1710 m/z.   
 
Synthesis of phosphonate functionalized alkene (E)-41i: Following GP2, allyl bromide 
(E)-89i (341 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41i (311 mg, 78%) 
as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +13.8o (c = 1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.18 (2H, d, J = 8.4 Hz, l), 6.88 (2H, d, J = 8.4 Hz, m), 5.71 
(1H, dd, J = 13.3, 7.0 Hz, e), 4.12-4.09 (1H, m, g), 4.03-3.91 (5H, m, b+b'+h(1H)), 3.83 
(3H, s, o), 3.49 (1H, dd, J = 7.7, 7.0 Hz, h(1H)), 2.97-2.89 (2H, m, c), 2.43-2.27 (2H, m, 
f), 1.38 (3H, s, j or j'), 1.35 (3H, s, j or j'), 1.22 (3H, t, J = 7.0 Hz, a or a'), 1.21 (3H, t, J = 
7.0 Hz, a or a') ppm; 13C NMR (175 MHz, CDCl3) δ 158.82 (n), 133.16 (d, 3JC-P = 10.5 Hz, 
k), 132.36 (d, 2JC-P = 3.5 Hz, d), 129.93 (l), 126.90 (d, 
3JC-P = 12.25 Hz, e), 113.73 (m), 
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109.11 (i), 75.74 (d, 3JC-P = 3.5 Hz, g), 69.18 (h), 61.90 (d, 
2JC-P = 7.0 Hz, b or b'), 61.87 
(d, 2JC-P = 5.25 Hz, b or b'), 55.45 (o), 36.61 (d, 
1JC-P = 137 Hz, c), 33.66 (d, 
4JC-P = 3.50 
Hz, f), 27.02 (j or j'), 25.85 (j or j'), 16.53 (d, 3JC-P = 7.0 Hz, a or a'), 16.52 (d, 
3JC-P = 5.25 
Hz, a or a') ppm; 31P NMR (283 MHz, CDCl3) δ 26.82 ppm; IR (neat) 2983 (aromatic C-
H), 2905 (aliphatic C-H), 1608 (C=C), 1512, 1456 (aromatic C=C), 1368 (aromatic C=C), 
1244 (P=O), 1024 (C-O), 958 (P-O) cm-1; HRMS (EI) calculated for C20H31O6P = 
398.1858, found 398.1874 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-41j: Following GP2, allyl bromide 
(E)-89j (346 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41j (326 mg, 81%) 
as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +21.9o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.32 (2H, d, J = 8.4 Hz, m), 7.20 (2H, d, J = 8.4 Hz, l), 5.76 
(1H, dd, J = 13.0, 7.0 Hz, e), 4.11-3.92 (6H, m, b+b'+g+h(1H)), 3.49-3.45 (1H, m, h(1H)), 
2.90 (2H, d, 2JP-H = 21.6 Hz, c), 2.34-2.23 (2H, m, f), 1.37 (3H, s, j or j'), 1.33 (3H, s, j or 
j'), 1.23-1.19 (6H, m, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 138.49 (d, 2JC-P = 4.0 Hz, 
d), 133.20 (n), 132.61 (d, 3JC-P = 11 Hz, k), 130.22 (d, 
4JC-P = 1.75 Hz, l), 128.54 (m), 
128.08 (d, 3JC-P = 12 Hz, e), 109.19 (i), 75.51 (d, 
5JC-P = 3.0 Hz, g), 69.10 (h), 61.97 (d, 
2JC-
P = 7.0 Hz, b or b'), 61.94 (d, 
2JC-P = 7.0 Hz, b or b'), 36.44 (d, 
1JC-P = 137 Hz, c), 33.65 (d, 
4JC-P = 4.0 Hz, f), 26.99 (j or j'), 25.79 (j or j'), 16.49 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 26.23 ppm; IR (neat) 2983 (aromatic C-H), 2904 (aliphatic C-
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H), 1595 (C=C), 1491 (aromatic C=C), 1369 (aromatic C=C), 1248 (P=O), 1024 (C-O), 
958 (P-O) cm-1; HRMS (EI) calculated for C19H28ClO5P = 402.1363, found 402.1349 m/z.  
 
Synthesis of phosphonate functionalized alkene (E)-41k: Following GP2, allyl bromide 
(E)-89k (379 mg, 1.00 mmol, 1.00 eq) yields the alkene substrate (E)-41k (319 mg, 73%) 
as a light buff colored oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; [α]D20 = +19o 
(c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.61 (2H, d, J = 8.0 Hz, m), 7.39 (2H, d, 
J = 8.0 Hz, m), 5.82 (1H, dd, J = 13.0, 7.0 Hz, e), 4.16-3.90 (6H, m, b+b'+g+h(1H)), 3.49 
(1H, dd, J = 7.6, 7.2 Hz, h(1H)), 2.93 (2H, d, 2JP-H = 21.6 Hz, c), 2.27-2.20 (2H, m, f), 1.37 
(3H, s, j or j'), 1.34 (3H, s, j or j'), 1.22-1.17 (6H, m, a+a') ppm; 13C NMR (100 MHz, 
CDCl3) δ 143.86 (d), 132.62 (d, 3JC-P = 11 Hz, k), 129.53 (q, 2JC-F = 32 Hz, n), 129.26 (d, 
4JC-P = 2.0 Hz, l), 128.73 (d, 
3JC-P = 12 Hz, e), 125.34 (q, 
3JC-F = 4 Hz, m), 124.32 (q, 
1JC-F 
= 272 Hz, CF3), 109.26 (i), 75.43 (d, 
5JC-P = 4.0 Hz, g), 69.08 (h), 62.01 (d, 
2JC-P = 6.0 Hz, 
b or b'), 61.98 (d, 2JC-P = 6.0 Hz, b or b'), 36.39 (d, 
1JC-P = 138 Hz, c), 33.68 (d, 
4JC-P = 3.0 
Hz, f), 26.98 (j or j'), 25.77 (j or j'), 16.46 (d, 3JC-P = 6.0 Hz, a or a'), 16.44 (d, 
3JC-P = 6.0 
Hz, a or a') ppm; 31P NMR (162 MHz, CDCl3) δ 25.93 ppm; 19F NMR (376 MHz, CDCl3) 
δ -62.59 ppm; IR (neat) 2984 (aromatic C-H), 2905 (aliphatic C-H), 1616 (C=C), 1369 
(aromatic C=C), 1323 (C-F), 1249 (P=O), 1024 (C-O), 959 (P-O) cm-1; HRMS (EI) 
calculated for C20H28F3O5P = 436.1626, found 436.1636 m/z.  
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5.3. Ligand synthesis 
 
Procedure for preparation of TADDOL-derived phosphite L2: xylyl-TADDOL was 
prepared as previously reported by Seebach.8  The preparation of the chiral phosphite is 
done according to previously reported procedure9 with the following modifications: A 
solution of xylyl-TADDOL (500 mg, 0.864 mmol, 1.00 eq) and triethylamine (TEA; 0.48 
mL, 3.4 mmol, 4.0 eq) in dry THF (35 mL) was cooled to –78° C using a dry-ice acetone 
bath and to the resulting mixture was added PCl3 (70 µL, 0.86 mmol, 1.0 eq) rapidly in one 
portion. The resultant mixture was stirred for 30 minutes at –78oC. At this point, the crude 
31P NMR spectrum showed the disappearance of the PCl3 peak at ~220 ppm and the 
appearance of a new peak at ~147 ppm which indicates the presence of the intermediate 
(RO)2P–Cl in solution. To the resultant reaction mixture at –78oC, triethylamine (0.48 mL, 
3.4 mmol, 4.0 eq) and neat o-cresol (90 µL, 0.86 mmol, 1.0 eq) were sequentially added in 
single portions. The mixture was allowed to warm up to room temperature and stirred for 
a total of ca. 2 hours. The completion of reaction is indicated by the disappearance of the 
peak at ~147 ppm and appearance of a new peak at ~131 ppm in the crude 31P NMR 
spectrum of the final reaction mixture. Afterwards the mixture was filtered over Celite and 
the volatiles were removed under reduced pressure. Flash chromatography on silica gel 
(ethyl-acetate/hexanes 95:5) afforded (R,R)-T2 as a foamy white solid (464 mg, 75%): 
222 
 
Melting point = 88-92oC; TLC analysis (ethyl-acetate/hexanes 95:5) Rf = 0.5; [α]D20 = –
90.0° (c = 1.0, CHCl3); 
1H NMR (400 MHz, CD2Cl2) δ 7.35-6.88 (16H, m, aryl), 5.17 (1H, 
d, J = 8.4 Hz), 5.09 (1H, d, J = 8.4 Hz), 2.35 (12H, s), 2.29 (6H, s), 2.26 (6H, s), 2.10 (3H, 
s), 1.13 (3H, s), 0.62 (3H, s) ppm; 13C NMR (100 MHz, CD2Cl2) δ 150.79, 146.39 (d, JC-P 
= 2 Hz), 141.25 (d, JC-P = 2 Hz), 140.86, 137.70, 137.22, 136.98, 136.66, 130.97, 130.05 
(d, JC-P = 3 Hz), 129.37, 129.16, 129.02, 128.84, 126.71, 126.66, 126.37, 125.04, 124.93, 
123.72, 120.69, 120.57, 112.65, 84.77 (d, JC-P = 6 Hz), 83.79, 82.83 (d, JC-P = 16 Hz), 82.09 
(d, JC-P = 4 Hz), 26.97, 25.97, 21.37, 21.31, 21.22, 16.46 ppm; 
31P NMR (162 MHz, 
CD2Cl2) δ 133.40 ppm; IR (neat) 2915 (aromatic C-H), 2864.04 (aliphatic C-H), 1601, 
1489, 1455, 1371, 1216 (C-O-C), 1159, 1035, 939 cm-1; HRMS (ESI) calculated for 
C46H51O5P+Na
+ 737.3372, found 737.3378 m/z. 
 
Procedure for preparation of BINOL-derived phosphoramidite B2: (R)-(3,3'-bis(Ph))-
BINOL is prepared as previously reported.10 The chiral cyclic phosphoramidite (R)-(3,3'-
bis(Ph))-BINOL-PN(Bn)Ph (B2) is prepared according to previously reported procedure11 
from our lab as follows: PCl3 (0.26 mL, 1.1 equiv, 3.00 mmol) is added dropwise to a 
solution of N-Benzylaniline (549 mg, 1.10 equiv, 3.00 mmol) and triethylamine (TEA; 
0.70 mL, 1.85 equiv, 5.00 mmol) in dry THF (20 mL) under nitrogen at room temperature. 
The resultant mixture is refluxed for 6 hours, then cooled down to room temperature and 
eventually to -78oC using a dry ice-acetone bath. A solution of (R)-(3,3'-bis(Ph))-BINOL 
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(1.20 mg, 2.73 mmol, 1.00 equiv) and TEA (1.36 mL, 9.80 mmol, 3.60 equiv) in THF (20 
mL) is then added drop-wise to the reaction mixture. The resultant mixture is allowed to 
slowly warm up to room temperature and stir for a total of ca. 12 hours. Afterwards, the 
mixture is filtered over a bed of celite, celite bed washed with THF and the combined 
filtrates were concentrated in vacuum. Flash chromatography over silica gel 
(dichloromethane/hexanes 20:80) affords the title compound (1.24 g, 70%) as a foamy 
white solid: Melting point = 145-150 oC; TLC analysis (dichloromethane/hexanes 20:80) 
Rf = 0.5; [α]D20 = -210o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.10 (2H, d, J = 
12.5 Hz), 8.01 (2H, d, J = 8 Hz), 7.84-7.82 (2H, m), 7.73-7.72 (2H, m), 7.55-7.30 (12H, 
m), 7.13-7.06 (3H, m), 6.92-6.86 (5H, m), 6.18-6.15 (2H, m), 4.41 (1H, d, J = 15.5 Hz), 
3.66 (1H, d, J = 15.5 Hz) ppm; 13C NMR (100 MHz, CDCl3) δ 147.22, 147.18, 146.98, 
143.46, 143.20, 138.73, 138.31, 137.95, 135.34, 135.33, 134.68, 132.72, 132.51, 131.55, 
131.11, 138.31, 137.95, 135.35, 135.33, 134.68, 132.72, 132.51, 131.55, 131.11, 130.66, 
130.63, 130.49, 130.47, 130.33, 128.66, 128.61, 128.22, 128.07, 127.82, 127.79, 127.63, 
127.23, 127.18, 126.70, 126.38, 125.57, 125.53, 125.47, 125.32, 124.78, 124.66, 124.19, 
50.72, 50.67 ppm (Note: Peak splitting in the 13C NMR due to JC-P was not feasible to 
resolve in this case because of the severity of peak overlap.); 31P NMR (162 MHz, CDCl3) 
δ 135.99 ppm; HRMS (ESI) calculated for C45H32NO2P+Na+ = 672.2068, found 672.2082 
m/z.   
 
5.4. Ligand Screening Data 
The data presented here is for the series of ligands that were tested on methylidene 
phosphonate substrate 5a. Borane screening demonstrated pinacolborane is optimal for this 
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reaction as it yielded significant amounts of hydroboration products. Usage of tmdBH 
resulted in very high (ca. 40-50%) amounts of reduction side products and usage of 
catecholborane (catBH) resulted in uncatalyzed background reactions. The yields for 
ligand screenings were determined post CAHB via crude 31P NMR analysis. The 
enantiomer ratios were determined after oxidation to the corresponding alcohols via chiral 
HPLC analysis. The ligand T2 was chosen empirically from the screening data as the ligand 
of choice for subsequent development of the chemistry because of its superior performance 
as compared to the others tested.  
 
 
Summary of the screening results (Yields determined via crude 31P NMR analysis): 
Entry Ligand used 
5a 
unreacted 
(%) 
6a 
yield 
(%) 
6a 
er 
6a' 
yield 
(%) 
6a' 
er 
6a:6a' 
ratio 
6a'' 
yield 
(%) 
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1 T1 0 81 95:5 13 92:8 6.2:1 5 
2 T2 0 84 97:3 11 88:12 7.6:1 3 
3 T3 0 48 63:37 49 82:18 1:1 3 
4 T4 0 75 96:4 12 92:8 6.2:1 13 
5 T5 0 65 68:32 25 88:12 2.5:1 9 
6 T6 0 9 51:49 50 59:41 1:5.5 40 
7 T7 0 75 92:8 13 64:36 5.6:1 12 
8 T8 0 77 91:9 10 70:30 7.7:1 13 
9 T9 0 69 94:6 12 63:37 5.3:1 19 
10 T10 0 70 91:9 20 89:11 3.5:1 10 
11 T11 0 75 92:8 11 88:12 6.8:1 12 
12 T12 0 3 70:30 36 62:38 1:12 27 
13 T13 0 4 56:44 32 76:24 1:8 18 
14 T14 0 3 66:34 41 57:43 1:14 27 
15 T15 0 14 52:48 45 53:47 1:3.1 28 
16 T16 49 0 -- 12 66:34 -- 35 
17 T17 0 73 90:10 14 65:35 5.3:1 13 
18 T18 0 4 65:35 35 63:37 1:8.8 36 
19 B3 10 0 -- 45 48:52 -- 42 
20 B4 39 17 68:32 25 56:44 -- 19 
21 BINAP 100 -- -- -- -- -- -- 
 
 As evident from Scheme 2.1, the TADDOL-derived chiral cyclic phosphites (with 
few exceptions) generally afford efficient enantioinduction for product 6a from 
methylidene vinyl arene substrate 5a. On the other hand, TADDOL-derived chiral cyclic 
phosphoramidites, BINOL-derived chiral cyclic phosphites and phosphoramidites 
generally afford poor levels of enantioinduction. The success of a specific ligand type in 
the directed-CAHB hinges significantly on the alkene’s substitution pattern. While the 
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TADDOL-derived phosphites are remarkable for efficient enantioinduction for CAHB of 
methylidene vinyl arenes, the BINOL-derived phosphoramidites show superior selectivity 
for the isomeric 1,2-disubstituted vinyl arene substrates (Chapter 3). 
 
The data presented below is a series of ligands that were screened on the substrate (E)-18a 
as part of the initial optimizations. Preliminary screening of boranes demonstrated the 
superior performance of pinacolborane (pinBH) over tmdBH in forming significant 
amounts of hydroboration products. With catecholborane (catBH), uncatalyzed 
background reactions were observed. The yields for the screening data are estimated from 
the 31P NMR analysis of the crude CAHB mixtures. The enantiomer ratios are obtained 
after oxidation to the corresponding alcohols via chiral HPLC analysis. BINOL-derived 
phosphoramidite (R)-B2 was empirically chosen as the ligand of choice for the subsequent 
development of chemistry because it gave the highest possible enantioinduction for product 
19a as compared to others tested. The major side product in the CAHB of (E)-18a is the 
alkene reduction product 19a". The minor regioisomer 19a' is formed in trace quantities. 
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Summary of the small-scale (50 μmol substrate) screening results. (Note: Yields are 
estimated by 31P NMR analysis of the crude reaction mixtures.) 
Entry 
Ligand 
Used 
Unreacted 
(E)-18a 
(%) 
Yield 
of 19a 
(%) 
Enantiomer 
Ratio of 19a 
Yield 
of 
19a" 
(%) 
Ratio of 
19a:19a" 
Total 
mass 
balance 
1 T1 0 81 64:36 14 6:1 95 
2 T2 0 82 48:52 9 9:1 91 
3 T3 27 66 43:57 4 19:1 97 
4 T5 3 77 34:66 17 5:1 97 
5 T6 0 84 29:71 7 12:1 91 
6 T4 0 68 40:60 17 4:1 85 
7 T11 0 86 82:18 7 12:1 93 
8 T7 7 82 79:21 11 7:1 100 
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9 T8 0 91 80:20 6 15:1 97 
10 T10 0 82 29:71 13 6:1 95 
11 T9 0 81 55:45 12 7:1 93 
12 T12 0 87 58:42 5 17:1 92 
13 T13 0 90 60:40 7 13:1 97 
14 T14 0 86 61:39 8 11:1 94 
15 T15 0 85 36:64 8 11:1 93 
16 T16 0 89 59:41 9 10:1 98 
17 T17 0 89 76:24 8 11:1 97 
18 T18 0 91 59:41 6 15:1 97 
19 B1 6 86 90:10 4 22:1 96 
20 B2 0 87 97:3 10 9:1 97 
21 B3 82 9 
Not 
determined 
9 1:1 100 
22 B4 0 83 94:6 15 6:1 98 
23 B5 0 80 95:5 17 5:1 97 
24 
(R)-
BINAP 
95 0 -- 0 -- 95 
25 
No 
catalyst 
100 0 -- 0 -- 100 
 
Note: Entry 25 is carried out to look for any background reaction of the substrate with 
pinacolborane in the absence of chiral rhodium catalyst under standard conditions.  
 
5.5. General Procedure for Catalytic Asymmetric HydroBoration (CAHB) & 
Synthesis of Phosphonate-Functionalized Chiral Boronic Esters 
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Representative procedure for Catalytic Asymmetric HydroBoration (CAHB) of 
conjugated methylidenes and trisubstituted alkenes (GP4): Catalyst Preparation: The 
active hydroboration catalyst is prepared in the dry nitrogen glovebox as follows: 
[Rh(cod)Cl]2 (2.5 mg, 5.1 μmol) is dissolved in dry dichloromethane (0.5 mL) in an 8 mL 
glass vial equipped with a small teflon stirbar. To the resultant yellow/orange solution, a 
0.05 M solution of AgBF4 in THF (0.21 mL, 10.5 μmol) is added and the mixture is allowed 
to stir vigorously for 10 minutes at room temperature. The formed AgCl precipitate is 
filtered through a Pasteur pipette packed with cotton into a dry 8 mL vial and the cotton 
pack was further washed with additional 0.5 mL THF. The combined washings were dried 
in the vacuum chamber over 30 minutes. Following this, 1.02 mL of a stock solution of the 
ligand (R,R)-T2 (Prepared by dissolving 8.65 mg of the ligand in 1.21 mL THF) is added 
to the dry Rh(I)-precursor and the resultant mixture is stirred vigorously for 15 minutes at 
room temperature to afford the active hydroboration catalyst. Alternative Catalyst 
Preparation: Alternatively, the catalyst can be prepared from Rh(nbd)2BF4 as follows: 
Rh(nbd)2BF4 (3.8 mg, 10 μmol) is weighed out in a dry 8 mL glass vial equipped with a 
small teflon stirbar and to the weighed crystals is added a 1.02 mL of a stock solution of 
the ligand (R,R)-T2 (Prepared by dissolving 8.65 mg of the ligand in 1.21 mL THF). The 
resultant mixture is stirred vigorously for 1 hour to afford the active hydroboration catalyst. 
Note: In both the procedures above, the total volume of the active hydroboration catalyst 
is 1.02 mL which is about 1 mol% catalyst load for five 0.2 mmol CAHB reactions. 
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Catalysts prepared using either methods described above are comparable in their 
efficiencies for CAHB reactions. 
CAHB procedure: Substrate 5a (51 mg, 0.2 mmol) is weighed out in a dry 8 mL vial 
charged with a small teflon stirbar. Dry THF (0.2 mL) is added, followed by neat 
pinacolborane (29 μL, 0.2 mmol, 1.0 eq) and the resultant mixture is stirred for 10 minutes. 
Afterwards, 0.2 mL of the chiral rhodium catalyst is added drop wise (over 10 minutes) 
and the reaction mixture is capped, taken outside of the glovebox and is stirred at room 
temperature (18 oC) for ca. 3 hours. The completion of the reaction is indicated by the 
disappearance of the starting material peak (~26 ppm) and the appearance of the product 
peak (~30 ppm) in the crude 31P NMR spectrum of the reaction mixture. Afterwards, the 
reaction mixture is concentrated under reduced pressure and the crude mixture is purified 
by flash chromatography on silica gel (ethyl acetate/hexanes 1:1) to afford the chiral 
tertiary benzylic boronic ester (R)-6a as a colorless oil (62 mg, 81%). [Note: Typical 
CAHB reactions were carried out with an overall substrate concentration of 0.5 M in THF 
and the typical reaction times were 3 hours at r.t. Gram scale reactions, however, were 
carried out with an overall substrate concentration of 1.0M in THF and with a reduced 
catalyst loading (0.5 mol%) and the reactions were run for 12 hours at r.t. Absolute 
configuration assignment: See section 9. (R,R)-T2 affords (R)-6a.] Characterization data 
for (R)-6a: TLC analysis (ethyl acetate/hexanes 2:3) Rf = 0.5; [α]D20 = -3.9o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.38 (2H, d, J = 7.5 Hz, i), 7.28 (2H, dd, J = 7.5, 
7.0 Hz, j), 7.15 (1H, d, J = 7.0 Hz, k), 4.06-3.91 (4H, m, b+b'), 2.51-2.12 (2H, m, c), 1.58 
(3H, s, e), 1.28-1.20 (18H, a+a'+g) ppm; 13C NMR (100 MHz, CDCl3) δ 146.28 (d, 3JC-P = 
16.0 Hz, h), 128.30 (j), 126.67 (i), 125.68 (k), 83.93 (f), 61.32 (d, 2JC-P = 6.0 Hz, b or b'), 
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60.95 (d, 2JC-P = 6 Hz, b or b'), 35.49 (d, 
1JC-P = 138 Hz, c), 24.85 (g or g'), 24.71 (g or g'), 
22.27 (d, 3JC-P = 4.0 Hz, e), 16.58 (d, 
3JC-P = 5.0 Hz, a or a'), 16.53 (d, 
3JC-P = 5.0 Hz, a or 
a') ppm; 11B NMR (128 MHz, CDCl3) δ 34.0 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 
31.58 ppm; IR (neat) 2977 (aromatic C-H), 2931 (aliphatic C-H), 1495 (aromatic C=C), 
1469 (aromatic C=C), 1444 (aromatic C=C), 1240 (P=O), 1053 (C-O), 1023 (C-O), 953 
(P-O) cm-1; HRMS (EI) calculated for C19H32BO5P = 382.2080, found 382.2087 m/z. The 
enantiomer ratio of this boronic ester is determined after oxidation to the chiral tertiary 
alcohol 18a.  
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6b: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (R,R)-T2, the substrate 5b 
(54 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6b (64 mg, 81%) 
as a colorless oil: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = -3.1o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.27 (2H, d, J = 8.0 Hz, i), 7.09 (2H, d, J = 8.0 Hz, 
j), 4.09-3.90 (4H, m, b+b'), 2.46 (1H, dd, J = 18.0, 15.0 Hz, c), 2.30 (3H, s, l), 2.12 (1H, 
dd, J = 18.0, 15.0 Hz, c), 1.56 (3H, s, e), 1.28 (3H, t, J = 7.0 Hz, a or a'), 1.24 (3H, t, J = 
3.0 Hz, a or a'), 1.20 (12H, s, g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 143.22 (d, 3JC-P = 
16.0 Hz, h), 135.01 (k), 128.99 (j), 126.45 (i), 83.86 (f), 61.32 (d, 2JC-P = 6.0 Hz, b or b'), 
60.96 (d, 2JC-P = 6.5 Hz, b or b'), 35.50 (d, 
1JC-P = 137 Hz, c), 24.83 (g or g'), 24.70 (g or 
g'), 22.34 (d, 3JC-P = 4.0 Hz, e), 20.98 (l), 16.54 (d, 
3JC-P = 5.5 Hz, a or a'), 16.49 (d, 
3JC-P 
= 6.0 Hz, a or a') ppm; 11B NMR (128 MHz, CDCl3) δ 33.25 (br s) ppm; 31P NMR (162 
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MHz, CDCl3) δ 31.75 ppm; IR (neat) 2977 (aromatic C-H), 2906 (aliphatic C-H), 1511, 
1463 (aromatic C=C), 1345, 1240 (P=O), 1153, 1054, 1025 (C-O), 955 (P-O), 836, 729 
cm-1; The enantiomer ratio of this boronic ester is determined after oxidation to the tertiary 
alcohol 18b.          
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6c: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5c 
(64 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6c (69 mg, 77%) 
as a colorless liquid: TLC analysis (ethyl acetate/hexanes 1:3) Rf = 0.5; [α]D20 = -5.5o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.53 (4H, dd, J = 12.5, 9.0 Hz, i+j), 4.06-3.86 
(4H, m, b+b'), 2.41 (1H, dd, J = 18.0, 15.0 Hz, c), 2.20 (1H, dd, J = 18.0, 15.0 Hz, c), 1.60 
(3H, s, e), 1.25-1.18 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 150.46 (d, 
3JC-P = 14.0 Hz, h), 127.96 (q, 
2JC-F = 32.0 Hz, k), 127.25 (i), 125.11 (q, 
3JC-F = 4.0 Hz, j), 
124.55 (q, 1JC-F = 272 Hz, CF3), 84.22 (f), 61.41 (d, 
2JC-P = 6.0 Hz, b or b'), 61.07 (d, 
2JC-P 
= 7.0 Hz, b or b'), 35.49 (d, 1JC-P = 139 Hz, c), 22.24 (g or g'), 22.19 (g or g'), 22.21 (d, 
3JC-
P = 5.0 Hz, e), 16.49 (d, 
3JC-P = 6.0 Hz, a or a'), 16.43 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
11B 
NMR (128 MHz, CDCl3) δ 34.28 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.66 ppm; 
19F NMR (376 MHz, CDCl3) δ -62.37 ppm; IR (neat) 2979 (aromatic C-H), 2932 (aliphatic 
C-H), 1616, 1469 (aromatic C=C), 1381 (aromatic C=C), 1324 (C-F), 1240 (P=O), 1120, 
1053 (C-O), 1025 (C-O), 955 (P-O), 844, 831, 679 cm-1; The enantiomer ratio of this 
boronic ester is determined after oxidation to the chiral tertiary alcohol 18c. 
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Synthesis of chiral tertiary benzylic boronic ester (R)-6d: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5d 
(57 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6d (63 mg, 76%) 
as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = -18o 
(c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.22 (2H, t, J = 8.0 Hz, l), 7.00 (1H, s, i), 
6.97-6.86 (1H, m, m), 6.72 (1H, dd, J = 6.5, 2.0 Hz, k), 4.09-3.95 (4H, m, b+b'), 3.80 (3H, 
d, J = 2.0 Hz, n), 2.47 (1H, dd, J = 18.0., 15.0 Hz, c(1H)), 2.15 (1H, dd, J = 17.5, 15.0 Hz, 
c(1H)), 1.56 (3H, s, e), 1.31-1.23 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, CDCl3) 
δ 159.60 (j), 148.20 (d, 3JC-P = 16.0 Hz, h), 129.13 (l), 119.08 (i), 112.74 (m), 110.93 (k), 
83.90 (f), 41.42 (d, 2JC-P = 6.0 Hz, b or b'), 61.04 (d, 
2JC-P = 6.5 Hz, b or b'), 55.33 (n), 
35.56 (d, 1JC-P = 138 Hz, c), 24.94 (g or g'), 24.80 (g or g’), 22.38 (d, 3JC-P = 4.0 Hz, e), 
16.62 (d, 3JC-P = 5.5 Hz, a or a'), 16.57 (d, 
3JC-P = 5.0 Hz, a or a') ppm; 
11B NMR (128 MHz, 
CDCl3) δ 33.8 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 31.55 ppm; IR (neat) 2977 
(aromatic C-H), 2933 (aliphatic C-H), 1599, 1580, 1486 (aromatic C=C), 1464 (aromatic 
C=C), 1240 (P=O), 1143, 1024 (C-O), 955 (P-O) cm-1; The enantiomer ratio of this boronic 
ester is determined after oxidation to the chiral tertiary alcohol 18d.  
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Synthesis of chiral tertiary benzylic boronic ester (R)-6e: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5e 
(57 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6e (58 mg, 70%) 
as a dense waxy liquid: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; [α]D20 = +4.5o 
(c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.31 (2H, d, J = 9.0 Hz, i), 6.83 (2H, d, J 
= 9.0 Hz, j), 4.08-3.90 (4H, m, b+b'), 3.78 (3H, s, l), 2.43 (1H, dd, J = 18.0, 15.0 Hz, c), 
2.12 (1H, dd, J = 18.0, 15.0 Hz, c), 1.55 (3H, s, e), 1.29-1.21 (18H, m, a+a'+g+g') ppm; 
13C NMR (100 MHz, CDCl3) δ 157.55 (k), 138.32 (d, 3JC-P = 16.0 Hz, h), 127.71 (i), 113.71 
(j), 83.92 (f), 61.35 (d, 2JC-P = 6.0 Hz, b or b'), 61.02 (d, 
2JC-P = 6.0 Hz, b or b'), 55.40 (l), 
35.73 (d, 1JC-P = 138 Hz, c), 24.89 (g or g'), 24.76 (g or g'), 22.50 (e), 16.53 (d, 
3JC-P = 4.5 
Hz, a or a'), 16.58 (d, 3JC-P = 4.5 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 33.0 (br 
s) ppm; 31P NMR (162 MHz, CDCl3) δ 31.65 ppm; IR (neat) 2976 (aromatic C-H), 2906 
(aliphatic C-H), 1607, 1510, 1463 (aromatic C=C), 1242 (P=O), 1142, 1024 (C-O), 954 (P-
O) cm-1; The enantiomer ratio of this boronic ester is determined after oxidation to the 
chiral tertiary alcohol 18e. 
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6f: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5f 
(60 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6f (66 mg, 77%) 
as a colorless liquid (Note: This boronic ester was air sensitive. After purification, this 
product was stored under nitrogen in the freezer): TLC analysis (ethyl acetate) Rf = 0.5; 
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[α]D20 = -7.1o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.92 (1H, d, J = 2.0 Hz, i), 
6.83 (1H, dd, J = 8.0, 2.0 Hz, i), 6.73 (1H, d, J = 8.0 Hz, j), 5.90 (2H, s, l), 4.06-3.93 (4H, 
m, b+b'), 2.38 (1H, dd, J = 18.0, 15.0 Hz, c), 2.09 (1H, dd, J = 18.0, 15.0 Hz, c), 1.52 (3H, 
s, e), 1.29-1.21 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 147.65 (j or k), 
145.45 (j or k), 140.33 (d, 3JC-P = 16.0 Hz, h), 119.57 (i), 108.00 (j), 107.62 (i), 100.89 (l), 
83.95 (f), 61.33 (d, 2JC-P = 6.0 Hz, b or b'), 60.98 (d, 
2JC-P = 6.0 Hz, b or b'), 35.38 (d, 
1JC-
P = 138 Hz, c), 24.85 (g or g'), 24.70 (g or g'), 22.57 (d, 
3JC-P = 4.5 Hz, e), 16.56 (d, 
3JC-P = 
5.0 Hz, a or a'), 16.49 (d, 3JC-P = 5.0 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 34.1 
(br s) ppm; 31P NMR (162 MHz, CDCl3) δ 31.34 ppm; IR (neat) 2977 (aromatic C-H), 
2906 (aliphatic C-H), 1487 (aromatic C=C), 1321, 1234 (P=O), 1142, 1024 (C-O), 956 (P-
O), 936, 729 cm-1; The enantiomer ratio of this boronic ester is determined after oxidation 
to the chiral tertiary alcohol 18f.  
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6g: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5g 
(56 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6g (62 mg, 76%) 
as a colorless liquid: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = -4.3o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 6.99 (2H, s, i), 6.80 (1H, s, l), 4.11-3.92 (4H, 
m, b+b'), 2.46 (1H, dd, J = 18.0, 15.0 Hz, c), 2.29 (6H, s, k), 2.12 (1H, dd, J = 18.0, 15.0 
Hz, c), 1.56 (3H, s, e), 1.30 (3H, t, J = 7.0, a or a'), 1.25 (3H, t, J = 7.0, a or a'), 1.22 (12H, 
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s, g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 146.32 (d, 3JC-P = 17 Hz, h), 137.53 (j), 127.33 
(l), 124.41 (i), 83.86 (f), 61.32 (d, 2JC-P = 6.0 Hz, b or b'), 60.91 (d, 
2JC-P = 7.0 Hz, b or b'), 
35.39 (d, 1JC-P = 137 Hz, c), 24.86 (g or g'), 24.67 (g or g'), 22.45 (d, 
3JC-P = 3.5 Hz, e), 
21.63 (k), 16.58 (d, 2JC-P = 6.0 Hz, a or a'), 16.52 (d, 
2JC-P = 6.0 Hz, a or a') ppm; 
11B NMR 
(128 MHz, CDCl3) δ 33.30 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 31.90 ppm; IR (neat) 
2976 (aromatic C-H), 2915 (aliphatic C-H), 1598, 1461 (aromatic C=C), 1321 (aromatic 
C=C), 1240 (P=O), 1164, 1053 (C-O), 1025 (C-O), 954 (P-O), 839, 697 cm-1; The 
enantiomer ratio of this boronic ester is determined after oxidation to the chiral tertiary 
alcohol 18g. 
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6h: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5h 
(54 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6h (51 mg, 62%) 
as a colorless liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = -5.8o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.35 (2H, dd, J = 8.5, 5.5 Hz, i), 6.96 (2H, t, J 
= 8.5 Hz, j), 4.06-3.88 (4H, m, b+b'), 2.39 (1H, dd, J = 18.0, 15.0 Hz, c), 2.14 (1H, dd, J = 
18.0, 15.0 Hz, c), 1.56 (3H, s, e), 1.27-1.20 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, 
CDCl3) δ 161.15 (d, 1JC-F = 244 Hz, k), 141.78 (dd, 4JC-F = 3.0 Hz, 3JC-P = 15.0 Hz, h), 
128.28 (d, 3JC-F = 8.0 Hz, i), 114.89 (d, 
2JC-F = 21 Hz, j), 84.01 (f), 61.32 (d, 
2JC-P = 6.0 Hz, 
b or b'), 60.99 (d, 2JC-P = 7.0 Hz, b or b'), 35.76 (d, 
1JC-P = 138 Hz, c), 24.80 (g or g'), 24.68 
(g or g'), 22.46 (d, 3JC-P = 5.0 Hz, e), 16.55 (d, 
3JC-P = 4.5 Hz, a or a'), 16.49 (d, 
3JC-P = 5.0 
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Hz, a or a') ppm; 11B NMR (128 MHz, CDCl3) δ 34.00 (br s) ppm; 31P NMR (162 MHz, 
CDCl3) δ 31.12 ppm; 19F NMR (376 MHz, CDCl3) δ -118.33 ppm; IR (neat) 2977 
(aromatic C-H), 2932 (aliphatic C-H), 1603, 1508 (C-F), 1469 (aromatic C=C), 1343 
(aromatic C=C), 1323 (aromatic C=C), 1237 (P=O), 1143, 1053 (C-O), 1024 (C-O), 955 
(P-O), 838 cm-1; The enantiomer ratio of this boronic ester is determined after oxidation to 
the chiral tertiary alcohol 18h.  
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6i: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5i 
(58 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6i (68 mg, 82%) 
as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = -
8.5o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.32 (2H, d, J = 8.5 Hz, i or j), 7.24 
(2H, d, J = 8.5 Hz, i or j), 4.06-3.88 (4H, m, b+b'), 2.38 (1H, dd, J = 18.0, 15.0 Hz, c), 2.13 
(1H, dd, J = 18.0, 15.0 Hz, c), 1.55 (3H, s, e), 1.27-1.19 (18H, m, a+a'+g+g') ppm; 13C 
NMR (100 MHz, CDCl3) δ 144.75 (d, 3JC-P = 15 Hz, h), 131.44 (k), 128.28 (i or j), 128.24 
(i or j), 84.06 (f), 61.36 (d, 2JC-P = 6.0 Hz, b or b'), 61.02 (d, 
2JC-P = 7.0 Hz, b or b'), 35.52 
(d, 1JC-P = 139 Hz, c), 24.80 (g or g'), 24.68 (g or g'), 22.24 (d, 
3JC-P = 5.0 Hz, e), 16.54 (d, 
3JC-P = 5.0 Hz, a or a'), 16.48 (d, 
3JC-P = 5.5 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) 
δ 33.13 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.99 ppm; IR (neat) 2977 (aromatic 
C-H), 2931 (aliphatic C-H), 1740, 1492 (aromatic C=C), 1323 (aromatic C=C), 1240 
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(P=O), 1143, 1053 (C-O), 1024 (C-O), 954 (P-O), 830 (C-Cl) cm-1; The enantiomer ratio 
of this boronic ester is determined after oxidation to the chiral tertiary alcohol 18i. 
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6j: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5j 
(58 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6j (53 mg, 64%) 
as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 2:5) Rf = 0.5; [α]D20 = -
12.4o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.36 (1H, s, i), 7.27 (1H, d, J = 8.0 
Hz, m or k), 7.20 (1H, t, J = 8.0 Hz, l), 7.12 (1H, d, J = 8.0 Hz, m or k), 4.07-3.89 (4H, m, 
b+b'), 2.39 (1H, dd, J = 18.0, 15.0 Hz, c), 2.13 (1H, dd, J = 18.0, 15.0 Hz, c), 1.55 (3H, s, 
e), 1.27-1.20 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 148.49 (d, 3JC-P = 
15 Hz, h), 134.17 (j), 129.43 (l), 127.06 (i), 125.82 (m or k), 125.06 (m or k), 84.11 (f), 
61.39 (d, 2JC-P = 6.0 Hz, b or b'), 61.00 (d, 
2JC-P = 7.0 Hz, b or b'), 35.40 (d, 
1JC-P = 139 Hz, 
c), 24.79 (g or g'), 24.65 (g or g'), 22.16 (d, 3JC-P = 4.0 Hz, e), 16.53 (d, 
3JC-P = 5.0 Hz, a or 
a'), 16.47 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 34.19 (br s) ppm; 
31P NMR (162 MHz, CDCl3) δ 30.99 ppm; IR (neat) 2977 (aromatic C-H), 2931 (aliphatic 
C-H), 1593, 1567, 1472 (aromatic C=C), 1323 (aromatic C=C), 1240 (P=O), 1143, 1053 
(C-O), 1024 (C-O), 955 (P-O), 833 (C-Cl) cm-1; The enantiomer ratio of this boronic ester 
is determined after oxidation to the chiral tertiary alcohol 18j. 
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Synthesis of chiral tertiary benzylic boronic ester (R)-6k: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5k 
(67 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6k (63 mg, 68%) 
as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = -
5.2o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.40 (2H, d, J = 8.6 Hz, i or j), 7.27 
(2H, d, J = 8.6 Hz, i or j), 4.07-3.89 (4H, m, b+b'), 2.39 (1H, dd, J = 18.0, 15.0 Hz, c), 2.14 
(1H, dd, J = 18.0, 15.0 Hz, c), 1.55 (3H, s, e), 1.28-1.20 (18H, m, a+a'+g+g') ppm; 13C 
NMR (100 MHz, CDCl3) δ 144.32 (d, 3JC-P = 15 Hz, h), 131.25 (i or j), 128.68 (i or j), 
119.59 (k), 84.10 (f), 61.40 (d, 2JC-P = 6.0 Hz, b or b'), 61.06 (d, 
2JC-P = 6.0 Hz, b or b'), 
35.74 (d, 1JC-P = 138 Hz, c), 24.83 (g or g'), 24.71 (g or g'), 22.19 (d, 
3JC-P = 5.0 Hz, e), 
16.56 (d, 3JC-P = 5.0 Hz, a or a'), 16.51 (d, 
3JC-P = 5.5 Hz, a or a') ppm; 
11B NMR (128 MHz, 
CDCl3) δ 34.05 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.96 ppm; IR (neat) 2977 
(aromatic C-H), 2930 (aliphatic C-H), 1488 (aromatic C=C), 1371 (aromatic C=C), 1240 
(P=O), 1142, 1053 (C-O), 1023 (C-O), 955 (P-O), 830, 686 (C-Br) cm-1; The enantiomer 
ratio of this boronic ester is determined after oxidation to the chiral tertiary alcohol 18k.  
 
Synthesis of chiral tertiary benzylic boronic ester (S)-6l: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5l 
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(52 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (S)-6l (66 mg, 85%) 
as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = 
+6.5o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.12-7.11 (1H, m, k), 6.92-6.90 (2H, 
m, i+j), 4.09-3.98 (4H, m, b+b'), 2.51 (1H, dd, J = 18.0, 15.0 Hz, c), 2.15 (1H, dd, J = 18.0, 
15.0 Hz, c), 1.62 (3H, s, e), 1.31-1.23 (18H, m, a+a'+g+g') ppm; 13C NMR (100 MHz, 
CDCl3) δ 152.35 (d, 3JC-P = 20 Hz, h), 126.78 (i or j), 123.24 (i or j), 122.97 (k), 84.19 (f), 
61.53 (d, 2JC-P = 6.0 Hz, b or b'), 61.10 (d, 
2JC-P = 7.0 Hz, b or b'), 37.03 (d, 
1JC-P = 138 Hz, 
c), 24.83 (g or g'), 24.76 (g or g'), 24.17 (d, 3JC-P = 5.0 Hz, e), 16.57 (d, 
3JC-P = 6.5 Hz, a+a') 
ppm; 11B NMR (128 MHz, CDCl3) δ 33.78 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 
30.16 ppm; IR (neat) 2978 (aromatic C-H), 2931 (aliphatic C-H), 1739, 1463 (aromatic 
C=C), 1325 (aromatic C=C), 1236 (P=O), 1142, 1052 (C-O), 1023 (C-O/C=S), 955 (P-O), 
731, 692 cm-1; The enantiomer ratio of this boronic ester is determined after oxidation to 
the chiral tertiary alcohol 18l.      
 
Synthesis of chiral tertiary benzylic boronic ester (R)-6m: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 5m 
(52 mg, 0.2 mmol) yields the tertiary benzylic boronic ester product (R)-6m (62 mg, 80%) 
as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = -
6.4o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.23 (1H, dd, J = 5.0, 3.0 Hz, j), 7.10 
(1H, dd, J = 5.0, 1.3 Hz, i), 7.03 (1H, dd, J = 3.0, 1.3 Hz, k), 4.11-3.94 (4H, m, b+b'), 2.45 
(1H, dd, J = 18.0, 15.0 Hz, c), 2.10 (1H, dd, J = 18.0, 15.0 Hz, c), 1.55 (3H, s, e), 1.30-1.24 
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(6H, m, a+a'), 1.20 (12H, s, g+g') ppm; 13C NMR (100 MHz, CDCl3) δ 147.64 (d, 3JC-P = 
17.5 Hz, h), 127.28 (i), 125.00 (j), 119.11 (k), 83.97 (f), 61.39 (d, 2JC-P = 6.0 Hz, b or b'), 
61.06 (d, 2JC-P = 6.5 Hz, b or b'), 35.64 (d, 
1JC-P = 138 Hz, c), 24.82 (g or g'), 24.74 (g or 
g'), 22.84 (d, 3JC-P = 5.0 Hz, e), 16.58 (d, 
3JC-P = 6.0 Hz, a or a'), 16.56 (d, 
3JC-P = 6.0 Hz, a 
or a') ppm; 11B NMR (128 MHz, CDCl3) δ 34.29 (br s) ppm; 31P NMR (162 MHz, CDCl3) 
δ 31.08 ppm; IR (neat) 2977 (aromatic C-H), 2931 (aliphatic C-H), 1739, 1462 (aromatic 
C=C), 1339 (aromatic C=C), 1320 (C=C), 1239 (P=O), 1143, 1053 (C-O), 1024 (C-
O/C=S), 954 (P-O), 776 cm-1; The enantiomer ratio of this boronic ester is determined after 
oxidation to the chiral tertiary alcohol 18m. 
 
Synthesis of chiral tertiary boronic ester (R)-38a: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate 37a (1.18 g, 4.00 
mmol) yields the tertiary boronic ester product (R)-38a (1.39 g, 82%) as a colorless viscous 
oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.5; [α]D20 = +6.91o (c = 1.0, CHCl3); 1H 
NMR (300 MHz, CDCl3) δ 7.29-7.15 (5H, m, aryl), 4.11-4.00 (4H, m, b+b'), 2.59 (2H, t, J 
= 7.5 Hz, h). 2.05-1.39 (6H, m, c+f+g), 1.33-1.24 (18H, a+a'+j), 1.11 (3H, s, e) ppm; 13C 
NMR (75 MHz, CDCl3) δ 142.66 (aryl), 128.35 (aryl), 128.23 (aryl), 125.60 (aryl), 83.40 
(i), 61.06-60.78 (m, b+b'), 39.73 (d, 3JC-P = 15 Hz, f), 36.67 (d), 36.67 (h), 34.05 (d, 
1JC-P 
= 136.5 Hz, c), 27.34 (g), 24.89 (j), 22.03 (d, 3JC-P = 6.75 Hz, e), 16.53-16.43 (m, a+a') 
ppm; 31P NMR (121 MHz) δ 32.35 ppm; 11B NMR (96 MHz) δ 34.65 ppm; IR (neat) 
3025.66 (sp2 C-H), 2977.90 (sp3 C-H), 1739.56, 1603.55, 1371.34, 1240.12 (P=O), 
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1053.39 (C-O), 1026.23 (C-O), 953.50, 733.60 cm-1; HRMS (ESI) calculated for 
C22H38BO5P 424.2550, found 424.2566 m/z. The enantiomer ratio was determined by 
chiral HPLC analysis after oxidation to the tertiary alcohol 40a. [Note: The isomeric 
substrate (Z)-37a reacted under identical conditions to afford ca. 40% of the chiral tertiary 
boronic ester (R)-38a with an enantiomer ratio of 99:1 and majority of the remaining 
mixture was the reduced side product.]  
Note: Absolute configuration assignment. The stereochemical identity of bakuchiol 
methyl ether derived from the sequence starting with the boronic ester 38q generated via 
CAHB of 37q using (S,S)-T2 was found to be (S) by comparison of the optical rotation 
value with the literature data.12 Therefore, the absolute configuration of the tertiary boronic 
ester 38q formed from CAHB of trisubstituted alkene 37q using (S,S)-T2 is assigned to be 
“S”. Similarly, the enantiomeric (R)-(-)-bakuchiol methyl ether was obtained in the 
sequence starting with the boronic ester 38q generated via CAHB of 37q using (R,R)-T2. 
The absolute configurations of all other tertiary boronic esters generated via CAHB using 
(R,R)-T2, which was used for most of the examples reported in this dissertation, are hence 
assigned as “R” by analogy.  
 
Synthesis of the tertiary boronic ester (R)-38b: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene 37b (91 mg, 0.25 mmol) yields tertiary boronic ester (R)-38b (96 mg, 78%) as a 
viscous light buff colored oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = 
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+1.5o (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.53 (2H, d, J = 8 Hz, m), 7.28 (2H, 
d, J = 8 Hz, l), 4.10-4.01 (4H, m, b+b'), 2.66 (2H, t, J = 7.4 Hz, h), 1.95 (1H, dd, J = 18, 
15.4 Hz, c), 1.74 (1H, dd, J = 18, 15.4 Hz, c), 1.66-1.44 (4H, m, f+g), 1.25 (3H, s, e), 1.33-
1.29 (6H, m, a+a'), 1.25 (12H, s, j), 1.12 (3H, s, e) ppm; 13C NMR (100 MHz, CDCl3) δ 
146.88 (k), 128.78 (aryl), 128.29 (aryl), 127.97 (CF3), 125.32 (aryl), 125.28 (aryl), 125.25 
(aryl), 83.56 (i), 61.17-60.95 (m, b+b'), 39.40 (d, 3JC-P = 13 Hz, f), 36.53 (h), 34.09 (d, 
1JC-
P = 137 Hz, c), 27.14 (g), 24.96 (j), 22.22 (d, 
3JC-P = 7 Hz, e), 16.56 (dd, 
3JC-P = 4 Hz, a+a') 
ppm; 11B NMR (128 MHz, CDCl3) δ 35.59 ppm; 31P NMR (162 MHz, CDCl3) δ 32.12 
ppm; 19F NMR (376 MHz, CDCl3) δ –62.29 ppm; IR (neat) 2978 (aromatic C-H), 2917 
(aliphatic C-H), 1618, 1466, 1323 (C-F), 1241 (P=O), 1119 (C-O), 1026 (C-O), 953 (P-O) 
cm-1; Enantiomer ratio was determined by chiral HPLC analysis of the tertiary alcohol 
derivative 40b.  
 
Synthesis of the tertiary boronic ester (R)-38c: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37c (83 mg, 0.25 mmol) yields tertiary boronic ester (R)-38c (87 mg, 76%) as 
a colorless viscous oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +2.0o (c 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.28-7.22 (2H, m, m), 7.11-7.08 (2H, m, l), 
4.10-4.03 (4H, m, b+b'), 2.56 (2H, t, J = 7.2 Hz, h), 1.99-1.91 (1H, m, c), 1.76-1.68 (1H, 
m, c), 1.64-1.39 (4H, m, f+g), 1.33-1.11 (18H, m, a+a'+j), 1.11 (3H, s, e) ppm; 13C NMR 
(100 MHz, CDCl3) δ 141.18 (k), 131.39 (n), 129.82 (l), 128.46 (m), 83.54 (i), 61.18-60.94 
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(m, b+b'), 39.52 (d, 3JC-P = 14 Hz, f), 3604 (h), 34.13 (d, 
1JC-P = 136 Hz, c), 27.32 (g), 25.00 
(j), 22.17 (d, 3JC-P = 7 Hz, e), 16.63-16.55 (m, a+a') ppm; 
11B NMR (128 MHz, CDCl3) δ 
36.17 ppm; 31P NMR (162 MHz, CDCl3) δ 32.22 ppm; IR (neat) 2977 (aromatic C-H), 
2933 (aliphatic C-H), 1492, 1406, 1316, 1241, 1144, 1054, 1026, 953 cm-1; Enantiomer 
ratio was determined by chiral HPLC analysis of the tertiary alcohol derivative 40c. 
 
Synthesis of the tertiary boronic ester (R)-38d: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37d (76 mg, 0.25 mmol) yields tertiary boronic ester (R)-38d (83 mg, 78%) as 
a colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +1.2o (c 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.11 (1H, dd, J = 6.8, 1.6 Hz, n), 6.91 (1H, dd, J = 
6.8, 4.8 Hz, m), 6.78-6.77 (1H, m, l), 4.12-4.03 (4H, m, b+b'), 2.81 (2H, t, J = 7.2 Hz, h), 
2.03-1.92 (1H, m, c), 1.79-1.45 (5H, m, c+f+g), 1.34-1.27 (18H, m, a+a'+j), 1.13 (3H, s, e) 
ppm; 13C NMR (75 MHz, CDCl3) δ 145.61 (k), 126.63 (m), 123.93 (l), 122.76 (n), 83.47 
(i), 61.09-60.83 (m, b+b'), 39.50 (d, 3JC-P = 15 Hz, f), 34.07 (d, 
1JC-P = 136.5 Hz, c), 30.63 
(h), 27.77 (g), 24.91 (j), 22.06 (d, 3JC-P = 7.5 Hz, e), 16.54-16.43 (m, a+a') ppm;
 11B NMR 
(96 MHz, CDCl3) δ 36.18 ppm; 31P NMR (121 MHz, CDCl3) δ 32.24 ppm; IR (neat) 2978 
(C-H), 2165, 2027, 1739, 1465, 1371, 1215 (P=O), 1142 (C-O), 1026 (C-O/C-B), 961 (P-
O) cm-1; Enantiomer ratio was determined by chiral HPLC analysis of the tertiary alcohol 
derivative 40d. 
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Synthesis of the tertiary boronic ester (R)-38e: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37e (78 mg, 0.25 mmol) yielded tertiary boronic ester (R)-38e (79 mg, 71%) as 
a colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +1.9o (c 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 5.77 (2H, s, m), 4.14-4.04 (4H, m, b+b'), 3.70 (2H, 
t, J = 7.5 Hz, h), 2.23 (6H, s, l), 1.98-1.72 (2H, m, c), 1.69-1.43 (4H, m, g+h), 1.36-1.26 
(18H, m, a+a'+j), 1.12 (3H, s, e) ppm; 13C NMR (75 MHz, CDCl3) δ 127.21 (k), 104.92 
(m), 83.51 (i), 61.03 (dd, 2JC-P = 6 Hz, b+b'), 44.23 (h), 36.13 (d, 
3JC-P = 12 Hz, f), 33.72 
(d, 1JC-P = 136.5 Hz, c), 27.14 (g), 24.88 (j), 22.31 (d, 
3JC-P = 9 Hz, e), 16.50 (d, 
3JC-P = 
5.25 Hz, a+a'), 12.43 (l) ppm; 11B NMR (96 MHz, CDCl3) δ 35.59 ppm; 31P NMR (121 
MHz, CDCl3) δ 31.96 ppm; IR (neat) 2976 (sp2 C-H), 2932 (sp3 C-H), 1371 (C=N/B-O), 
1299, 1245 (P=O), 1052 (C-O), 1025 (C-O), 955 (P-O), 741 cm-1; Enantiomer ratio was 
determined by chiral HPLC analysis of the tertiary alcohol derivative 40e. 
 
Synthesis of the tertiary boronic ester (R)-38f: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37f (69 mg, 0.25 mmol) yields tertiary boronic ester (R)-38f (84 mg, 83%) as a 
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colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.7; [α]D20 = +1.1o (c 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 4.12-4.00 (4H, m, b+b'), 2.03-1.94 (1H, m, c), 1.75-
1.67 (1H, m, c), 1.50-1.42 (2H, m, m), 1.36-1.27 (28H, a+a'+f+g+h+j+k+l), 1.12 (3H, s, 
e), 0.89 (3H, t, J = 7.0 Hz, n) ppm; 13C NMR (100 MHz, CDCl3) δ 83.46 (i), 61.14-60.86 
(m, b+b'), 40.40 (d, 3JC-P = 16 Hz, f), 34.28 (d, 
1JC-P = 136 Hz, c), 31.95, 30.44, 29.36, 
25.37, 25.01 (j), 22.75 (m), 22.04 (d, 3JC-P = 6 Hz, e),, 16.60-16.54 (m, a+a'), 14.21 (n) 
ppm; 11B NMR (128 MHz, CDCl3) δ 35.14 ppm; 31P NMR (162 MHz, CDCl3) δ 32.56 
ppm; IR (neat) 2976 (C-H), 1467, 1371 (B-O), 1241 (P=O), 1144, 1055, 1027 (C-O), 953 
(P-O) cm-1; Enantiomer ratio was determined by NMR analysis of the γ-amino-
phosphonate derivative 79f.  
 
Synthesis of the tertiary boronic ester (R)-38g: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37g (62 mg, 0.25 mmol) yielded tertiary boronic ester (R)-38g (76 mg, 80%) as 
a colorless oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.5; [α]D20 = +0.9o (c = 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 4.10-4.00 (4H, m, b+b'), 1.97 (1H, dd, J = 18, 15.5 
Hz, c), 1.68 (1H, dd, J = 18, 15.5 Hz, c), 1.49-1.36 (3H, m, h+ f or g), 1.33-1.23 (18H, m, 
a+a'+k), 1.19-1.13 (2H, m, f or g), 1.095 (3H, s, e), 0.86 (6H, d, J = 6.6 Hz, i) ppm; 13C 
NMR (75 MHz, CDCl3) δ 83.55 (j), 61.05-60.71 (m, b+b'), 38.17 (d, 3JC-P = 15.75 Hz, f), 
34.23 (d, 1JC-P = 135.75 Hz, c), 34.42 (d, 
4JC-P = 1.5 Hz, g), 28.74 (h), 24.90 (k), 22.66 (i), 
21.83 (d, 3JC-P = 6 Hz, e), 16.50-16.41 (m, a+a') ppm; 
11B NMR (96 MHz) δ 34.01 ppm; 
247 
 
31P NMR (121 MHz) δ 32.55 ppm; IR (neat) 2976 (C-H), 1468, 1241 (P=O), 1054 (C-O), 
1026.20 (C-O), 953, 686 cm-1; The enantiomer ratio was determined by chiral HPLC 
analysis of the furan coupled derivative 73g. 
 
Synthesis of the tertiary boronic ester (2R,5S)-38h: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
chiral substrate (S)-37h (80 mg, 0.25 mmol) yields diastereomeric tertiary boronic ester 
(2R,5S)-38h (93 mg, 83%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf 
= 0.5; [α]D20 = +3.75o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 4.10-4.01 (4H, m, 
b+b'), 2.01-1.91 (1H, m, c), 1.73-1.61 (1H, m, c), 1.54-1.07 (33H, m, a+a'+e+f+g+h+j+k 
+l+m+n), 0.87-0.83 (9H, m, i+o) ppm; 13C NMR (100 MHz, CDCl3) δ 83.60 (i), 61.24-
60.96 (m, b+b'), 39.65, 38.17 (d, 3JC-P = 15 Hz, f), 37.62, 34.81 (d, 
1JC-P = 137 Hz, c), 
33.86, 32.86, 28.22, 25.21 (j), 25.19, 22.87, 22.78, 22.15 (d, 3JC-P = 5 Hz, e), 19.97, 16.67 
(d, 3JC-P = 6 Hz, a+a') ppm;
 11B NMR (128 MHz) δ 35.80 ppm; 31P NMR (162 MHz) δ 
32.36 ppm; IR (neat) 2927 (C-H ), 1466, 1371, 1315, 1242 (P=O), 1145 (B-O), 1055 (C-
O), 1027 (C-O), 953 (C-O) cm-1; HRMS (ESI) calculated for C23H48BO5P+Na
+ 468.3266, 
found 468.3268 m/z. Diastereomer ratio (dr) estimate = >20:1. The dr was estimated from 
13C NMR analysis of the sample by comparison with the 13C NMR spectrum of its 
diastereomer (2S,5S)-38h. 
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Synthesis of the tertiary boronic ester (2S,5S)-38h: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the phosphonate functionalized 
chiral substrate (S)-37h (80 mg, 0.25 mmol) yields diastereomeric tertiary boronic ester 
(2S,5S)-38h (92 mg, 82%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 
0.5; [α]D20 = –3.25o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 4.10-4.02 (4H, m, 
b+b'), 2.03-1.94 (1H, m, c), 1.73-1.65 (1H, m, c), 1.58-1.06 (33H, m, 
a+a'+e+f+g+h+j+k+l+m+n), 0.88-0.85 (9H, m, i+o) ppm; 13C NMR (100 MHz, CDCl3) δ 
83.62 (i), 61.25-60.97 (m, b+b'), 39.66, 38.15 (d, 3JC-P = 15 Hz, f), 37.62, 34.66 (d, 
1JC-P = 
137 Hz, c), 33.88, 32.89, 28.23, 25.20 (j), 25.04, 22.88, 22.80, 22.25 (d, 3JC-P = 6 Hz, e), 
19.98, 16.67 (d, 3JC-P = 4 Hz, a+a') ppm; 
11B NMR (128 MHz) δ 34.69 ppm; 31P NMR (162 
MHz) δ 32.42 ppm; IR (neat) 2927 (C-H ), 1467, 1371, 1315, 1242 (P=O ), 1145 (B-O ), 
1055 (C-O ), 1027 (C-O ), 953 (C-O ) cm-1; HRMS (ESI) calculated for C23H48BO5P+Na
+ 
468.3266, found 468.3268 m/z. Diastereomer ratio (dr) estimate = >20:1. The dr was 
estimated from 13C NMR analysis of the sample by comparison with the 13C NMR 
spectrum of its diastereomer (2S,5S)-38h. 
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Synthesis of the tertiary boronic ester (E)-37i: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37i (102 mg, 0.25 mmol) yields tertiary boronic ester (R)-38i (94 mg, 70%) as 
a colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +1.5o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, DMSO-d6, 353K) δ 7.34-7.22 (5H, m, aryl), 4.38 (2H, s, k), 
4.01-3.93 (4H, m, b+b'), 3.11 (2H, t, J = 7.0 Hz, h), 1.83-1.75 (1H, m, c), 1.64-1.56 (1H, 
m, c), 1.42 (9H, s, m), 1.47-1.19 (4H, m, f+h), 1.24-1.22 (6H, m, a+a'), 1.20 (12H, s, j), 
0.98 (3H, s, e) ppm; 13C NMR (100 MHz, DMSO-d6, 353K) 155.59 (carbamate C=O), 
139.40 (aryl), 128.83 (aryl), 127.74 (aryl), 127.42 (aryl), 83.67 (i), 79.26 (l), 61.10-60.94 
(m, b+b'), 50.48 (k), 47.80 (h), 37.22 (d, 3JC-P = 14 Hz, f), 34.44 (d, 
1JC-P = 136 Hz, c), 
28.69 (m), 25.25 (j), 24.34 (g), 22.51 (d, 3JC-P = 7 Hz, e), 16.73 (d, 
3JC-P = 5 Hz, a+a') ppm;
 
11B NMR (128 MHz, DMSO-d6, 353K) 34.84 ppm; 31P NMR (162 MHz, DMSO-d6, 
353K) 30.99 ppm; IR (neat) 2976 (aromatic C-H), 2931 (aliphatic C-H), 1691 (carbamate 
C=O), 1454, 1413, 1365, 1241 (P=O), 1164 (B-O), 1143 (C-O), 1026 (C-O), 954 (P-O) 
cm-1. The enantiomer ratio was determined by NMR analysis of diastereomer ratio of the 
derivative 79i. [Note: NMR data for this molecule were recorded at a higher temperature 
(80oC, 353K) to speed up the interconversions between the tertiary amide rotamers at the 
NMR time scale which resulted in clean spectra. Room temperature NMR shows broadened 
peaks which results due to slow interconversions between the rotamers.] 
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Synthesis of the tertiary boronic ester (R)-38j: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37j (85 mg, 0.25 mmol) yields tertiary boronic ester (R)-38j (75 mg, 64%) as a 
colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = –3.8o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 8.04 (2H, d, J = 7.2 Hz, k), 7.56-7.53 (1H, m, m), 
7.45-7.41 (2H, m, l), 4.28 (2H, t, J = 6.4 Hz, h), 4.10-4.02 (4H, m, b+b'), 2.02-1.53 (6H, 
m, c+f+g), 1.32-1.28 (6H, m, a+a'), 1.25 (12H, s, j), 1.14 (3H, s, e) ppm; 13C NMR (100 
MHz, CDCl3) δ 166.70 (C=O), 132.89 (m), 130.59 (n), 129.65 (k), 128.39 (l), 83.64 (i), 
65.63 (h), 61.24-61.00 (m, b+b'), 36.01 (d, 3JC-P = 15 Hz, f), 34.15 (d, 
1JC-P = 137 Hz, c), 
24.99 (j), 24.92 (g), 22.20 (d, 3JC-P = 8 Hz, e), 16.58 (d, 
3JC-P = 6 Hz, a+a') ppm;
 11B NMR 
(128 MHz, CDCl3) δ 36.12 ppm; 31P NMR (162 MHz, CDCl3) δ 32.00 ppm; IR (neat) 2976 
(aromatic C-H), 2870 (aliphatic C-H), 1717 (C=O), 1452, 1272 (P=O), 1144 (B-O), 1052 
(C-O), 1024 (C-O), 954 (P-O) cm-1; Enantiomer ratio was determined by chiral HPLC 
analysis of the tertiary alcohol derivative 40j. 
 
Synthesis of the tertiary boronic ester (R)-38k: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37k (79 mg, 0.25 mmol) yields tertiary boronic ester (R)-38k (89 mg, 78%) as 
a colorless oil: TLC analysis (ethyl-acetate:hexanes 1:1) Rf = 0.5; [α]D20 = +2.0o (c = 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.36-7.23 (5H, m, aryl), 4.49 (2H, s, k), 4.12-4.00 
(4H, m, b+b'), 3.44 (2H, t, J = 6.6 Hz, h), 2.02-1.37 (6H, m, c+f+g), 1.32-1.25 (18H, m, 
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a+a'+j), 1.12 (3H, s, e) ppm; 13C NMR (75 MHz, CDCl3) δ 138.68 (aryl), 128.29 (aryl), 
127.58 (aryl), 127.42 (aryl), 83.43 (i), 72.73 (k), 71.02 (h), 61.07-60.81 (m, b+b'), 36.06 
(d, 3JC-P = 15 Hz, f), 34.04 (d, 
1JC-P = 136.5 Hz, c), 25.52 (g), 24.91 (j), 22.03 (d, 
3JC-P = 
7.5 Hz, e), 16.46 (d, 3JC-P = 6 Hz, a+a') ppm; 
11B NMR (96 MHz) 33.38 ppm; 31P NMR 
(121 MHz) 32.24 ppm; IR (neat) 2976 (aromatic C-H), 2866 (aliphatic C-H), 1454, 1370, 
1316, 1240 (P=O), 1098 (B-O), 1053 (C-O), 1025 (C-O), 954 (P-O) cm-1; Enantiomer ratio 
was determined by chiral HPLC analysis of the tertiary alcohol derivative 40k. 
 
Synthesis of the tertiary boronic ester (R)-38l: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37l (89 mg, 0.25 mmol) yields tertiary boronic ester (R)-38l (98 mg, 81%) as a 
colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +2.2o (c = 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.36-7.25 (5H, m, aryl), 4.74 (2H, s, l), 4.59 (2H, 
s, k), 4.13-3.98 (4H, m, b+b'), 3.56 (2H, t, J = 6.4 Hz, h), 2.03-1.38 (6H, m, c+f+g), 1.33-
1.25 (18H, m, a+a'+j), 1.13 (3H, s, e) ppm; 13C NMR (75 MHz, CDCl3) δ 137.97 (aryl), 
128.39 (aryl), 127.86 (aryl), 127.63 (aryl), 94.48 (k), 83.46 (i), 69.20 (l), 68.58 (h), 61.10-
60.83 (m, b+b'), 36.22 (d, 3JC-P = 15 Hz, f), 34.09 (d, 
1JC-P = 137.25 Hz, c), 25.49 (g), 24.91 
(j), 22.01 (d, 3JC-P = 6.75 Hz, e), 16.47 (d, 
3JC-P = 6 Hz, a+a') ppm; 
11B NMR (96 MHz) 
33.33 ppm; 31P NMR (121 MHz) 32.21 ppm; IR (neat) 2976 (aromatic C-H), 2929 
(aliphatic C-H), 1468, 1371, 1316, 1241 (P=O), 1144 (B-O), 1025 (C-O), 953 (P-O) cm-1; 
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Enantiomer ratio was determined by chiral HPLC analysis of the tertiary alcohol derivative 
40l.  
 
Synthesis of the tertiary boronic ester (2R,5S)-38m: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (2E,5S)-37m (77 mg, 0.25 mmol) yielded tertiary boronic ester (2R,5S)-4m (89 mg, 
82%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +1.4o 
(c = 1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 4.10-4.02 (6H, m, b+b'+k/h), 3.53-3.50 
(1H, m, k/h), 1.97-1.93 (1H, m, c), 1.76-1.71 (1H, m, c), 1.66-1.60 (2H, m, g), 1.51-1.49 
(1H, m, f), 1.40 (3H, s, m or m'), 1.34 (3H, s, m or m'), 1.32-1.30 (6H, m, a+a'), 1.26 (13H, 
s, j; 1-H of f overlaps), 1.11 (3H, s, e) ppm; 13C NMR (175 MHz, CDCl3) 108.58 (l), 83.52 
(i), 76.51 (h), 69.46 (k), 61.09-60.92 (m, b+b'), 35.26 (d, 3JC-P = 14 Hz, f), 33.91 (d, 
1JC-P 
= 138.25 Hz, c), 29.45 (g), 26.92 (m or m'), 25.71 (m or m'), 24.91 (j), 22.01 (d, 3JC-P = 
8.75 Hz, e), 16.46 (d, 3JC-P = 5.25 Hz, a+a') ppm;
 11B NMR (128 MHz) δ 35.80 ppm; 31P 
NMR (162 MHz) δ 32.03 ppm; IR (neat) 2978 (C-H), 1466, 1370, 1240 (P=O), 1144 (B-
O), 1053 (C-O), 1025 (C-O), 954 (P-O) cm-1; Diastereomer ratio (dr) was determined by 
31P-NMR analysis of the tertiary alcohol derivative (2S,5S)-38m.  
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Synthesis of the tertiary boronic ester (2S,5S)-38m: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the phosphonate functionalized 
alkene (2E,5S)-37m (77 mg, 0.25 mmol) yielded tertiary boronic ester (2S,5S)-38m (88 
mg, 81%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = 
+1.1o (c = 1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 4.07-3.99 (6H, m, b+b'+k/h), 3.52-
3.50 (1H, m, k/h), 1.95-1.90 (1H, m, c), 1.74-1.67 (1H, m, c), 1.49-1.41 (5H, m, f+g+h), 
1.37 (3H, s, m or m'), 1.32 (3H, s, m or m'), 1.30-1.23 (6H, m, a+a'), 1.23 (13H, s, j; 1-H 
of f overlaps), 1.09 (3H, s, e) ppm; 13C NMR (175 MHz, CDCl3) 108.54 (l), 83.49 (i), 76.51 
(h), 69.45 (k), 61.07-60.87 (m, b+b'), 35.37 (d, 3JC-P = 14 Hz, f), 33.72 (d, 
1JC-P = 136.5 
Hz, c), 29.65 (g), 26.91 (m or m'), 25.69 (m or m'), 24.88 (j), 22.04 (d, 3JC-P = 7 Hz, e), 
16.47-16.42 (m, a+a') ppm; 11B NMR (128 MHz) 35.80 ppm; 31P NMR (162 MHz) 32.03 
ppm; IR (neat) 2980 (C-H), 1467, 1370, 1241 (P=O), 1144 (B-O), 1053 (C-O), 1025 (C-
O), 954 (P-O) cm-1; Diastereomer ratio (dr) was determined by 31P-NMR analysis of the 
tertiary alcohol derivative (2R,5S)-38m.  
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Synthesis of the tertiary boronic ester (2R,4S)-38n: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (2E,4S)-37n (74 mg, 0.25 mmol) yields tertiary boronic ester (2R,4S)-38n (54 mg, 
51%) as a colorless oil [Note: A higher catalyst loading (3 mol%) and extended reaction 
time (24 hours) was needed to force reaction to completion.]: TLC analysis (7:3 ethyl 
acetate : hexanes) Rf = 0.5; [α]D20 = +1.1o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 
4.23-4.20 (1H, m, g or h), 4.12-4.03 (5H, m, b+b' and g or h), 3.45-3.43 (1H, m, g or h), 
2.00-1.93 (2H, m, c), 1.82-1.79 (1H, m, f), 1.74-1.71 (1H, m, f), 1.38 (3H, s, l or l'), 1.33 
(3H, s, l or l'), 1.33-1.30 (6H, m, a+a'), 1.26 (6H, s, j), 1.25 (6H, s, j), 1.19 (3H, s, e) ppm; 
13C NMR (175 MHz, CDCl3) δ 108.79 (k), 83.70 (i), 73.93 (g), 70.50 (h), 61.26-61.06 (m, 
b+b'), 41.95 (d, 3JC-P = 10.5 Hz, f), 33.17 (d, 
1JC-P = 136.5 Hz, c), 27.29 (l or l'), 26.25 (l or 
l'), 25.16 (j), 24.88 (j), 23.25 (d, 3JC-P = 7 Hz, e), 16.69-16.61 (m, a+a') ppm;
 11B NMR (128 
MHz, CDCl3) δ 35.10 ppm; 31P NMR (162 MHz, CDCl3) δ 32.29 (Minor diastereomer; 
9.4%), 32.11 (Major diastereomer; 90.6%); IR (neat) 2982 (C-H), 1518, 1474, 1371, 1265 
(P=O), 1143 (B-O), 1054 (C-O), 1026 (C-O), 965 (P-O), 733 cm-1; HRMS (ESI) calculated 
for C19H38BO7P+Na
+ 443.2346, found 443.2362 m/z. 
 
Synthesis of the tertiary boronic ester (R)-38o: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene (E)-37o (69 mg, 0.25 mmol) yielded tertiary boronic ester (R)-38o (53 mg, 52%) as 
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a colorless oil [Note: A higher catalyst loading (3 mol%) and extended reaction time (24 
hours) was needed to force reaction to completion.]: TLC analysis (ethyl-acetate/hexanes 
4:6) Rf = 0.5; [α]D20 = +1.1o (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ 4.16-4.03 
(4H, m, b+b'), 2.05-1.94 (1H, m, c), 1.75-0.91 (35H, m, overlapping 
a+a'+c(1H)+e+f+g+h+j+k+l) ppm; 31C NMR (75 MHz, CDCl3) δ 83.42 (i), 61.07-60.71 
(m, b+b'), 47.71 (d, 3JC-P = 15 Hz, f), 35.08 (h), 34.43 (d, 
1JC-P = 135.75 Hz, c), 34.93 (g), 
26.44 (k), 26.29 (l), 25.03 (j), 24.95 (j), 22.31 (d, 3JC-P = 4.5 Hz, e), 16.50-16.42 (m, a+a') 
ppm; 11B NMR (96 MHz, CDCl3) δ 34.32 ppm; 31P NMR (121 MHz, CDCl3) δ 32.37 ppm; 
IR (neat) 2921 (C-H), 1488, 1371, 1315, 1242 (P=O), 1142 (B-O), 1054 (C-O), 1026 (C-
O), 953 (P-O), 833 cm-1; The enantiomer ratio was determined by chiral HPLC analysis of 
the furan coupled derivative 73o.  
 
Synthesis of the tertiary boronic ester (R)-38p: Following the general procedure for 
catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the phosphonate functionalized 
alkene 37p (71 mg, 0.25 mmol) yielded tertiary boronic ester (R)-38p (55 mg, 53%) as a 
viscous light yellow oil: TLC analysis (ethyl-acetate:hexanes 4:6) Rf = 0.5; [α]D20 = +3.5o 
(c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.30-7.14 (5H, m, aryl), 4.15-4.05 (4H, 
m, b+b'), 2.68-2.53 (2H, m, g), 2.11-2.00 (1H, m, c), 1.86-1.63 (3H, m, c+f), 1.35-1.30 
(18H, m, a+a'+j), 1.22 (3H, s, e) ppm; 13C NMR (75 MHz, CDCl3) δ 143.03 (aryl), 128.35 
(aryl), 128.28 (aryl), 125.60 (aryl), 83.55 (i), 61.17-60.88 (m, b+b'), 42.32 (d, 3JC-P = 15 
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Hz, f), 34.04 (d, 1JC-P = 137.25 Hz, c), 31.90 (g), 24.98 (j), 22.04 (d, 
3JC-P = 6.75 Hz, e), 
16.50 (d, 3JC-P = 6 Hz, a+a') ppm; 
11B NMR (96 MHz) δ 34.02 ppm; 31P NMR (121 MHz) 
δ 32.20 ppm; IR (neat) 3025 (aliphatic C-H), 2977 (aliphatic C-H), 2227, 1604, 1371, 1241 
(P=O), 1053 (C-O), 1025 (C-O), 954, 730 cm-1; Enantiomer ratio was determined by chiral 
HPLC analysis of the tertiary alcohol derivative 40p. 
 
Synthesis of chiral tertiary benzylic boronic ester (R)-42a: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (E)-
41a (54 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (R)-42a (60 mg, 
82%) as a colorless liquid: TLC analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +6.0o 
(c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.36-7.11 (10H, m, aryl), 4.05-3.84 (4H, 
m, b+b'), 2.65-2.53 (2H, m, g), 2.40 (2H, d, J = 18.0 Hz, c), 2.27-2.12 (2H, m, e), 1.56-
1.49 (1H, m, f(1H)), 1.45-1.34 (1H, m, f(1H)), 1.27-1.21 (18H, m, a+a') ppm; 13C NMR 
(100 MHz, CDCl3) δ 144.33 (d, 3JC-P = 15 Hz, n), 142.91 (h), 128.48 (aryl), 128.29 (aryl), 
128.25 (aryl), 127.16 (aryl), 125.65 (aryl), 125.57 (aryl), 83.86 (l), 61.32 (d, 2JC-P = 6.0 Hz, 
b or b'), 60.81 (d, 2JC-P = 7.0 Hz, b or b'), 36.70 (g), 35.14 (d, 
3JC-P = 6.0 Hz, e), 31.11 (d, 
1JC-P = 139 Hz, c), 26.58 (f), 24.87 (m or m'), 24.84 (m or m'), 16.58 (d, 
3JC-P = 6.0 Hz, a 
or a'), 16.54 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 32.54 (br s) 
ppm; 31P NMR (162 MHz, CDCl3) δ 32.13; IR (neat) 2983 (aromatic C-H), 2932 (aliphatic 
C-H), 1618, 1373 (aromatic C=C), 1327 (aromatic C=C), 1239 (P=O), 1055 (C-O), 1024 
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(C-O), 957 (P-O) cm-1; The enantiomer ratio of this boronic ester is determined after 
oxidation to the chiral tertiary alcohol 43a.  
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42b: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (R,R)-T2, the substrate (Z)-
41b (56 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42b (62 
mg, 82%) as a colorless viscous liquid. Alternatively, following GP4 using (R,R)-T2, the 
diastereomeric substrate (E)-41b (56 mg, 0.15 mmol) yields the tertiary benzylic boronic 
ester product (2S,5S)-42b  (61 mg, 81%) as a colorless viscous liquid. TLC analysis (ethyl 
acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +2.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.13 (1H, dd, J = 5.0, 1.3 Hz, p), 6.93-6.90 (2H, m, n+o), 4.06-3.87 (6H, m, 
b+b'+g+h(1H)), 3.48-3.43 (1H, m, h(1H)), 2.42 (1H, dd, J = 18.0, 15.0 Hz, c), 2.34 (1H, 
dd, J = 18.0, 15.0 Hz, c), 2.15 (1H, ddd, J = 18.0, 13.5, 4.5 Hz, e(1H)), 1.96 (1H, ddd, J = 
18.0, 13.5, 4.5 Hz, e(1H)), 1.69-1.61 (1H, m, f(1H)), 1.39-1.30 (1H, m, f(1H)), 1.35 (3H, 
s, j or j'), 1.32 (3H, s, j or j'), 1.29-1.22 (18H, m, a+a'+l+l') ppm; 13C NMR (100 MHz, 
CDCl3) δ 149.73 (d, 3JC-P = 18 Hz, m), 126.76 (n or o), 124.41 (n or o), 123.30 (p), 108.66 
(i), 84.24 (k), 76.55 (g), 69.67 (h), 61.55 (d, 2JC-P = 6.0 Hz, b or b'), 61.14 (d, 
2JC-P = 7.0 
Hz, b or b'), 33.74 (d, 2JC-P = 7.0 Hz, e), 33.20 (d, 
1JC-P = 140 Hz, c), 28.72 (f), 27.04 (j or 
j'), 25.84 (j or j'), 24.93 (l or l'), 24.91 (l or l'), 16.56 (d, 3JC-P = 7.0 Hz, a+a') ppm; 
11B NMR 
(128 MHz, CDCl3) δ 34.01 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.31 ppm; IR (neat) 
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2979 (aromatic C-H), 2933 (aliphatic C-H), 1369 (aromatic C=C), 1326 (aromatic C=C), 
1239 (P=O), 1142, 1052 (C-O), 1024 (C-O/C=S), 956 (P-O), 833, 692 cm-1; The 
enantiomer ratio of this boronic ester is determined after oxidation to the chiral tertiary 
alcohol (2R,5S)-43b. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42b: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the substrate (Z)-
41b (56 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42b (61 
mg, 81%) as a colorless viscous liquid. Alternatively, following GP4 with (S,S)-T2, the 
diastereomeric substrate (E)-41b (56 mg, 0.15 mmol) yields the tertiary benzylic boronic 
ester product (2R,5S)-42b (60 mg, 79%) as a colorless viscous liquid.: TLC analysis (ethyl 
acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +6.0o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.13 (1H, dd, J = 5.0, 1.0 Hz, p), 6.95 (1H, dd, J = 3.5, 1.0 Hz, o), 6.91 (1H, dd, J = 5.0, 
3.5 Hz, n), 4.07-3.86 (6H, m, b+b'+g+h(1H)), 3.52-3.43 (1H, m, h(1H)), 2.42 (1H, dd, J = 
18.0, 15.0 Hz, c), 2.34 (1H, dd, J = 18.0, 15.0 Hz, c), 2.16 (1H, ddd, J = 17.0, 13.0, 4.0 Hz, 
e(1H)), 1.93 (1H, ddd, J = 18.0, 13.5, 4.5 Hz, e(1H)), 1.58-1.41 (2H, m, f), 1.35 (3H, s, j 
or j'), 1.32 (3H, s, j or j'), 1.30-1.22 (18H, m, a+a'+l+l') ppm; 13C NMR (100 MHz, CDCl3) 
δ 149.56 (d, 3JC-P = 18 Hz, m), 126.78 (n), 124.66 (o), 123.26 (p), 108.67 (i), 84.23 (k), 
76.60 (g), 69.59 (h), 61.60 (d, 2JC-P = 6.0 Hz, b or b'), 61.11 (d, 
2JC-P = 7.0 Hz, b or b'), 
33.89 (d, 2JC-P = 7.0 Hz, e), 33.44 (d, 
1JC-P = 140 Hz, c), 28.86 (f), 27.08 (j or j'), 25.87 (j 
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or j'), 24.95 (l or l'), 24.88 (l or l'), 16.55 (d, 3JC-P = 7.0 Hz, a+a') ppm; 
11B NMR (128 MHz, 
CDCl3) δ 32.59 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.32 ppm; IR (neat) 2978 
(aromatic C-H), 2933 (aliphatic C-H), 1369 (aromatic C=C), 1326 (aromatic C=C), 1240 
(P=O), 1142, 1051 (C-O), 1024 (C-O/C=S), 959 (P-O), 833, 693 cm-1; The enantiomer 
ratio of this boronic ester is determined after oxidation to the chiral tertiary alcohol (2S,5S)-
43a.  
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42c: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (E)-
41c (55 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42c (60 
mg, 80%; 91:9 dr, determined via 31P NMR analysis) as a colorless viscous liquid. 
Alternatively, following GP4 with (R,R)-T2, the diastereomeric substrate (Z)-41c (55 mg, 
0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42c  (62 mg, 83%; 
96:4 dr, determined via 31P NMR analysis) as a colorless viscous liquid. Characterization 
data for (2R,5S)-42c: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +10.8o (c 
= 1.0, CHCl3); 
1H NMR (700 MHz, C6D6) δ 7.42 (2H, d, J = 7.5 Hz, n), 7.17 (2H, t, J = 
7.5 Hz, o), 7.02 (1H, t, J = 7.5 Hz, p), 3.97-3.83 (5H, m, b+b'+g), 3.68 (1H, dd, J = 7.5, 6.0 
Hz, h(1H)), 3.30 (1H, t, J = 7.5 Hz, h(1H)), 2.62-2.26 (4H, m, c+e), 1.75-1.70 (1H, m, f), 
1.33 (j or j'), 1.33-1.28 (1H, m, f(1H)), 1.27 (3H, s, j or j'), 1.16 (6H, s, l or l'), 1.13 (6H, s, 
l or l'), 1.08-1.06 (6H, m, a+a') ppm; 13C NMR (175 MHz, C6D6) δ 145.37 (d, 3JC-P = 18 
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Hz, m), 128.87 (o), 127.79 (n), 126.19 (p), 108.86 (i), 84.23 (k), 77.34 (g), 70.13 (h), 61.47 
(d, 2JC-P = 6.0 Hz, b or b'), 61.10 (d, 
2JC-P = 6.5 Hz, b or b'), 32.80 (d, 
3JC-P = 5.0 Hz, e), 
31.45 (d, 1JC-P = 140 Hz, c), 28.79 (f), 27.55 (j or j'), 26.31 (j or j'), 25.46 (l or l'), 25.27 (l 
or l'), 16.91 (d, 3JC-P = 6.0 Hz, a or a'), 16.85 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 
MHz, C6D6) δ 33.02 (br s) ppm; 31P NMR (283 MHz, C6D6) δ 32.30 (4%; minor 
diastereomer), 32.18 (96%; major diastereomer) ppm; IR (neat) 2979 (aromatic C-H), 2934 
(aliphatic C-H), 1369 (aromatic C=C), 1320 (aromatic C=C), 1241 (P=O), 1143, 1052 (C-
O), 1025 (C-O), 954 (P-O) cm-1; HRMS (EI) calculated for C25H42BO7P = 496.2761, found 
496.2780 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42c: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (S,S)-T2, the substrate (E)-
41c (55 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42c (58 
mg, 78%; 85:15 dr, determined via 31P NMR analysis) as a colorless viscous liquid. 
Alternatively, following GP4 with (S,S)-T2, the diastereomeric substrate (Z)-41c (55 mg, 
0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42c (63 mg, 84%; 
97:3 dr, determined via 31P NMR analysis) as a colorless viscous liquid. Characterization 
data for (2S,5S)-42c: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +6.5o (c = 
1.0, CHCl3); 
1H NMR (700 MHz, C6D6) δ 7.45 (2H, d, J = 8.0 Hz, n), 7.17 (2H, dd, J = 
8.0, 7.5 Hz, o), 7.02 (1H, t, J = 7.5 Hz, p), 3.96-3.82 (5H, m, b+b'+g), 3.75 (1H, dd, J = 
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7.5, 6.0 Hz, h(1H)), 3.40 (1H, t, J = 7.5 Hz, h(1H)), 2.62-2.25 (4H, m, c+e), 1.55-1.44 (2H, 
m, f), 1.35 (j or j'), 1.28 (3H, s, j or j'), 1.16 (6H, s, l or l'), 1.12 (6H, s, l or l'), 1.07-1.02 
(6H, m, a+a') ppm; 13C NMR (175 MHz, C6D6) δ 145.09 (d, 3JC-P = 17 Hz, m), 128.83 (o), 
127.91 (n), 126.18 (p), 108.86 (i), 84.22 (k), 77.22 (g), 69.94 (h), 61.61 (d, 2JC-P = 6.0 Hz, 
b or b'), 61.00 (d, 2JC-P = 6.5 Hz, b or b'), 32.68 (d, 
3JC-P = 6.0 Hz, e), 31.70 (d, 
1JC-P = 140 
Hz, c), 29.03 (f), 27.66 (j or j'), 26.36 (j or j'), 25.39 (l or l'), 25.30 (l or l'), 16.90 (d, 3JC-P 
= 6.0 Hz, a or a'), 16.80 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, C6D6) δ 32.71 
(br s) ppm; 31P NMR (283 MHz, C6D6) δ 32.30 (97%; major diastereomer), 32.18 (3%; 
major diastereomer) ppm; IR (neat) 2979 (aromatic C-H), 2933 (aliphatic C-H), 1369 
(aromatic C=C), 1320 (aromatic C=C), 1240 (P=O), 1143, 1051 (C-O), 1024 (C-O), 954 
(P-O) cm-1; HRMS (EI) calculated for C25H42BO7P = 496.2761, found 496.2781 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (R)-42d: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (R,R)-T2, the substrate (E)-
41d (50 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (R)-42d (41 mg, 
60%) as a colorless liquid. Alternatively, following GP4 with (R,R)-T2, the diastereomeric 
substrate (Z)-41d (50 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product 
(R)-42d (49 mg, 71%). Characterization data of (R)-42d: TLC analysis (ethyl 
acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +55o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.34-7.26 (4H, m, aryl), 7.19-7.10 (6H, m, aryl), 7.08-3.71 (4H, m, b+b'), 3.48 (1H, dd, 
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J = 71, 14 Hz, e), 2.43-2.20 (2H, m, c), 1.29-1.16 (18H, m, a+a') ppm; 13C NMR (100 MHz, 
CDCl3) δ 144.00 (d, 3JC-P = 13.0 Hz, l), 139.06 (f), 130.95 (aryl), 128.20 (aryl), 127.64 
(aryl), 127.59 (aryl), 126.02 (aryl), 125.84 (aryl), 84.12 (j), 61.23 (d, 2JC-P = 6.0 Hz, b or 
b'), 60.95 (d, 2JC-P = 7.0 Hz, b or b'), 40.52 (d, 
3JC-P = 3.75 Hz, e), 30.12 (d, 
1JC-P = 140 Hz, 
c), 25.05 (k or k'), 24.99 (k or k'), 16.57 (d, 3JC-P = 6.0 Hz, a or a'), 16.42 (d, 
3JC-P = 6.5 Hz, 
a or a') ppm; 11B NMR (128 MHz, CDCl3) δ 33.54 ppm; 31P NMR (162 MHz, CDCl3) δ 
31.81; IR (neat) 2978 (aromatic C-H), 2930 (aliphatic C-H), 1497 (aromatic C=C), 1379 
(aromatic C=C), 1371 (aromatic C=C), 1321 (aromatic C=C), 1241 (P=O), 1051 (C-O), 
1027 (C-O), 956 (P-O), 701 cm-1; The enantiomer ratio of this boronic ester is determined 
after oxidation to the chiral tertiary alcohol 43d. 
 
Synthesis of chiral tertiary benzylic boronic ester (S)-42e: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (Z)-
41e (56 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (S)-42e (63 mg, 
85%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 
= -8.2o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.28-7.23 (2H, m, aryl), 7.18-7.13 
(4H, m, aryl), 6.95 (1H, dd, J = 3.5, 1.0 Hz, o), 6.92 (1H, dd, J = 5.0, 3.5 Hz, n), 4.08-3.84 
(4H, m, b+b'), 2.66-2.54 (2H, m, g), 2.42 (1H, dd, J = 18.0, 15.0 Hz, c), 2.37 (1H, dd, J = 
18.0, 15.0 Hz, c), 2.18-2.07 (2H, m, e), 1.67-1.44 (2H, m, f), 1.30-1.23 (18H, m, a+a'+l+l') 
ppm; 13C NMR (100 MHz, CDCl3) δ  150.12 (d, 3JC-P = 17 Hz, m), 142.83 (h), 128.53 
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(aryl), 128.35 (aryl), 126.70 (n), 125.73 (aryl), 124.43 (o), 123.09 (aryl), 84.15 (k), 61.48 
(d, 2JC-P = 6.0 Hz, b or b'), 61.02 (d, 
2JC-P = 7.0 Hz, b or b'), 37.87 (d, 
3JC-P = 8.0 Hz, e), 
36.60 (g), 33.61 (d, 1JC-P = 140 Hz, c), 26.70 (f), 24.94 (l or l'), 24.90 (l or l'), 16.63 (d, 
3JC-
P = 7.0 Hz, a or a'), 16.56 (d, 
3JC-P = 6.5 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 
33.83 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 30.58 ppm; IR (neat) 2976 (aromatic C-
H), 2933 (aliphatic C-H), 1371 (aromatic C=C), 1324 (aromatic C=C), 1241 (P=O), 1142, 
1051 (C-O), 1024 (C-O/C=S), 958 (P-O), 696 cm-1; The enantiomer ratio of this boronic 
ester is determined after oxidation to the chiral tertiary alcohol (R)-43e. 
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42f: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2 (Note: 2 mol% 
catalyst loading was used), the substrate (Z)-41f (58 mg, 0.15 mmol) yields the tertiary 
benzylic boronic ester product (2S,5S)-42f (42 mg, 55%) as a colorless viscous liquid 
(Note: 2 mol% catalyst loading used. Even when higher catalyst loading is used, the 
reactions with this substrate did not proceed to complete consumption of substrate, perhaps 
due to the presence of three chelating sites leading to catalyst inactivation): TLC analysis 
(ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +9.1o (c = 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.14 (1H, dd, J = 5.0, 1.0 Hz, s), 7.00 (1H, dd, J = 3.5, 1.0 Hz, r), 6.92 (1H, dd, 
J = 5.0, 3.5 Hz, q), 5.09-5.06 (1H, m, k), 4.07-3.78 (4H, m, b+b'), 2.45-2.32 (2H, m, c), 
2.11-1.87 (4H, m, e+j), 1.68 (3H, s, m or m'), 1.58 (3H, s, m or m'), 1.44-1.20 (21H, 
a+a'+f+g+o+o'), 1.14-0.94 (2H, m, i), 0.87 (3H, d, J = 6.5 Hz, h) ppm; 13C NMR (100 MHz, 
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CDCl3) δ  150.34 (d, 3JC-P = 15 Hz, p), 131.07 (l), 126.63 (q), 125.24 (k), 124.70 (r), 123.02 
(s), 84.12 (n), 61.38 (d, 2JC-P = 6.0 Hz, b or b'), 61.03 (d, 
2JC-P = 7.0 Hz, b or b'), 37.33,  
35.91 (d, 3JC-P = 8.5 Hz, e) , 34.11 (d, 
1JC-P = 140 Hz, c), 33.15, 31.86, 25.90 (m or m'), 
25.81, 25.01 (o or o'), 24.94 (o or o'), 19.71 (h), 17.83 (m or m'), 16.58 (d, 2JC-P = 6.0 Hz, 
a or a'), 16.55 (d, 2JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 33.81 (br s) 
ppm; 31P NMR (162 MHz, CDCl3) δ 30.71 (92%; major diastereomer), 30.67 (8%; minor 
diastereomer) ppm; IR (neat) 2977 (aromatic C-H), 2933 (aliphatic C-H), 1373 (aromatic 
C=C), 1325 (aromatic C=C), 1239 (P=O), 1143, 1053 (C-O), 1025 (C-O/C=S), 958 (P-O) 
cm-1; HRMS (EI) calculated for C26H46BO5PS = 512.2897, found 512.2907  m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42f: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (S,S)-T2 (Note: 2 mol% 
catalyst loading was used), the substrate (Z)-41f (58 mg, 0.15 mmol) yields the tertiary 
benzylic boronic ester product (2R,5S)-42f (44 mg, 58%) as a colorless viscous liquid: TLC 
analysis (ethyl acetate/hexanes 1:2) Rf = 0.5; [α]D20 = +6.1o (c = 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.13 (1H, dd, J = 5.0, 1.0 Hz, s), 7.00 (1H, dd, J = 3.5, 1.0 Hz, r), 6.92 (1H, 
dd, J = 5.0, 3.5 Hz, q), 5.07 (1H, t, J = 7.0 Hz, k), 4.09-3.75 (4H, m, b+b'), 2.45-2.31 (2H, 
m, c), 2.08-1.82 (4H, m, e+j), 1.68 (3H, s, m or m'), 1.58 (3H, s, m or m'), 1.42-1.04 (23H, 
a+a'+f+g+i+o+o'), 0.87 (3H, d, J = 6.5 Hz, h) ppm; 13C NMR (100 MHz, CDCl3) δ  150.34 
(d, 3JC-P = 15 Hz, p), 131.07 (l), 126.63 (q), 125.25 (k), 124.77 (r), 84.12 (n), 61.39 (d, 
2JC-
P = 6.0 Hz, b or b'), 61.02 (d, 
2JC-P = 7.0 Hz, b or b'), 37.13, 36.10 (d, 
3JC-P = 9.0 Hz, e), 
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34.26 (d, 1JC-P = 140 Hz, c), 33.23, 31.79, 25.91, 25.74 (m or m'), 25.03 (o or o'), 24.95 (o 
or o'), 19.85 (h), 17.83 (m or m'), 16.58 (d, 2JC-P = 6.0 Hz, a or a'), 16.55 (d, 
2JC-P = 6.0 Hz, 
a or a') ppm; 11B NMR (128 MHz, CDCl3) δ 34.41 (br s) ppm; 31P NMR (162 MHz, CDCl3) 
δ 30.71 (9%; minor diastereomer), 30.67 (91%; major diastereomer) ppm; IR (neat) 2978 
(aromatic C-H), 2933 (aliphatic C-H), 1373 (aromatic C=C), 1325 (aromatic C=C), 1239 
(P=O), 1143, 1053 (C-O), 1025 (C-O/C=S), 958 (P-O) cm-1; HRMS (EI) calculated for 
C26H46BO5PS = 512.2897, found  512.2900 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42g: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (Z)-
41g (64 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42g (56 
mg, 68%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +11.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.62-7.60 (2H, m, p+s), 
7.26 (1H, s, n), 7.21-7.19 (1H, m, q or r), 7.10-7.07 (1H, m, q or r), 4.10-3.91 (5H, m, 
b+b'+g), 3.84-3.79 (1H, m, h(1H)), 3.51-3.43 (1H, m, h(1H)), 2.79-2.68 (2H, m, 
c(1H)+e(1H)), 2.58-2.54 (1H, m, c(1H)), 2.49-2.44 (1H, m, e(1H)), 1.96-1.91 (1H, m, 
f(1H)), 1.64-1.59 (1H, m, f(1H)), 1.43 (3H, s, j or j'), 1.37 (3H, s, j or j'), 1.30 (6H, s, l or 
l'), 1.25 (6H, s, l or l'), 1.15 (3H, t, J = 7.0 Hz, a or a'), 1.09 (3H, t, J = 7.0 Hz, a or a') ppm; 
13C NMR (175 MHz, C6D6) δ 152.07 (d, 3JC-P = 20 Hz, m), 141.01 (o or t), 140.07 (o or t), 
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124.71 (q or r), 124.25 (q or r), 123.62 (p or s), 122.70 (p or s), 121.79 (n), 109.98 (i), 84.73 
(k), 77.20 (g), 70.05 (h), 61.70 (d, 2JC-P = 6.0 Hz, b or b'), 61.34 (d, 
2JC-P = 6.5 Hz, b or b'), 
34.71 (d, 3JC-P = 6.5 Hz, e), 33.40 (d, 
1JC-P = 141 Hz, c), 28.95 (f), 27.55 (j or j'), 26.25 (j 
or j'), 25.49 (l or l'), 25.38 (l or l'), 16.82 (d, 3JC-P = 6.0 Hz, a or a'), 16.79 (d, 
3JC-P = 5.0 
Hz, a or a') ppm; 11B NMR (128 MHz, C6D6) δ 34.00 (br s) ppm; 31P NMR (283 MHz, 
C6D6) δ 30.55 (92%; major diastereomer), 30.51 (8%; minor diastereomer) ppm; IR (neat) 
2980 (aromatic C-H), 2933 (aliphatic C-H), 1370 (aromatic C=C), 1329 (aromatic C=C), 
1239 (P=O), 1141, 1052 (C-O), 1024 (C-O/C=S), 960 (P-O), 734 cm-1; HRMS (EI) 
calculated for C27H42BO7PS = 552.2482, found  552.2499 m/z.  
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42g: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the substrate (Z)-
41g (64 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42g (57 
mg, 69%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +5.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.63-7.60 (2H, m, p+s), 7.43 
(1H, s, n), 7.20-7.18 (1H, m, q or r), 7.11-7.08 (1H, m, q or r), 4.08-3.94 (4H, m, b+b'), 
3.89-3.80 (2H, m, g+h(1H)), 3.51-3.47 (1H, m, h(1H)), 2.74-2.67 (2H, m, c(1H)+e(1H)), 
2.58-2.52 (1H, m, c(1H)), 2.39-2.35 (1H, m, e(1H)), 1.81-1.72 (2H, m, f), 1.46 (3H, s, j or 
j'), 1.38 (3H, s, j or j'), 1.32 (6H, s, l or l'), 1.26 (6H, s, l or l'), 1.11 (3H, t, J = 7.0 Hz, a or 
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a'), 1.02 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (175 MHz, C6D6) δ 151.79 (d, 3JC-P = 
18 Hz, m), 141.05 (o or t), 140.07 (o or t), 124.65 (q or r), 124.22 (q or r), 123.67 (p or s), 
122.69 (p or s), 122.42 (n), 109.05 (i), 84.71 (k), 77.08 (g), 69.90 (h), 61.74 (d, 2JC-P = 6.0 
Hz, b or b'), 61.20 (d, 2JC-P = 6.0 Hz, b or b'), 35.23 (d, 
3JC-P = 9.0 Hz, e), 34.36 (d, 
1JC-P = 
140 Hz, c), 29.52 (f), 27.65 (j or j'), 26.32 (j or j'), 25.49 (l or l'), 25.46 (l or l'), 16.78 (d, 
3JC-P = 6.0 Hz, a or a'), 16.72 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, C6D6) 
δ 33.96 (br s) ppm; 31P NMR (283 MHz, C6D6) δ 30.55 (8%; minor diastereomer), 30.51 
(92%; major diastereomer) ppm; IR (neat) 2980 (aromatic C-H), 2933 (aliphatic C-H), 
1372 (aromatic C=C), 1333 (aromatic C=C), 1239 (P=O), 1141, 1050 (C-O), 1023 (C-
O/C=S), 958 (P-O), 735 cm-1; HRMS (EI) calculated for C27H42BO7PS = 552.2482, found 
552.2496  m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42h: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (E)-
41h (61 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42h (61 
mg, 76%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +5.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.40-7.36 (2H, m, p+s), 7.07-
7.01 (2H, m, q+r), 6.85 (1H, s, n), 3.93-3.60 (6H, m, b+b'+g+h(1H)), 3.41-3.38 (1H, m, 
h(1H)), 2.63 (1H, dd, J = 15.0, 17.5 Hz, c(1H)), 2.51 (1H, dd, J = 15.0, 17.5 Hz, c(1H)), 
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2.48-2.43 (1H, m, e(1H)), 2.30-2.19 (1H, m, e(1H)), 1.75-1.68 (1H, m, f(1H)), 1.61-1.56 
(1H, m, f(1H)), 1.35 (3H, s, j or j'), 1.26 (3H, s, j or j'), 1.23 (6H, s, l or l'), 1.20 (6H, s, l or 
l'), 0.99 (3H, t, J = 7.0 Hz, a or a'), 0.80 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (175 
MHz, C6D6) δ 161.81 (d, 3JC-P = 14 Hz, m), 155.58 (t), 129.87 (o), 123.95 (q or r), 123.14 
(q or r), 121.19 (p or s), 111.28 (p or s), 109.00 (i), 104.90 (n), 84.70 (k), 76.81 (g), 69.83 
(h), 61.42 (d, 2JC-P = 6.0 Hz, b or b'), 61.32 (d, 
2JC-P = 6.0 Hz, b or b'), 32.68 (d, 
3JC-P = 11 
Hz, e), 32.40 (d, 1JC-P = 140 Hz, c), 30.28 (f), 27.58 (j or j'), 26.23 (j or j'), 25.53 (l or l'), 
25.46 (l or l'), 16.75 (d, 3JC-P = 6.0 Hz, a or a'), 16.52 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
11B 
NMR (128 MHz, C6D6) δ 34.01 (br s) ppm; 31P NMR (283 MHz, C6D6) δ 30.00 (7%; minor 
diastereomer), 29.95 (93%; major diastereomer) ppm; IR (neat) 2980 (aromatic C-H), 2932 
(aliphatic C-H), 1455 (aromatic C=C), 1370 (aromatic C=C), 1242 (P=O), 1141, 1051 (C-
O), 1024 (C-O), 960 (P-O) cm-1; HRMS (EI) calculated for C27H42BO8P = 536.2710, found 
536.2733 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42h: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the substrate (E)-
41h (61 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5R)-42h (59 
mg, 73%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +1.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.41-7.36 (2H, m, p+s), 7.07-
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7.01 (3H, m, n+q+r), 3.92-3.56 (6H, m, b+b'+g+h(1H)), 3.31-3.29 (1H, m, h(1H)), 2.64 
(1H, dd, J = 15.0, 17.5 Hz, c(1H)), 2.53-2.43 (2H, m, c(1H)+e(1H)), 2.23-2.19 (1H, m, 
e(1H)), 1.74-1.66 (1H, m, f(1H)), 1.51-1.66 (1H, m, f(1H)), 1.36 (3H, s, j or j'), 1.27 (9H, 
s, j or j' and l or l'), 1.23 (6H, s, l or l'), 1.00 (3H, t, J = 7.0 Hz, a or a'), 0.72 (3H, t, J = 7.0 
Hz, a or a') ppm; 13C NMR (175 MHz, C6D6) δ 161.32 (d, 3JC-P = 12 Hz, m), 155.58 (t), 
129.92 (o), 123.95 (q or r), 123.13 (q or r), 121.23 (p or s), 111.28 (p or s), 109.03 (i), 
105.61 (n), 84.70 (k), 76.78 (g), 69.93 (h), 61.40 (d, 2JC-P = 6.0 Hz, b or b'), 61.30 (d, 
2JC-P 
= 6.0 Hz, b or b'), 33.78 (d, 3JC-P = 14 Hz, e), 33.29 (d, 
1JC-P = 141 Hz, c), 30.80 (f), 27.61 
(j or j'), 26.28 (j or j'), 25.68 (l or l'), 25.46 (l or l'), 16.76 (d, 3JC-P = 6.0 Hz, a or a'), 16.41 
(d, 3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, C6D6) δ 33.90 (br s) ppm; 31P NMR 
(283 MHz, C6D6) δ 30.00 (80%; major diastereomer), 29.95 (20%; minor diastereomer) 
ppm; IR (neat) 2979 (aromatic C-H), 2933 (aliphatic C-H), 1454 (aromatic C=C), 1370 
(aromatic C=C), 1242 (P=O), 1141, 1052 (C-O), 1024 (C-O), 961 (P-O) cm-1; HRMS (EI) 
calculated for C27H42BO8P = 536.2710, found 536.2696 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42i: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (R,R)-T2, the substrate (E)-
41i (60 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42i (59 
mg, 75%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
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[α]D20 = +22o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.35 (2H, d, J = 8.5 Hz, n), 
6.81 (2H, d, J = 8.5 Hz, o), 4.00-3.87 (5H, m, b+b'+g), 3.73 (1H, dd, J = 7.5, 6.5 Hz, h(1H)), 
3.36 (1H, t, J = 7.5 Hz, h(1H)), 3.31 (3H, s, q), 2.58-2.29 (4H, m, c+e), 1.79-1.73 (1H, m, 
f(1H)), 1.38-1.32 (1H, m, f(1H)), 1.35 (3H, s, j or j'), 1.29 (3H, s, j or j'), 1.19 (6H, s, l or 
l'), 1.15 (6H, s, l or l'), 1.08 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (175 MHz, C6D6) δ 
158.52 (p), 137.02 (d, 3JC-P = 18 Hz, m), 128.74 (n), 114.38 (o), 108.89 (i), 84.19 (k), 77.40 
(g), 70.17 (h), 61.49 (d, 2JC-P = 6.0 Hz, b or b'), 61.13 (d, 
2JC-P = 6.5 Hz, b or b'), 55.04 (q), 
32.90 (d, 3JC-P = 5.0 Hz, e), 31.75 (d, 
1JC-P = 140 Hz, c), 28.81 (f), 27.58 (j or j'), 28.30 (j 
or j'), 25.49 (l or l'), 25.31 (l or l'), 16.92 (d, 3JC-P = 6.0 Hz, a or a'), 16.86 (d, 
3JC-P = 6.0 
Hz, a or a') ppm; 11B NMR (128 MHz, C6D6) δ 34.66 (br s) ppm; 31P NMR (283 MHz, 
C6D6) δ 32.40 (10%; minor diastereomer), 32.29 (90%; major diastereomer) ppm; IR (neat) 
2980 (aromatic C-H), 2934 (aliphatic C-H), 1608, 1510, 1378 (aromatic C=C), 1245 
(P=O), 1142, 1052 (C-O), 1026 (C-O), 955 (P-O), 835, 733 cm-1; HRMS (EI) calculated 
for C26H44BO8P = 526.2867, found 526.2868 m/z.           
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42i: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the substrate (E)-
41i (60 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42i (59 
mg, 75%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
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[α]D20 = +13.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, C6D6) δ 7.38 (2H, d, J = 8.5 Hz, n), 
6.82 (2H, d, J = 8.5 Hz, o), 4.00-3.85 (5H, m, b+b'+g), 3.78 (1H, t, J = 7.5 Hz, h(1H)), 3.43 
(1H, t, J = 7.5 Hz, h(1H)), 3.31 (3H, s, q), 2.61-2.25 (4H, m, c+e), 1.59-1.51 (1H, m, f(1H)), 
1.38 (3H, s, j or j'), 1.30 (3H, s, j or j'), 1.18 (6H, s, l or l'), 1.14 (6H, s, l or l'), 1.07 (3H, t, 
J = 7.0 Hz, a or a'), 1.05 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (175 MHz, C6D6) δ 
158.51 (p), 136.78 (d, 3JC-P = 17.5 Hz, m), 128.88 (n), 114.35 (o), 108.94 (i), 84.17 (k), 
77.31 (g), 70.00 (h), 61.61 (d, 2JC-P = 6.0 Hz, b or b'), 61.00 (d, 
2JC-P = 6.5 Hz, b or b'), 
55.04 (q), 32.82 (d, 3JC-P = 6.0 Hz, e), 31.94 (d, 
1JC-P = 140 Hz, c), 28.97 (f), 27.69 (j or j'), 
26.37 (j or j'), 25.43 (l or l'), 25.35 (l or l'), 16.92 (d, 3JC-P = 5.0 Hz, a or a'), 16.86 (d, 
3JC-P 
= 6.0 Hz, a or a') ppm; 11B NMR (128 MHz, C6D6) δ 34.52 (br s) ppm; 31P NMR (283 MHz, 
C6D6) δ 32.40 (90%; major diastereomer), 32.29 (10%; minor diastereomer) ppm; IR (neat) 
2982 (aromatic C-H), 2937 (aliphatic C-H), 1608, 1510 , 1379 (aromatic C=C), 1246 
(P=O), 1142, 1051 (C-O), 1027 (C-O), 958 (P-O), 835, 732 cm-1; HRMS (EI) calculated 
for C26H44BO8P = 526.2867, found 526.2881 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42j: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (R,R)-T2, the substrate (E)-
41j (60 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42j (50 
mg, 63%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +3.1o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 7.30 (2H, d, J = 8.5 Hz, n 
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or o), 7.27 (2H, d, J = 8.5 Hz, n or o), 4.03-3.88 (6H, m, b+b'+g+h(1H)), 3.42-3.40 (1H, 
m, h(1H)), 2.37-2.28 (2H, m, c), 2.22-2.15 (1H, m, e(1H)), 2.01-1.94 (1H, m, e(1H)), 1.58-
1.53 (1H, m, f(1H)), 1.38-1.32 (7H, m, f(1H)+j+j'), 1.28-1.20 (18H, m, a+a'+l+l') ppm; 13C 
NMR (175 MHz, CDCl3) δ 142.70 (d, 3JC-P = 14.0 Hz, m), 131.62 (p), 128.77 (n or o), 
128.46 (n or o), 108.74 (i), 84.19 (k), 76.56 (g), 69.71 (h), 61.48 (d, 2JC-P = 6.0 Hz, b or b'), 
61.12 (d, 2JC-P = 6.5 Hz, b or b'), 31.55 (d, 
3JC-P = 6.5 Hz, e), 31.36 (d, 
1JC-P = 140 Hz, c), 
28.91 (f), 27.07 (j or j'), 25.86 (j or j'), 24.94 (l+l'), 16.55 (d, 3JC-P = 6.0 Hz, a or a'), 16.54 
(d, 3JC-P = 6.0 Hz, a or a') ppm; 
11B NMR (128 MHz, CDCl3) δ 34.02 (br s) ppm; 31P NMR 
(283 MHz, CDCl3) δ 31.35 (17%; minor diastereomer), 31.16 (83%; major diastereomer) 
ppm; IR (neat) 2979 (aromatic C-H), 2935 (aliphatic C-H), 1492, 1510, 1369 (aromatic 
C=C), 1325 (aromatic C=C), 1240 (P=O), 1142, 1052 (C-O), 1026 (C-O), 958 (P-O), 836, 
729 (C-Cl) cm-1; HRMS (EI) calculated for C25H41BClO7P = 530.2372, found 530.2391 
m/z.  
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42j: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (S,S)-T2, the substrate (E)-
41j (60 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42j (48 
mg, 60%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +2.0o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 7.31 (2H, d, J = 8.5 Hz, n 
or o), 7.27 (2H, d, J = 8.5 Hz, n or o), 4.08-3.89 (6H, m, b+b'+g+h(1H)), 3.50-3.48 (1H, 
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m, h(1H)), 2.44-2.28 (2H, m, c), 2.22-2.15 (1H, m, e(1H)), 2.02-1.95 (1H, m, e(1H)), 1.39-
1.31 (8H, m, f+j+j'), 1.28-1.20 (18H, m, a+a'+l+l') ppm; 13C NMR (175 MHz, CDCl3) δ 
142.55 (d, 3JC-P = 15.0 Hz, m), 131.63 (p), 128.77 (n or o), 128.46 (n or o), 108.73 (i), 
84.18 (k), 76.59 (g), 69.61 (h), 61.61 (d, 2JC-P = 6.0 Hz, b or b'), 61.10 (d, 
2JC-P = 7.0 Hz, b 
or b'), 31.47 (d, 3JC-P = 6.0 Hz, e), 31.17 (d, 
1JC-P = 140 Hz, c), 28.78 (f), 27.11 (j or j'), 
25.88 (j or j'), 24.94 (l or l'), 24.92 (l or l'), 16.59 (d, 3JC-P = 6.0 Hz, a or a'), 16.56 (d, 
3JC-P 
= 5.0 Hz, a or a') ppm; 11B NMR (128 MHz, CDCl3) δ 33.56 (br s) ppm; 31P NMR (283 
MHz, CDCl3) δ 31.35 (83%; major diastereomer), 31.16 (17%; minor diastereomer) ppm; 
IR (neat) 2979 (aromatic C-H), 2934 (aliphatic C-H), 1491, 1511, 1369 (aromatic C=C), 
1324 (aromatic C=C), 1242 (P=O), 1141, 1052 (C-O), 1028 (C-O), 959 (P-O), 836, 732 
(C-Cl) cm-1; HRMS (EI) calculated for C25H41BClO7P = 530.2372, found 530.2393 m/z. 
 
Synthesis of chiral tertiary benzylic boronic ester (2R,5S)-42k: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) with (R,R)-T2, the substrate (E)-
41k (65 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2R,5S)-42k (57 
mg, 56%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +4.9o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.56 (2H, d, J = 8.5 Hz, o), 
7.50 (2H, d, J = 8.5 Hz, n), 4.06-3.83 (6H, m, b+b'+g+h(1H)), 3.46-3.41 (1H, m, h(1H)), 
2.43-2.30 (2H, m, c), 2.26-2.18 (1H, m, e(1H)), 2.09-1.98 (1H, m, e(1H)), 1.59-1.49 (1H, 
m, f(1H)), 1.40-1.30 (7H, m, h(1H)+j+j'), 1.29-1.19 (18H, m, a+a'+l+l') ppm; 13C NMR 
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(100 MHz, CDCl3) δ 148.52 (d, 3JC-P = 12.0 Hz, m), 129.13 (q, 2JC-F = 32.0 Hz, p), 127.82 
(n), 125.23 (q, 3JC-F = 3.75 Hz, o), 124.54 (q, 
1JC-F = 272 Hz, CF3), 108.79 (i), 84.33 (k), 
76.49 (g), 69.68 (h), 61.46 (d, 2JC-P = 6.0 Hz, b or b'), 61.15 (d, 
2JC-P = 7.0 Hz, b or b'), 
31.68 (d, 1JC-P = 140 Hz, c), 31.68 (d, 
3JC-P = 7.0 Hz, e), 29.11 (f), 27.06 (j or j'), 25.85 (j 
or j'), 24.96 (l or l'), 24.95 (l or l'), 16.48 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
11B NMR (128 MHz, 
CDCl3) δ 34.71 (br s) ppm; 31P NMR (162 MHz, CDCl3) δ 31.00 (13%; minor 
diastereomer), 30.75 (87%; major diastereomer) ppm; 19F NMR (282 MHz, CDCl3) δ -
62.37 (85%; major diastereomer), -62.39 (15%; minor diastereomer) ppm; IR (neat) 2982 
(aromatic C-H), 2932 (aliphatic C-H), 1617, 1370 (aromatic C=C), 1326 (aromatic C=C/C-
F), 1240 (P=O), 1120, 1051 (C-O), 1025 (C-O), 959 (P-O), 844, 735, 678 cm-1; HRMS 
(EI) calculated for C26H41BF3O7P = 564.2635, found 564.2654 m/z.   
 
Synthesis of chiral tertiary benzylic boronic ester (2S,5S)-42k: Following the general 
procedure for catalytic asymmetric hydroboration (GP4) using (S,S)-T2, the substrate (E)-
41k (65 mg, 0.15 mmol) yields the tertiary benzylic boronic ester product (2S,5S)-42k (58 
mg, 57%) as a colorless viscous liquid: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +2.9o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 (2H, d, J = 8.5 Hz, o), 
7.50 (2H, d, J = 8.5 Hz, n), 4.06-3.85 (6H, m, b+b'+g+h(1H)), 3.52-3.45 (1H, m, h(1H)), 
2.43-2.35 (2H, m, c), 2.31-2.19 (1H, m, e(1H)), 2.09-1.98 (1H, m, e(1H)), 1.43-1.32 (8H, 
m, h+j+j'), 1.26-1.15 (18H, m, a+a'+l+l') ppm; 13C NMR (100 MHz, CDCl3) δ 148.38 (d, 
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3JC-P = 15.0 Hz, m), 129.12 (q, 
2JC-F = 32.0 Hz, p), 127.77 (n), 125.24 (q, 
3JC-F = 3.75 Hz, 
o), 124.88 (q, 1JC-F = 272 Hz, CF3), 108.78 (i), 84.31 (k), 76.49 (g), 69.55 (h), 61.60 (d, 
2JC-P = 6.0 Hz, b or b'), 61.14 (d, 
2JC-P = 7.0 Hz, b or b'), 31.61 (d, 
1JC-P = 140 Hz, c), 31.38 
(d, 3JC-P = 7.0 Hz, e), 28.92 (f), 27.08 (j or j'), 25.84 (j or j'), 24.95 (l or l'), 24.91 (l or l'), 
16.41 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
11B NMR (128 MHz, CDCl3) δ 34.73 (br s) ppm; 31P 
NMR (162 MHz, CDCl3) δ 31.00 (85%; major diastereomer), 30.75 (15%; minor 
diastereomer) ppm; 19F NMR (282 MHz, CDCl3) δ -62.37 (17%; minor diastereomer), -
62.39 (83%; major diastereomer) ppm; IR (neat) 2983 (aromatic C-H), 2932 (aliphatic C-
H), 1618, 1369 (aromatic C=C), 1325 (aromatic C=C/C-F), 1241 (P=O), 1122, 1053 (C-
O), 1025 (C-O), 958 (P-O), 845, 736, 681 cm-1; HRMS (EI) calculated for C26H41BF3O7P 
= 564.2635, found 564.2648 m/z. 
5.6. Oxidation Of Phosphonate-Functionalized Chiral Boronic Esters To Form Chiral 
Hydroxy Phosphonates 
Representative procedure for oxidation of chiral tertiary benzylic boronic esters to 
the corresponding chiral tertiary benzylic alcohols (GP5): Oxidation of isolated and 
purified phosphonate-functionalized boronic esters is carried out as follows. (Note: Minor 
modifications in this procedure is carried out for different classes of chiral boronic esters). 
A mixture of the chiral boronic ester and NaBO3.4H2O (5 equiv.) in THF/H2O or 
THF/MeOH/H2O is stirred vigorously for 9-12 hours. Afterwards, brine is added, and the 
reaction mixture extracted with ethyl acetate. The combined extracts are concentrated and 
purified via silica gel chromatography using varying combinations of ethyl-acetate, 
hexanes and methanol to afford the desired hydroxyphosphonates. Alternatively, for cases 
where the boronic ester is not easily isolable from the regioisomers or the reduced products, 
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the CAHB mixture is partially purified using silica gel chromatography and the mixture of 
regioisomeric boronic esters and the reduced products are oxidized. Typically the 
regioisomeric alcohols were separable after oxidation.  
 
Synthesis of chiral tertiary β-hydroxyphosphonate (S)-13a: Following GP5, the chiral 
boronic ester (R)-6a (57 mg, 0.15 mmol, 1.0 eq) affords the chiral tertiary  β-
hydroxyphosphonate (S)-13a (37 mg, 90%): TLC analysis (ethyl acetate/hexanes 3:1) Rf = 
0.5; [α]D20 = +2.5 o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.51 (2H, d, J = 8.0 
Hz, g), 7.36 (2H, dd, J = 8.0, 7.5 Hz, h), 7.25 (1H, t, J = 7.5 Hz, i), 5.00 (1H, br s, OH), 
4.14-4.00 (2H, m, b or b'), 3.78-3.67 (1H, m, b or b'), 3.45-3.35 (1H, m, b or b'), 2.53-2.32 
(2H, m, c), 1.64 (3H, d, J = 2.5 Hz, e), 1.33 (3H, t, J = 7.0 Hz, a or a'), 1.02 (3H, t, J = 7.0 
Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 147.40 (d, 3JC-P = 7.0 Hz, f), 128.31 (h), 
126.94 (i), 124.98 (g), 72.18 (d, 2JC-P = 5.0 Hz, d), 61.95 (d, 
2JC-P = 7.0 Hz, b or b'), 61.63 
(d, 2JC-P = 7.0 Hz, b or b'), 39.93 (d, 
1JC-P = 136 Hz, c), 32.68 (d, 
3JC-P = 14.0 Hz, e), 16.53 
(d, 3JC-P = 6.5 Hz, a or a'), 16.28 (d, 
3JC-P = 6.3 Hz, a or a') ppm; 
31P NMR (162 MHz, 
CDCl3) δ 28.90 ppm; IR (neat) 3400 (O-H), 2979 (aromatic C-H), 2932 (aliphatic C-H), 
1491 (aromatic C=C), 1446 (aromatic C=C), 1215 (P=O), 1048 (C-O), 1021 (C-O), 960 
(P-O) cm-1; HRMS (ESI) calculated for C13H21O4P+Na
+ = 295.1075, found 295.1081 m/z. 
Enantiomer ratio = 97:3, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK AD; Mobile Phase = 95:5 Hexanes:Isopropanol; Flow rate = 1 mL/min. 
HPLC UV detector λ = 210 nm, rt. HPLC traces: 
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(a) R:S = 3:97, CAHB of 5a with (R,R)-T2, 
then oxidation: 
 
(b) R:S = 97:3, CAHB of 5a with (S,S)-T2, 
then oxidation: 
 
 
For characterization data for alcohol (S)-13b (Obtained from substrate 5b), see section 
5.11.2.  
 
Synthesis of chiral primary alcohol (S)-13c: Following the general procedure for CAHB 
(GP4), the substrate 5c (57 mg, 0.2 mmol) yields a mixture of boronic esters and reduced 
products that were not separable via silica gel chromatography. The crude CAHB mixture 
was chromatographed (ethyl acetate/hexanes 3:1) over silica gel to get rid of the non-polar 
colored complex and the polar metal residues. The crude mixture obtained after this partial 
purification was subjected to oxidation following GP5 to obtain the chiral primary alcohol 
(S)-13c (48 mg, 80%) as a colorless oil: TLC analysis (ethyl acetate/methanol 19:1) Rf = 
0.5; [α]D20 = +4.0o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26-7.19 (2H, m, aryl), 
7.94 (1H, t, J = 7.5 Hz, aryl), 6.88 (1H, d, J = 8.0 Hz, j), 4.10-4.01 (4H, m, b+b'), 3.87-3.84 
(5H, m, e+l), 3.67-3.58 (1H, m, d), 3.27 (1H, br s, OH), 2.32 (1H, ddd, J = 18.0, 15.0, 8.5 
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Hz, c(1H)), 2.19 (1H, ddd, J = 19.0, 18.0, 5.5 Hz, c(1H)), 1.30 (3H, t, J = 7.0 Hz, a or a'), 
1.28 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 157.07 (k), 130.48 (d, 
3JC-P = 12.5 Hz, f), 128.61 (aryl), 128.08 (aryl), 120.82 (aryl), 110.85 (j), 66.40 (d, 
3JC-P = 
8.0 Hz, e), 61.97 (d, 2JC-P = 6.5 Hz, b or b'), 61.75 (d, 
2JC-P = 6.5 Hz, b or b'), 55.45 (l), 
37.47 (d, 2JC-P = 2.0 Hz, d), 28.24 (d, 
1JC-P = 139 Hz, c), 16.48 (d, 
3JC-P = 6.0 Hz, a or a'), 
16.46 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.39 ppm; IR (neat) 
3369 (O-H), 2980 (sp2 C-H), 2907 (sp3 C-H), 1493 (aromatic C=C), 1391 (aromatic C=C), 
1239 (P=O), 1020 (C-O), 958 (P-O), 752 cm-1. HRMS (ESI) calculated for C14H23O5P+Na
+ 
= 325.1181, found 325.1184 m/z. Enantiomer ratio = 74:26, determined by chiral HPLC 
analysis: Stationary phase = CHIRALPAK IC; Mobile phase = 90:10 Hexanes: 
Isopropanol; Flow rate = 1.5 mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces: 
(a) R:S = 26:74, CAHB of 5c with (R,R)-
T2, then oxidation to yield 13c:  
 
(b) R:S = 74:26, CAHB of 5c with (S,S)-
T2, then oxidation to yield 13c: 
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Synthesis of chiral tertiary benzyl alcohol (S)-13d: Following GP5, the chiral boronic 
ester (R)-6d (40 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13d 
(28 mg, 91%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = -8.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 (2H, d, J = 8.0 Hz, g), 
7.16 (2H, d, J = 8.0 Hz, h), 4.94 (1H, br s, OH), 4.14-4.00 (2H, m, b or b'), 3.79-3.69 (1H, 
m, b or b'), 3.49-3.40 (1H, m, b or b'), 2.49-2.29 (5H, m, c+j), 1.62 (3H, d, 4JP-H = 2.0 Hz, 
e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.03 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 
MHz, CDCl3) δ 144.49 (d, 3JC-P = 7.5 Hz, f), 136.43 (i), 128.91 (h), 124.82 (g), 72.04 (d, 
2JC-P = 5.0 Hz, d), 61.93 (d, 
2JC-P = 6.5 Hz, b or b'), 61.56 (d, 
2JC-P = 6.5 Hz, b or b'), 39.95 
(d, 1JC-P = 135 Hz, c), 32.58 (d, 
3JC-P = 14.0 Hz, e), 21.07 (j), 16.49 (d, 
3JC-P = 6.0 Hz, a or 
a'), 16.22 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.98 ppm; IR 
(neat) 3397 (O-H), 2979 (aromatic C-H), 2923 (aliphatic C-H), 1513 (aromatic C=C), 1392 
(aromatic C=C), 1214 (P=O), 1019 (C-O), 960 (P-O), 819 cm-1; HRMS (ESI) calculated 
for C14H23O4P+Na
+ = 309.1232, found 309.1238 m/z. Enantiomer ratio = 96:4, determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK AS-H; Mobile phase = 95:5 
Hexanes:Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC 
traces:  
(a) R:S = 4:96, CAHB of 5d with (R,R)-T2, 
then oxidation to yield 13d: 
(b) R:S = 96:4, CAHB of 5d with (S,S)-T2, 
then oxidation to yield 13d: 
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Synthesis of chiral tertiary benzyl alcohol (S)-13e: Following GP5, the chiral boronic 
ester (R)-6e (45 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13e 
(28 mg, 83%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +10.2o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.62 (4H, br s, g+h), 5.17 
(1H, br s, OH), 4.16-4.02 (2H, m, b or b'), 3.79-3.69 (1H, m, b or b'), 3.55-3.45 (1H, m, b 
or b'), 2.47 (1H, dd, J = 17.0, 15.0 Hz, c (1H)), 2.36 (1H, dd, J = 17.0, 15.0 Hz, c(1H)), 
1.64 (3H, s, e), 1.34 (3H, t, J = 7.0 Hz, a or a'), 0.99 (3H, t, J = 7.0 Hz, a or a') ppm; 13C 
NMR (100 MHz, CDCl3) δ 151.45 (d, 3JC-P = 7.5 Hz, f), 129.31 (q, 2JC-F = 32.0 Hz, i), 
125.55 (g), 125.40 (d, 1JC-F = 272 Hz, CF3), 125.25 (q, 
3JC-F = 4.0 Hz, h), 72.12 (d, 
2JC-P = 
5.0 Hz, d), 61.99 (d, 2JC-P = 6.5 Hz, b or b'), 61.96 (d, 
2JC-P = 6.5 Hz, b or b'), 39.58 (d, 
1JC-
P = 136.0 Hz, c), 32.52 (d, 
3JC-P = 14.5 Hz, e), 16.53 (d, 
3JC-P = 6.0 Hz, a or a'), 16.09 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.30 ppm; 19F NMR (376 
MHz, CDCl3) δ -62.48 ppm; IR (neat) 3385 (O-H), 2982 (sp2 C-H), 2933 (sp3 C-H), 1618, 
1444 (aromatic C=C), 1409 (aromatic C=C), 1325 (C-F), 1218 (P=O), 1049 (C-O), 1015 
Chrom Perfect Chromatogram Report
Printed on 6/15/2017 9:29:50 PM Page 1 of 1
 1
 
 2
 
 1
1
.7
1
 
 1
3
.7
6
 
 A
=
3
.9
8
%
 
 A
=
9
6
.0
2
%
 
D:\Suman\HPLC raw data\SC_20170615_S1(1).0030.RAW SC_20170615_S1
10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0 15.5 16.0
Time - Minutes
0
100
200
300
400
500
600
700
800
900
1000
R
e
s
p
o
n
s
e
 -
 M
ill
iV
o
lt
s
Chrom Perfect Chromatogram Report
Printed on 6/15/2017 9:13:41 PM Page 1 of 1
 1
 
 2
 
 1
1
.4
0
 
 1
3
.4
6
 
 A
=
9
5
.9
8
%
 
 A
=
4
.0
2
%
 
D:\Suman\HPLC raw data\SC_20170615_S1.0030.RAW SC_20170615_S1
10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0
Time - Minutes
0
200
400
600
800
1000
1200
1400
1600
1800
2000
R
e
s
p
o
n
s
e
 -
 M
ill
iV
o
lt
s
281 
 
(C-O), 961 (P-O), 840 cm-1. HRMS (ESI) calculated for C14H20F3O4P+Na
+ = 363.0949, 
found 363.0955 m/z. Enantiomer ratio = 96:4, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK AD; Mobile phase = 95:5 Hexanes: Isopropanol; Flow 
rate = 1.25 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) R:S = 4:96, CAHB of 5e with (R,R)-T2, 
then oxidation to yield 13e: 
 
(b) R:S = 96:4, CAHB of 5e with (S,S)-T2, 
then oxidation to yield 13e: 
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13f: Following GP5, the chiral boronic 
ester (R)-6f (41 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13f 
(26 mg, 85%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +3.0o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.25 (1H, t, J = 8.0 Hz, j), 
7.09 (1H, t, J = 2.0 Hz, g), 7.02 (1H, d, J = 8.0 Hz, k), 6.78 (1H, dd, J = 8.0, 2.0 Hz, i), 
5.00 (1H, br s, OH), 4.11-4.05 (2H, m, b or b'), 3.84 (3H, s, l), 3.79-3.70 (1H, m, b or b'), 
3.52-3.42 (1H, m, b or b'), 2.50-2.29 (2H, m, c), 1.61 (3H, d, 4JP-H = 2.0 Hz, e), 1.32 (3H, 
t, J = 7.0 Hz, a or a'), 1.04 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 
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159.71 (h), 149.23 (d, 3JC-P = 7.5 Hz, f), 129.26 (j), 117.36 (k), 112.36 (g), 110.73 (i), 72.09 
(d, 2JC-P = 5.0 Hz, d), 61.97 (d, 
2JC-P = 6.5 Hz, b or b'), 61.59 (d, 
2JC-P = 6.5 Hz, b or b'), 
55.39 (l), 39.76 (d, 1JC-P = 136 Hz, c), 32.54 (d, 
3JC-P = 14.0 Hz, e), 16.48 (d, 
3JC-P = 6.0 
Hz, a or a'), 16.24 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.84 
ppm; IR (neat) 3403 (O-H), 2979 (aromatic C-H), 2933 (aliphatic C-H), 1600, 1583, 1455 
(aromatic C=C), 1390 (aromatic C=C), 1215 (P=O), 1020 (C-O), 961 (P-O), 781 cm-1; 
HRMS (ESI) calculated for C14H23O5P+Na
+ = 325.1181, found 325.1186 m/z. Enantiomer 
ratio = 97:3, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK AD; 
Mobile phase = 95:5 Hexanes: Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ 
= 210 nm, rt. HPLC traces: 
(a) R:S = 3:97, CAHB of 5f with (R,R)-T2, 
then oxidation to yield 13f: 
 
(b) R:S = 97:3, CAHB of 5f with (S,S)-
T2, then oxidation to yield 13f:  
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13g: Following GP5, the chiral boronic 
ester (R)-6g (41 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13g 
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(24 mg, 78%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +2.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.41 (2H, d, J = 8.75 Hz, 
g), 6.89 (2H, d, J = 8.75 Hz, h), 4.95 (1H, br s, OH), 4.14-3.99 (2H, m, b or b'), 3.81 (3H, 
s, j), 3.81-3.71 (1H, m, b or b'), 3.53-3.43 (1H, m, b or b'), 2.49-2.29 (2H, m, c), 1.61 (3H, 
d, 4JP-H = 2.0 Hz, e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.06 (3H, t, J = 7.0 Hz, a or a') ppm; 
13C NMR (100 MHz, CDCl3) δ 158.59 (i), 139.69 (d, 3JC-P = 7.5 Hz, f), 126.12 (g), 113.59 
(h), 71.92 (d, 2JC-P = 5.0 Hz, d), 61.96 (d, 
2JC-P = 6.5 Hz, b or b'), 61.60 (d, 
2JC-P = 6.5 Hz, 
b or b'), 55.49 (j), 39.98 (d, 1JC-P = 135 Hz, c), 32.71 (d, 
3JC-P = 14.0 Hz, e), 16.52 (d, 
3JC-P 
= 6.0 Hz, a or a'), 16.32 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 
29.00 ppm; IR (neat) 3400 (O-H), 2980 (aromatic C-H), 2931 (aliphatic C-H), 1610, 1510, 
1443 (aromatic C=C), 1391 (aromatic C=C), 1245 (P=O), 1021 (C-O), 961 (P-O), 832 cm-
1; HRMS (ESI) calculated for C14H23O5P+Na
+ = 325.1181, found 325.1184 m/z. 
Enantiomer ratio = 94:6, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK AD; Mobile phase = 90:10 Hexanes: Isopropanol; Flow rate = 1 mL/min. 
HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a) R:S = 6:94, CAHB of 5g with (R,R)-T2, 
then oxidation to yield 13g:  
 
(b) R:S = 94:6, CAHB of 5g with (S,S)-
T2, then oxidation to yield 13g: 
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Synthesis of chiral tertiary benzyl alcohol (S)-13h: Following GP5, the chiral boronic 
ester (R)-6h (43 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13h 
(24 mg, 75%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.5; 
[α]D20 = +6.4o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.98 (1H, d, J = 2.0 Hz, g), 
6.95 (1H, dd, J = 8.0, 2.0 Hz, k), 6.77 (1H, d, J = 8.0 Hz, j), 5.93 (2H, s, l), 4.95 (1H, br s, 
OH), 4.14-4.00 (2H, m, b or b'), 3.86-3.76 (1H, m, b or b'), 3.65-3.55 (1H, m, b or b'), 2.45-
2.25 (2H, m, c), 1.59 (3H, d, 4JP-H = 2.0 Hz, e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.10 (3H, 
t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 6.147.64 (h or i), 146.38 (h or 
i), 141.78 (d, 3JC-P = 8.0 Hz, f), 118.02 (k), 107.89 (j), 106.09 (g), 101.10 (l), 72.05 (d, 
2JC-
P = 5.0 Hz, d), 61.98 (d, 
2JC-P = 6.5 Hz, b or b'), 61.66 (d, 
2JC-P = 6.5 Hz, b or b'), 39.89 (d, 
1JC-P = 135 Hz, c), 32.65 (d, 
3JC-P = 14.0 Hz, e), 16.49 (d, 
3JC-P = 6.5 Hz, a or a'), 16.29 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.79 ppm; IR (neat) 3397 (O-
H), 2980 (aromatic C-H), 2908 (aliphatic C-H), 1488 (aromatic C=C), 1434 (aromatic 
C=C), 1231 (P=O), 1021 (C-O), 938 (P-O), 813, 730 cm-1; HRMS (ESI) calculated for 
C14H21O6P+Na
+ = 339.0973, found 339.0979 m/z. Enantiomer ratio = 94:6, determined by 
chiral HPLC analysis: Stationary phase = CHIRALPAK AD; Mobile phase = 60:40 
Hexanes: Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC 
traces:  
(a) R:S = 6:94, CAHB of 5h with (R,R)-T2, 
then oxidation to yield 13h: 
(b) R:S = 94:6, CAHB of 5h with (S,S)-
T2, then oxidation to yield 13h: 
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Synthesis of chiral tertiary benzyl alcohol (S)-13i: Following GP5, the chiral boronic 
ester (R)-6i (41 mg, 0.1 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13i (25 
mg, 83%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +7o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.10 (2H, s, g), 6.88 (1H, s, 
i), 4.91 (1H, br s, OH), 4.14-4.00 (2H, m, b or b'), 3.80-3.70 (1H, m, b or b'), 3.51-3.41 
(1H, m, b or b'), 2.49-2.29 (8H, m, c+j), 1.61 (3H, d, 4JP-H = 2.0 Hz, e), 1.33 (3H, t, J = 7.0 
Hz, a or a'), 1.05 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 147.37 
(d, 3JC-P = 8.0 Hz, f), 137.70 (h), 128.45 (i), 122.67 (g), 72.06 (d, 
2JC-P = 5.0 Hz, d), 61.93 
(d, 2JC-P = 6.5 Hz, b or b'), 61.51 (d, 
2JC-P = 6.5 Hz, b or b'), 39.89 (d, 
1JC-P = 135 Hz, c), 
32.52 (d, 3JC-P = 13.5 Hz, e), 21.61 (j), 16.48 (d, 
3JC-P = 6.5 Hz, a or a'), 16.22 (d, 
3JC-P = 
6.5 Hz, a or a') ppm; 31P NMR (162 MHz, CDCl3) δ 29.05 ppm; IR (neat) 3407 (O-H), 
2980 (sp2 C-H), 2915 (sp3 C-H), 1443 (aromatic C=C), 1392 (aromatic C=C), 1217 (P=O), 
1051 (C-O), 1021 (C-O), 960 (P-O), 849 cm-1. HRMS (ESI) calculated for C15H25O4P+Na
+ 
= 323.1388 found 323.1392 m/z. Enantiomer ratio = 96:4, determined by chiral HPLC 
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analysis: Stationary phase = CHIRALPAK IC; Mobile phase = 90:10 Hexanes: 
Isopropanol; Flow rate = 1.5 mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces:  
(a) R:S = 4:96, CAHB of 5i with (R,R)-T2, 
then oxidation to yield 13i: 
 
(b) R:S = 96:4, CAHB of 5i with (S,S)-T2, 
then oxidation to yield 13i: 
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13j: Following GP5, the chiral boronic 
ester (R)-6j (40 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13j 
(23 mg, 80%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = +4.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.48-7.43 (2H, m, g), 7.05-
6.99 (2H, m, h), 5.05 (1H, br s, OH), 4.14-4.00 (2H, m, b or b'), 3.80-3.81 (1H, m b or b'), 
3.56-3.46 (1H, m, b or b'), 2.44 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.32 (1H, dd, J = 18.0, 
15.0 Hz, c(1H)), 1.61 (3H, d, 4JP-H = 2.5 Hz, e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.05 (3H, 
t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 161.90 (d, 1JC-F = 245 Hz, i), 
143.24 (dd, 3JC-P = 7.5 Hz, 
4JC-F = 3.0 Hz, f), 126.74 (d, 
3JC-F = 8.0 Hz, g), 114.93 (d, 
2JC-F 
= 21 Hz, h), 71.91 (d, 2JC-P = 5.0 Hz, d), 61.94 (d, 
3JC-P = 6.5 Hz, b or b'), 61.77 (d, 
3JC-P = 
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6.5 Hz, b or b'), 39.83 (d, 1JC-P = 136 Hz, c), 32.73 (d, 
3JC-P = 14.0 Hz, e), 16.50 (d, 
3JC-P = 
6.0 Hz, a or a'), 16.26 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.65 
ppm; 19F NMR (376 MHz, CDCl3) δ -116.79 ppm; IR (neat) 3395 (O-H), 2981 (sp2 C-H), 
2932 (sp3 C-H), 1602, 1508 (C-F), 1444 (aromatic C=C), 1392 (aromatic C=C), 1219 
(P=O), 1021 (C-O), 960 (P-O), 836 cm-1. HRMS (ESI) calculated for C13H20FO4P+Na
+ = 
313.0981, found 313.0992 m/z. Enantiomer ratio = 96:4, determined by chiral HPLC 
analysis: Stationary phase = CHIRALPAK IC; Mobile phase = Isopropanol; Flow rate = 1 
mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) 13j Racemate                 
 
                                  
(b) R:S = 96:4, CAHB of 5j with (S,S)-
T2, then oxidation to yield 13j.   
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13k: Following GP5, the chiral boronic 
ester (R)-6k (42 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13k 
(29 mg, 95%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = -5.7o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.43 (2H, d, J = 8.5 Hz, h), 
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7.31 (2H, d, J = 8.5 Hz, g), 5.06 (1H, s, OH), 4.14-4.00 (2H, m, b or b'), 3.81-3.72 (1H, m, 
b or b'), 3.58-3.48 (1H, m, b or b'), 2.42 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.32 (1H, dd, 
J = 18.0, 15.0 Hz, c(1H)), 1.60 (3H, d, 4JC-P = 2.5 Hz, e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 
1.05 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 145.01 (d, 3JC-P = 7.5 
Hz, f), 131.74 (i), 127.32 (g), 125.56 (h), 70.91 (d, 2JC-P = 5.0 Hz, d), 60.99 (d, 
2JC-P = 6.5 
Hz, b or b'), 60.82 (d, 2JC-P = 6.5 Hz, b or b'), 38.66 (d, 
1JC-P = 136 Hz, c), 31.55 (d, 
3JC-P = 
14.0 Hz, e), 15.51 (d, 3JC-P = 6.0 Hz, a or a'), 15.23 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 28.52 ppm; IR (neat) 3382 (O-H), 2979 (sp2 C-H), 2929 (sp3 
C-H), 1489 (aromatic C=C), 1391 (aromatic C=C), 1215 (P=O), 1022 (C-O), 961 (P-O), 
831 (C-Cl) cm-1. HRMS (ESI) calculated for C13H20ClO4P+Na
+ = 329.0685, found 
329.0693 m/z. Enantiomer ratio = 96:4, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK IA; Mobile phase = 95:5 Hexanes: Isopropanol; Flow rate = 1 
mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) 13k Racemate                 
 
 
(b) R:S = 96:4, CAHB of 5k with (S,S)-
T2, then oxidation to yield 13k.   
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Synthesis of chiral tertiary benzyl alcohol (S)-13l: Following GP5, the chiral boronic 
ester (R)-6l (42 mg, 0.10 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13l 
(27 mg, 88%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = -5.7o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.48 (1H, t, J = 2.0 Hz, aryl), 
7.37 (1H, dt, J = 7.5, 1.5 Hz, aryl), 7.27 (1H, t, J = 7.5 Hz, aryl), 7.22 (1H, dt, J = 7.5, 1.5 
Hz, aryl), 5.07 (1H, br s, OH), 4.14-3.99 (2H, m, b or b'), 3.82-3.71 (1H, m, b or b'), 3.59-
3.49 (1H, m, b or b'), 2.43 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.31 (1H, dd, J = 18.0, 15.0 
Hz, c(1H)), 1.60 (3H, d, 4JP-H = 2.5 Hz, e), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.05 (3H, t, J = 
7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 149.63 (d, 3JC-P = 7.5 Hz, f), 134.25 
(h), 129.59 (aryl), 127.03 (aryl), 125.47 (aryl), 123.23 (aryl), 71.90 (d, 2JC-P = 5.0 Hz, d), 
61.99 (d, 2JC-P = 6.5 Hz, b or b'), 61.82 (d, 
2JC-P = 6.5 Hz, b or b'), 39.51 (d, 
1JC-P = 136 Hz, 
c), 32.51 (d, 3JC-P = 14.0 Hz, e), 16.49 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, 
CDCl3) δ 28.36 ppm; IR (neat) 3370 (O-H), 2980 (sp2 C-H), 2931 (sp3 C-H), 1596, 1571, 
1475 (aromatic C=C), 1392 (aromatic C=C), 1215 (P=O), 1020 (C-O), 960 (P-O), 738 (C-
Cl) cm-1. HRMS (ESI) calculated for C13H20ClO4P+Na
+ = 329.0685, found 329.0688 m/z. 
Enantiomer ratio = 97:3, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK AS-H; Mobile phase = 90:10 Hexanes:Isopropanol; Flow rate = 1.25 
mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces: 
(a) R:S = 4:96, CAHB of 5l with (R,R)-T2, 
then oxidation to yield 13l: 
(b) R:S = 98:2, CAHB of 5l with (S,S)-
T2, then oxidation to yield 13l: 
290 
 
  
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13m: Following GP5, the chiral boronic 
ester (R)-6m (46 mg, 0.1 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13m 
(28 mg, 81%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; 
[α]D20 = -1.3o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 (2H, d, J = 8.5 Hz, h), 
7.37 (2H, d, J = 8.5 Hz, g), 5.05 (1H, br s, OH), 4.14-4.00 (2H, m, b or b'), 3.82-3.72 (1H, 
m, b or b'), 3.59-3.49 (1H, m, b or b'), 2.42 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.31 (1H, 
dd, J = 18.0, 15.0 Hz, c(1H)), 1.60 (3H, d, 4JC-P = 2.0 Hz, e), 1.33 (3H, t, J = 7.0 Hz, a or 
a'), 1.05 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 146.55 (d, 3JC-P = 
7.5 Hz, f), 131.29 (h), 126.95 (g), 120.86 (i), 71.96 (d, 2JC-P = 5.0 Hz, d), 62.01 (d, 
2JC-P = 
6.5 Hz, b or b'), 61.84 (d, 2JC-P = 6.5 Hz, b or b'), 39.62 (d, 
1JC-P = 136 Hz, c), 32.51 (d, 
3JC-
P = 14.0 Hz, e), 16.52 (d, 
3JC-P = 6.0 Hz, a or a'), 16.23 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 28.49 ppm; IR (neat) 3391 (O-H), 2980 (sp2 C-H), 2931 (sp3 
C-H), 1590, 1486 (aromatic C=C), 1393 (aromatic C=C), 1214 (P=O), 1021 (C-O), 960 
(P-O), 828, 731 (C-Br) cm-1. HRMS (ESI) calculated for C13H20BrO4P+Na
+ = 375.0160, 
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found 375.0173 m/z. Enantiomer ratio = 94:6, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK AS-H; Mobile phase = 90:10 Hexanes:Isopropanol; Flow 
rate = 1.25 mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces:  
(a) R:S = 6:94, CAHB of 5m with (R,R)-
T2, then oxidation to yield 13m: 
 
(b) R:S = 93:7, CAHB of 5m with (S,S)-
T2, then oxidation to yield 13m:  
 
 
 
Synthesis of chiral tertiary benzyl alcohol (R)-13n: Following GP5, the chiral boronic 
ester (S)-6n (39 mg, 0.1 mmol) yields the chiral tertiary  β-hydroxyphosphonate (R)-13n 
(23 mg, 83%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
[α]D20 = +16o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.20 (1H, dd, J = 4.0, 2.0 
Hz, i), 6.96-6.94 (2H, m, g+h), 5.29 (1H, br s, OH), 4.15-4.05 (2H, m b or b'), 3.94-3.84 
(1H, m, b or b'), 3.73-3.63 (1H, m, b or b'), 2.50 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.39 
(1H, dd, J = 18.0, 15.0 Hz, c(1H)), 1.73 (3H, d, 4JP-H = 2.0 Hz, e), 1.34 (3H, t, J = 7.0 Hz, 
a or a'), 1.16 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 153.07 (d, 3JC-
P = 10.0 Hz, f), 126.84 (g or h), 124.12 (i), 122.54 (g or h), 71.45 (d, 
2JC-P = 5.0 Hz, d), 
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62.22 (d, 2JC-P = 6.5 Hz, b or b'), 61.77 (d, 
2JC-P = 6.5 Hz, b or b'), 40.73 (d, 
1JC-P = 136 Hz, 
c), 33.36 (d, 3JC-P = 12.5 Hz, e), 16.52 (d, 
3JC-P = 6.5 Hz, a or a'), 16.40 (d, 
3JC-P = 6.0 Hz, 
a or a') ppm; 31P NMR (162 MHz, CDCl3) δ 28.09 ppm; IR (neat) 3367 (O-H), 2980 (sp2 
C-H), 2930 (sp3 C-H), 1442 (aromatic C=C), 1391 (aromatic C=C), 1214 (P=O), 1018 (C-
O), 959 (P-O), 836, 695 cm-1. HRMS (ESI) calculated for C11H19O4PS+Na
+ = 301.0639, 
found 301.0644 m/z. Enantiomer ratio = 97:3, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK AS-H; Mobile phase = 90:10 Hexanes:Isopropanol; Flow 
rate = 1.25 mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces:  
(a) 13n Racemate 
 
 
(b) R:S = 7:93, CAHB of 5n with (S,S)-
T2, then oxidation to yield 13n. 
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-13o: Following GP5, the chiral boronic 
ester (R)-6o (39 mg, 0.1 mmol) yields the chiral tertiary  β-hydroxyphosphonate (S)-13o 
(24 mg, 87%) as a colorless viscous oil: TLC analysis (ethyl acetate/hexanes 2:1) Rf = 0.5; 
[α]D20 = -11.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.03 (1H, dd, J = 4.0, 2.0 
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Hz, h), 7.28-7.26 (2H, m, g+i), 5.04 (1H, br s, OH), 4.14-4.00 (2H, m b or b'), 3.87-3.77 
(1H, m, b or b'), 3.62-3.52 (1H, m, b or b'), 2.42 (1H, dd, J = 18.0, 15.0 Hz, c(1H)), 2.32 
(1H, dd, J = 18.0, 15.0 Hz, c(1H)), 1.62 (3H, d, 4JP-H = 2.0 Hz, e), 1.32 (3H, t, J = 7.0 Hz, 
a or a'), 1.11 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 149.48 (d, 3JC-
P = 8.0 Hz, f), 125.91 (g or i), 125.68 (g or i), 120.04 (h), 71.17 (d, 
2JC-P = 5.0 Hz, d), 61.98 
(d, 2JC-P = 6.5 Hz, b or b'), 61.66 (d, 
2JC-P = 6.5 Hz, b or b'), 39.89 (d, 
1JC-P = 136 Hz, c), 
32.27 (d, 3JC-P = 14.0 Hz, e), 16.51 (d, 
3JC-P = 6.0 Hz, a or a'), 16.38 (d, 
3JC-P = 6.0 Hz, a or 
a') ppm; 31P NMR (162 MHz, CDCl3) δ 28.66 ppm; IR (neat) 3391 (O-H), 2978 (sp2 C-H), 
2922 (sp3 C-H), 1443 (aromatic C=C), 1392 (aromatic C=C), 1221 (P=O), 1020 (C-O), 
960 (P-O), 790 cm-1. HRMS (ESI) calculated for C11H19O4PS+Na
+ = 301.0639, found 
301.0646 m/z. Enantiomer ratio = 88:12, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK IC; Mobile phase = 90:10 Hexanes: Isopropanol; Flow rate = 1.5 
mL/min. HPLC UV detector λ = 220 nm, rt. HPLC traces:  
(a) R:S = 12:88, CAHB of 5o with (R,R)-
T2, then oxidation to yield 13o:  
 
(b) R:S = 88:12, CAHB of 5o with (S,S)-
T2, then oxidation to yield 13o:  
 
 
Synthesis of chiral primary alcohol (S)-101: See sec. 5.11.3 CAHB of non-conjugated 
methylidene substrate 7.  
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Synthesis of chiral alcohols 35 & 36: Following the general procedure for CAHB (GP4; 
12 h total reaction time), the substrate 10 (54 mg, 0.2 mmol) yields about a 1:1 mixture of 
regioisomeric boronic esters (tertiary boronic ester 11 and primary boronic ester 12) that 
were not separable. The crude CAHB mixture was chromatographed (ethyl acetate/hexanes 
1:1) over silica gel to get rid of the non-polar colored complex and the polar metal residues. 
The crude mixture obtained after this partial purification is subjected to oxidation following 
GP5 to obtain the corresponding alcohols that were separated and purified by silica gel 
chromatography.  
The tertiary alcohol 90 is obtained as a colorless oil (23 mg, 40%): TLC analysis 
(ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +1.0o (c = 1.0, CHCl3); 1H NMR (700 MHz, 
CDCl3) δ 7.44 (2H, d, J = 8.0 Hz, h), 7.36 (2H, dd, J = 8.0, 7.5 Hz, i), 7.26 (1H, t, J = 7.5 
Hz, j), 4.12-4.02 (4H, m, b+b'), 2.80 (1H, br s, OH), 2.18-2.08 (2H, m, d), 1.79-1.72 (1H, 
m, c(1H)), 1.62-1.55 (4H, m, c(1H)+f), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.29 (3H, t, J = 7.0 
Hz, a or a') ppm; 13C NMR (175 MHz, CDCl3) δ 146.92 (g), 128.52 (i), 126.94 (j), 125.04 
(h), 74.21 (d, 3JC-P = 13.5 Hz, e), 61.87 (d, 
2JC-P = 6.5 Hz, b+b'), 36.65 (d, 
2JC-P = 4.0 Hz, 
d), 30.97 (f), 20.76 (d, 1JC-P = 142 Hz, c), 16.64 (d, 
3JC-P = 6.5 Hz, a or a'), 16.60 (d, 
3JC-P 
= 6.5 Hz, a or a') ppm; 31P NMR (283 MHz, CDCl3) δ 33.68 ppm; IR (neat) 3361 (O-H), 
3025 (aromatic C-H), 2931 (aliphatic C-H), 1446 (aromatic C=C), 1392 (aromatic C=C), 
295 
 
1219 (P=O), 1052 (C-O), 1021 (C-O), 960 (P-O) 700 cm-1; Enantiomer ratio = 86:14, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK AS-H; Mobile 
Phase = 40:60 Hexanes:Isopropanol. Flow rate = 1 mL/min. HPLC UV detector λ = 210 
nm, rt. HPLC traces:   
(a) Racemate 
 
 
(b) Er = 86:14, CAHB of 10 with (S,S)-
T2, then oxidation to yield 90. 
 
 
The primary alcohol 91 is obtained as a colorless oil (24 mg, 41%): TLC analysis (ethyl 
acetate) Rf = 0.5; [α]D20 = -1.6o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.37-7.21 
(5H, m, aryl), 4.13-4.00 (4H, m, b+b'), 3.78 (2H, br t, J = 5.0 Hz, f), 2.88-2.81 (1H, m, e), 
2.16-2.05 (1H, m, d(1H)), 1.95-1.84 (1H, m, d(1H)), 1.76 (1H, br s, OH), 1.70-1.56 (2H, 
m, c), 1.31 (3H, t, J = 7.0 Hz, a or a'), 1.30 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 
MHz, CDCl3) δ 141.18 (g), 129.04 (h or i), 128.25 (h or i), 127.31 (j), 67.27 (f), 61.71 (d, 
2JC-P = 6.0 Hz, b+b'), 49.34 (d, 
3JC-P = 16 Hz, e), 24.98 (d, 
2JC-P = 4.5 Hz, d), 23.75 (d, 
1JC-
P = 141 Hz, c), 16.65 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.17 
ppm; IR (neat) 3363 (O-H), 2989 (aromatic C-H), 2930 (aliphatic C-H), 1447 (aromatic 
C=C), 1389 (aromatic C=C), 1220 (P=O), 1052 (C-O), 1021 (C-O), 963 (P-O) 702 cm-1; 
Enantiomer ratio = 46:54, determined by chiral HPLC analysis: Stationary phase = 
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CHIRALPAK IC; Mobile Phase = 30:70 Hexanes:Isopropanol. Flow rate = 1 mL/min. 
HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a) Er = 54:46, CAHB of 10 with (R,R)-T2, 
then oxidation to yield 91: 
 
(b) Er = 53:47, CAHB of 10 with (S,S)-
T2, then oxidation to yield 91: 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22a: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E/Z)-18a (76 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22a (67 mg, 82%) as a 
colorless oil: TLC analysis (ethyl acetate) Rf = 0.2; [α]D20 = -29.1o (c = 1.0, CHCl3) 
[Absolute Configuration Assignment: Alcohol 22a is a previously reported13 compound 
in the literature and the negative value of optical rotation obtained for 22a is expected for 
the (S)-enantiomer.]; 1H NMR (400 MHz, CDCl3) δ 7.37-7.29 (5H, m, aryl), 4.80 (1H, dd, 
J = 6.5, 6.0 Hz, e), 4.15-4.06 (4H, m, b+b'), 2.87 (1H, br s, OH), 2.09-2.04 (2H, m, d), 
1.94-1.79 (2H, m, c), 1.33 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (175 MHz, CDCl3) δ 
144.04 (f), 128.69 (g or h), 127.82 (i), 125.96 (g or h), 74.02 (d, 3JC-P = 15 Hz, e), 61.89 
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(d, 2JC-P = 7.0 Hz, b or b'), 61.86 (d, 
2JC-P = 7.0 Hz, b or b'), 31.99 (d, 
2JC-P = 5.0 Hz, d), 
22.15 (d, 1JC-P = 142 Hz, c), 16.63 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (283 MHz, 
CDCl3) δ 32.83 ppm; IR (neat) 3369 (O-H), 3026 (sp2 C-H), 2928 (sp3 C-H), 1493 
(aromatic C=C), 1452 (aromatic C=C), 1392 (aromatic C=C), 1225 (P=O), 1053 (C-O), 
1021 (C-O), 956 (P-O), 700 cm-1; HRMS (ESI) calculated for C13H21O4P+Na
+ = 295.1075, 
found 295.1081 m/z. Enantiomer ratio = 96:4, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow 
rate = 1.0 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 4:96, CAHB of (E/Z)-18a using (R)-B2 followed by oxidation: 
  
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22b: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18b (81 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22b (72 mg, 84%) as a 
colorless oil: TLC analysis (2% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -37o (c = 1.0, 
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CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.22 (2H, d, J = 8.0 Hz, g), 7.13 (2H, d, J = 8.0 Hz, 
h), 4.67 (1H, t, J = 6.0 Hz, e), 4.11-3.95 (4H, m, b+b'), 3.57 (1H, br s, OH), 2.32 (3H, s, j), 
2.04-1.92 (2H, m, d), 1.90-1.67 (2H, m, c), 1.28 (3H, t, J = 7.0 Hz, a or a'), 1.27 (3H, t, J = 
7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 141.26 (f), 137.12 (i), 129.14 (h), 
125.88 (g), 73.52 (d, 3JC-P = 16 Hz, e), 61.71 (d, 
2JC-P = 6.5 Hz, b or b'), 61.68 (d, 
2JC-P = 
6.5 Hz, b or b'), 31.86 (d, 2JC-P = 4.5 Hz, d), 21.96 (d, 
1JC-P = 142 Hz, c), 21.18 (j), 16.51 
(d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.93 ppm; IR (neat) 3358 
(O-H), 2981 (aromatic C-H), 2927 (aliphatic C-H), 1513 (aromatic C=C), 1441 (aromatic 
C=C), 1392 (aromatic C=C), 1226 (P=O), 1058 (C-O), 1019 (C-O), 954 (P-O), 816, 524 
cm-1; HRMS (ESI) calculated for C14H23O4P+Na
+ = 309.1232, found 309.1242 m/z. 
Enantiomer ratio = 97:3, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 3:97, CAHB of (E)-18b using (R)-B2 followed by oxidation to yield (S)-9b: 
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Preparation of chiral secondary benzylic alcohol (S)-22c: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18c (81.0 
mg, 0.25 mmol) affords the chiral secondary benzylic alcohol (S)-22c (67 mg, 78%) as a 
colorless oil: TLC analysis (1% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -22o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.58 (2H, d, J = 8.2 Hz, h), 7.46 (2H, d, J = 8.2 Hz, 
g), 4.81 (1H, t, J = 6.0 Hz, e), 4.30 (1H, br s, OH), 4.11-3.96 (4H, m, b+b'), 2.08-1.75 (4H, 
m, c+d), 1.28 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 148.49 (f), 
129.70 (q, 2JC-F = 32.31 Hz, i), 126.27 (g), 125.45 (q, 
3JC-F = 4.0 Hz, h), 124.33 (q, 
1JC-F = 
272 Hz, CF3), 72.88 (d, 
3JC-P = 14 Hz, e), 61.99 (d, 
2JC-P = 6.0 Hz, b or b'), 61.94 (d, 
2JC-P 
= 6.0 Hz, b or b'), 32.06 (d, 2JC-P = 4.5 Hz, d), 21.83 (d, 
1JC-P = 142 Hz, c), 16.53 (d, 
3JC-P 
= 6.0 Hz, a+a') ppm; 31P NMR (162 MHz, CDCl3) δ 32.64 ppm; 19F NMR (376 MHz, 
CDCl3) δ -62.48 ppm; IR (neat) 3332 (O-H), 2986 (aromatic C-H), 2932 (aliphatic C-H), 
1442 (aromatic C=C), 1413 (aromatic C=C), 1323 (C-F), 1226 (P=O), 1161, 1120, 1064 
(C-O), 1016 (C-O), 959 (P-O) cm-1; HRMS (ESI) calculated for C14H20F3O4P+Na
+ = 
363.0949, found 363.0950 m/z; Enantiomer ratio = 97:3, determined by chiral HPLC 
analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 20:80 
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Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 3:97, CAHB of (E)-18c using (R)-B2 followed by oxidation to yield (S)-22c 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22d: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18d (82 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22d (62 mg, 71%) as a 
colorless oil: TLC analysis (1% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -34o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.32-7.28 (2H, m, g), 7.02-6.97 (2H, m, h), 4.70 
(1H, t, J = 6.0 Hz, e), 4.11-3.95 (4H, m, b+b'), 3.91 (1H, br s, OH), 2.02-1.90 (2H, m, d), 
1.88-1.67 (2H, m, c), 1.28 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 
162.21 (d, 1JC-F = 245 Hz, i), 140.11 (d, 
4JC-P = 3.0 Hz, f), 127.57 (d, 
3JC-F = 8.0 Hz, g), 
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115.28 (d, 2JC-F = 21.3 Hz, h), 72.97 (d, 
3JC-P = 15.25 Hz, e), 61.85 (d, 
2JC-P = 6.0 Hz, b or 
b'), 61.82 (d, 2JC-P = 6.0 Hz, b or b'), 32.07 (d, 
2JC-P = 4.5 Hz, d), 21.94 (d, 
1JC-P = 142 Hz, 
c), 16.54 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.75 ppm; 19F 
NMR (376 MHz, CDCl3) δ -115.41 ppm; IR (neat) 3356 (O-H), 2982 (aromatic C-H), 2931 
(aliphatic C-H), 1508 (C-F), 1218 (P=O), 1054 (C-O), 1021 (C-O), 957 (P-O), 833 cm-1; 
HRMS (ESI) calculated for C13H20FO4P+Na
+ = 313.0981, found 313.0983 m/z; 
Enantiomer ratio = 94:6, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 20:80 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 6:94, CAHB of (E)-18d using (R)-B1 followed by oxidation to yield (S)-22d: 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22e: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18e (85 
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mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22e (70 mg, 77%) as a 
colorless oil: TLC analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -26o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.27 (2H, d, J = 8.5 Hz, g), 6.88 (2H, d, J = 8.5 Hz, 
h), 4.70 (1H, t, J = 6.25 Hz, e), 4.14-3.99 (4H, m, b+b'), 3.81 (3H, s, j), 3.05 (1H, br s, OH), 
2.09-1.94 (2H, m, d), 1.93-1.69 (2H, m, c), 1.31 (6H, t, J = 3.0 Hz, a+a') ppm; 13C NMR 
(100 MHz, CDCl3) δ 159.22 (i), 136.27 (f), 127.21 (g), 114.01 (h), 73.57 (d, 3JC-P = 15.5 
Hz, e), 61.83 (d, 2JC-P = 6.5 Hz, b or b'), 61.80 (d, 
2JC-P = 6.5 Hz, b or b'), 55.46 (j), 31.96 
(d, 2JC-P = 4.5 Hz, d), 22.15 (d, 
1JC-P = 142 Hz, c), 16.61 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 32.85 ppm; IR (neat) 3361 (O-H), 2982 (aromatic C-H), 2836 
(aliphatic C-H), 1511, 1442 (aromatic C=C), 1392 (aromatic C=C), 1241 (P=O), 1020 (C-
O), 956 (P-O) cm-1; HRMS (ESI) calculated for C14H23O5P+Na
+ = 325.1181, found 
325.1183 m/z; Enantiomer ratio = 94:6, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1.5 
mL/min; HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 6:94, CAHB of (E)-18e using (R)-B2 followed by oxidation to yield (S)-22e: 
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Preparation of chiral secondary benzylic alcohol (S)-22f: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18f (85 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22f (76 mg, 83%) as a 
colorless oil: TLC analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -21o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.25 (1H, dd, J = 8.25, 7.68 Hz, h), 6.93-6.91 (2H, 
m, g+k), 6.82-6.79 (1H, m, i), 4.73 (1H, t, J = 6.0 Hz, e), 4.13-3.99 (4H, m, b+b'), 3.81 
(3H, s, l), 3.33 (1H, br s, OH), 2.08-1.95 (2H, m, d), 1.93-1.72 (2H, m, c), 1.30 (6H, t, J = 
7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 159.92 (j), 149.91 (f), 129.63 (h), 118.29 
(g), 113.17 (i), 111.45 (k), 73.74 (d, 3JC-P = 15 Hz, e), 61.86 (d, 
2JC-P = 6.5 Hz, b or b'), 
61.82 (d, 2JC-P = 6.5 Hz, b or b'), 55.39 (l), 31.94 (d, 
2JC-P = 4.5 Hz, d), 22.02 (d, 
1JC-P = 
142 Hz, c), 16.60 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.87 ppm; 
IR (neat) 3352 (O-H), 2982 (aromatic C-H), 2837 (aliphatic C-H), 1600, 1486 (aromatic 
C=C), 1436 (aromatic C=C), 1226 (P=O), 1020 (C-O), 957 (P-O) cm-1; HRMS (ESI) 
calculated for C14H23O5P+Na
+ = 325.1181, found 325.1184 m/z. Enantiomer ratio = 98:2, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
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= 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 
oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 2:98, CAHB of (E)-18f using (R)-B2 followed by oxidation to yield (S)-22f 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22g: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18g (75.0 
mg, 0.25 mmol) affords the chiral secondary benzylic alcohol (S)-22g (55 mg, 70%) as a 
colorless oil: TLC analysis (5% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -39o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 6.85 (1H, d, J = 1.25 Hz, k), 6.77-6.71 (2H, m, 
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g+h), 5.92 (2H, s, l), 4.62 (1H, t, J = 6.0 Hz, e), 4.13-4.96 (4H, m, b+b'), 3.62 (1H, br s, 
OH), 2.02-1.62 (4H, m, c+d), 1.28 (3H, t, J = 7.0 Hz, a or a'), 1.27 (3H, t, J = 7.0 Hz, a or 
a') ppm; 13C NMR (100 MHz, CDCl3) δ 147.85 (i or j), 146.93 (i or j), 138.38 (f), 119.30 
(g), 108.13 (h), 106.48 (k), 101.06 (l), 73.54 (d, 3JC-P = 16 Hz, e), 61.79 (d, 
2JC-P = 6.0 Hz, 
b or b'), 61.75 (d, 2JC-P = 6.0 Hz, b or b'), 31.96 (d, 
2JC-P = 4.5 Hz, d), 21.99 (d, 
1JC-P = 142 
Hz, c), 16.54 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.81 ppm; IR 
(neat) 3336 (O-H), 2982 (aromatic C-H), 2903 (aliphatic C-H), 1486 (aromatic C=C), 1440 
(aromatic C=C), 1234 (P=O), 1020 (C-O), 957 (P-O) cm-1; HRMS (ESI) calculated for 
C14H21O6P+Na
+ = 339.0973, found 339.0975 m/z; Enantiomer ratio = 94:6, determined by 
chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 50:50 
Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 6:94, CAHB of (E)-18g using (R)-B2 followed by oxidation to yield (S)-22g 
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Preparation of chiral secondary benzylic alcohol (S)-22h: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: CAHB carried out for 
12 hours), the substrate (E)-18h (71.0 mg, 0.25 mmol) affords the chiral secondary benzylic 
alcohol (S)-22h (54 mg, 72%) as a colorless oil: TLC analysis (4% methanol in ethyl 
acetate) Rf = 0.5; [α]D20 = -29o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.35 (1H, 
dd, J = 7.5, 1.5 Hz, aryl), 7.23 (1H, td, J = 8.0, 1.5 Hz), 6.95 (1H, td, J = 7.5, 1.0 Hz, aryl), 
6.85 (1H, d, J = 8.25 Hz, aryl), 4.93 (1H, t, J = 6.0 Hz, e), 4.15-3.99 (4H, m, b+b'), 3.82 
(3H, s, l), 3.41 (1H, br s, OH), 2.12-1.71 (4H, m, c+d), 1.30 (3H, t, J = 7.0 Hz, a or a'), 1.29 
(3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 156.37 (g), 131.85 (f), 
128.47 (aryl), 126.97 (aryl), 120.84 (aryl), 110.50 (aryl), 70.09 (d, 3JC-P = 17 Hz, e), 61.67 
(d, 2JC-P = 6.5 Hz, b+b'), 55.34 (l), 30.05 (d, 
2JC-P = 4.5 Hz, d), 22.17 (d, 
1JC-P = 141 Hz, c), 
16.55 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 33.22 ppm; IR (neat) 
3367 (O-H), 2981 (aromatic C-H), 2907 (aliphatic C-H), 1489 (aromatic C=C), 1464 
(aromatic C=C), 1439 (aromatic C=C), 1235 (P=O), 1048 (C-O), 1022 (C-O), 957 (P-O), 
754, 729 cm-1; HRMS (ESI) calculated for C14H23O5P+Na
+ = 325.1181, found 325.1183 
m/z; Enantiomer ratio = 94:6, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
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(b) R:S = 6:94, CAHB of (E)-18h using (R)-B2 followed by oxidation to yield (S)-22h 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22i: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18i (80 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22i (64 mg, 74%) as a 
colorless oil: TLC analysis (1% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -39o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.58 (1H, d, J = 7.5 Hz, h), 7.22-7.11 (3H, m, i+k), 
4.97 (1H, dd, J = 6.5, 4.5 Hz, e), 4.12-3.98 (4H, m, b+b'), 3.37 (1H, br s, OH), 2.32 (3H, s, 
l), 2.04-1.79 (4H, m, c+d), 1.30 (3H, t, J = 7.0 Hz, a or a'), 1.29 (3H, t, J = 7.0 Hz, a or a') 
ppm; 13C NMR (100 MHz, CDCl3) δ 142.38 (f), 134.36 (g), 130.47 (aryl), 127.30 (aryl), 
126.33 (aryl), 125.38 (h), 70.03 (d, 3JC-P = 15 Hz, e), 61.79 (d, 
2JC-P = 6.5 Hz, b or b'), 61.73 
(d, 2JC-P = 6.5 Hz, b or b'), 30.67 (d, 
2JC-P = 4.5 Hz, d), 22.09 (d, 
1JC-P = 142 Hz, c), 19.14 
(l), 16.56 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.95 ppm; IR (neat) 
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3361 (O-H), 2980 (aromatic C-H), 2930 (aliphatic C-H), 1485 (aromatic C=C), 1441 
(aromatic C=C), 1391 (aromatic C=C), 1224 (P=O), 1020 (C-O), 957 (P-O), 755 cm-1; 
HRMS (ESI) calculated for C14H23O4P+Na
+ = 309.1232, found 309.1234 m/z; Enantiomer 
ratio = 91:9, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; 
Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ 
= 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 9:91, CAHB of (E)-18i using (R)-B2 followed by oxidation to yield (S)-22i 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22j: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used and CAHB carried out for 12 hours), the substrate (E)-18j (74.0 mg, 0.25 mmol) 
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affords the chiral secondary benzylic alcohol (S)-22j (53 mg, 67%) as a colorless oil: TLC 
analysis (5% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -22o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.21 (2H, d, J = 8.75 Hz, g), 6.70 (2H, d, J = 8.75 Hz, g), 4.61 (1H, 
dd, J = 7.0, 5.5 Hz, e), 4.14-3.98 (4H, m, b+b'), 2.93 (7H, s, j+OH), 2.08-1.66 (4H, m, c+d), 
1.30 (3H, t, J = 7.0 Hz, a or a'), 1.29 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, 
CDCl3) δ 150.35 (i), 131.98 (f), 126.94 (g), 112.71 (h), 73.77 (d, 3JC-P = 17 Hz, e), 61.67 
(d, 2JC-P = 6.5 Hz, b or b'), 61.65 (d, 
2JC-P = 6.5 Hz, b or b'), 40.81 (j), 31.62 (d, 
2JC-P = 4.5 
Hz, d), 22.20 (d, 1JC-P = 141 Hz, c), 16.57 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 
MHz, CDCl3) δ 32.94 ppm; IR (neat) 3351 (O-H), 2980 (aromatic C-H), 2904 (aliphatic 
C-H), 1617, 1522, 1225 (P=O), 1054 (C-O/C-N), 1022 (C-O/C-N), 945 (P-O), 815, 728 
cm-1; Note: HRMS analysis was not successful on alcohol 9i in detecting the molecular 
ion. The structure proof of 9i is based on the NMR and IR analysis only. Enantiomer ratio 
= 92:8, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 
nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 8:92, CAHB of (E)-18j using (R)-B2 followed by oxidation to yield (S)-22j 
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Preparation of chiral secondary benzylic alcohol (S)-22k: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used and CAHB carried out for 12 hours), the substrate (E)-18k (68 mg, 0.2 mmol) affords 
the chiral secondary benzylic alcohol (S)-22k (39 mg, 55%) as a colorless oil: TLC analysis 
(10% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -20o (c = 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.28 (2H, d, J = 8.5 Hz, g), 6.91 (2H, d, J = 8.5 Hz, h), 4.71 (1H, t, J = 6.0 
Hz, e), 4.17-4.04 (4H, m, b+b'), 3.88 (4H, t, J = 5.0 Hz, k), 3.17 (4H, t, J = 5.0 Hz, j), 2.09-
1.96 (2H, m, d), 1.94-1.72 (2H, m, c), 1.33 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 
MHz, CDCl3) δ 151.08 (i), 135.36 (i), 127.00 (g), 115.85 (h), 73.82 (d, 3JC-P = 15 Hz, e), 
67.10 (k), 61.86 (d, 2JC-P = 6.0 Hz, b or b'), 61.83 (d, 
2JC-P = 6.0 Hz, b or b'), 49.55 (j), 
31.79 (d, 2JC-P = 4.5 Hz, d), 22.28 (d, 
1JC-P = 142 Hz, c), 16.68 (d, 
3JC-P = 6.0 Hz, a+a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 32.82 ppm; IR (neat) 3355 (O-H), 2995 (aromatic C-
H), 2901 (aliphatic C-H), 1525, 1226 (P=O), 1051 (C-O/C-N), 1022 (C-O/C-N), 949 (P-
O) cm-1; HRMS (ESI) calculated for C17H28NO5P+Na
+ = 380.1603, found 380.1603 m/z. 
Enantiomer ratio = 94:6, determined by chiral HPLC analysis: Stationary phase = 
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CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1.5 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 6:94, CAHB of (E)-18k using (R)-B2 followed by oxidation to yield (S)-22k 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22l: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used and CAHB carried out for 12 hours), the substrate (E)-18l (66.0 mg, 0.15 mmol) 
affords the chiral secondary benzylic alcohol (S)-22l (47 mg, 68%) as a colorless oil: TLC 
analysis (6% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -20o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.25 (2H, d, J = 8.5 Hz, g), 6.90 (2H, d, J = 8.5 Hz, h), 4.67 (1H, t, J 
= 6.0 Hz, e), 4.14-4.00 (4H, m, b+b'), 3.57 (4H, t, J = 5.0 Hz, k), 3.12 (4H, t, J = 5.0 Hz, 
312 
 
j), 2.09-1.94 (2H, m, d), 1.92-1.64 (2H, m, c), 1.49 (9H, s, n), 1.30 (6H, t, J = 7.0 Hz, a+a') 
ppm; 13C NMR (100 MHz, CDCl3) δ 154.89 (l), 150.92 (i), 135.75 (f), 126.96 (g), 116.69 
(h), 80.09 (m), 73.60 (d, 3JC-P = 16 Hz, e), 61.80 (d, 
2JC-P = 6.0 Hz, b or b'), 61.77 (d, 
2JC-P 
= 6.0 Hz, b or b'), 49.59 (j), 44.00 (k), 31.77 (d, 2JC-P = 4.5 Hz, d), 28.59 (n), 22.17 (d, 
1JC-
P = 141 Hz, c), 16.62 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.86 
ppm; IR (neat) 3374 (O-H), 2977 (aromatic C-H), 2818 (aliphatic C-H), 1692 (C=O), 1421 
(aromatic C=C), 1227 (P=O), 1022 (C-N/C-O), 959 (P-O), 751 cm-1; HRMS (ESI) 
calculated for C22H37N2O6P+Na
+ = 479.2287, found 479.2287 m/z. Enantiomer ratio = 
91:9, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1.5 mL/min; HPLC UV Detector λ = 210 
nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 9:91, CAHB of (E)-18l using (R)-B2 followed by oxidation to yield (S)-22l 
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Preparation of chiral secondary benzylic alcohol (S)-22m: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used in CAHB), the substrate (E)-18m (79 mg, 0.2 mmol) affords the chiral secondary 
benzylic alcohol (S)-22m (64 mg, 78%) as a colorless oil: TLC analysis (2% methanol in 
ethyl acetate) Rf = 0.5; [α]D20 = -42o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.19 
(1H, br s, k), 7.58 (1H, d, J = 3.6 Hz, h), 7.53 (1H, d, J = 8.0 Hz, m), 7.25 (1H, dd, J = 8.0, 
1.0 Hz, l), 6.55 (1H, d, J = 3.6 Hz, g), 4.87 (1H, t, J = 6.0 Hz, e), 4.13-4.00 (4H, m, b+b'), 
2.97 (1H, br s, OH), 2.15-2.05 (2H, m, d), 1.97-1.73 (2H, m, c), 1.68 (9H, s, p), 1.31 (6H, 
t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 149.86 (n),140.48 (j), 135.49 (f), 
130.25 (i), 126.35 (h), 121.13 (m), 120.82 (l), 112.95 (k), 107.24 (g), 83.87 (o), 74.67 (d, 
3JC-P = 16 Hz, e), 61.82 (d, 
2JC-P = 6.0 Hz, b or b'), 61.77 (d, 
2JC-P = 6.0 Hz, b or b'), 32.21 
(d, 2JC-P = 4.5 Hz, d), 28.37 (p), 22.25 (d, 
1JC-P = 142 Hz, c), 16.61 (d, 
3JC-P = 6.0 Hz, a+a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 32.85 ppm; IR (neat) 3359 (O-H), 2981 (aromatic C-
H), 2930 (aliphatic C-H), 1731 (C=O), 1438 (aromatic C=C), 1341 (aromatic C=C), 1251 
(P=O), 1022 (C-O/C-N), 961 (P-O), 726 cm-1; HRMS (ESI) calculated for 
C20H30NO6P+Na
+ = 434.1708, found 434.1711 m/z; Enantiomer ratio = 96:4, determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 50:50 
Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate: 
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(b) R:S = 4:96, CAHB of (E)-18m using (R)-B2 followed by oxidation to yield (S)-
22m: 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22n: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used and CAHB carried out for 12 hours), the substrate (E)-18n (69 mg, 0.2 mmol) affords 
the chiral secondary benzylic alcohol (S)-22n (62 mg, 86%) as a colorless oil: TLC analysis 
(3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -23o (c = 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.18-7.17 (2H, m, h+i), 6.19 (1H, dd, J = 3.0, 2.0 Hz, g), 4.68 (1H, t, J = 6.0 Hz, 
e), 4.14-4.01 (4H, m, b+b'), 3.02 (1H, br s, OH), 2.08-1.74 (4H, m, c+d), 1.58 (9H, s, l), 
1.31 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (162 MHz, CDCl3) δ 148.96 (j), 130.57 (f), 
120.77 (h or i), 116.83 (h or i), 110.25 (g), 83.85 (k), 68.11 (d, 3JC-P = 16 Hz, e), 61.81 (d, 
2JC-P = 6.0 Hz, b or b'), 61.78 (d, 
2JC-P = 6.0 Hz, b or b'), 30.89 (d, 
2JC-P = 4.5 Hz, d), 28.13 
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(l), 21.97 (d, 1JC-P = 142 Hz, c), 16.59 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, 
CDCl3) δ 32.92 ppm; IR (neat) 3361 (O-H), 2980 (aromatic C-H), 2932 (aliphatic C-H), 
1738 (C=O), 1485 (aromatic C=C), 1395 (aromatic C=C), 1346 (aromatic C=C), 1237 
(P=O), 1155 (C-N), 1056 (C-O), 1023 (C-O), 967 (P-O), 729 cm-1; HRMS (ESI) calculated 
for C16H28NO6P+Na
+ = 384.1552, found 384.1553 m/z; Enantiomer ratio = 99:1, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
= 60:40 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 
oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 1:99, CAHB of (E)-18n using (R)-B2 followed by oxidation to yield (S)-22n: 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (R)-22o: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5; Note: 2 eq. of pinBH was 
used in CAHB), the substrate (E)-18o (69 mg, 0.2 mmol) affords the chiral secondary 
benzylic alcohol (R)-22o (61 mg, 85%) as a colorless oil: TLC analysis (2% methanol in 
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ethyl acetate) Rf = 0.5; [α]D20 = -0.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.15-
7.14 (1H, m, i), 6.20-6.19 (1H, m, h), 6.08 (1H, t, J = 3.5 Hz, g), 4.87 (1H, t, J = 6.5 Hz, 
e), 4.26-4.02 (5H, m, b+b'+OH), 2.20-2.02 (3H, m, c(1H)+d), 1.89-1.74 (1H, m, c(1H)), 
1.59 (9H, s, l), 1.31 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 150.36 
(j), 137.38 (f), 122.16 (i), 111.77 (h), 110.49 (g), 84.78 (k), 66.62 (d, 3JC-P = 18 Hz, e), 
61.65 (d, 2JC-P = 6.0 Hz, b or b'), 61.63 (d, 
2JC-P = 6.0 Hz, b or b'), 28.09 (l), 27.77 (d, 
2JC-
P = 4.25 Hz, d), 22.58 (d, 
1JC-P = 142 Hz, c), 16.56 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR 
(162 MHz, CDCl3) δ 32.56 ppm; IR (neat) 3372 (O-H), 2980 (aliphatic C-H), 2933 
(aromatic C-H), 1735 (C=O), 1325, 1228 (P=O), 1054 (C-O), 1022 (C-O), 960 (P-O), 722 
cm-1; HRMS (ESI) calculated for C16H28NO6P+Na
+ = 384.1552, found 384.1555 m/z; 
Enantiomer ratio = 80:20, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 60:40 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 80:20, CAHB of (E)-18o using (R)-B2 followed by oxidation to yield (R)-
22o: 
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Preparation of chiral secondary benzylic alcohol (S)-9o: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18p (78 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22p (69 mg, 83%) as a 
colorless oil: TLC analysis (2% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -20o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.32 (1H, dd, J = 5.0, 3.0 Hz, h), 7.24-7.23 (1H, 
m, i), 7.08 (1H, dd, J = 5.0, 1.25 Hz, g), 4.91-4.87 (1H, m, e), 4.17-4.03 (4H, m, b+b'), 3.02 
(1H, d, J = 4.0 Hz, OH), 2.17-2.02 (2H, m, d), 1.95-1.79 (2H, m, c), 1.34 (3H, t, J = 7.0 
Hz, a or a'), 1.33 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 145.56 
(f), 126.45 (h), 125.71 (g), 121.09 (i), 70.34 (d, 3JC-P = 15 Hz, e), 61.93 (d, 
2JC-P = 6.5 Hz, 
b or b'), 61.90 (d, 2JC-P = 6.5 Hz, b or b'), 31.37 (d, 
2JC-P = 4.5 Hz, d), 22.01 (d, 
1JC-P = 142 
Hz, c), 16.66 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.85 ppm; IR 
(neat) 3368 (O-H), 2983 (aromatic C-H), 2905 (aliphatic C-H), 1441 (aromatic C=C), 1391 
(aromatic C=C), 1224 (P=O), 1052 (C-O), 1020 (C-O), 956 (P-O), 784 cm-1; HRMS (ESI) 
calculated for C11H19O4PS+Na
+ = 301.0639, found 301.0641 m/z; Enantiomer ratio = 
85:15, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
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Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1.5 mL/min; HPLC UV Detector λ = 210 
nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 15:85, CAHB of (E)-18p using 
(R)-B2 followed by oxidation to yield (S)-
22p: 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22q: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18q (78 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22q (67 mg, 80%) as a 
colorless oil: TLC analysis (2% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -13o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.21 (1H, dd, J = 4.5, 2.0 Hz, i), 6.95-6.93 (2H, m, 
g+h), 4.97 (1H, t, J = 6.0 Hz, e), 4.11-3.97 (4H, m, b+b'), 2.13-2.04 (2H, m, d), 1.99-1.69 
(2H, m, c), 1.29 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 148.40 (f), 
126.75 (h), 124.44 (i), 123.61 (g), 69.69 (d, 3JC-P = 16 Hz, e), 61.87 (d, 
2JC-P = 6.0 Hz, b or 
b'), 61.82 (d, 2JC-P = 6.0 Hz, b or b'), 32.22 (d, 
2JC-P = 4.5 Hz, d), 21.88 (d, 
1JC-P = 142 Hz, 
c), 16.54 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.58 ppm; IR (neat) 
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3360 (O-H), 2980 (aromatic C-H), 2904 (aliphatic C-H), 1440 (aromatic C=C), 1391 
(aromatic C=C), 1219 (P=O), 1017 (C-O), 958 (P-O), 697 cm-1; HRMS (ESI) calculated 
for C11H19O4PS+Na
+ = 301.0639, found 301.0639 m/z; Enantiomer ratio = 95:5, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
= 40:60 Isopropanol:Hexanes; Flow rate = 1.5 mL/min; HPLC UV Detector λ = 210 nm, 
25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 5:95, CAHB of (E)-18q using (R)-B2 followed by oxidation to yield (S)-22q.  
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22r: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18r (77.6 
mg, 0.25 mmol) affords the chiral secondary benzylic alcohol (S)-22r (53 mg, 65%) as a 
waxy solid: TLC analysis (1% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -21o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.81-7.79 (2H, m, i or l), 7.71-7.69 (2H, m, i or l), 
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7.36-7.27 (2H, m, j+k), 7.19 (1H, s, g), 5.07 (1H, t, J = 6.0 Hz, e), 4.23-3.99 (5H, m, 
b+b'+OH), 2.22-2.13 (2H, m, d), 1.98-1.80 (2H, m, c), 1.30 (3H, t, J = 7.0 Hz, a or a'), 1.29 
(3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 149.07 (f), 139.75 (h), 
139.46 (m), 124.38 (j or k), 124.20 (j or k), 123.56 (i or l), 122.56 (i or l), 120.21 (g), 70.17 
(d, 3JC-P = 15 Hz, e), 62.00 (d, 
2JC-P = 6.0 Hz, b or b'), 61.93 (d, 
2JC-P = 6.0 Hz, b or b'), 
31.91 (d, 2JC-P = 4.5 Hz, d), 21.77 (d, 
1JC-P = 142 Hz, c), 16.56 (d, 
3JC-P = 6.0 Hz, a+a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 32.54 ppm; IR (neat) 3252 (O-H), 2979 (aromatic C-
H), 2927 (aliphatic C-H), 1219 (P=O), 1027 (C-O), 1011 (C-O), 950 (P-O) cm-1; HRMS 
(ESI) calculated for C15H21O4PS+Na
+ = 351.0796, found 351.0798 m/z; Enantiomer ratio 
= 89:11, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; 
Mobile Phase = 40:60 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ 
= 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 11:89, CAHB of (E)-18r using (R)-B2 followed by oxidation to yield (S)-
22r: 
321 
 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22s: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18s (73 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22s (60 mg, 76%) as a 
colorless oil: TLC analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -5.5o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.37-7.35 (2H, m, h+i), 6.37 (1H, br s, g), 4.70 
(1H, t, J = 6.0 Hz, e), 4.12-3.98 (4H, m, b+b'), 3.64 (1H, br s, OH), 2.05-1.72 (4H, m, c+d), 
1.29 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 143.41 (h), 139.27 (i), 
128.69 (f), 108.60 (g), 66.55 (d, 3JC-P = 16 Hz, e), 61.84 (d, 
2JC-P = 6.5 Hz, b or b'), 61.81 
(d, 2JC-P = 6.5 Hz, b or b'), 30.76 (d, 
2JC-P = 4.5 Hz, d), 21.79 (d, 
1JC-P = 142 Hz, c), 16.55 
(d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.85 ppm; IR (neat) 3357 
(O-H), 2982 (C-H), 1501 (aromatic C=C), 1442 (aromatic C=C), 1391 (aromatic C=C), 
1222 (P=O), 1159, 1016 (C-O), 957 (P-O), 873, 788, 600 cm-1; HRMS (ESI) calculated for 
C11H19O5P+Na
+ = 285.0862, found 285.0867 m/z; Enantiomer ratio = 83:17, determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 60:40 
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Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate 
  
 
(b) R:S = 17:83, CAHB of (E)-18s using (R)-B2 followed by oxidation to yield (S)-22s 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22t: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18t (77 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22t (68 mg, 82%) as a 
colorless oil: TLC analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -11o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 6.10 (1H, d, J = 3.0 Hz, g), 5.87 (1H, dd, J = 3.0, 
1.0 Hz, h), 4.65 (1H, t, J = 6.5 Hz, e), 4.13-3.99 (4H, m, b+b'), 3.44 (1H, br s, OH), 3.16 
(3H, s, j), 2.15-2.00 (2H, m, d), 1.93-1.72 (2H, m, c), 1.29 (6H, t, J = 7.0 Hz, a+a') ppm; 
13C NMR (100 MHz, CDCl3) δ 154.36 (f), 151.73 (i), 107.01 (g), 106.12 (h), 67.44 (d, 3JC-
P = 17 Hz, e), 61.82 (d, 
2JC-P = 6.0 Hz, b or b'), 61.80 (d, 
2JC-P = 6.0 Hz, b or b'), 28.62 (d, 
2JC-P = 4.5 Hz, d), 21.88 (d, 
1JC-P = 142 Hz, c), 16.54 (d, 
3JC-P = 6.0 Hz, a+a'), 13.64 (j) 
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ppm; 31P NMR (162 MHz, CDCl3) δ 32.63 ppm; IR (neat) 3353 (O-H), 2982 (aromatic C-
H), 2925 (aliphatic C-H), 1566, 1442 (aromatic C=C), 1391 (aromatic C=C), 1220 (P=O), 
1018 (C-O), 956 (P-O), 784 cm-1; HRMS (ESI) calculated for C12H21O5P+Na
+ = 299.1024, 
found 299.1023 m/z; Enantiomer ratio = 84:16, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow 
rate = 1.5 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 16:84, CAHB of (E)-18t using (R)-B2 followed by oxidation to yield (S)-22t: 
 
 
 
 
 
Preparation of chiral secondary benzylic alcohol (S)-22u: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18u (73.6 
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mg, 0.25 mmol) affords the chiral secondary benzylic alcohol (S)-22u (43 mg, 55%) as a 
light yellow oil: TLC analysis (2% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -18o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.53-7.51 (2H, m, i), 7.45-7.43 (2H, m, l), 
7.28-7.19 (2H, m, j+k), 6.67 (1H, s, g), 4.90 (1H, dd, J = 7.0, 5.5 Hz, d), 4.13-4.02 (5H, m, 
b+b'+OH), 2.32-2.13 (2H, m, d), 1.99-1.81 (2H, m, c), 1.31 (3H, t, J = 7.0 Hz, a or a'), 1.29 
(3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 159.13 (f), 154.92 (m), 
128.32 (h), 124.16 (j or k), 122.89 (j or k), 121.15 (i), 111.32 (l), 102.98 (g), 67.78 (d, 3JC-
P = 15 Hz, e), 62.03 (d, 
2JC-P = 6.0 Hz, b or b'), 61.01 (d, 
2JC-P = 6.0 Hz, b or b'), 28.71 (d, 
2JC-P = 4.5 Hz, d), 21.56 (d, 
1JC-P = 142 Hz, c), 16.55 (d, 
3JC-P = 5.5 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 32.71 ppm; IR (neat) 3309 (O-H), 2981 (aromatic C-H), 2907 
(aliphatic C-H), 1454 (aromatic C=C), 1224 (P=O), 1021 (C-O), 956 (P-O), 804 cm-1; 
HRMS (ESI) calculated for C15H21O5P+Na
+ = 335.1024, found 335.1031 m/z; Enantiomer 
ratio = 89:11, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; 
Mobile Phase = 40:60 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ 
= 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 21:79, CAHB of (E)-18u using (R)-B2 followed by oxidation to yield (S)-
22u: 
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Preparation of chiral secondary benzylic alcohol (S)-22v: Following the general 
procedure for sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18v (75 
mg, 0.3 mmol) affords the chiral secondary benzylic alcohol (S)-22v (63 mg, 78%) as a 
white solid (regioisomeric ratio, rr = 7:1): Melting point = 124-125 oC; TLC analysis (ethyl 
acetate) Rf = 0.5; [α]D20 = -50o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.35-7.24 
(10 H, m, aryl), 6.39 (1H, br s, NH), 4.72 (1H, br s, e), 4.37 (2H, d, J = 5.75 Hz, a), 4.15 
(1H, br s, OH), 2.35-2.31 (2H, m, c), 2.11-1.96 (1H, m, d) ppm; 13C NMR (100 MHz, 
CDCl3) δ 173.69 (b), 144.58 (aryl), 138.27 (aryl), 128.82 (aryl), 128.51 (aryl), 127.89 
(aryl), 127.63 (aryl), 127.46 (aryl), 125.88 (aryl), 73.57 (e), 43.80 (a), 34.58 (d), 32.96 (c) 
ppm; IR (neat) 3297 (O-H), 3009 (C-H), 1639 (C=O), 1544, 1494 (aromatic C=C), 1453 
(aromatic C=C), 1216, 1060 (C-O), 1027 (C-O), 746, 697, 666 cm-1; Enantiomer ratio = 
94:6, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
Phase = 25:75 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 
nm, 25 oC. HPLC traces: 
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(a) Racemate 
 
 
 
(b) R:S = 6:94, CAHB of (E)-18v using (R)-B1 followed by oxidation to yield (S)-22v: 
 
 
 
 
Absolute Configuration Assignment: The amide-functionalized chiral secondary benzyl 
alcohol 22v obtained from (E)-18v via CAHB using (R)-B2 followed by oxidation was 
converted to 1-phenylbutane-1,4-diol ([α]D20 = -45o (c = 1.0, CHCl3)) via sequential 
hydrolysis (NaOH/H2O) and reduction (LiAlH4). 1-phenylbutane-1,4-diol is a previously 
reported compound in the literature14 and the negative value of optical rotation is expected 
for the (S)-enantiomer. Hence, the chiral secondary benzyl alcohol 22v is assigned “S”.  
 
 
Preparation of chiral secondary alcohol (S)-92: Following the general procedure for 
sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-87 (76 mg, 0.3 mmol) 
affords the chiral secondary alcohol (S)-92 (38 mg, 47%) as a colorless oil (Note: About a 
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3:1:1 ratio of the β-regioisomer : γ-regioisomer : reduced product is formed in CAHB. 
Yield after oxidation is low because of the high polarity of the products and the potential 
hydrolysis of the methyl phosphonate. This example is carried for the absolute 
configuration assignment of the product (S)-37 (vide infra)): TLC analysis (5% methanol 
in ethyl acetate) Rf = 0.5; [α]D20 = +9.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.30-7.18 (5H, m, aryl), 4.05-4.03 (1H, m, c), 3.76 (3H, d, 3JP-H = 11 Hz, a or a'), 3.74 (3H, 
d, 3JP-H = 11 Hz, a or a'), 3.46 (1H, br s, OH), 2.65 (2H, t, J = 7.5 Hz, f), 2.01-1.49 (4H, m, 
d+e) ppm; 13C NMR (100 MHz, CDCl3) δ 142.32 (g), 128.57 (h or i), 128.47 (h or i), 
125.94 (j), 66.48 (d, 2JC-P = 5.5 Hz, d), 52.62 (d, 
2JC-P = 6.0 Hz, a or a'), 52.59 (d, 
2JC-P = 
6.0 Hz, a or a'), 37.92 (d, 3JC-P = 17 Hz, d), 35.80 (f), 32.72 (d, 
1JC-P = 138 Hz, b), 27.36 
(d, 4JC-P = 1.0 Hz, e) ppm; 
31P NMR (162 MHz, CDCl3) δ 33.08 ppm; IR (neat) 3375 (O-
H), 2950 (aromatic C-H), 2852 (aliphatic C-H), 1496 (aromatic C=C), 1453 (aromatic 
C=C), 1223 (P=O), 1023 (C-O), 842, 817, 749, 699 cm-1; Enantiomer ratio = 77:23, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
= 60:40 Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 
oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 23:77, CAHB of (E)-87 using (R)-B2 followed by oxidation to yield (S)-92: 
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Absolute Configuration Assignment: The dimethyl phosphonate substrate (E)-87 is 
prepared because the product alcohol 92 is a previously reported compound in the 
literature.15 CAHB of (E)-87 using (R)-B2 followed by oxidation yields 92 with a positive 
value of optical rotation ([α]D20 = +9.5o (c = 1.0, CHCl3)) which is expected for the “S” 
enantiomer. The configuration of chiral secondary alkyl alcohol 22w (vide infra) is based 
on analogy to this assignment.   
 
Preparation of chiral secondary alcohol (S)-22w: Following the general procedure for 
sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18w (85 mg, 0.3 mmol) 
affords the chiral secondary alcohol (S)-22w (54 mg, 60%) as a colorless oil: TLC analysis 
(2% methanol in ethyl acetate) Rf = 0.5; [α]D20 = +8.5o (c = 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.30-7.17 (5H, m, aryl), 4.20-4.02 (5H, m, b+d), 3.58 (1H, br s, OH), 2.65 
(2H, t, J = 7.5 Hz, g), 2.00-1.49 (c+e+f), 1.34 (3H, t, J = 7.0 Hz, a or a'), 1.33 (3H, t, J = 
7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 142.37 (h), 128.57 (i or j), 128.46 (i 
or j), 125.91 (k), 66.53 (d, 2JC-P = 5.5 Hz, d), 62.02 (d, 
2JC-P = 6.5 Hz, b+b'), 37.88 (d, 
3JC-
P = 17 Hz, e), 35.84 (g), 33.66 (d, 
1JC-P = 138 Hz, c), 27.38 (f), 16.59 (d, 
3JC-P = 6.0 Hz, a 
or a'), 16.56 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 30.51 ppm; IR 
(neat) 3377 (O-H), 2981 (aromatic C-H), 2930 (aliphatic C-H), 1496 (aromatic C=C), 1453 
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(aromatic C=C), 1391 (aromatic C=C), 1219 (P=O), 1020 (C-O), 957 (P-O), 698 cm-1; 
Enantiomer ratio = 75:25, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate: 
 
 
 
(b) R:S = 25:75, CAHB of (E)-18w using (R)-B2 followed by oxidation to yield (S)-
22w: 
 
 
 
 
Absolute Configuration Assignment: The absolute configuration of alcohol 22w is 
based on analogy to the assignment of alcohol 92.  
 
Preparation of chiral secondary alcohol (S)-22x: Following the general procedure for 
sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-18x (85 mg, 0.3 mmol) 
affords the chiral secondary benzylic alcohol (S)-22x (43 mg, 47%) as a colorless oil (Note: 
About a 2.5:1 ratio of benzylic : non-benzylic boronic esters is estimated from 31P NMR 
of crude CAHB mixture): TLC analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -
330 
 
4.5o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.32-7.18 (5H, m, aryl), 4.63 (1H, t, 
J = 6.5 Hz, g), 4.08-3.97 (4H, m, b+b'), 2.99 (1H, br s, OH), 1.83-1.32 (8H, m, c+d+e+f), 
1.27 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 145.20 (h), 128.44 (i or 
j), 127.44 (k), 125.99 (i or j), 74.06 (g), 61.53 (d, 2JC-P = 6.5 Hz, b+b'), 38.70 (f), 26.90 (d 
or e), 26.73 (d or e), 25.62 (d, 1JC-P = 141 Hz, c), 16.55 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 32.31 ppm; IR (neat) 3370 (O-H), 2981 (aromatic C-H), 2932 
(aliphatic C-H), 1452 (aromatic C=C), 1391 (aromatic C=C), 1218 (P=O), 1051 (C-O), 
1020 (C-O), 956 (P-O), 700 cm-1; HRMS (ESI) calculated for C15H25O4P+Na
+ = 323.1388, 
found 323.1395 m/z; Enantiomer ratio = 88:12, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK IC; Mobile Phase = 75:25 Isopropanol:Hexanes; Flow 
rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 12:88, CAHB of (E)-18x using (R)-B2 followed by oxidation to yield (S)-22x 
 
 
 
 
Absolute Configuration Assignment: See section 5.11.6. Kinetic Acylation of Chiral 
Secondary Benzylic Alcohols using Benzotetramisole (BTM).  
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Preparation of chiral secondary alcohol (S)-25: Following the general procedure for 
sequential hydroboration-oxidation (GP4/GP5), the substrate (E)-23 (80 mg, 0.3 mmol) 
affords the chiral secondary benzylic alcohol (S)-25 (68 mg, 79%) as a colorless oil. 
Alternatively, the substrate (Z)-23 (80 mg, 0.3 mmol) affords the chiral secondary benzylic 
alcohol (S)-25 (70 mg, 81%) as a colorless oil: (Note: >20:1 regioisomeric ratio of benzylic 
: non-benzylic boronic esters is estimated from 31P NMR of crude CAHB mixture): TLC 
analysis (3% methanol in ethyl acetate) Rf = 0.5; [α]D20 = -16o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.30-7.13 (5H, m, aryl), 4.61 (1H, dd, J = 7.0, 4.5 Hz, f), 4.05-3.92 
(4H, m, b+b'), 3.49 (1H, br s, OH), 1.84-1.51 (6H, m, c+d+e), 1.25 (3H, t, J = 7.0 Hz, a or 
a'), 1.24 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 145.08 (g), 128.39 
(h or i), 127.35 (j), 125.91 (h or i), 73.57 (f), 61.54 (d, 2JC-P = 6.5 Hz, b+b'), 39.84 (d, 
3JC-
P = 16 Hz, e), 25.39 (d, 
1JC-P = 140 Hz, c), 18.95 (d, 
2JC-P = 5.0 Hz, d), 16.48 (d, 
3JC-P = 6.0 
Hz, a+a') ppm; 31P NMR (162 MHz, CDCl3) δ 32.24 ppm; IR (neat) 3365 (O-H), 2979 
(aromatic C-H), 2905 (aliphatic C-H), 1492 (aromatic C=C), 1452 (aromatic C=C), 1391 
(aromatic C=C), 1226 (P=O), 1020 (C-O), 955 (P-O), 700 cm-1; HRMS (ESI) calculated 
for C14H23O4P+Na
+ = 309.1232, found 309.1239; Enantiomer ratio = 95:5, determined by 
chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 50:50 
Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate 
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(b) R:S = 5:95, CAHB of (E/Z)-23 using (R)-B2 followed by oxidation to yield (S)-25: 
 
 
 
 
Absolute Configuration Assignment: See section 5.11.6. Kinetic Acylation of Chiral 
Secondary Benzylic Alcohols using Benzotetramisole (BTM).  
 
Synthesis of chiral tertiary alcohol (S)-40b: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38b (64 
mg, 0.13 mmol) yields the chiral tertiary alcohol (S)-40b (47 mg, 95%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate:hexanes 7:3) Rf = 0.5; [α]D20 = –5.8o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.54 (2H, d, J = 8.0 Hz, k), 7.31 (2H, d, J = 8.0 Hz, 
k), 4.19-4.06 (4H, m, b+b'), 3.96 (1H, s, OH), 2.70 (2H, t, J = 7.4 Hz, h), 2.07-2.92 (2H, 
m, c), 1.79-1.61 (4H, m, f+g), 1.36-1.31 (9H, m, a+a'+e) ppm; 13C NMR (100 MHz, CDCl3) 
δ 146.53 (aryl), 128.81 (aryl), 125.39 (aryl), 125.36 (aryl), 125.32 (aryl), 125.28 (aryl), 
70.46 (d, 2JC-P = 5 Hz, d), 61.77 (dd, 
2JC-P = 7.0, 4.0 Hz, b+b'), 43.03 (d, 
3JC-P = 11 Hz, f), 
37.41 (d, 1JC-P = 135 Hz, c), 36.09 (h), 28.10 (d, 
3JC-P = 10 Hz, e), 25.77 (g), 16.48 (d, 
3JC-
333 
 
P = 5 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 29.96 ppm; 19F NMR (376 MHz, 
CDCl3) δ -62.31 ppm; IR (neat) 3398 (O-H), 2982 (Aromatic C-H), 2942 (Aliphatic C-H), 
1618, 1640, 1416, 1391, 1323 (C-F), 1222 (P=O), 1161, 1117 (C-O), 1018 (C-O), 959 (P-
O) cm-1; HRMS (ESI) calculated for C17H26F3NaO4P+Na
+ 405.1413, found 405.1420 m/z. 
Enantiomer ratio = >99:1, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 1:1 isopropanol:hexanes; Flow rate = 0.5 mL/min; 
HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 1:99, CAHB of 37b with (R,R)-
T2, then oxidation: 
 
(b). Racemate: 
 
 
 
 
Synthesis of chiral tertiary alcohol (S)-40c: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38c (60 
mg, 0.13 mmol) yields the chiral tertiary alcohol (S)-40c (42, 93%) as a colorless viscous 
oil: TLC analysis (7:3 ethyl acetate : hexanes) Rf = 0.5; [α]D20 = +7.8o (c = 1.0, CHCl3); 1H 
Chrom Perfect Chromatogram Report
Printed on 12/30/2016 6:43:33 PM Page 1 of 1
 1
 
 2
 
 1
3
.2
8
 
 1
4
.4
8
 
 A
=
0
.7
6
%
 
 A
=
9
9
.2
4
%
 
D:\Bochat\AJB-5-xx\AJB-5-10\SC_20161230_S2ROH.0002.RAW SC_20161230_S2ROH
12.5 13.0 13.5 14.0 14.5 15.0 15.5 16.0
Time - Minutes
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
R
e
s
p
o
n
s
e
 -
 M
ill
iV
o
lt
s
Chrom Perfect Chromatogram Report
Printed on 12/30/2016 6:41:55 PM Page 1 of 1
 1
 
 2
 
 1
3
.1
0
 
 1
4
.2
8
 
 A
=
5
2
.1
1
%
 
 A
=
4
7
.8
9
%
 
D:\Bochat\AJB-5-xx\AJB-5-10\SC_20161230_S2_Rac.0001.RAW SC_20161230_S2_Rac
12.5 13.0 13.5 14.0 14.5 15.0 15.5 16.0
Time - Minutes
0
50
100
150
200
250
300
350
400
R
e
s
p
o
n
s
e
 -
 M
ill
iV
o
lt
s
334 
 
NMR (400 MHz, CDCl3) δ 7.26 (2H, d, J = 8.4 Hz, k), 7.13 (2H, d, J = 8.4 Hz, j), 4.18-
4.07 (4H, m, b+b'), 3.94 (1H, s, OH), 2.61 (2H, t, J = 7.4 Hz, h), 2.07-1.92 (2H, m, c), 1.75-
1.59 (4H, m, f+g), 1.40-1.30 (9H, m, a+a'+e) ppm; 13C NMR (100 MHz, CDCl3) δ 140.84 
(i), 131.59 (l), 129.85 (j), 128.50 (k), 70.50 (d, 2JC-P = 5 Hz, d), 61.77 (d, 
2JC-P = 7 Hz, 
b+b'), 43.07 (d, 3JC-P = 12 Hz, f), 37.39 (d, 
1JC-P = 134 Hz, c), 35.62 (h), 28.11 (d, 
3JC-P = 
10 Hz, e), 26.00 (g), 16.55-16.47 (m, a+a') ppm; 31P NMR (162 MHz, CDCl3) δ 30.04 ppm; 
IR (neat) 3410 (O-H), 2980 (aromatic C-H), 2865 (aliphatic C-H), 1492, 1391, 1220 (P=O), 
1051 (C-O), 1023 (C-O), 958 (P-O), 818 cm-1; HRMS (ESI) calculated for 
C16H26ClO4P+Na
+ 371.1149, found 371.1157 m/z. Enantiomer ratio = 99:1, determined by 
chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 1:1 
isopropanol:hexanes; Flow rate = 0.5 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC 
traces: 
(a). R:S = 1:99, CAHB of 37c with (R,R)-
T2, then oxidation: 
 
(b). Racemate: 
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Synthesis of chiral tertiary alcohol (S)-40d: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38d (56 
mg, 0.13 mmol) yielded the chiral tertiary alcohol (S)-40d (38 mg, 91%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +1.2o (c = 1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.14-7.12 (1H, dd, J = 5.1, 1.2 Hz, l), 6.94-6.91 
(1H, m, k), 6.82-6.80 (1H, m, j), 4.17-4.07 (4H, m, b+b'), 3.95 (1H, s, OH), 2.86 (2H, t, J 
= 7.2 Hz, h), 2.06-1.92 (2H, m, c), 1.82-1.65 (4H, m, f+g), 1.38-1.33 (9H, m, a+a'+e) ppm; 
13C NMR (75 MHz, CDCl3) δ 145.18 (i), 126.71 (j), 124.17 (k), 122.93 (l), 70.43 (d, 2JC-P 
= 4.5 Hz, d), 61.68 (d, 2JC-P = 6.75 Hz, b+b'), 42.89 (d, 
3JC-P = 11.25 Hz, f), 37.25 (d, 
1JC-P 
= 135 Hz, c), 30.20 (h), 28.00 (d, 3JC-P = 9.75 Hz, e), 26.49 (g), 16.40 (d, 
3JC-P = 6.75 Hz, 
a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 30.05 ppm; IR (neat) 3408 (O-H), 2979 
(aromatic C-H), 2907 (aliphatic C-H), 2165, 2028, 1741, 1468, 1371, 1220 (P=O), 1145 
(C-O), 1021 (C-O), 958 (P-O) cm-1; HRMS (ESI) calculated for C14H25O4PS 320.1211, 
found 320.1203 m/z. Enantiomer ratio = 98.5:1.5, determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK IC; Mobile Phase = 3:2 isopropanol:hexanes; Flow rate 
= 1.5 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 1:99, CAHB of 37d with (R,R)-
T2, then oxidation: 
 
(b). R:S = 98:2, CAHB of 37d with (S,S)-
T2, then oxidation: 
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Synthesis of chiral tertiary alcohol (S)-40e: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38e (57 
mg, 0.13 mmol) yielded the chiral tertiary alcohol (S)-40e (31 mg, 73%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +5.8o (c 1.0, 
CH3OH); 
1H NMR (300 MHz, CDCl3) δ 5.78 (2H, s, k), 4.18-4.07 (4H, m, b+b'), 3.78-3.74 
(2H, m, h), 2.44 (6H, s, j), 2.09-1.90 (2H, m, c), 1.79-1.60 (5H, m, f+g+OH), 1.38-1.34 
(9H, m, a+a'+e) ppm; 13C NMR (75 MHz, CDCl3) δ 127.27 (i), 105.11 (k), 70.21 (d, 2JC-P 
= 5.25 Hz, d), 61.77 (d, 2JC-P = 6 Hz, b+b'), 43.73 (h), 40.33 (d, 
3JC-P = 11.25 Hz, f), 37.24 
(d, 1JC-P = 135 Hz, c), 27.99 (d, 
3JC-P = 9.75 Hz, e), 25.79 (g), 16.47-16.35 (m, a+a'), 12.55 
(j) ppm; 31P NMR (121 MHz, CDCl3) δ 29.86 ppm; IR (neat) 3348 (O-H), 2977 (sp2 C-H), 
2940 (sp3 C-H), 1370 (C=N), 1241 (P=O), 1051 (C-O), 1023 (C-O), 953 (P-O) cm-1; 
HRMS (ESI) calculated for C16H30NO4P 331.1912, found 331.1905 m/z. Enantiomer ratio 
= 97:3, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
Phase = isopropanol; Flow rate = 1 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC 
traces: 
(a). R:S = 3:97, CAHB of 37e with (R,R)-
T2, then oxidation:  
(b). R:S = 97:3, CAHB of 37e with (S,S)-
T2, then oxidation: 
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Synthesis of chiral tertiary alcohol (S)-40j: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38j 
(46.8 mg, 0.10 mmol) yielded the chiral tertiary alcohol (S)-40j (34 mg, 95%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +2.5o (c 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 8.06-8.04 (2H, m, j), 7.58-7.55 (1H, m, l), 7.47-
7.43 (2H, m, k), 4.36 (2H, t, J = 6.6 Hz, h), 4.19-4.08 (4H, m, b+b'), 4.08 (1H, s, OH), 2.12-
1.71 (6H, m, c+f+g), 1.38-1.31 (9H, m, a+a'+e) ppm; 13C NMR (100 MHz, CDCl3) δ 
166.69 (carbonyl C), 132.98 (l), 130.47 (i), 129.65 (j), 128.44 (k), 70.30 (d, 2JC-P = 5.0 Hz, 
d), 65.27 (h), 61.84 (dd, 2JC-P = 6.0 Hz, b+b'), 39.85 (d, 
3JC-P = 12 Hz, f), 37.47 (d, 
1JC-P = 
135 Hz, c), 28.08 (d, 3JC-P = 9 Hz, e), 23.73 (g), 16.49 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 29.81 ppm; IR (neat) 3370 (O-H), 2979 (aromatic C-H), 2905 
(aliphatic C-H), 1717 (C=O), 1452, 1371, 1273 (P=O), 1023 (C-O), 957 (P-O), 712 cm-1; 
HRMS (ESI) calculated for C17H27O6P+Na
+ 381.1437, found 381.1444 m/z. Enantiomer 
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ratio = >99:1, determined via chiral HPLC analysis: Stationary phase = CHIRALPAK IC; 
Mobile Phase = isopropanol; Flow rate = 1 mL/min; HPLC UV detector λ = 210 nm, rt.  
HPLC traces: 
(a). R:S = 0.6 : 99.4, CAHB of 37j with 
(R,R)-T2, then oxidation: 
 
(b). Racemate 
 
 
 
 
Synthesis of chiral tertiary alcohol (S)-40k: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (R)-38k (45 
mg, 0.10 mmol) yields the chiral tertiary alcohol (S)-40k (33 mg, 95%) as a colorless oil: 
TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = –1.05o (c 1.0, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 7.38-7.25 (5H, m, aryl), 4.52 (2H, s, i), 4.21-4.05 (4H, m, b+b'), 4.01 
(1H, s, OH), 3.51 (2H, t, J = 7.0 Hz, h), 2.12-1.93 (2H, m, c), 1.73-1.70 (4H, m, f+g), 1.37-
1.31 (9H, m, a+a'+e) ppm; 13C NMR (75 MHz, CDCl3) δ 138.47 (aryl), 128.36 (aryl), 
127.65 (aryl), 127.54 (aryl), 72.94 (i), 70.65 (h), 70.34 (d, 2JC-P = 4.5 Hz, d), 61.54 (d, 
2JC-
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P = 9.0, 6.0 Hz Hz, b+b'), 40.11 (d, 
3JC-P = 11.25 Hz, f), 37.30 (d, 
1JC-P = 131 Hz, c), 28.01 
(d, 3JC-P = 9 Hz, e), 24.58 (g), 16.38 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, 
CDCl3) δ 29.95 ppm; IR (neat) 3439 (O-H), 2978 (C-H), 2117, 1790, 1454, 1371, 1316, 
1214 (P=O), 1144, 1052 (C-O), 1023 (C-O), 956 (P-O) cm-1; HRMS (ESI) calculated for 
C17H29O5P 344.1753, found 344.1766 m/z. Enantiomer ratio = 99:1, determined via chiral 
HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = isopropanol; Flow 
rate = 1.5 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 1:99, CAHB of 37k with (R,R)-
T2, then oxidation: 
 
(b). R:S = 99:1, CAHB of 37k with (S,S)-
T2, then oxidation:  
 
 
 
Synthesis of chiral tertiary alcohol (S)-40l: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5 using (R,R)-T2, the chiral tertiary boronic 
ester  (R)-38l (48 mg, 0.10 mmol) yields the chiral tertiary alcohol (S)-40l (35 mg, 91%) 
as a colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +1.4o (c 1.0, 
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CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.39-7.26 (5H, m, aryl), 4.77 (2H, s, j), 4.61 (2H, 
s, i), 4.20-4.01 (4H, m, b+b'), 3.98 (1H, s, OH), 3.64-3.60 (2H, m, h), 2.12-1.92 (2H, m, c), 
1.77-1.64 (4H, m, f+g), 1.37-1.32 (9H, m, a+a'+e) ppm; 13C NMR (75 MHz, CDCl3) δ 
137.92 (aryl), 128.42 (aryl), 127.86 (aryl), 127.68 (aryl), 94.61 (j), 70.30 (d, 2JC-P = 4.5 Hz, 
d), 69.31 (i), 68.26 (h), 61.67 (dd, 2JC-P = 6.0, 3.0 Hz, b+b'), 40.11 (d, 
3JC-P = 12 Hz, f), 
38.31 (d, 1JC-P = 135 Hz, c), 27.98 (d, 
3JC-P = 8.25 Hz, e), 24.47 (g), 16.39 (d, 
3JC-P = 6 Hz, 
a+a') ppm; 31P NMR (121 MHz, CDCl3) δ 29.96 ppm; IR (neat) 3423 (O-H), 2978 (C-H), 
1758, 1454, 1375, 1223 (P=O), 1023 (C-O), 958 (P-O), 737 cm-1; HRMS (ESI) calculated 
for C18H31O6P+Na
+ 397.1750, found 397.1754 m/z. Enantiomer ratio = 98.5:1.5, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
= isopropanol; Flow rate = 1 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 2 : 98, CAHB of 37l with (R,R)-
T2, then oxidation:  
 
(b). R:S = 99:1, CAHB of 37l with (S,S)-
T2, then oxidation: 
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Synthesis of chiral tertiary alcohol (2S,5S)-40m: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (2R,5S)-
38m (57 mg, 0.13 mmol) yields the chiral tertiary alcohol (2S,5S)-40m (41 mg, 95%) as a 
colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +1.1o (c 1.0, CHCl3); 1H NMR 
(700 MHz, CDCl3) δ 4.15-3.99 (7H, m, b+b'+k+OH), 3.53 (1H, dd, J = 7.7, 7.0 Hz, h), 
2.05-1.93 (2H, m, c), 1.74-1.54 (4H, m, f+g), 1.39 (m or m'), 1.33-1.32 (12H, m or m' 
+a+a'+e) ppm; 13C NMR (175 MHz, CDCl3) δ 108.76 (l), 76.12 (h), 70.10 (d, 2JC-P = 5.25 
Hz, d), 69.30 (k), 61.70 (dd, 2JC-P = 8.75, 7.00 Hz, b+b'), 39.23 (d, 
3JC-P = 12.25 Hz, f), 
37.12 (d, 1JC-P = 136.5 Hz, c), 28.08 (d, 
3JC-P = 8.75 Hz, e), 28.06 (g), 26.92 (m or m'), 
25.65 (m or m'), 16.37 (d, 3JC-P = 5.25 Hz, a+a') ppm; 
31P NMR (283 MHz, CDCl3) δ 29.82 
(97%, Major diastereomer), 29.70 (3%, Minor diastereomer) ppm; IR (neat) 3399 (O-H), 
2982 (C-H), 1456, 1369, 1214 (P=O), 1050 (C-O), 1022 (C-O), 958 (P-O), 837 cm-1; 
HRMS (ESI) calculated for C14H29O6P+Na
+ 347.1594, found 347.1604 m/z. 
 
Synthesis of the tertiary alcohol (2R,5S)-40m: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5, the chiral tertiary boronic ester (2S,5S)-
38m (56.5 mg, 0.13 mmol) yields the chiral tertiary alcohol (2R,5S)-40m (40.4 mg, 95%) 
as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +0.76o (c 1.0, CHCl3); 1H 
NMR (700 MHz, CDCl3) δ 4.15-3.99 (7H, m, b+b'+k+OH), 3.52 (1H, dd, J = 7.7, 7.0 Hz, 
h), 2.05-1.95 (2H, m, c), 1.73-1.58 (4H, m, f+g), 1.40 (m or m'), 1.33-1.32 (12H, m or m' 
342 
 
+a+a'+e) ppm; 13C NMR (175 MHz, CDCl3) δ 108.77 (l), 76.23 (h), 70.14 (d, 2JC-P = 3.5 
Hz, d), 69.41 (k), 61.69 (dd, 2JC-P = 8.75, 7.00 Hz, b+b'), 39.37 (d, 
3JC-P = 12.25 Hz, f), 
37.45 (d, 1JC-P = 134.75 Hz, c), 28.08 (g), 27.80 (d, 
3JC-P = 8.75 Hz, e), 26.92 (m or m'), 
25.67 (m or m'), 16.37 (d, 3JC-P = 7 Hz, a+a') ppm; 
31P NMR (283 MHz, CDCl3) δ 29.82 
(2%, Major diastereomer), 29.70 (98%, Minor diastereomer) ppm; IR (neat) 3394 (O-H), 
2982 (C-H), 1456, 1369, 1214 (P=O), 1050 (C-O), 1022 (C-O), 958 (P-O), 839 cm-1; 
HRMS (ESI) calculated for C14H29O6P+Na
+ 347.1594, found 347.1603 m/z. 
 
Synthesis of chiral tertiary alcohol (S)-40p: Following the general procedure for 
oxidation of chiral tertiary boronic esters GP5 using (R,R)-T2, the chiral tertiary boronic 
ester (R)-38p (41 mg, 0.10 mmol) yielded the chiral tertiary alcohol (S)-40p (29 mg, 95%) 
as a colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = –5.05o (c = 
1.0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.32-7.14 (5H, m, aryl), 4.22-4.09 (4H, m, 
b+b'), 4.03 (1H, s, OH), 2.77-2.71 (2H, m, g), 2.19-1.87 (4H, m, c+f), 1.43 (3H, s, e), 1.40-
1.32 (6H, m, a+a') ppm; 13C NMR (75 MHz, CDCl3) δ 142.22 (aryl), 128.40 (aryl), 128.33 
(aryl), 125.79 (aryl), 70.40 (d, 2JC-P = 5.25 Hz, d), 61.82-61.69 (m, b+b'), 45.29 (d, 
3JC-P = 
11.25 Hz, f), 37.35 (d, 1JC-P = 135 Hz, c), 30.44 (g), 28.07 (d, 
3JC-P = 9.75 Hz, e), 16.41 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz) δ 29.98 ppm; IR (neat) 3389.56 (OH), 
2978.57 (C-H), 1473.74, 1217.80 (P=O), 1147.38, 1022.88 (C-O), 953.88, 698.96 cm-1; 
HRMS (ESI) calculated for C15H25O4P = 300.1490, found 300.1483 m/z. Enantiomer ratio 
343 
 
= 98:2, determined via chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile 
Phase = Isopropanol; Flow rate = 1.50 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC 
traces: 
(a). R:S = 3:97, CAHB of 37p with (R,R)-
T2, then oxidation: 
 
(b). R:S = 98.5:1.5, CAHB of 37p with 
(S,S)-T2, then oxidation: 
 
 
 
Synthesis of chiral tertiary benzyl alcohol (S)-43a: Following the general procedure for 
oxidation of chiral tertiary benzylic boronic esters (GP5), the chiral boronic ester (R)-42a 
(36 mg, 75 μmol) yields the chiral tertiary alcohol (S)-43a (25 mg, 88%) as a colorless 
viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +0.8o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.44-7.09 (10H, m, aryl), 5.04 (1H, br s, OH), 4.10-
3.97 (2H, m, b or b'), 3.68-3.59 (1H, m, b or b'), 3.31-3.21 (1H, m, b or b'), 2.61-2.32 (4H, 
m, c+g), 1.97-1.69 (3H, m, e+f(1H)), 1.41-1.29 (4H, m, a or a' + f(1H)), 0.97 (3H, t, J = 
7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 145.57 (d, 3JC-P = 6.0 Hz, l), 142.40 
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(h), 128.52 (aryl), 128.34 (aryl), 128.17 (aryl), 128.79 (aryl), 125.77 (aryl), 125.60 (aryl), 
74.16 (d, 2JC-P = 5.0 Hz, d), 61.81 (d, 
2JC-P = 6.5 Hz, b or b'), 61.49 (d, 
2JC-P = 6.5 Hz, b or 
b'), 44.61 (d, 3JC-P = 15.5 Hz, e), 38.87 (d, 
1JC-P = 136 Hz, c), 36.00 (g), 25.13 (d, 
4JC-P = 
2.5 Hz, f), 16.45 (d, 3JC-P = 6.0 Hz, a or a'), 16.20 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR 
(162 MHz, CDCl3) δ 29.28 ppm; IR (neat) 3376 (O-H), 2985 (sp2 C-H), 2908 (sp3 C-H), 
1451 (aromatic C=C), 1396 (aromatic C=C), 1220 (P=O), 1049 (C-O), 1021 (C-O/C=S), 
965 (P-O), 729, 699 cm-1. HRMS (ESI) calculated for C21H29O4P+Na
+ = 399.1701, found 
399.1706 m/z. Enantiomer ratio = 93:7, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK AS-H; Mobile phase = 95:5 Hexanes:Isopropanol; Flow rate = 1 
mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) R:S = 12:88, CAHB of (E)-41a with 
(R,R)-T2, then oxidation to yield 43a:  
 
(b) R:S = 88:12, CAHB of (E)-41a with 
(S,S)-T2, then oxidation to yield 43a: 
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Synthesis of chiral tertiary benzyl alcohol (2R,5S)-43b: Following the general procedure 
for oxidation of chiral tertiary benzylic boronic esters (GP5), the chiral boronic ester 
(2S,5S)-42b (38 mg, 75 μmol; obtained via CAHB of (Z)-41b using (R,R)-T2) yields the 
chiral tertiary benzyl alcohol product (2R,5S)-43b (24 mg, 82%; 95:5 dr, determined via 
31P NMR analysis) as a light buff colored viscous oil. Alternatively, the chiral boronic ester 
(2S,5S)-42b (38 mg, 75 μmol; obtained via CAHB of (E)-41b using (R,R)-T2) yields the 
chiral tertiary benzyl alcohol product (2R,5S)-43b (23 mg, 80%; 95:5 dr, determined via 
31P NMR analysis) as a buff colored viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) 
Rf = 0.5; [α]D20 = +10.0o (c = 1.0, CHCl3); 1H NMR (400 MHz, C6D6) δ 6.83 (1H, dd, J = 
5.0, 1.0 Hz, aryl), 6.81 (1H, dd, J = 3.5, 1.0 Hz, aryl), 6.71 (1H, dd, J = 5.0, 3.5 Hz, aryl), 
6.21 (1H, br s, OH), 3.88-3.56 (5H, m, b+b'(total 3H)+g+h(1H)), 3.37-3.23 (2H, m, b or 
b'(1H)+h(1H)), 2.28 (1H, dd, J = 19.0, 15.0 Hz, c(1H)), 2.24 (1H, dd, J = 19.0, 15.0 Hz, 
c(1H)), 2.09 (1H, ddd, J = 18.0, 13.0, 5.0 Hz, e(1H)), 1.97 (1H, dd, J = 18.0, 13.0, 4.5 Hz, 
e(1H)), 1.82-1.73 (1H, m, f(1H)), 1.53-1.43 (1H, m, f(1H)), 1.34 (3H, s, j or j'), 1.29 (3H, 
s, j or j'), 0.98 (3H, t, J = 7.0 Hz, a or a'), 0.80 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR 
(100 MHz, C6D6) δ 152.45 (d, 3JC-P = 7.5 Hz, m), 127.19 (aryl), 124.63 (aryl), 123.77 (aryl), 
109.05 (i), 76.70 (g), 73.94 (d, 2JC-P = 5.0 Hz, d), 69.94 (h), 62.15 (d, 
2JC-P = 6.0 Hz, b or 
b'), 61.59 (d, 2JC-P = 6.0 Hz, b or b'), 43.09 (d, 
3JC-P = 14.0 Hz, e), 40.50 (d, 
1JC-P = 135 Hz, 
c), 28.66 (d, 4JC-P = 2.0 Hz, f), 27.64 (j or j'), 26.36 (j or j'), 16.66 (d, 
3JC-P = 6.0 Hz, a or 
a'), 16.56 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, C6D6) δ 28.85 (5%, minor 
diastereomer), 28.77 (95%, major diastereomer) ppm; IR (neat) 3377 (O-H), 2983 
(aromatic C-H), 2933 (aliphatic C-H), 1443 (aromatic C=C), 1368 (aromatic C=C), 1214 
346 
 
(P=O), 1158, 1021 (C-O/C=S), 962 (P-O) cm-1; HRMS (ESI) calculated for 
C17H29O6PS+Na
+ = 415.1320, found 415.1327 m/z. 
 
Synthesis of chiral tertiary benzyl alcohol (2S,5S)-42b: Following the general procedure 
for oxidation of chiral tertiary benzylic boronic esters (GP5), the chiral boronic ester 
(2R,5S)-42b (38 mg, 75 μmol; obtained via CAHB of (Z)-41b using (S,S)-T2) yields the 
chiral tertiary benzyl alcohol product (2S,5S)-43b (25 mg, 85%; 94:6 dr, determined via 
31P NMR analysis) as a light buff colored viscous oil. Alternatively, the chiral boronic ester 
(2R,5S)-42b (38 mg, 75 μmol; obtained via CAHB of (E)-41b using (S,S)-T2) yields the 
chiral tertiary benzyl alcohol product (2S,5S)-43b (24 mg, 82%; 95:5 dr, determined via 
31P NMR analysis) as a buff colored viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) 
Rf = 0.5; [α]D20 = +3.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, C6D6) δ 6.84 (1H, dd, J = 
5.0, 1.0 Hz, aryl), 6.80 (1H, dd, J = 3.5, 1.0 Hz, aryl), 6.72 (1H, dd, J = 5.0, 3.5 Hz, aryl), 
6.21 (1H, br s, OH), 3.85-3.57 (5H, m, b+b'(total 3H)+g+h(1H)), 3.37-3.23 (2H, m, b or 
b'(1H)+h(1H)), 2.31-2.16 (3H, m, c+e(1H)), 1.93-1.76 (2H, m, e(1H)+f(1H)), 1.51-1.43 
(1H, m, f(1H)), 1.38 (3H, s, j or j'), 1.29 (3H, s, j or j'), 0.99 (3H, t, J = 7.0 Hz, a or a'), 0.80 
(3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, C6D6) δ 152.85 (d, 3JC-P = 7.0 Hz, 
m), 127.22 (aryl), 124.58 (aryl), 123.77 (aryl), 109.09 (i), 76.54 (g), 73.77 (d, 2JC-P = 5.0 
Hz, d), 69.88 (h), 62.14 (d, 2JC-P = 6.0 Hz, b or b'), 61.60 (d, 
2JC-P = 6.0 Hz, b or b'), 43.08 
(d, 3JC-P = 14.0 Hz, e), 40.06 (d, 
1JC-P = 136 Hz, c), 28.49 (d, 
4JC-P = 2.0 Hz, f), 27.60 (j or 
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j'), 26.32 (j or j'), 16.66 (d, 3JC-P = 6.0 Hz, a or a'), 16.56 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, C6D6) δ 28.85 (94%, minor diastereomer), 28.77 (6%, major 
diastereomer) ppm; IR (neat) 3378 (O-H), 2981 (aromatic C-H), 2933 (aliphatic C-H), 
1445 (aromatic C=C), 1363 (aromatic C=C), 1213 (P=O), 1158, 1021 (C-O/C=S), 963 (P-
O) cm-1; HRMS (ESI) calculated for C17H29O6PS+Na
+ = 415.1320, found 415.1329 m/z. 
 
Synthesis of chiral tertiary alcohol (S)-43d: Following the general procedure for 
oxidation of chiral tertiary benzylic boronic esters (GP5), the chiral boronic ester (R)-42d 
(34 mg, 75 μmol; obtained via CAHB of (E)-41d using (R,R)-T2) yields the chiral tertiary 
benzyl alcohol product (S)-43d (21 mg, 80%; 97:3 er, determined via chiral HPLC 
analysis) as a light buff colored viscous oil. Alternatively, the chiral boronic ester (R)-42d 
(34 mg, 75 μmol; obtained via CAHB of (Z)-41d using (R,R)-T2) yields the chiral tertiary 
benzyl alcohol product (S)-43d (20 mg, 76%; 70:30 er, determined via chiral HPLC 
analysis) as a buff colored viscous oil. Characterization data for enantioenriched (S)-43d: 
TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = -19.3o (c = 1.0, CHCl3); 1H 
NMR (400 MHz, C6D6) δ 7.42-7.20 (8H, m, aryl), 7.06-7.05 (2H, m, aryl), 5.05 (1H, br s, 
OH), 4.04-3.96 (2H, m, b or b'), 3.66-3.57 (1H, m, b or b'), 3.25-3.04 (3H, m, b or b' 
(1H)+e), 2.55 (1H, dd, J = 19.0, 15.0 Hz, c(1H)), 2.34 (1H, dd appearing as t, J = 16.0 Hz, 
c(1H)), 1.28 (3H, t, J = 7.0 Hz, a or a'), 0.95 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 
MHz, CDCl3) δ 145.54 (d, 3JC-P = 4.5 Hz, j), 136.64 (f), 131.10 (aryl), 128.00 (aryl), 127.85 
(aryl), 127.00 (aryl), 126.61 (aryl), 125.99 (aryl), 74.63 (d, 2JC-P = 4.5 Hz, d), 61.93 (d, 
2JC-
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P = 6.5 Hz, b or b'), 61.50 (d, 
2JC-P = 6.5 Hz, b or b'), 51.62 (d, 
3JC-P = 17.0 Hz, e), 37.26 
(d, 1JC-P = 137 Hz, c), 16.43 (d, 
3JC-P = 6.5 Hz, a or a'), 16.22 (d, 
3JC-P = 6.0 Hz, a or a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 29.49 ppm; IR (neat) 3398 (O-H), 2981 (sp2 C-H), 
2917 (sp3 C-H), 1495 (aromatic C=C), 1392 (aromatic C=C), 1222 (P=O), 1022 (C-O), 
967 (P-O), 728, 698 cm-1. HRMS (ESI) calculated for C19H25O4P+Na
+ = 371.1388, found 
371.1393 m/z. Enantiomer ratio determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK AS-H; Mobile phase = 90:10 Hexanes: Isopropanol; Flow rate = 1 mL/min. 
HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) R:S = 4:96, CAHB of (E)-41d with 
(R,R)-T2, then oxidation to yield 43d:  
 
(b) R:S = 96:4, CAHB of (E)-41d with 
(S,S)-T2, then oxidation to yield 43d: 
 
(c) R:S = 30:70, CAHB of (Z)-41d with 
(R,R)-T2, then oxidation to yield 43d: 
 
(d) R:S = 70:30, CAHB of (Z)-41d with 
(S,S)-T2, then oxidation to yield 43d: 
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Synthesis of chiral tertiary benzyl alcohol (R)-43e: Following the general procedure for 
oxidation of chiral tertiary benzylic boronic esters (GP5), the chiral boronic ester (S)-42e 
(37 mg, 75 μmol) yields the chiral tertiary benzyl alcohol (R)-43e (25 mg, 87%) as a 
colorless viscous oil: TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = -3.0o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.28-7.12 (6H, m, aryl), 3.96 (1H, dd, J = 4.5, 
4.0 Hz, aryl), 6.90 (1H, d, J = 3.5 Hz, aryl), 5.42 (1H, br s, OH), 4.09-3.99 (2H, m, b or b'), 
3.86-3.76 (1H, m, b or b'), 3.59-3.49 (1H, m, b or b'), 2.64-2.52 (2H, m, g), 2.43 (1H, dd, 
J = 22.0, 15.0 Hz, c(1H)), 2.38 (1H, dd, J = 22.0, 15.0 Hz, c(1H)), 2.00-1.73 (3H, m, 
e+f(1H)), 1.57-1.47 (1H, m, e(1H)), 1.32 (3H, t, J = 7.0 Hz, a or a'), 1.10 (3H, t, J = 7.0 
Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 151.39 (d, 3JC-P = 7.5 Hz, m), 142.33 (h), 
128.57 (aryl), 128.40 (aryl), 126.85 (aryl), 125.86 (aryl), 124.23 (aryl), 123.22 (aryl), 73.68 
(d, 2JC-P = 5.0 Hz, d), 62.14 (d, 
2JC-P = 6.5 Hz, b or b'), 61.67 (d, 
2JC-P = 6.5 Hz, b or b'), 
45.65 (d, 3JC-P = 14.0 Hz, e), 39.49 (d, 
1JC-P = 136 Hz, c), 35.94 (g), 25.39 (d, 
4JC-P = 2.0 
Hz, f), 16.50 (d, 3JC-P = 6.5 Hz, a or a'), 16.35 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
13C NMR 
(162 MHz, CDCl3) δ 28.57 ppm; IR (neat) 3380 (O-H), 2982 (sp2 C-H), 2908 (sp3 C-H), 
1453 (aromatic C=C), 1391 (aromatic C=C), 1217 (P=O), 1049 (C-O), 1020 (C-O/C=S), 
962 (P-O), 728, 697 cm-1. HRMS (ESI) calculated for C19H27O4PS+Na
+ = 405.1265, found 
405.1265 m/z. Enantiomer ratio = 93:7, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK AS-H; Mobile phase = 95:5 Hexanes: Isopropanol; Flow rate = 1 
mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces:  
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(a) R:S = 93:7, CAHB of 41e with (R,R)-
T2, then oxidation to yield 43e:  
 
(b) R:S = 7:93, CAHB of 41e with (S,S)-
T2, then oxidation to yield 43e: 
 
 
5.7. Stereospecific Functionalizations of Phosphonate-Functionalized Chiral Boronic 
Esters 
 
Representative procedure for transformation of phosphonate-functionalized chiral 
boronic esters to the corresponding potassium trifluoroborate salts (GP6): This 
transformation was carried out with a slight modification of the original procedure reported 
procedure16 by Aggarwal as follows: To a solution of the chiral tertiary benzylic boronic 
ester (R)-6a (57 mg, 0.15 mmol, 1.0 eq) in methanol (0.75 mL) was added 4.5M solution 
of KHF2 in H2O (0.15 mL, 0.67 mmol, 4.5 eq) dropwise at room temperature and the 
resultant mixture was stirred vigorously for 1 hour. Afterwards, the volatiles were removed 
under reduced pressure and the residue was redissolved in 1:1 Ethanol: Benzene (3 mL) 
and the mixture was evaporated in rotary evaporator to get rid of the solvents. This process 
was repeated 4 times to get rid of pinacol diol. To the resultant residue was added dry 
acetone (3 mL) and the resultant mixture was evaporated. This process was repeated 3 
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times. Finally, the resultant residue was triturated with dry acetone (3 mL x 4) and the 
combined organics were dried under reduced pressure to afford the potassium 
trifluoroborate salt (R)-55 as white powder (47 mg, 87%): [α]D20 = -21o (c = 1.0, CH3CN); 
1H NMR (400 MHz, CD3OD) δ 7.42 (2H, d, J = 8.0 Hz, g), 7.23 (2H, dd, J = 8.0, 7.0 Hz, 
h), 7.05 (2H, dd, J = 7.0 Hz, h), 3.88-3.56 (4H, m, b+b'), 2.62 (1H, t, J = 16.0 Hz, c(1H)), 
2.18 (1H, t, J = 17.0 Hz, c(1H)), 1.45 (3H, s, e), 1.13 (3H, t, J = 7.0 Hz, a or a'), 1.06 (3H, 
t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CD3OD) δ 151.29 (d, 3JC-P = 4.0 Hz, f), 
128.07 (g+h), 124.39 (i), 61.89 (d, 2JC-P = 7.0 Hz, b or b'), 61.87 (d, 
2JC-P = 7.0 Hz, b or b'), 
34.46 (d, 1JC-P = 133 Hz, c), 21.09 (d, 
3JC-P = 4.0 Hz, e), 16.55 (d, 
3JC-P = 6.0 Hz, a or a'), 
16.49 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CD3OD) δ 36.04 ppm; 19F NMR 
(376 MHz, CD3OD) δ -153.57 ppm; 11B NMR (128 MHz, CD3OD) δ 4.87 (br, s) ppm; IR 
(neat) 2983 (aromatic C-H), 2909 (aliphatic C-H), 1599, 1442 (aromatic C=C), 1409 
(aromatic C=C), 1280 (P=O), 1187, 1056 (C-O), 1005 (C-O), 967, 856, 823, 791, 700 cm-
1. HRMS (ESI) calculated for C13H20BF3KO3P+K
+ = 401.0469, found 401.0459 m/z.  
 
Representative procedure for protodeboronation of chiral tertiary benzylic boronic 
esters to the corresponding chiral reduced products (GP7): This transformation was 
carried out according to the procedure reported17 by Aggarwal as follows. To a solution of 
the chiral tertiary benzylic boronic ester (R)-6a (57 mg, 0.15 mmol, 1.0 eq) in toluene (0.75 
mL) was added tetrabutylammonium fluoride (TBAF, 0.3 mL; 1M solution in THF) and 
the resultant mixture was vigorously stirred at 50oC for 6 hours. (Note: Commercial TBAF 
is contaminated with up to 5% H2O and hence addition of water separately was not 
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necessary). Afterwards, the reaction mixture was concentrated and purified by flash 
chromatography on silica gel (ethyl acetate) to afford the chiral reduced product (R)-6a" 
as a colorless oil (33 mg, 85%): TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +15.9 o (c 
= 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.33-7.19 (5H, m, aryl), 4.08-3.87 (4H, m, 
b+b'), 3.29-3.17 (1H, m, d), 2.21-1.96 (2H, m, c), 1.41 (3H, d, J = 7.0 Hz, e), 1.26 (3H, t, 
J = 7.0 Hz, a or a'), 1.22 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 
140.90 (d, 3JC-P = 12.0 Hz, f), 128.68 (g or h), 126.85 (g or h), 126.56 (i), 61.56 (d, 
2JC-P = 
7.0 Hz, b or b'), 61.39 (d, 2JC-P = 6.5 Hz, b or b'), 34.87 (d, 
2JC-P = 3.5 Hz, d), 34.48 (d, 
1JC-
P = 138.5 Hz, c), 23.71 (d, 
3JC-P = 9.0 Hz, e), 16.52 (d, 
3JC-P = 7.0 Hz, a or a'), 16.51 (d, 
3JC-
P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 30.16 ppm; IR (neat) 2978 
(aromatic C-H), 2905 (aliphatic C-H), 1453 (aromatic C=C), 1391 (aromatic C=C), 1246 
(P=O), 1053 (C-O), 1022 (C-O), 953 (P-O), 699 cm-1; Enantiomer ratio = 96:4, determined 
by chiral HPLC analysis: Stationary phase = CHIRALCEL OJ-H; Mobile Phase = 97:3 
Hexanes:Isopropanol; Flow rate = 1.25 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC 
traces: 
(a) R:S = 96:4, CAHB of 5a with (R,R)-T2, 
then protodeboronation:  
 
(b) Racemate: 
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Representative procedure for the cross coupling of chiral tertiary benzylic boronic 
esters with furan/derivatives (GP8): This procedure is carried out with slight 
modifications of the original procedure18 reported by Aggarwal and coworkers as follows. 
A solution of furan (2.5 equiv.) in THF (1.5 ml/0.5 mmol furan) was cooled to -78 oC using 
a dry ice-acetone bath and a solution of nBuLi in hexanes is added dropwise (2.5 equiv.). 
The resultant mixture is stirred at -78 oC for 30 minutes, warmed to 0 oC for 30 minutes 
and then cooled to -78 oC again.  The phosphonate-functionalized chiral boronic ester (1.0 
equiv.) in THF (1.5 mL/0.5 mmol) is added dropwise to the solution of furan-2-yl-lithium 
and the resultant mixture is stirred at -78 oC for 1.5 hours. Afterwards, a solution of NBS 
(2.5 equiv.) in THF (1.5 mL/0.5 mmol) is added dropwise and the resultant mixture stirred 
at room temperature for 1.5 hours. A saturated solution of Na2S2O3 (5 mL) is added and 
the reaction mixture is allowed to warm up to room temperature and stirred for a total of 1 
hour. The resultant mass was extracted with 1:1 ethyl acetate:diethyl-ether and the 
combined organic extracts are washed with brine, dried over Na2SO4 and concentrated in 
vacuum. Purification is carried out by flash chromatography over silica gel (ethyl 
acetate/hexanes). [Tips & Tricks: It is common to see the appearance of minor brominated 
side products in the 31P-NMR spectrum (bromination of the coupled furan ring occurs 
under reaction conditions: 5-10%) which cannot be separated from the desired cross-
coupling product in chromatography. To solve this problem, the mixture post-
chromatography is dissolved in dry THF under N2, cooled to –78oC and 1 eq. of nBuLi is 
added (ascertaining lithium-halogen exchange). The resultant mixture is stirred for 1 hour 
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at –78oC and then quenched with the addition of water. Post-workup, the desired product 
is obtained in high purity.] 
 
Cross-coupling of chiral tertiary benzylic boronic ester (R)-6a with furan: This 
transformation is carried out according to GP8. The chiral tertiary benzylic boronic ester 
(R)-6a (57 mg, 0.15 mmol, 1.0 eq) affords the coupling product (R)-56 (44 mg, 91%) as a 
light-yellow oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +4.1 o (c = 1.0, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 7.35-7.19 (6H, m, g+h+i+m), 6.33 (1H, dd, J = 3.0, 2.0 Hz, l), 
6.20 (1H, d, J = 3.0 Hz, k), 3.97-3.72 (4H, m, b+b'), 2.79-2.59 (2H, m, c), 1.93 (3H, s, e), 
1.18 (3H, t, J = 7.0 Hz, a or a'), 1.16 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, 
CDCl3) δ 160.14 (d, 3JC-P = 12.0 Hz, j), 146.59 (d, 3JC-P = 12.0 Hz, f), 141.56 (m), 128.36 
(g or h), 126.64 (i), 126.26 (g or h), 110.15 (l), 105.83 (k), 61.35 (d, 2JC-P = 6.5 Hz, b+b'), 
41.49 (d, 2JC-P = 2.0 Hz, d), 36.97 (d, 
1JC-P = 141 Hz, c), 26.16 (d, 
3JC-P = 2.0 Hz, e), 16.42 
(d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 27.52 ppm; IR (neat) 2920 
(aromatic C-H), 2853 (aliphatic C-H), 1715, 1496 (aromatic C=C), 1445 (aromatic C=C), 
1240 (P=O), 1054 (C-O), 1024 (C-O), 956 (P-O) cm-1; HRMS (ESI) calculated for 
C17H23O4P+Na
+ = 345.1232, found = 345.1235 m/z. Enantiomer ratio = 97.5:3.5, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC (3 micron); 
Mobile Phase = 80:20 Hexanes:Isopropanol; Flow rate = 1.0 mL/min. HPLC UV detector 
λ = 210 nm, rt. HPLC traces: 
(a) R:S = 96:4, CAHB of 5a with (R,R)-T2, 
then coupling: 
(b) R:S = 3:97, CAHB of 5a with (S,S)-
T2, then coupling: 
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Cross-coupling of chiral tertiary boronic ester (R)-38a with furan: This transformation 
is carried out according to GP8. The chiral tertiary boronic ester (R)-38a (85 mg, 0.2 mmol, 
1.0 eq) affords the coupling product (R)-73a (52 mg, 71%) as a colorless viscous oil: TLC 
analysis (ethyl-acetate/hexanes 3:1) Rf = 0.6; [α]D20 = +1.67o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.33-7.12 (6H, aryl, j+k+l+p), 6.27 (1H, dd, J = 3.2, 1.6 Hz, o), 6.03 
(1H, dd, J = 3.2, 0.4 Hz, n), 4.00-3.89 (4H, m, b+b'), 2.55 (2H, t, J = 7.6 Hz, h), 2.29-2.09 
(2H, m, c), 1.89-1.77 (2H, m, f), 1.53-1.49 (1H, m, g), 1.49 (3H, s, e), 1.35-1.28 (1H, m, 
g), 1.28-1.21 (6H, m, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 160.23 (d, 3JC-P = 10 Hz, 
m), 142.49 (i), 140.97 (p), 128.45 (j), 128.34 (k), 125.79 (l), 109.97 (o), 104.85 (n), 61.31-
61.19 (dd, 2JC-P = 6 Hz, b+b'), 41.44 (d, 
3JC-P = 12 Hz, f), 37.29 (d, 
2JC-P = 2 Hz, d), 36.58 
(d, 1JC-P = 138 Hz, c), 36.20 (h), 26.29 (g), 23.70 (d, 
3JC-P = 4 Hz, e), 16.48 (d, 
3JC-P = 6 
Hz, a+a') ppm; 31P NMR (162 MHz, CDCl3) δ 28.43 ppm; IR (neat) 2978 (aromatic C-H), 
2864 (aliphatic C-H), 1602 (furan C=C), 1243 (P=O), 1054 (C-O), 1025 (C-O), 955 (P-O) 
cm-1. 
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Cross-coupling of chiral secondary benzylic boronic ester (S)-6a with benzofuran: 
This transformation is carried out according to GP8. The chiral secondary benzylic boronic 
ester (R)-19a (95 mg, 0.25 mmol, 1.0 eq) affords the coupling product (S)-68 (63 mg, 68%) 
as a light yellow oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = -15o (c = 1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.51 (1H, d, J = 7.5 Hz, l or o), 7.42 (1H, d, J = 8.0 Hz, l or 
o), 7.36-7.33 (4H, m, aryl), 7.29-7.19 (3H, m, aryl), 6.51 (1H, s, j), 4.15-4.07 (5H, m, 
b+b'+e), 2.55 (1H, br s, d(1H)), 2.30 (1H, br s, d(1H)), 1.83-1.72 (2H, m, c), 1.34 (6H, t, J 
= 7.0 Hz, a+a') ppm; 13C NMR (100 MHz, CDCl3) δ 159.98 (aryl), 155.02 (aryl), 140.92 
(aryl), 128.96 (aryl), 128.20 (aryl), 127.39 (aryl), 123.82 (aryl), 122.81 (aryl), 120.78 
(aryl), 111.24 (aryl), 103.17 (j), 61.81 (d, 2JC-P = 6.5 Hz, b+b'), 46.31 (d, 
3JC-P = 17.5 Hz, 
e), 27.52 (d, 2JC-P = 4.0 Hz, d), 24.16 (d, 
1JC-P = 142 Hz, c), 16.68 (d, 
3JC-P = 6.0 Hz, a+a') 
ppm; 31P NMR (162 MHz, CDCl3) δ 31.47 ppm; IR (neat) 2980 (C-H), 2232, 1716, 1454, 
1230 (P=O), 1024 (C-O), 957 (P-O), 726, 699, 644 cm-1; HRMS (ESI) calculated for 
C21H25O4P+Na
+ = 395.1388, found 395.1392 m/z. Enantiomer ratio = 96:4, determined by 
chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 60:40 
Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate: 
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(b) R:S = 4:96, CAHB of (E/Z)-18a using (R)-B2 followed by cross-coupling to form 
68: 
 
 
 
(c) R:S = 29:71, CAHB of (E/Z)-18a using (R)-B2 followed by cross-coupling using 
Crudden’s Conditions with 2-iodobenzofuran to obtain 68 (GP15; vide infra): 
 
 
 
 
 
Representative procedure for vinylation of phosphonate-functionalized chiral 
boronic esters to the corresponding vinylated derivative (GP9): The transformation is 
carried out using slight modification of the original procedure19 reported by Aggarwal and 
co-workers as follows. To a solution of the chiral boronic ester (1.00 eq) in anhydrous THF 
(10 mL/1 mmol) at –78oC was added a 1M solution of vinyl magnesium bromide in THF 
(6.00 equiv.) dropwise. The reaction mixture is allowed to warm up to room temperature 
and stirred for a total of 2 hours. The reaction mass is cooled to – 78oC and a solution of I2 
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(6.00 equiv.) in methanol (2.5 mL/1 mmol) is added dropwise. The resultant mixture is 
stirred at -78 oC for a total of 2 hours, following which, a suspension of sodium methoxide 
(10 equiv.) in methanol (1.5 mL/1 mmol) is added and the reaction mixture is warmed up 
to room temperature and stirred for a total of 2 hours. The reaction mixture is quenched 
with aqueous Na2S2O3 (sat.) and the phases are separated. The aqueous phase is extracted 
with 1:1 ethyl acetate : diethyl ether and the combined organic layers were washed with 
brine, dried over anhydrous Na2SO4 and concentrated in vacuum. Purification is carried 
out using flash chromatography over silica gel.  
 
Vinylation of the tertiary benzylic boronic ester (R)-6a: This transformation was carried 
out according to GP9. The chiral tertiary benzylic boronic ester (R)-6a (57 mg, 0.15 mmol, 
1.0 eq) affords the vinylated product (S)-57 (30 mg, 71%) as a colorless oil: TLC analysis 
(ethyl acetate) Rf = 0.5; [α]D20 = -7.1 o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.37 (2H, d, J = 8.0 Hz, g), 7.31 (2H, dd, J = 8.0, 7.0 Hz, h), 7.20 (1H, t, J = 7.0 Hz, i), 
6.16 (1H, dd, J = 17.0, 11.0 Hz, j), 5.13 (1H, d, J = 11.0 Hz, k(1H)), 5.08 (1H, d, J = 17.0 
Hz, k(1H)), 3.98-3.67 (4H, m, b+b'), 2.43-2.26 (2H, m, c), 1.67 (3H, s, e), 1.19 (3H, t, J = 
7.0 Hz, a or a'), 1.13 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 146.70 
(d, 3JC-P = 12.0 Hz, j), 146.25 (d, 
3JC-P = 8.5 Hz, f), 128.24 (h), 126.77 (g), 126.41 (i), 
111.85 (k), 61.25 (d, 2JC-P = 6.0 Hz, b or b'), 61.20 (d, 
2JC-P = 6.5 Hz, b or b'), 42.37 (d, 
2JC-
P = 2.0 Hz, d), 37.94 (d, 
1JC-P = 140 Hz, c), 25.97 (d, 
3JC-P = 5.0 Hz, e), 16.45 (d, 
3JC-P = 
6.0 Hz, a or a'), 16.39 (d, 3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 28.47 
ppm; IR (neat) 2978 (sp2 C-H), 2905 (sp3 C-H), 1635 (C=C), 1600 (C=C), 1494 (aromatic 
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C=C), 1445 (aromatic C=C), 1391 (aromatic C=C), 1238 (P=O), 1054 (C-O), 1024 (C-O), 
954 (P-O), 698 cm-1; Enantiomer ratio = 97:3, Determined from derivatives obtained via 
oxophosphonate intermediate 61.   
 
Vinylation of the chiral tertiary boronic ester (R)-38a: This transformation was carried 
out according to GP9. The chiral tertiary benzylic boronic ester (R)-38a (424 mg, 1.00 
mmol, 1.00 eq) affords the vinylated product (S)-38a (302 mg, 93%) as a colorless oil: 
TLC analysis (ethyl-acetate/hexanes 3:1) Rf = 0.6; [α]D20 = +1.12 (c 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.30-7.16 (5H, m, aryl), 5.85 (1H, dd, J = 10.8, 6.4 Hz, m), 5.03-4.94 
(2H, m, n), 4.11-4.03 (4H, m, b+b'), 2.59 (2H, br, h), 1.85 (2H, d, J = 18.8 Hz), 1.58-1.55 
(4H, m, f+g), 1.31 (6H, t, J = 7.1 Hz, a+a'), 1.21 (3H, s, e); 13C NMR (100 MHz, CDCl3) 
δ 146.20 (d, 3JC-P = 10 Hz, m), 142.64 (i), 128.48 (aryl), 128.37 (aryl), 125.79 (aryl), 111.85 
(n), 61.34-61.17 (m, b+b'), 41.40 (d, 3JC-P = 9 Hz, f), 38.27 (d, 
2JC-P = 2 Hz, d), 36.87 (d, 
1JC-P = 138 Hz, c), 36.51 (h), 26.37 (g), 24.14 (d, 
3JC-P = 6 Hz, e), 16.54 (
3JC-P = 6 Hz, a+a'); 
31P NMR (162 MHz, CDCl3) δ 29.62 ppm; IR (neat) 3025.69 (sp2 C-H), 2904.16 (sp3 C-
H), 1636.80 (C=C), 1242.06 (P=O) cm-1; HRMS (ESI) calculated for C18H29O3P+Na
+ 
347.1747, found 347.1756 m/z. Enantiomer ratio = 98:2 (obtained from the derivatives 78a 
and 79a). 
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Vinylation of the chiral tertiary boronic ester (S)-19a: This transformation was carried 
out according to GP9. The chiral tertiary benzylic boronic ester (S)-19a (76 mg, 0.2 mmol, 
1.0 eq) affords the vinylated product (R)-67 (44.5 mg, 79%) as a colorless oil: TLC analysis 
(ethyl acetate) Rf = 0.5; [α]D20 = -11.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.33-7.28 (2H, m, aryl), 7.23-7.18 (3H, m, aryl), 5.98-5.89 (1H, m, k), 5.10-5.06 (2H, m, 
l), 4.14-4.00 (4H, m, b+b'), 7.54 (1H, dt, J = 7.5 Hz, e), 2.10-1.93 (2H, m, d), 1.81-1.55 
(2H, m, c), 1.31 (3H, t, J = 7.0 Hz, a or a'), 1.30 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR 
(100 MHz, CDCl3) δ 143.1750 (f), 141.14 (k), 128.77 (aryl), 127.72 (aryl), 126.70 (aryl), 
115.20 (l), 61.60 (d, 2JC-P = 6.5 Hz, b+b'), 50.48 (d, 
3JC-P = 17.5 Hz, e), 28.07 (d, 
2JC-P = 
4.2 Hz, d), 23.99 (d, 1JC-P = 141.39 Hz, c), 16.60 (d, 
3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR 
(162 MHz, CDCl3) δ 32.20 ppm; IR (neat) 2982 (sp2 C-H), 2905 (sp3 C-H), 1636 (C=C), 
1600 (C=C), 1492 (aromatic C=C), 1452 (aromatic C=C), 1391 (aromatic C=C), 1240 
(P=O), 1055 (C-O), 1024 (C-O), 954 (P-O) cm-1; HRMS (ESI) calculated for 
C15H23O3P+Na
+ = 305.1283, found 305.1284 m/z. Enantiomer ratio = 95:5, determined by 
chiral HPLC analysis (Note: The enantiomers of vinylated product 67 are not separable in 
chiral HPLC. Instead, 67 is treated with BH3 and H2O2 to obtain the alcohol derivative for 
chiral HPLC analysis. The data given here is for the alcohol derivative): Stationary phase 
= CHIRALPAK AS-H; Mobile Phase = 20:80 Isopropanol:Hexanes; Flow rate = 2 
mL/min; HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate of the alcohol derivative of 67: 
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(b) R:S = 5:95, CAHB of (E/Z)-18a using (R)-B2 followed by vinylation to obtain (R)-
67. Hydroboration/oxidation of (R)-67 is carried out to obtain the (S)-alcohol derivative. 
Note: The trace below is for the (S)-enriched alcohol derivative obtained from (R)-
enriched 67.  
 
 
 
 
 
Representative procedure for the reductive ozonolysis of chiral vinyl phosphonates 
(GP10): The transformation was carried out according to the procedure20 reported by Hon 
et. al. as follows: The chiral vinyl phosphonate (1 equiv.) is dissolved in CH2Cl2 (25 mL) 
ozone is bubbled through the reaction mixture for 10 minutes at 0 oC under air. Afterwards, 
triethylamine (5 equiv.) is added and the reaction mixture is stirred at room temperature 
for a total of 3 hours. The reaction mixture is concentrated under reduced pressure and is 
purified via flash chromatography on silica gel.  
362 
 
 
Ozonolysis of the vinylphosphonate (R)-74a: This transformation was carried out 
according to GP10. The vinylphosphonate (R)-74a (162 mg, 0.5 mmol, 1 equiv.) gives the 
phosphonoaldehyde (R)-75a (140 mg, 86%) as a colorless oil: TLC analysis (ethyl-
acetate/hexanes 2:1) Rf = 0.5; [α]D20 = +2.5 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ 
9.42 (1H, d, J = 1.2 Hz, m), 7.29-7.13 (5H, m, aryl), 4.11-4.02 (4H, m, b+b'), 2.62-2.57 
(2H, m, h), 2.08-1.88 (2H, m, c), 1.77-1.46 (2H, m, f+g), 1.32-1.27 (6H, m, a+a'), 1.24 (3H, 
s, e); 13C NMR (75 MHz, CDCl3) δ 203.95 (d, 3JC-P = 9.75 Hz, m), 141.66 (i), 128.37 (aryl), 
128.34 (aryl), 125.93 (aryl), 61.65-61.49 (m, b+b'), 46.88 (d, 2JC-P = 2.25 Hz, d), 36.14 (d, 
3JC-P = 9 Hz, f), 36.08 (h), 30.93 (d, 
1JC-P = 141 Hz, c), 25.84 (g), 20.03 (d, 
3JC-P = 6 Hz, e), 
16.43 (a+a'); 31P NMR (121 MHz, CDCl3) δ 28.42 ppm; IR (neat) 3026.87 (sp2 C-H), 
2980.93 (sp3 C-H), 2707.57 (aldehyde C-H), 1725.22 (C=O), 1236.37 (P=O) cm-1; 
Enantiomer ratio = 98:2 (obtained for the derivative 79a). 
 
Representative procedure for the transformation of chiral vinylphosphonates into 
chiral phosphonate-functionalized carboxylic acids (GP11): The chiral vinyl 
phosphonate is subjected to ozonolysis according to GP10. Lindgren/Pinnick oxidation of 
the same was carried out according to the reported procedure21 by Huang et. al. as follows: 
To a stirred solution of the chiral phosphonoaldehyde in tBuOH (2 mL/0.2 mmol) at room 
temperature, 2-methyl-2-butene (1.5 eq), aq. NaH2PO4 solution (0.50 M, 1.3 eq) and aq. 
NaClO2 solution (0.50 M, 1.3 eq) are sequentially added. The reaction mixture is stirred 
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for a total of ca. 2 hours and then was quenched with the addition of aq. NaHSO3 solution 
(1 mL/0.2 mmol phosphonoaldehyde, 1.0 M). The resulting mixture is extracted with ethyl-
acetate and the combined extracts are washed with brine, dried over anhydrous Na2SO4 
and concentrated in vacuum. Flash chromatography on silica gel is carried out to obtain 
the carboxylic acid.  
 
Transformation of the vinylphosphonate (R)-75a to chiral phosphonate-
functionalized carboxylic acid (R)-77a: This transformation is carried out according to 
GP11. The vinylphosphonate (R)-75a (64 mg, 0.2 mmol) yields the carboxylic acid (R)-
77a (55 mg, 80%) as a colorless viscous oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = 
+5.1 (c 1.0, CHCl3); 
1H NMR (300 MHz, CD2Cl2) δ 10.25 (1H, br s, COOH), 7.25-7.11 
(5H, m, aryl), 4.10-4.00 (4H, m, b+b'), 2.56 (2H, t, J = 6.6 Hz, h), 2.29-2.17 (1H, m, c), 
1.98-1.87 (1H, m, c), 1.69-1.47 (4H, m, f+g), 1.28-1.25 (9H, m, a+a'+e) ppm; 13C NMR 
(75 MHz, CD2Cl2) δ 178.39 (m), 142.23 (aryl), 128.33 (aryl), 128.23 (aryl), 125.72 (aryl), 
62.08-61.85 (m, b+b'), 43.19 (d), 40.16 (d, 3JC-P = 14.25 Hz, f), 36.02 (f+h), 34.21 (d, 
1JC-
P = 138.75 Hz, c), 26.08 (g), 22.39 (d, 
3JC-P = 6.75 Hz, e), 16.14 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CD2Cl2) δ 28.88 ppm; IR (neat) 3025 (O-H), 2981 (sp2 C-H), 2916 
(sp3 C-H), 1717 (C=O), 1453, 1166 (P=O), 1050 (C-O), 1021 (C-O), 961 (P-O) cm-1; 
Enantiomer ratio = 98:2 (Obtained for the derivative 78a).  
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Representative procedure for the ruthenium-catalyzed reductive silylation of chiral 
phosphonoaldehydes (GP12): The synthesis of silyl protected chiral gamma amino 
phosphonate is carried out via reductive silylation of the chiral phosphonoaldehyde 
according to a reported procedure22 by Gunanathan and co-workers as follows: To a stirred 
mixture of the chiral phosphonoaldehyde (1.0 eq) and [Ru(p-cymene)Cl2]2 (3.2 mol%) in 
toluene (0.5 mL/0.10 mmol phosphonoaldehyde) in a 4 mL vial was added triethylsilane 
(1.3 eq) and the resultant mixture is stirred at 50 oC for 9 hours. Afterwards the reaction 
mixture is concentrated and is purified using silica gel chromatography.  
 
Transformation of phosphonoaldehyde (R)-75a to silyl-protected γ-hydroxy 
phosphonate (R)-76a: This transformation is carried out according to GP12. The 
phosphonoaldehyde (R)-75a (33 mg, 0.10 mmol, 1.0 equiv.) yields the silyl-protected γ-
hydroxyphosphonate (R)-76a (32 mg, 72%) as a buff colored oil: TLC analysis (ethyl-
acetate/hexanes 3:7) Rf = 0.5; [α]D20 = –3.38o (c 1.0, CHCl3); 1H NMR (400 MHz, CD2Cl2) 
δ 7.31-7.27 (2H, m, aryl), 7.21-7.17 (3H, m, aryl), 4.12-4.03 (4H, m, b+b'), 3.46-3.39 (2H, 
m, i), 2.60 (2H, t, J = 7.4 Hz, h), 1.83 (2H, d, J = 19.2 Hz, c), 1.64-1.46 (4H, m, f+g), 1.33 
(6H, t, J = 7.1 Hz, a+a'), 1.04 (3H, s, e), 0.97 (9H, t, J = 8.0 Hz, k), 0.60 (6H, q, J = 8.0 Hz, 
j) ppm; 13C NMR (100 MHz, CD2Cl2) δ 142.93 (aryl), 128.57 (aryl), 128.44 (aryl), 125.83 
(aryl), 69.48 (d, 3JC-P = 12 Hz, i), 61.21 (d, 
2JC-P = 7 Hz, b+b'), 37.60 (d, 
3JC-P = 7 Hz, f), 
37.58 (d, 2JC-P = 3 Hz, d), 36.93 (h), 32.55 (d, 
1JC-P = 137 Hz, c), 26.11 (g), 22.63 (d, 
3JC-P 
= 6.0 Hz, e), 16.65 (d, 3JC-P = 6.0 Hz, a+a'), 7.02 (k), 4.59 (j) ppm; 
31P NMR (162 MHz, 
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CD2Cl2) δ 31.24 ppm; IR (neat) 2952 (aromatic C-H), 2875 (aliphatic C-H), 1242 (P=O & 
Si-C), 1088 (C-O & Si-OR), 1055 (C-O & Si-OR), 1026 (Si-OR & P-OR), 954 (P-O) cm-
1.  
 
Representative procedure for the synthesis of chiral β-amino phosphonates via 
Curtius rearrangement (GP13): The transformation is carried out with slight 
modifications of the reported procedure23 by Sigman et. al. as follows: To a stirred mixture 
of the quaternary phosphono-carboxylic acid (1 eq) and triethylamine (3 eq) in dry toluene 
(1 mL/0.1 mmol phosphono-carboxylic acid), diphenyl phosphoryl azide (1.4 eq) is added 
dropwise at room temperature and the resultant mixture heated to reflux for 3 hours. 31P 
NMR analysis shows the disappearance of the starting material peak and a new field upfield 
relative to the starting material corresponding to the isocyanate intermediate. To the 
resultant mixture, dry ethanol (0.3 mL/0.1 mmol phosphono-carboxylic acid) is added and 
the resultant mixture refluxed for 6 hours. Afterwards, the reaction mixture is concentrated, 
and the product purified via flash chromatography on silica gel.  
 
Synthesis of chiral β-aminophosphonate (S)-78a: This transformation was carried out 
according to GP13. The phosphono-carboxylic acid (R)-77a (35 mg, 0.1 mmol, 1.0 equiv.) 
was transformed to chiral β-aminophosphonate (S)-78a (29 mg, 76%), the latter was 
formed as a colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +3.75o 
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(c 1.0, CHCl3); 
1H NMR (300 MHz, CD2Cl2) δ 7.31-7.17 (5H, m, aryl), 5.21 (1H, br s, 
NH), 4.12-4.02 (6H, m, b+b'+i), 2.62 (2H, t, J = 7.8 Hz, h), 2.41-2.30 (1H, m, c), 2.18-2.06 
(1H, m, c), 2.04-1.77 (2H, m, f), 1.67-1.56 (2H, m, g), 1.44 (3H, s, e), 1.31 (6H, t, J = 7.1 
Hz, a+a'), 1.23 (3H, t, J = 7.2 Hz, j) ppm; 13C NMR (75 MHz, CDCl3) δ 155.14 (carbamate 
carbonyl carbon), 142.29 (aryl), 128.35 (aryl), 128.32 (aryl), 125.80 (aryl), 61.46 (d, 2JC-P 
= 6 Hz, b+b'), 60.19 (i), 53.27 (d, 2JC-P = 3.75 Hz, d), 39.91 (d, 
3JC-P = 10.5 Hz, f), 36.00 
(h), 34.65 (d, 1JC-P = 136.5 Hz, c), 25.89 (g), 25.71 (d, 
3JC-P = 7.5 Hz, e), 16.38 (d, 
3JC-P = 
6 Hz, a+a'), 14.58 (j) ppm; 31P NMR (121 MHz, CDCl3) δ 28.04 ppm; IR (neat) 3292 (N-
H), 3026 (aromatic C-H), 2935 (aliphatic C-H), 1713 (C=O), 1388 (C-N), 1229 (P=O), 
1051 (C-O), 1024 (C-O), 957 (P-O) cm-1; Enantiomer ratio = 98:2, determined by chiral 
HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 100% Isopropanol; 
Flow rate = 1 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 2:98, Curtius rearrangement of 
(R)-78a: 
 
(b). R:S = 98:2, Curtius rearrangement of 
(S)-78a:  
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Representative procedure for the synthesis of chiral γ-amino phosphonate via tandem 
reductive amination and trifluoroacetylation (GP14) A mixture of the quaternary chiral 
aldehyde (R)-75a (65 mg, 0.20 mmol, 1.0 eq) and (R)-(+)-Phenylethylamine (26 mg, 0.20 
mmol, 1.0 eq) in methanol (1 mL) was stirred at room temperature for 1 hour. [Note: This 
premixing affords cleaner reductive amination products presumably due to quantitative 
imine formation in methanol as described by Magid et. al24. Reductive aminations carried 
out without premixing in methanol are usually contaminated with product arising from the 
reduction of the aldehyde.] Glacial acetic acid (30 μL, 2.6 eq) is added to the mixture 
followed by sodium cyanoborohydride (13 mg, 1.0 eq) and the resultant mixture is stirred 
at room temperature for 2 hours. The reaction is quenched with the addition of 1 mL of 
20% aqueous NaOH and the resultant mixture stirred for 30 minutes. Afterwards, the 
product is extracted with CH2Cl2 (10 mL x 3) and the combined extracts are dried over 
anhydrous magnesium sulfate and concentrated in vacuum. Flash chromatography on silica 
gel (methanol/ethyl-acetate 1:50) affords the gamma amino phosphonate (R,R)-93a as a 
colorless oil (70 mg, 81%): TLC analysis (methanol/ethyl-acetate 1:50) Rf = 0.5; [α]D20 = 
+17.7o (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.33-7.18 (10H, m, aryl), 4.09-4.03 
(4H, m, b+b'), 3.68 (1H, q, J = 6.8 Hz, j), 2.60-2.57 (2H, m, h), 2.49 (1H, d, J = 12 Hz, i), 
2.26 (1H, d, J = 12 Hz, i), 1.91-1.73 (2H, m, c), 1.56-1.44 (5H, m, f+g+NH), 1.34-1.29 
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(9H, m, a+a'+k), 1.03 (3H, s, e) ppm; 13C NMR (400 MHz, CDCl3) δ 146.59 (aryl), 142.85 
(aryl), 128.58 (aryl), 128.45 (aryl), 128.43 (aryl), 126.83 (aryl), 125.87 (aryl), 61.25 (dd, 
2JC-P = 6 Hz, b+b'), 59.05 (j), 56.44 (d, 
3JC-P = 10 Hz, i), 38.68 (d, 
3JC-P = 8 Hz, f), 36.74 
(h), 36.40 (d, 2JC-P = 3 Hz, d), 33.83 (d, 
1JC-P = 137 Hz, c), 25.89 (g), 24.89 (k), 24.62 (d, 
3JC-P = 9 Hz, e), 16.65 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 31.19 
ppm; IR (neat) 3308 (N-H), 3061 (aromatic C-H), 2978 (aliphatic C-H), 1603 (N-H), 1494 
(aromatic C=C), 1452 (aromatic C=C), 1233 (P=O), 1054 (C-O), 1025 (C-O), 955, 748, 
698 cm-1. Diastereomer ratio (dr) = 98:2 (determined from the 1H and 31P NMR analysis 
of the acylated derivative (R,R)-79a).  
 
Preparation of (R,R)-79a: Trifluoroacetic anhydride (30 µL, 0.21 mmol, 2.1 eq) is added 
to a mixture of (R,R)-93a (44 mg, 0.10 mmol, 1.0 eq) and triethylamine (70 µL, 0.50 mmol, 
5.0 eq) in dry THF (0.5 mL) and the resultant mixture is stirred at room temperature for 2 
hours. Afterwards, saturated NaHCO3 is added (0.5 mL) and the reaction mixture extracted 
with ethyl-acetate (5 mL x 3). The combined organics are washed with brine, concentrated 
in vacuum and purified by flash chromatography on silica gel (ethyl-acetate/hexanes 3:7) 
to afford the product (R,R)-79a (49.5 mg, 94%) as a colorless oil: TLC analysis (ethyl-
acetate/hexanes 3:7) Rf = 0.5; [α]D20 = +10.2o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.39-7.15 (10H, m, aryl), 5.31 (1H, q, J = 6.8 Hz, j), 4.05-3.93 (4H, m, b+b'), 3.43 (1H, 
d, J = 14.4 Hz, i), 3.26 (1H, d, J = 14.8 Hz, i), 2.53 (2H, broad m, h), 1.66-1.24 (15H, m, 
a+a'+c+f+g+k), 0.79 (2.93H, s, e; Major diastereomer), 0.74 (0.07H, s, e; Minor 
diastereomer) ppm; 13C NMR (100 MHz, CDCl3) δ 159.70 (d, 2JC-F = 35 Hz, l), 142.70 
(aryl), 138.54 (aryl), 129.05 (aryl), 128.69 (aryl), 128.59 (aryl), 128.50 (aryl), 128.28 
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(aryl), 125.96 (aryl), 61.30 (dd, 2JC-P = 4.0 Hz, b+b'), 56.04 (j), 52.83 (d, 
3JC-P = 10 Hz, i), 
40.13 (d, 3JC-P = 6 Hz, f), 36.82 (d, 
2JC-P = 3 Hz, d), 36.63 (h), 34.76 (d, 
1JC-P = 136 Hz, c), 
26.33 (g), 24.76 (d, 3JC-P = 10 Hz, e), 18.31 (k), 16.61 (dd, 
3JC-P = 6 Hz, a+a') ppm; 
31P 
NMR (162 MHz, CDCl3) δ 30.09 (Minor diastereomer, 2%), 29.93 (Major diastereomer, 
98%) ppm; 19F NMR (376 MHz, CDCl3) δ –67.41 ppm; IR (neat) 2981 (aromatic C-H), 
2937 (aliphatic C-H), 1687 (C=O), 1496, 1453, 1389, 1199 (P=O), 1136, 1097, 1053, 1025, 
955 cm-1.  
 
Synthesis of diastereomeric γ-aminophosphonate (S,R)-79a: (S)-75a (65 mg, 0.20 
mmol, 1.0 eq) was subjected to reductive amination as per the protocol outlined in GP14. 
Flash chromatography on silica gel afforded the diastereomeric gamma amino phosphonate 
(S,R)-93a as a colorless oil (72 mg, 83%): TLC analysis (methanol/ethyl-acetate 1:50) Rf 
= 0.5; [α]D20 = +12.2o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.33-7.16 (10H, m, 
aryl), 4.12-4.04 (4H, m, b+b'), 3.68 (1H, q, J = 6.8 Hz, j), 2.59-2.55 (2H, m, h), 2.47 (1H, 
d, J = 12 Hz, i), 2.28 (1H, d, J = 12 Hz, i), 1.95-1.71 (2H, m, c), 1.51-1.42 (5H, m, f+g+NH), 
1.35-1.30 (9H, m, a+a'+k), 1.03 (3H, s, e) ppm; 13C NMR (100 MHz, CDCl3) δ 146.59 
(aryl), 142.83 (aryl), 128.56 (aryl), 128.41 (aryl), 126.84 (aryl), 125.85 (aryl), 61.25 (d, 
2JC-P = 7 Hz, b+b'), 59.07 (j), 56.18 (d, 
3JC-P = 9 Hz, i), 39.18 (d, 
3JC-P = 11 Hz, f), 36.70 
(h), 36.34 (d, 2JC-P = 3 Hz, d), 34.03 (d, 
1JC-P = 136 Hz, c), 25.79 (g), 24.94 (k), 24.26 (d, 
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3JC-P = 7 Hz, e), 16.64 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 31.21 
ppm; IR (neat) 3308 (N-H), 3061 (aromatic C-H), 2978 (aliphatic C-H), 1603 (N-H), 1494 
(aromatic C=C), 1452 (aromatic C=C), 1233 (P=O), 1054 (C-O), 1025 (C-O), 955, 748, 
698 cm-1. Diastereomer ratio (dr) = 98:2 (determined from the 1H and 31P NMR analysis 
of the derivative (S,R)-79a).  
 
Preparation of (S,R)-79a: Similar to the procedure outlined for the preparation of (R,R)-
79a, (S,R)-93a (30 mg, 70 μmol, 1.0 eq) yields (S,R)-79a (37 mg, 91%) as a colorless oil: 
TLC analysis (etyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +12.6o (c 1.0, CHCl3);  1H NMR 
(400 MHz, CDCl3) δ 7.38-7.13 (10H, m, aryl), 5.31 (1H, q, J = 6.8 Hz, j), 4.08-3.97 (4H, 
m, b+b'), 3.52 (1H, d, J = 14.4 Hz, i), 3.24 (1H, d, J = 14.8 Hz, i), 2.43 (2H, broad m, h), 
1.96-1.12 (15H, m, a+a'+c+f+g+k), 0.80 (0.06H, s, e; Minor diastereomer), 0.74 (2.94H, s, 
e; Major diastereomer) ppm; 13C NMR (100 MHz, CDCl3) δ 160.07 (d, 2JC-F = 35 Hz, l), 
142.77 (aryl), 138.42 (aryl), 129.97 (aryl), 128.74 (aryl), 128.57 (aryl), 128.51 (aryl), 
128.48 (aryl), 125.93 (aryl), 61.34 (dd, 2JC-P = 4.0 Hz, b+b'), 56.22 (j), 52.31 (d, 
3JC-P = 10 
Hz, i), 39.96 (d, 3JC-P = 6 Hz, f), 36.92 (d), 36.62 (h), 35.16 (d, 
1JC-P = 137 Hz, c), 26.22 
(g), 24.71 (d, 3JC-P = 10 Hz, e), 18.29 (k), 16.61 (dd, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 
MHz, CDCl3) δ 30.05 (Major diastereomer, 98%), 29.90 (Major diastereomer, 2%) ppm; 
19F NMR (376 MHz, CDCl3) δ –67.42 ppm; IR (neat) 2980 (aromatic C-H), 2935 (aliphatic 
C-H), 1690 (C=O), 1496, 1452, 1389, 1197 (P=O), 1138, 1097, 1057, 1025, 956 cm-1.  
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General procedure for palladium-catalyzed cross coupling of chiral secondary 
benzylic boronic esters with 4-iodoanisole (GP15): This transformation is carried out 
with slight modifications of the original procedure25 reported by Crudden and co-workers 
as follows. The chiral secondary benzylic boronic ester (S)-19a (102 mg of 88% purity 
containing 90.0 mg of (S)-19a, 0.23 mmol, 1.00 equiv), 4-iodoanisole (73.0 mg, 0.31 
mmol, 1.35 equiv), Ag2O (72.6 mg, 0.31 mmol, 1.35 equiv), PPh3 (84.0 mg, 0.32 mmol) 
and Pd2(dba)3 (11.4 mg, 12.4 μmol, 10.7 mol% Pd) are taken up in dry THF (4 mL) in an 
oven dry 8 mL vial charged with borosilicate glass beads. The vial is sealed inside the 
glovebox, taken outside and is vigorously shaken for 18 hours in a shaker-incubator at 60 
oC for 18 hours. Afterwards, the reaction mixture is filtered, and the concentrated filtrate 
is purified via silica gel chromatography (ethyl acetate/hexanes 3:1) to afford the desired 
cross-coupled product (S)-69 (50 mg, 60%) as a colorless oil (Note: In this procedure, 
triphenylphosphine oxide is a major side product and it overlaps significantly with the 
cross-coupling product (S)-69. Separating (S)-69 from triphenylphosphine oxide and the 
protodeborylated side product isn’t trivial and traces of triphenylphosphine oxide peaks 
can be seen in the NMR’s of (S)-69.): TLC analysis (ethyl acetate/hexanes 3:1) Rf = 0.4; 
[α]D20 = +6.5o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 7.30-7.28 (2H, m, h), 7.23 
(2H, d, J = 7.25 Hz, g), 7.20-7.18 (1H, t, J = 7.25 Hz, i), 7.16 (2H, d, J = 8.65 Hz, k), 6.85 
(2H, d, J = 8.65 Hz, l), 4.12-4.03 (4H, m, b+b'), 3.90 (1H, t, J = 7.9 Hz, e), 3.78 (3H, s, n), 
2.36-2.29 (2H, m, d), 1.75-1.65 (2H, m, c), 1.31 (6H, t, J = 7.0 Hz, a+a') ppm; 13C NMR 
(100 MHz, CDCl3) δ 158.26 (m), 144.37 (f), 136.07 (j), 128.90 (k),128.71 (g), 127.87 (h), 
126.49 (i), 144.10 (l), 61.63 (d, 2JC-P = 6.5 Hz, b+b'), 55.36 (n), 51.11 (d, 
3JC-P = 18 Hz, e), 
28.56 (d, 2JC-P = 4.0 Hz, d), 24.50 (d, 
1JC-P = 141 Hz, c), 16.62 (d, 
3JC-P = 6.0 Hz, a+a') 
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ppm; 31P NMR (162 MHz, CDCl3) δ 32.11 ppm; IR (neat) 2985 (C-H), 1458 (aromatic 
C=C), 1247 (P=O), 1025 (C-O), 959 (P-O) cm-1; HRMS (ESI) calculated for 
C20H27O4P+Na
+ = 385.1545. found 385.1554 m/z. Enantiomer ratio = 77:23, determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 40:60 
Isopropanol:Hexanes; Flow rate = 1 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 23:77, CAHB of (E/Z)-18a using (R)-B2 followed by cross-coupling with 4-
iodoanisole to form 69.  
 
 
 
 
Absolute configuration assignment: The chiral boronic ester (S)-19a (102 mg of 88% 
purity containing 90.0 mg of (S)-19a, 0.23 mmol, 1.00 equiv) is subjected to cross-coupling 
under Crudden’s Conditions (GP15) with 2-iodobenzofuran (76.0 mg, 0.31 mmol, 1.35 
equiv) to afford (S)-68 (47 mg, 55%; 71:29 er). Matching the HPLC traces of 68 formed 
from (S)-19a with GP8 and GP15 (see HPLC traces under GP8) shows that 68 is formed 
with predominant retention of stereochemistry using GP15. Hence, GP15 with (S)-19a 
occurs with retention of stereochemistry and the configuration of (S)-69 is assigned based 
on this analogy.  
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General procedure for rhodium-catalyzed cross-coupling of chiral secondary benzylic 
boronic esters with 4-nitrobenzaldehyde/oxidation (GP16): The first step of coupling 
is carried out according to Tang’s modification26 of the original procedure27 reported by 
Aggarwal and co-workers as follows. The chiral secondary benzylic boronic ester (S)-19a 
(108 mg of 88% purity containing 95.0 mg of (S)-19a, 0.25 mmol, 1.00 equiv), 4-
nitrobenzaldehyde (50.0 mg, 0.33 mmol, 1.32 equiv) and [Rh(cod)Cl]2 (5.0 mg, 10 μmol, 
4 mol%) are taken up in deoxygenated dioxane (2.5 mL) in an oven dry 8 mL vial charged 
with a stir-bar inside the glovebox. The resultant mixture is stirred vigorously for 10 
minutes. Following this, a solution of KHF2 in deoxygenated H2O (80 mg KHF2 dissolved 
in 1 mL H2O; 0.35 mL, 0.36 mmol, 1.43 eq) is added drop-wise to the above solution and 
the resultant mixture is sealed, taken outside the glovebox and is stirred vigorously at 80 
oC for 16 hours. Afterwards, the reaction mixture is cooled down to room temperature and 
saturated aqueous NH4Cl solution (2 mL) is added and the mixture is extracted with ethyl 
acetate (3 mL x 5). The combined organics are washed with brine, dried over anhydrous 
Na2SO4 and concentrated in vacuum. Flash chromatography over silica gel (1% methanol 
in ethyl acetate) affords the alcohol product as a sticky liquid (84 mg, 82%) as a mixture 
of diastereomers. To a cooled (0 oC) solution of the diastereomeric alcohols (84 mg, 0.2 
mmol) and trichloroisocyanuric acid (47 mg, 0.2 mmol) in dichloromethane (1.0 mL), 
TEMPO (6 mg, 20 mol%) is added and the resultant mixture is stirred at room temperature 
for 2 hours. Afterwards, the reaction mixture is diluted with dichloromethane, washed with 
water and brine and dried over anhydrous Na2SO4. Flash chromatography over silica gel 
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(ethyl acetate) affords the ketone product (S)-70 as a sticky liquid (75 mg, 74% yield over 
2 steps): TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +78o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 8.22 (2H, d, J = 9.0 Hz, l or m), 8.09 (2H, d, J = 9.0 Hz, l or m), 7.41-
7.21 (5H, m, g+h+i), 4.78 (1H, t, J = 7.25 Hz, e), 4.17-4.03 (4H, m, b+b'), 2.56-2.40 (1H, 
m, d(1H)), 2.22-2.10 (1H, m, d(1H)), 1.86-1.65 (2H, m, c), 1.32 (3H, t, J = 7.0 Hz, a or a'), 
1.31 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 197.92 (j), 150.24 (n), 
141.29 (k), 137.80 (f), 129.92 (l), 129.63 (g or h), 128.49 (g or h), 128.04 (i), 123.93 (m), 
61.85 (d, 2JC-P = 6.5 Hz, b or b'), 61.81 (d, 
2JC-P = 6.5 Hz, b or b'), 54.19 (d, 
3JC-P = 12.5 
Hz, e), 26.68 (d, 2JC-P = 4.5 Hz, d), 23.31 (d, 
1JC-P = 141 Hz, c), 16.66 (d, 
3JC-P = 6.0 Hz, 
a+a') ppm; 31P NMR (162 MHz, CDCl3) δ 31.26 ppm; IR (neat) 2981 (C-H), 1687 (C=O), 
1524 (N-O), 1344 (N-O), 1223 (P=O), 1052 (C-O), 1022 (C-O), 946 (P-O), 700 cm-1; 
HRMS (ESI) calculated for C20H24NO6P+Na
+ = 428.1239, found 428.1241 m/z. 
Enantiomer ratio = 6:94, determined by chiral HPLC analysis: Stationary phase = 
CHIRALPAK IC; Mobile Phase = 75:25 Isopropanol:Hexanes; Flow rate = 1.5 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 6:94, CAHB of (E/Z)-18a using (R)-B2 followed by cross-coupling with 4-
nitrobenzaldehyde, followed by oxidation to yield (S)-70: 
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General procedure for SE2 reaction of boron-ate complexes of chiral secondary 
benzylic boronic esters with electrophiles (GP17): This transformation is carried out 
with slight modifications of the original protocol28 developed by Aggarwal and co-workers 
as follows. To a solution of 3,5-bis(trifluoromethyl)bromobenzene (89 mg, 0.3 mmol, 1.5 
equiv) in dry THF (3 mL) at -78 oC is added nBuLi in hexanes (2.5M solution; 0.12 mL, 
0.3 mmol, 1.5 equiv) dropwise. The resultant solution is stirred for 1 hour at -78 oC. A 
solution of (S)-19a (86 mg of 88% purity containing 76 mg (S)-19a, 0.2 mmol, 1.0 equiv) 
in dry THF (1 mL) is added drop-wise to the solution of (3,5-
bis(trifluoromethyl)phenyl)lithium at -78 oC. The resultant mixture is stirred for 30 minutes 
in the dry ice-acetone bath (-78 oC). Following this, the dry ice-acetone bath is replaced by 
a dry ice-acetonitrile bath (-40 oC) and the resultant mixture stirred for another 30 minutes. 
At this point, solid cycloheptatrienyl tetrafluoroborate (71 mg, 0.4 mmol, 2.0 equiv) is 
added to the reaction mixture at room temperature and the reaction mixture stirred 
vigorously for 1 hour. A saturated aqueous solution of NaHCO3 is added and the reaction 
mixture is extracted with ethyl acetate (20 mL x 3). The combined organics are washed 
with brine, dried over anhydrous MgSO4 and concentrated under reduced pressure. Flash 
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chromatography over silica gel (4:1 ethyl acetate/hexanes) affords the desired product (S)-
71 (66 mg, 95%) as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.6; [α]D20 =  -64o (c 
= 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.33-7.30 (2H, m, aryl), 7.25-7.21 (1H, m, 
aryl), 7.14-7.12 (2H, m, aryl), 6.72-6.23 (2H, m, m+m'), 6.28 (1H, dd, J = 9.5, 5.5 Hz, l or 
l'), 6.03 (1H, dd, J = 9.5, 5.5 Hz, l or l'), 5.39 (1H, dd, J = 9.5, 6.0 Hz, k or k'), 4.98 (1H, 
dd, J = 9.5, 6.0 Hz, k or k'), 4.12-3.96 (4H, m, b+b'), 2.90 (1H, td, J = 11, 3.5 Hz, e), 2.40-
2.30 (1H, m, d(1H)), 1.86-1.73 (2H, m, d(1H)+j), 1.63-1.45 (2H, m, c), 1.29 (3H, t, J = 7.0 
Hz, a or a'), 1.28 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 142.59 
(f), 131.11 (m or m'), 130.82 (m or m'), 128.76 (aryl), 128.56 (aryl), 126.89 (aryl), 125.30 
(l or l'), 124.81 (k or k'), 124.63 (k or k'), 124.42 (l or l'), 61.56 (d, 2JC-P = 6.5 Hz, b+b'), 
48.80 (d, 3JC-P = 16.5 Hz, e), 44.55 (j), 27.63 (d, 
2JC-P = 4.5 Hz, d), 23.50 (d, 
1JC-P = 141 
Hz, c), 16.57 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 32.30 ppm; IR 
(neat) 2981 (C-H), 1584 (C=C), 1494 (aromatic C=C), 1453 (aromatic C=C), 1391 
(aromatic C=C), 1237 (P=O), 1054 (C-O), 1022 (C-O), 959 (P-O) cm-1; HRMS (ESI) 
calculated for C20H27O3P+Na
+ = 369.1596, found 369.1595 m/z. Enantiomer ratio = 95:5, 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase 
= 10:90 Isopropanol:Hexanes; Flow rate = 1.0 mL/min; HPLC UV Detector λ = 210 nm, 
25 oC. HPLC traces: 
(a) Racemate 
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(b) R:S = 95:5, CAHB of (E/Z)-18a using (R)-B2 followed by SE2 to form (S)-71: 
 
 
 
 
 
SE2 reaction with 4-methoxybenzenediazonium tetrafluoroborate: This transformation 
is carried according to GP17 with few changes as follows. To a solution of 3,5-
bis(trifluoromethyl)bromobenzene (89 mg, 0.3 mmol, 1.5 equiv) in dry THF (3 mL) at -78 
oC is added nBuLi in hexanes (2.5M solution; 0.12 mL, 0.3 mmol, 1.5 equiv) dropwise. 
The resultant solution is stirred for 1 hour at -78 oC. A solution of (S)-19a (86 mg of 88% 
purity containing 76 mg (S)-19a, 0.2 mmol, 1.0 equiv) in dry THF (1 mL) is added drop-
wise to the solution of (3,5-bis(trifluoromethyl)phenyl)lithium at -78 oC. The resultant 
mixture is stirred for 30 minutes in the dry ice-acetone bath (-78 oC). Following this, the 
dry ice-acetone bath is replaced by a dry ice-acetonitrile bath (-40 oC) and the resultant 
mixture stirred for another 30 minutes. Afterwards the dry ice-acetonitrile bath is removed, 
and the reaction flask is covered with an aluminum foil and placed in an ice-bath. The lights 
inside the fume hood are turned off and solid 4-methoxybenzenediazonium 
tetrafluoroborate (89 mg, 0.4 mmol, 2.0 equiv) is added directly to the reaction mixture 
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under vigorous stirring. The reaction mixture is stirred for 5 minutes at 0oC and is allowed 
to warm up to room temperature over 30 minutes. A saturated aqueous solution of NaHCO3 
is added and the reaction mixture is extracted with ethyl acetate (20 mL x 3). The combined 
organics are washed with brine, dried over anhydrous MgSO4 and concentrated under 
reduced pressure in the rotovap (water bath temperature set at 35 oC). Flash 
chromatography over silica gel (4:1 ethyl acetate/hexanes) affords the desired product (R)-
72 (43 mg, 55%) as a bright orange liquid (Note: The diazo product (R)-72 is highly light 
and heat sensitive. Care is taken to rigorously exclude light from the point the electrophile 
is added to the reaction mixture and through all work-up and purification procedures. The 
temperature of the water bath in rotovap is kept at 35 oC to concentrate the product. The 
product decomposed in chloroform within minutes, however, it is found to be stable in 
dichloromethane, methanol and isopropanol. NMR data for this compound is hence 
recorded using deuterated dichloromethane.): TLC analysis (ethyl acetate) Rf = 0.4; [α]D20 
=  -9.75o (c = 1.0, CH2Cl2); 
1H NMR (400 MHz, CD2Cl2) δ 7.75 (2H, d, J = 9.0 Hz, k), 
7.51 (2H, d, J = 7.3 Hz, g), 7.42 (2H, dd, J = 7.7, 7.3 Hz, h), 7.34 (1H, t, J = 7.3 Hz, i), 
6.99 (2H, d, J = 9.0 Hz, l), 4.71 (1H, t, J = 7.1 Hz, e), 4.13-4.01 (4H, m, b+b'), 3.88 (3H, 
s, n), 2.54-2.33 (2H, m, d), 1.78-1.62 (2H, m, c), 1.31 (6H, t, J = 7.0 Hz, a+a') ppm; 13C 
NMR (175 MHz, CD2Cl2) δ 161.86 (m), 146.07 (j), 140.12 (f), 128.64 (h), 127.88 (g), 
127.64 (i), 124.19 (k), 113.95 (l), 81.85 (d, 3JC-P = 17 Hz, e), 61.49 (d, 
2JC-P = 6.5 Hz, b+b'), 
55.53 (n), 28.44 (d, 2JC-P = 3.5 Hz, d), 22.38 (d, 
1JC-P = 141.5 Hz, c), 16.25 (d, 
3JC-P = 6.0 
Hz, a+a') ppm; 31P NMR (162 MHz, CH2Cl2) δ 30.96 ppm; IR (neat) 2981 (aromatic C-H), 
2832 (aliphatic C-H), 1506 (N=N stretch), 1441 (aromatic C=C), 1391 (aromatic C=C), 
1230 (P=O), 1141 (C-N), 1023 (C-O), 959 (P-O) cm-1; HRMS (ESI) calculated for 
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C20H27N2O4P+Na
+ = 413.1606, found 413.1602 m/z. Enantiomer ratio = 95:5, determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 30:70 
Isopropanol:Hexanes; Flow rate = 1.0 mL/min; HPLC UV Detector λ = 210 nm, 25 oC. 
HPLC traces: 
(a) Racemate 
 
 
 
(b) R:S = 95:5, CAHB of (E/Z)-18a using (R)-B2 followed by SE2 to form (R)-72: 
 
 
 
 
5.8. Miscellaneous transformations of phosphonate-functionalized chiral tertiary 
boronic esters without chromophores to determine enantiomer ratios 
 
Synthesis of chiral vinyl phosphonate (R)-74f: Following the general procedure for 
vinylation of chiral tertiary boronic esters (GP9), the chiral tertiary boronic ester (R)-38f 
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(81 mg, 0.20 mmol) yields the chiral vinyl phosphonate (R)-74f (56 mg, 91%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = –0.6o (c 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 5.86 (1H, dd, J = 17.2, 10.8 Hz, m), 5.03-4.94 (2H, 
m, n), 4.14-4.00 (4H, m, b+b'), 1.85 (2H, d, J = 18.8 Hz, c), 1.53-1.21 (21H, m, 
a+a'+e+f+g+h+i+j+k) 0.88 (3H, t, J = 6.8 Hz, l) ppm; 13C NMR (100 MHz, CDCl3) δ 
146.59 (d, 3JC-P = 10 Hz, m), 111.57 (n), 61.31-61.13 (m, b+b'), 41.90 (d, 
3JC-P = 10 Hz, f), 
38.28 (d, 2JC-P = 3 Hz, d), 36.85 (d, 
1JC-P = 135 Hz, c), 31.99, 30.28, 29.42, 24.29, 24.14 
(d, 3JC-P = 6 Hz, e), 22.76 (g), 16.52 (d, 
3JC-P = 6 Hz, a+a'), 14.19 (l) ppm; 
31P NMR (162 
MHz, CDCl3) δ 29.86 ppm; IR (neat) 2956 (sp2 C-H), 2856 (sp3 C-H), 1637 (C=C), 1466, 
1390, 1246 (P=O), 1055 (C-O), 1023 (C-O), 953 (P-O) cm-1.  
 
Synthesis of chiral phosphonoaldehyde (R)-75f: Following the general procedure for 
ozonolysis of chiral vinyl phosphonates (GP10), the chiral vinyl phosphonate (R)-74f (46 
mg, 0.15 mmol) yields the desired product (R)-75f (38 mg, 83%) as a colorless oil: TLC 
analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +2.05o (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) 9.45 (d, J = 1.6 Hz, m), 4.13-4.04 (4H, m, b+b'), 2.10-1.92 (2H, m, c), 1.66-
1.56 (2H, m, f), 1.35-1.16 (19H, m, a+a'+e+g+h+i+j+k), 0.89-0.86 (3H, m, l) ppm; 13C 
NMR (100 MHz, CDCl3) δ 204.42 (d, 3JC-P = 10 Hz, m), 61.83-61.69 (m, b+b'), 47.16 (d, 
2JC-P = 3 Hz, d), 37.00 (d, 
3JC-P = 10 Hz, f), 31.94, 31.10 (d, 
1JC-P = 142 Hz, c), 30.19, 29.29, 
24.15, 22.79, 20.19 (d, 3JC-P = 5 Hz, e), 16.56 (d, 
3JC-P = 6 Hz, a+a'), 14.25 (l) ppm; 
31P 
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NMR (162 MHz, CDCl3) δ 28.67 ppm; IR (neat) 2923 (sp2 C-H), 2856 (sp3 C-H), 1727 
(C=O), 1606, 1442, 1244 (P=O), 1053 (C-O), 1025 (C-O), 958 (P-O) cm-1.  
 
Synthesis of chiral γ-amino phosphonate (R,R)-79f: Following the general procedure for 
the synthesis of chiral γ-amino phosphonates via tandem reductive amination and 
trifluoroacetylation (GP14), the chiral phosphonoaldehyde (R)-75f (31 mg, 0.10 mmol) 
yields the  diastereomeric γ-amino phosphonate (R,R)-79f (36 mg; 71% overall) as a light 
yellow oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.5; [α]D20 = +9.7o (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) 7.04-7.32 (5H, m, aryl), 5.33-5.27 (1H, m, n), 4.11-3.92 (4H, 
m, b+b'), 3.43 (1H, d, J = 14.6 Hz, m), 3.21 (1H, d, J = 14.6 Hz, m), 1.66-1.17 (23H, m, 
a+a'+c+f+g+h+i+j+k+o), 0.88-0.85 (3H, m, l), 0.81 (2.91H, s, e; Major diastereomer), 
0.704 (0.09H, s, e; Minor diastereomer) ppm; 13C NMR (100 MHz, CDCl3) δ 159.71 (d, 
2JC-F = 35 Hz, CF3C=O), 138.62 (aryl), 129.05 (aryl), 128.66 (aryl), 128.23 (aryl), 61.28-
61.19 (m, b+b'), 56.03 (n), 52.87 (d, 3JC-P = 10 Hz, m), 40.58 (d, 
3JC-P = 6 Hz, f), 36.90 (d, 
2JC-P = 3 Hz, d), 34.66 (d, 
1JC-P = 136 Hz, c), 32.07, 30.40, 29.56, 24.86 (d, 
3JC-P = 10 Hz, 
e), 24.12, 22.85, 18.36 (o), 16.59 (d, 3JC-P = 6 Hz, a+a'), 14.31 (l) ppm; 
31P NMR (162 
MHz, CDCl3) 30.28 (3%; Minor diastereomer), 30.14 (97%; Major diastereomer) ppm; 
19F 
NMR (376 MHz, CDCl3) δ –67.41 (97%; Major diastereomer), –67.45 (3%; Minor 
diastereomer) ppm; IR (neat) 2989 (aromatic C-H), 2855 (aliphatic C-H), 1689 (C=O), 
1578 (C=O), 1453, 1202 (P=O), 1137 (C-F), 1053 (C-O), 1026 (C-O), 956 (P-O) cm-1; 
HRMS (ESI) calculated for C25H41F3NO4P+Na
+ 530.2618, found 530.2625 m/z. 
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Synthesis of chiral γ-amino phosphonate (S,R)-79f: Following the general procedure for 
the synthesis of chiral γ-amino phosphonates via tandem reductive amination and 
trifluoroacetylation (GP14), the enantiomeric chiral phosphonoaldehyde (S)-75f (31 mg, 
0.1 mmol) yields the  diastereomeric γ-amino phosphonate (S,R)-79f (37 mg; 73% overall) 
as a light yellow oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.5; [α]D20 = +8.3o (c 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) 7.38-7.31 (5H, m, aryl), 5.33-5.27 (1H, m, n), 
4.07-3.94 (4H, m, b+b'), 3.52 (1H, d, J = 14.4 Hz, m), 3.20 (1H, d, J = 14.4 Hz, m), 1.96-
0.90 (23H, m, a+a'+c+f+g+h+i+j+k+o), 0.88-0.85 (3H, m, l), 0.81 (0.09H, s, e; Minor 
diastereomer), 0.704 (2.91H, s, e; Major diastereomer) ppm; 13C NMR (100 MHz, CDCl3) 
δ 159.73 (d, 2JC-F = 35 Hz, CF3C=O), 138.48 (aryl), 128.95 (aryl), 128.75 (aryl), 128.56 
(aryl), 61.45-61.14 (m, b+b'), 56.22 (n), 52.43 (d, 3JC-P = 10 Hz, m), 40.27 (d, 
3JC-P = 6 Hz, 
f), 37.02 (d, 2JC-P = 3 Hz, d), 35.24 (d, 
1JC-P = 136 Hz, c), 32.09, 30.35, 29.53, 24.66 (d, 
3JC-P = 11 Hz, e), 23.96, 22.87, 18.34 (o), 16.60 (dd, 
3JC-P = 6 Hz, a+a'), 14.31 (l) ppm; 
31P 
NMR (162 MHz, CDCl3) 30.28 (97%; Major diastereomer), 30.14 (3%; Minor 
diastereomer) ppm; 19F NMR (376 MHz, CDCl3) δ –67.41 (3%; Minor diastereomer), –
67.45 (97%; Major diastereomer) ppm; IR (neat) 2990 (aromatic C-H), 2855 (aliphatic C-
H), 1688 (C=O stretch), 1580 (C=O stretch), 1453, 1203 (P=O), 1135 (C-F), 1053 (C-O), 
1023 (C-O), 953 (P-O) cm-1.  
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Synthesis of furan-coupled derivative (R)-73g: Following the general procedure for cross 
coupling of chiral tertiary boronic esters with furan (GP8), the chiral tertiary boronic ester 
(R)-38g (77 mg, 0.20 mmol) yields the furan-coupled derivative (R)-73g (45 mg, 71%) as 
a colorless oil: TLC analysis (ethyl-acetate/hexanes 7:3) Rf = 0.5; [α]D20 = +3.75o (c =1.0, 
CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.34 (1H, d, J = 1.2 Hz, m), 6.28-6.27 (1H, m, l), 
6.05-6.04 (1H, m, k), 4.01-3.89 (4H, m, b+b'), 2.31-2.07 (2H, m, c), 1.81-1.68 (2H, m, f), 
1.48-1.42 (4H, overlap of singlet & multiplet, e+h), 1.29-1.20 (6H, m, a+a'), 1.07-0.82 (8H, 
m, g+i) ppm; 13C NMR (75 MHz, CDCl3) δ 160.35 (d, 3JC-P = 9.75 Hz, j), 140.78 (m), 
109.80 (l), 104.68 (k), 61.20-61.04 (m, b+b'), 39.60 (d, 3JC-P = 11.25 Hz, f), 36.55 (d, 
1JC-
P = 138.75 Hz, c), 35.15 (d, 
2JC-P = 3 Hz, d), 33.16 (d, 
4JC-P = 1.5 Hz, g), 28.34 (h), 23.49 
(d, 3JC-P = 3.75 Hz, e), 22.60 (i), 16.37 (m, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 28.64 
ppm; IR (neat) 2954.90 (aromatic C-H), 2870.22 (aliphatic C-H), 1714.51 (furyl C-O), 
1289.93 (P=O), 1053.23 (C-O), 954.55 (P-O), 729.68 cm-1; HRMS (ESI) calculated for 
C16H29O4P 316.1803, found 316.1800 m/z. Enantiomer ratio = 98:2, determined via chiral 
HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile phase = 1:1 hexanes : 
isopropanol; Flow rate = 1.0 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 2 : 98, cross coupling of (R)-38g: 
 
(b). R:S = 2 : 98, cross coupling of (S)-
38g: 
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Synthesis of chiral vinyl phosphonate (R)-74i: Following the general procedure for 
vinylation of chiral tertiary boronic esters (GP9), the chiral tertiary boronic ester (R)-38i 
(56 mg, 0.10 mmol) yields the chiral vinyl phosphonate (R)-74i (40 mg, 88%) as a colorless 
viscous oil: TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = –3.50o (c =1.0, 
CH2Cl2); 
1H NMR (400 MHz, DMSO-d6, 353K) δ 7.35-7.23 (5H, m, aryl), 5.83 (1H, dd, 
J = 17.4, 11.2 Hz, m), 4.97-4.91 (2H, m, n), 4.38 (2H, s, i), 4.01-3.94 (4H, m, b+b'), 3.16-
3.10 (2H, br m, h), 1.78 (2H, d, J = 18.4 Hz, c), 1.46-1.41 (13H, m, f+g+l), 1.24 (6H, t, J 
= 7.0 Hz, a+a'), 1.11 (3H, s, e) ppm; 13C NMR (100 MHz, DMSO-d6, 353K) δ 154.57 (j), 
145.85 (d, 3JC-P = 10 Hz, m), 138.36 (aryl), 127.78 (aryl), 126.77 (aryl), 126.37 (aryl), 
110.83 (n), 78.24 (k), 60.10 (dd, 2JC-P = 7.0, 4.0 Hz, b+b'), 49.51 (i), 46.61 (h), 37.34 (d, 
3JC-P = 9 Hz, f), 37.15 (d, 
2JC-P = 2 Hz, d), 35.58 (d, 
1JC-P = 137 Hz, c), 27.65 (l), 23.60 (d, 
3JC-P = 7.0 Hz, e), 22.31 (g), 15.64 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 MHz, DMSO-
d6, 353K) δ 28.48 ppm; IR (neat) 2976 (aromatic C-H), 2930 (aliphatic C-H), 1689 (C=O), 
1454, 1413, 1390, 1364, 1242 (P=O), 1162 (C-N), 1054 (C-O), 1025 (C-O), 955 (P-O) cm-
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1. [Note: NMR data for this molecule were recorded at a higher temperature (80oC, 353K) 
to speed up the interconversions between the tertiary amide rotamers at the NMR time 
scale which resulted in clean spectra. Room temperature NMR shows broadened peaks 
which resulted due to slow interconversions between the rotamers.] 
 
Synthesis of chiral phosphonoaldehyde (R)-75i: Following the general procedure for 
ozonolysis of chiral vinyl phosphonates (GP10), the chiral vinyl phosphonate (R)-74i (35 
mg, 75 μmol) yields the chiral phosphonoaldehyde (R)-75i (27 mg, 78%) as a colorless oil: 
TLC analysis (ethyl-acetate/hexanes 1:1) Rf = 0.5; [α]D20 = –2.50o (c =1.0, CH2Cl2). 1H 
NMR (400 MHz, DMSO-d6, 353K) δ 9.42 (1H, s, m), 7.35-7.23 (5H, m, aryl), 4.38 (2H, 
s, i), 4.03-3.96 (4H, s, b+b'), 3.13 (2H, t, J = 7.0 Hz, h), 2.06-1.88 (2H, m, c), 1.53-1.36 
(13H, m, f+g+l), 1.25 (6H, t, J = 7.0 Hz, a+a'), 1.11 (3H, s, e) ppm; 13C NMR (100 MHz, 
DMSO-d6, 353K) δ 204.48 (d, 3JC-P = 9.0 Hz, m), 155.65 (j), 139.40 (aryl), 128.83 (aryl), 
127.84 (aryl), 127.44 (aryl), 79.47 (k), 61.58 (d, 2JC-P = 5.0 Hz, b+b'), 50.67 (i), 47.55 (h), 
46.77 (d), 33.90 (d, 3JC-P = 10 Hz, f), 31.76 (d, 
1JC-P = 139 Hz, c), 28.72 (l), 22.95 (g), 19.92 
(d, 3JC-P = 6.0 Hz, e), 16.59 (d, 
3JC-P = 5.0 Hz, a+a') ppm; 
31P NMR (162 MHz, DMSO-d6, 
353K) δ 27.70 ppm; IR (neat) 2977 (aromatic C-H), 2915 (aliphatic C-H), 1727 (aldehyde 
C=O), 1687 (carbamate C=O), 1454, 1414, 1365, 1241 (P=O), 1160 (C-N), 1052 (C-O), 
1023 (C-O), 958 (P-O) cm-1.  
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Synthesis of chiral γ-amino phosphonate (R,R)-79i: Following the general procedure for 
the synthesis of chiral γ-amino phosphonates via tandem reductive amination and 
trifluoroacetylation (GP14), the chiral phosphonoaldehyde (R)-75i (23 mg, 50 μmol) yields 
the  diastereomeric γ-amino phosphonate (R,R)-79i (24 mg; 73% overall) as a light yellow 
oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.4; [α]D20 = +11.2o (c 1.0, CHCl3); 1H 
NMR (400 MHz, DMSO-d6, 373K) δ 7.42-7.23 (10H, m, aryl), 5.13 (1H, br s, n), 4.38 
(2H, s, i), 3.98-3.89 (4H, m, b+b'), 3.47 (1H, d, J = 14.6 Hz, m), 3.29 (1H, d, J = 14.6 Hz, 
m), 3.10 (2H, t, J = 7.2 Hz, h), 1.70 (3H, d, J = 6.8 Hz, o), 1.60-1.33 (15H, m, c+f+g+l), 
1.22 (6H, td, J = 7.01, 4.10 Hz, a+a'), 0.87 (3H, s, e) ppm; 13C NMR (100 MHz, DMSO-
d6, 373K) δ 154.45 (j), 138.47 (aryl), 138.26 (aryl), 127.93 (aryl), 127.62 (aryl), 127.27 
(aryl), 126.64 (aryl), 127.59 (aryl), 126.22 (aryl), 78.18 (k), 60.10 (d, 2JC-P = 7 Hz, b+b'), 
49.47 (i), 46.56 (h), 36.08 (d, 2JC-P = 3 Hz, d), 35.92 (d, 
3JC-P = 6.0 Hz, f), 33.91 (d, 
1JC-P = 
136 Hz, c), 27.52 (l), 23.52 (d, 3JC-P = 9.0 Hz, e), 21.82 (g), 17.26 (o), 51.41 (d, 
3JC-P = 6 
Hz, a+a') ppm; 31P NMR (162 MHz, DMSO-d6, 373K) δ 28.53 ppm; 19F NMR (376 MHz, 
DMSO-d6, 373K) δ -66.54 ppm; IR (neat) 2978 (aromatic C-H), 2850 (aliphatic C-H), 
1700 (amide C=O stretch), 1689 (carbamate C=O stretch), 1455, 1276 (P=O), 1142 (C-F), 
1053 (C-O), 1027 (C-O), 959 (P-O) cm-1; HRMS (ESI) calculated for C33H48F3N2O6P+Na
+ 
679.3100, found 679.3109 m/z. Diastereomer ratio is estimated to be >20:1 by comparison 
of the NMRs with the diastereomeric (S,R)-79i.  
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Synthesis of chiral γ-amino phosphonate (S,R)-79i: Following the general procedure for 
the synthesis of chiral γ-amino phosphonates via tandem reductive amination and 
trifluoroacetylation (GP14), the enantiomeric chiral phosphonoaldehyde (S)-75i (23 mg, 
50 μmol) yielded the  diastereomeric γ-amino derivative (S,R)-79i (25 mg; 76% overall) as 
a light yellow oil: TLC analysis (ethyl-acetate/hexanes 3:7) Rf = 0.4; [α]D20 = +10.2o (c 1.0, 
CHCl3); 
1H NMR (400 MHz, DMSO-d6, 373K) δ 7.39-7.22 (10H, m, aryl), 5.12 (1H, br 
s, n), 4.37 (2H, s, i), 3.99-3.90 (4H, m, b+b'), 3.43 (1H, d, J = 14.6 Hz, m), 3.35 (1H, d, J 
= 14.6 Hz, m), 3.04 (2H, t, J = 7.2 Hz, h), 1.85-1.52 (5H, m, o+c), 1.46-1.35 (13H, m, 
f+g+l), 1.24-1.96 (6H, m, a+a'), 0.84 (3H, s, e) ppm; 13C NMR (100 MHz, DMSO-d6, 
373K) δ 154.46 (j), 138.50 (aryl), 138.28 (aryl), 127.92 (aryl), 127.65 (aryl), 127.27 (aryl), 
126.74 (aryl), 126.64 (aryl), 126.25 (aryl), 78.20 (k), 60.16 (d, 2JC-P = 7 Hz, b+b'), 49.45 
(i), 46.56 (h), 36.12 (d, 2JC-P = 3 Hz, d), 33.88 (d, 
1JC-P = 136 Hz, c), 27.56 (l), 23.39 (d, 
3JC-P = 9.0 Hz, e), 21.78 (g), 17.32 (o), 51.44 (d, 
3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 
MHz, DMSO-d6, 373K) δ 28.61 ppm; 19F NMR (376 MHz, DMSO-d6, 373K) δ -66.51 
ppm; IR (neat) 2979 (aromatic C-H), 2849 (aliphatic C-H), 1701 (amide C=O stretch), 
1689 (carbamate C=O stretch), 1455, 1276 (P=O), 1142 (C-F), 1053 (C-O), 1029 (C-O), 
958 (P-O) cm-1; Diastereomer ratio is estimated to be >20:1 by comparison of the NMRs 
with the diastereomeric (R,R)-79i.  
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Synthesis of the furan-coupled derivative (R)-38o: Following the general procedure for 
cross coupling of chiral tertiary boronic esters with furan (GP8), the chiral tertiary boronic 
ester (R)-38o (40 mg, 0.10 mmol) yields the furan-coupled derivative (R)-38o (22 mg, 
65%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 6:4) Rf = 0.5; [α]D20 = +3.3o 
(c =1.0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 7.32 (1H, br s, n), 6.27 (1H, br s, m), 6.05 
(1H, d, J = 3.0 Hz, l), 4.03-3.81 (4H, m, b+b'), 2.34-2.02 (2H, m, c), 1.78-0.93 (22H, m, 
a+a'+e+f+g+h+i+j) ppm; 13C NMR (75 MHz, CDCl3) δ 160.23 (d, 3JC-P = 9 Hz, k), 140.44 
(n), 110.09 (m), 104.69 (l), 61.11 (d, 2JC-P = 6.75, 3.75 Hz, b+b'), 49.79 (d, 
3JC-P = 12.75 
Hz, f), 37.47 (d, 1JC-P = 138 Hz, c), 37.06 (d, 
2JC-P = 3 Hz, d), 35.29, 33.98, 33.88 (d, 
4JC-P 
= 2.25 Hz, g), 26.49, 26.39, 26.24, 23.39 (d, 3JC-P = 3 Hz, e), 16.40 (d, 
3JC-P = 3 Hz, a+a') 
ppm; 31P NMR (121 MHz, CDCl3) δ 28.51 ppm; IR (neat) 2919 (aromatic C-H), 2949 
(aliphatic C-H), 1505 (furyl C-O), 1242 (P=O), 1053 (C-O), 1024 (C-O), 954 (P-O), 728 
cm-1; HRMS (ESI) calculated for C18H31O4P 342.1960, found 342.1957 m/z. Enantiomer 
ratio = 90:10, determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; 
Mobile Phase = 1:1 hexanes : isopropanol; Flow rate = 1.0 mL/min; HPLC UV detector λ 
= 210 nm, rt. HPLC traces: 
(a). R:S = 90 : 10, cross coupling of (R)-
38o: 
(b). R:S = 10 : 90, cross coupling of (S)-
38o:  
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5.9. Oxidations leading to α-hydroxy and oxophosphonates and their synthetic utility 
 
Synthesis of phosphonate (S)-58 via hydrogenation of vinylated derivative (S)-57: A 
mixture of vinylated derivative (S)-57 (282 mg, 1.00 mmol) and 10% Pd on activated 
carbon (20 mg, 2.0 mol% Pd loading) in ethanol (10 mL) is stirred under a hydrogen 
atmosphere (balloon pressure) for 6 hours. Afterwards, the mixture is concentrated under 
reduced pressure and the concentrate is dissolved in ethyl acetate (20 mL) and is filtered 
over a bed of celite to get rid of insoluble materials. The celite bed is washed with ethyl 
acetate (2 x 20 mL) and the combined filtrates were concentrated under reduced pressure 
to yield the reduced product (S)-58 (270 mg, 95%): TLC analysis (ethyl acetate/hexanes 
3:1) Rf = 0.5; [α]D20 = -5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.36-7.19 (5H, 
m, aryl), 3.92-3.66 (4H, m, b+b'), 2.29-2.10 (2H, m, c), 1.92-1.76 (2H, m, f), 1.56 (3H, s, 
e), 1.18 (3H, t, J = 7.0 Hz, a or a'), 1.12 (3H, t, J = 7.0 Hz, a or a'), 0.66 (3H, t, J = 7.4 Hz, 
g) ppm; 13C NMR (100 MHz, CDCl3) δ 146.67 (d, 3JC-P = 8 Hz, ipso C of phenyl group), 
128.19 (aryl), 126.51 (aryl), 125.98 (aryl), 61.18-61.02 (m, b+b'), 39.68 (d, 1JC-P = 138 Hz, 
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c), 39.66 (d, 2JC-P = 3 Hz, d), 36.88 (d, 
3JC-P = 14 Hz, f), 24.09 (d, 
3JC-P = 4 Hz, f), 16.50-
16.40 (m, a+a'), 8.81 (g) ppm; 31P NMR (162 MHz, CDCl3) δ 29.12 ppm; IR (neat) 3021 
(aromatic C-H), 2915 (aliphatic C-H), 1251 (P=O), 1015 (C-O), 940 (P-O) cm-1.  
 
Synthesis of α-hydroxyphosphonate 59: This transformation is carried out with few 
modifications of the original procedure29 reported by Weimer as follows: A solution of the 
chiral phosphonate (S)-58 (213 mg, 0.75 mmol, 1.00 eq) in dry THF (15 mL) is cooled 
down to -78oC using a dry ice-acetone bath and a solution of nBuLi in hexanes (2.5M; 0.6 
mL, 1.5 mmol, 2.0 eq) is added drop-wise. The resultant mixture is stirred at -78oC for 5 
minutes and then the cooling bath is removed and the mixture is stirred at room temperature 
for an hour. The mixture is re-cooled to -78oC and a solution of Davis' Oxaziridine (392 
mg, 1.50 mmol, 2.00 eq) in dry THF (5 mL) is added drop-wise. The resultant mixture is 
maintained at -78oC for a total of ca. 3 hours and then quenched with the addition of 
saturated aqueous NH4Cl solution (25 mL) at -78
oC. The resultant frozen mixture is 
allowed to slowly warm up to room temperature over 1 hour and is then extracted with 
ethyl acetate (25 mL x 3). The combined organics are washed with brine (10 mL), dried 
over anhydrous Na2SO4 and concentrated in vacuum. Flash chromatography over silica gel 
(ethyl acetate/hexanes 6:4) affords the product as an opaque semi-solid material (186 mg, 
83%; formed as a ~2:1 mixture of diastereomers): TLC analysis (ethyl acetate/hexanes 6:4) 
Rf = 0.5; 
1H NMR (700 MHz, CDCl3) δ 7.45-7.23 (5H, m, aryl), 4.10-3.75 (5H, m, b+b'+c), 
2.11-2.07 (1H, m, f), 2.00-1.97 (1H, m, f), 1.57 (0.9H, s, e (minor diastereomer)), 1.53 
(2.1H, s, e (major diastereomer)), 1.30 (0.98H, t, J = 7.0 Hz, a or a' (minor diastereomer)), 
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1.21 (0.89H, t, J = 7.0 Hz, a or a' (minor diastereomer)), 1.17 (2.01H, t, J = 7.0 Hz, a or a' 
(major diastereomer)), 1.11 (1.99H, t, J = 7.0 Hz, a or a' (major diastereomer)), 0.70-0.66 
(3H, m, g) ppm; 13C NMR (175 MHz, CDCl3) δ 143.57 (d, 3JC-P = 10 Hz, ipso C of aromatic 
ring (minor diastereomer)), 143.28 (d, 3JC-P = 10 Hz, ipso C of aromatic ring (major 
diastereomer)), 128.43 (meta C’s of aromatic ring (minor diastereomer)), 128.20 (meta C’s 
of aromatic ring (major diastereomer)), 127.74 (ortho C’s of aromatic ring (major 
diastereomer)), 127.66 (ortho C’s of aromatic ring (minor diastereomer)), 126.61 (para C 
of aromatic ring (minor diastereomer)), 126.46 (para C of aromatic ring (major 
diastereomer)), 76.93 (d, 1JC-P = 155 Hz, c (major diastereomer)), 76.66 (d, 
1JC-P = 155 Hz, 
c (minor diastereomer)), 62.43 (d, 2JC-P = 7 Hz, b or b' (minor diastereomer)), 62.43 (d, 
2JC-
P = 7 Hz, b or b' (major diastereomer)), 62.27 (d, 
2JC-P = 8 Hz, b or b' (minor diastereomer)), 
62.19 (d, 2JC-P = 6 Hz, b or b' (major diastereomer)), 31.26-31.18 (m, f), 19.27 (d, 
3JC-P = 
3 Hz, e (minor diastereomer)), 18.76 (d, 3JC-P = 3 Hz, e (major diastereomer)), 16.62 (d, 
3JC-P = 6 Hz, a or a' (minor diastereomer)), 16.56 (d, 
3JC-P = 6 Hz, a or a' (minor 
diastereomer)), 16.48 (d, 3JC-P = 6 Hz, a or a' (major diastereomer)), 16.41 (d, 
3JC-P = 6 Hz, 
a or a' (major diastereomer)), 8.41 (g, minor diastereomer), 8.29 (g, major diastereomer) 
ppm; 31P NMR (162 MHz, CDCl3) δ 23.43 (67%, major diastereomer), 23.32 (33%, minor 
diastereomer) ppm; IR (neat) 3256 (O-H), 2971 (aromatic C-H), 2906 (aliphatic C-H), 
1212 (P=O), 1026 (C-O), 975 (P-O), 699 cm-1. 
 
Synthesis of aldehyde (S)-60 from α-hydroxyphosphonate 59:11 This transformation is 
carried out with some modifications of the original procedure30 reported by Spilling and 
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coworkers as follows: A stirred suspension of hydroxyphosphonate 59 (60 mg, 0.2 mmol, 
1 eq) and sodium bicarbonate (84 mg, 1.0 mmol, 5 eq) in 1:1 MeOH:H2O (5 mL) is refluxed 
for 1 hour. Following this, the mixture is diluted with ethyl acetate (25 mL) and the aqueous 
layer separated. The organic layer is washed with brine (10 mL), dried over Na2SO4 and 
concentrated in vacuum to afford pure aldehyde (S)-60 (29 mg, 89%): TLC analysis (ethyl 
acetate/hexanes 1:40) Rf = 0.5; [α]D20 = +9.2o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 9.54 (1H, s, aldehyde H), 7.42-7.27 (5H, m, aryl), 2.07-1.88 (2H, m, d), 1.46 (3H, s, c), 
0.82 (3H, t, J = 7.4 Hz, e) ppm; 13C NMR (100 MHz, CDCl3) δ 202.91 (a), 140.14 (aryl), 
128.98 (aryl), 127.39 (aryl), 127.33 (aryl), 54.47 (b), 28.73 (d), 18.45 (c), 8.56 (e) ppm; IR 
(neat) 3057 (aldehyde C-H), 2968 (aromatic C-H), 2936 (aliphatic C-H), 1722 (C=O), 1494 
(aromatic C=C), 1446 (aromatic C=C) cm-1. Upon reduction with NaBH4 in MeOH, 
aldehyde (S)-60 is transformed to the alcohol (S)-(+)-62 (vide infra), which unambiguously 
confirmed its absolute configuration to be “S” based on the positive value of the optical 
rotation of (S)-(+)-62. Enantiomer ratio of aldehyde (S)-60 is determined via chiral HPLC 
analysis of the formed alcohol 62 (upon reduction using NaBH4): 95:5 er (vide infra).  
 
Synthesis of α-oxophosphonate (S)-61: A suspension of hydroxyphosphonate 59 (60 mg, 
0.2 mmol, 1 eq) and Dess-Martin Periodinane (170 mg, 0.4 mmol, 2 eq) in dichloromethane 
(5 mL) is stirred at room temperature for 3 hours. The completion of the reaction is 
indicated by the disappearance of the diastereomeric hydroxyphosphonate peaks at ~25 
ppm and appearance of a new peak at -3 ppm indicative of the presence of oxophosphonate 
in the reaction mixture. The mixture is diluted with ethyl acetate (25 mL), washed with 
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saturated NaHCO3 (10 mL), saturated Na2S2O3 (10 mL) and brine (5 mL). The resultant 
organic extract is dried over Na2SO4 and concentrated in vacuum. Flash chromatography 
on silica gel (ethyl acetate/hexanes 1:1) affords the desired product (S)-61 as a colorless 
viscous oil (55 mg, 92%) : TLC analysis (ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = 
+54.8o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.36-7.22 (5H, m, aryl), 3.94-3.72 
(4H, m, b+b'), 2.17-1.96 (2H, m, f), 1.60 (3H, s, e), 1.13 (6H, m, a+a'), 0.75 (3H, t, J = 7.4 
Hz, g) ppm; 13C NMR (100 MHz, CDCl3) δ 212.14 (d, 1JC-P = 155 Hz, c), 139.44 (aryl), 
128.73 (aryl), 127.50 (aryl), 127.37 (aryl), 63.48-63.23 (m, b+b'), 57.41 (d, 2JC-P = 51 Hz, 
d), 29.49 (f), 19.31 (e), 16.29 (dd, 3JC-P = 5 Hz, a+a'), 8.49 (g) ppm; 
31P NMR (162 MHz, 
CDCl3) δ -3.21 ppm; IR (neat) 2878 (aromatic C-H), 2936 (aliphatic C-H), 1678 (C=O), 
1496 (aromatic C=C), 1446 (aromatic C=C), 1255 (P=O), 1014 (C-O), 967 (P-O) cm-1. 
HRMS (EI) calculated for C15H23O4P = 298.1334, found 298.1329 m/z. 
 
Synthesis of oxophosphonate (±)-61: To a solution of (±)-2-methyl-2-phenylbutanoic 
acid (1.00 g, 5.61 mmol, 1.00 eq.) in dry dichloromethane (10 mL) is added oxalyl chloride 
(0.72 mL, 8.42 mmol, 1.5 eq.) dropwise at 0oC. After complete addition of oxalyl chloride, 
a drop of DMF is added and the reaction mixture is stirred at room temperature for a total 
of 2 hours. Following this, the reaction mixture is concentrated in vacuum to get rid of the 
volatiles and the concentrate is dissolved in dry dichloromethane (10 mL). 
Triethylphosphite (0.96 mL, 5.61 mmol, 1.50 eq) is added drop-wise to the solution of the 
intermediate acyl chloride in dichloromethane at room temperature.31 The completion of 
the modified Michaelis-Arbuzov Rearrangement (ca. 1 hour) is determined by the 31P 
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NMR analysis of the crude reaction mixture following disappearance of the 
triethylphosphite peak at ~130 ppm and appearance of a new peak at -3 ppm corresponding 
to the oxophosphonate product. Afterwards the reaction mixture is concentrated under 
reduced pressure. Flash chromatography on silica gel (ethyl acetate/hexanes 1:1) affords 
the desired product (±)-61 as a colorless viscous oil (1.49 g, 89%).  
 
Synthesis of alcohol (S)-62:11 This transformation is carried out with some modifications 
of the original reported procedure32 by Yamamoto and coworkers as follows: To a solution 
of acylphosphonate (S)-61 (60 mg, 0.2 mmol, 1 eq) in THF (2 mL) is added lithium 
aluminum hydride (30 mg, 0.8 mmol, 4 eq) at 0oC. The resultant mixture is stirred for 2 
hours at room temperature. The disappearance of the peak corresponding to oxo-
phosphonate in crude 31P NMR (~ -3 ppm) is indicative of reaction completion. The 
reaction mixture is cooled down to 0oC and is quenched with the addition of 2M HCl till 
pH 2. The resultant mixture is extracted with diethyl ether (3 mL x 4), the combined organic 
extracts were washed with brine, dried over Na2SO4 and concentrated in vacuum to yield 
the desired product (S)-62 (29 mg, 89%) as a colorless oil: TLC analysis (ethyl 
acetate/hexanes 2:8) Rf = 0.5; [α]D20 = +8.8o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.40-7.35 (4H, m, aryl), 7.28-7.22 (1H, m, aryl), 3.75 (1H, d, J = 10.8 Hz, a), 3.57 (1H, 
d, J = 10.8 Hz, a), 1.89-1.80 (1H, m, d), 1.64-1.55 (1H, m, d), 1.37 (3H, s, c), 1.29 (1H, br 
s, OH), 0.75 (3H, t, J = 7.4 Hz, e) ppm; 13C NMR (175 MHz, CDCl3) δ 144.78 (aryl), 
128.62 (aryl), 127.04 (aryl), 126.30 (aryl), 72.59 (a), 43.89 (b), 31.07 (d), 21.14 (c), 8.42 
(e) ppm; IR (neat) 3300 (O-H), 2920 (aromatic C-H), 2851 (aliphatic C-H), 1495 (aromatic 
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C=C), 1463 (aromatic C=C), 1034, 756 cm-1. Enantiomer ratio also determined by chiral 
HPLC analysis: 95:5. HPLC conditions:11 Stationary phase = CHIRALPAK IB; Mobile 
Phase = 99.5:0.5 Hexanes:Isopropanol; Flow rate = 0.5 mL/min; HPLC UV detector λ = 
210 nm, rt. HPLC traces:  
(a) Racemate: 
 
 
(b) R:S = 5:95. CAHB of 5a with (R,R)-T2, followed by transformations to yield (S)-
62. 
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Synthesis of ethyl ester (S)-63: This transformation is carried out with some modifications 
of the original procedure14 reported by Yamamoto and coworkers as follows: To a solution 
of acylphosphonate (S)-61 (60 mg, 0.2 mmol, 1 eq) in anhydrous ethanol (1 mL), DBU (30 
μL, 0.2 mmol, 1 eq) is added at room temperature. The completion of the reaction (ca. 30 
min) is indicated by the disappearance of the oxophosphonate peak at -3 ppm and 
appearance of the diethylphosphite peak at ~8 ppm. The reaction mixture is concentrated 
under reduced pressure and is dissolved in 10% ethyl acetate in hexanes (2 mL) and is 
filtered over a small plug of silica gel. The plug is subsequently washed with 2 more 
portions of the eluent (2 mL each time) and the combined filtrates are concentrated under 
reduced pressure to afford the ethyl ester (S)-63 as a colorless oil (39 mg, 95%): TLC 
analysis (ethyl acetate/hexanes 1:20) Rf = 0.6; [α]D20 = +6.1o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.37-7.22 (5H, m, aryl), 4.16 (2H, q, J = 7.2 Hz, b), 2.18-2.09 (1H, 
m, f), 2.02-1.93 (1H, m, f), 1.55 (3H, s, e), 1.21 (3H, t, J = 7.2 Hz, a), 0.86 (3H, t, J = 7.2 
Hz, g) ppm; 13C NMR (100 MHz, CDCl3) δ 176.43 (c), 144.24 (aryl), 128.45 (aryl), 126.70 
(aryl), 126.23 (aryl), 60.83 (b), 50.75 (d), 31.98 (f), 22.42 (e), 14.28 (a), 9.33 (g) ppm; IR 
(neat) 2975 (aromatic C-H), 2938 (aliphatic C-H), 1724 (C=O), 1496 (aromatic C=C), 1446 
(aromatic C=C), 1031 (C-O) cm-1. Ester (S)-63 is transformed to the carboxylic acid (S)-
65 (vide infra) via hydrolysis using LiOH in H2O. The formed carboxylic acid was 
derivatized to the L-phenyl-alanine ethyl ester derivative and the dr of the same was found 
to be 96:4 via 1H NMR analysis. Therefore, er of ethyl ester (S)-63 = 96:4. 
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Synthesis of acetamide (S)-64:33 This transformation is carried out with some 
modifications of the original reported procedure34 by Liu and Feng as follows: To a 
solution of acylphosphonate (S)-61 (45 mg, 0.15 mmol, 1 eq) in THF (1 mL) is added NH3 
solution in H2O (32%, 3 mL) under stirring. To the resultant mixture is added 
tetrabutylammonium bromide (TBABr; 4.8 mg, 15 μmol, 0.1 eq) and the reaction mixture 
is stirred at room temperature for 9 hours. Afterwards, the mixture is subjected to high 
vacuum to get rid of ammonia and the resultant mixture is extracted with ethyl acetate (5 
mL x 3). The combined organic extracts were washed with brine, dried over Na2SO4 and 
concentrated in vacuum. Flash chromatography over silica gel (ethyl acetate/hexanes 1:1) 
affords the desired product (S)-64 (23 mg, 85%) as colorless waxy solid: TLC analysis 
(ethyl acetate/hexanes 1:1) Rf = 0.5; [α]D20 = +14o (c = 1.0, C6H6); 1H NMR (400 MHz, 
CDCl3) δ 7.38-7.22 (5H, m, aryl), 6.14 (1H, br s, NHa or NHb), 5.25 (1H, br s, NHa or 
NHb), 2.11-1.97 (2H, m, d), 1.53 (3H, s, c), 0.82 (3H, t, J = 7.4 Hz, e) ppm; 
13C NMR (175 
MHz, CDCl3) δ 180.06 (a), 144.07 (aryl), 128.73 (aryl), 127.03 (aryl), 126.90 (aryl), 50.83 
(b), 31.57 (d), 23.19 (c), 8.94 (e) ppm; IR (neat) 3400 (N-H), 3203 (N-H), 2982 (aromatic 
C-H), 2969 (aliphatic C-H), 1648 (C=O), 1494 (aromatic C=C), 1459 (aromatic C=C), 
1363, 694 cm-1. Enantiomer ratio = 97:3, determined by chiral HPLC analysis: Stationary 
phase = CHIRALPAK AS-H; Mobile Phase = 60:40 Hexanes:Isopropanol; Flow rate = 
1.25 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces:  
(a) Racemate: 
 
(b) R:S = 3:97. CAHB of 5a with (R,R)-
T2, followed by transformations to 64:  
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Synthesis of carboxylic acid (S)-(+)-65:35 This transformation is carried out with some 
modifications of the original procedure14 reported by Yamamoto and coworkers as follows: 
To a solution of acylphosphonate (S)-61 (60 mg, 0.2 mmol, 1 eq) in tetrahydrofuran (0.5 
mL), 2M aqueous NaOH solution (0.5 mL, 1 mmol, 5 eq.) is added and the resultant 
biphasic mixture is stirred for 3 hours at room temperature. The completion of the reaction 
is indicated by the disappearance of the oxophosphonate peak at -3 ppm and appearance of 
the diethylphosphite peak at ~8 ppm. Afterwards, the reaction mixture is acidified to pH 1 
using 2N HCl and the resultant mixture is extracted with dichloromethane (10 mL x 3). 
The combined organic extracts are washed with brine (5 mL), dried over Na2SO4 and 
concentrated in vacuum to afford pure carboxylic acid (S)-65 (32.5 mg, 91%): TLC 
analysis (ethyl acetate/hexanes 2:8) Rf = 0.5; [α]D20 = +10.2o (c = 1.0, CHCl3); 1H NMR 
(400 MHz, DMSO-d6) δ 12.37 (1H, br s, COOH), 7.34-7.20 (5H, m, aryl), 2.03-1.84 (2H, 
m, d), 1.43 (3H, s, c), 0.78 (3H, t, J = 7.4 Hz, e) ppm; 13C NMR (100 MHz, DMSO-d6) δ 
177.15 (COOH), 144.29 (aryl), 126.41 (aryl), 126.02 (aryl), 49.90 (b), 31.37 (d), 22.16 (c), 
9.23 (e) ppm; IR (neat) 3200 (br, O-H), 2976 (aromatic C-H), 2941 (aliphatic C-H), 1690 
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(C=O), 1495 (aromatic C=C), 1445 (aromatic C=C), 1155 (C-O) cm-1. The above 
carboxylic acid, (S)-65 is transformed into the amino acid derivative 94 (vide infra) and 
the dr (96:4) is determined via 1H NMR analysis. Therefore, er of the carboxylic acid (S)-
65 = 96:4. 
 
Synthesis of the amino acid derivative 94: To a stirred solution of the carboxylic acid 
(S)-65 (36 mg, 0.2 mmol, 1 eq) in dry dichloromethane (2 mL), oxalyl chloride (34 μL, 0.4 
mmol, 2 eq) is added followed by a drop of dry DMF at 0oC. The mixture is allowed to 
warm up to room temperature and stirred for a total of 2 hours. Afterwards, the mixture is 
concentrated under high vacuum and the resultant residue is dissolved in dry 
dichloromethane (1 mL). A solution of L-phenylalanine ethyl ester (77 mg, 0.4 mmol, 2 
eq) in dry dichloromethane (1 mL) is added drop-wise to the mixture mixture. Following 
that, triethylamine (70 μL, 0.5 mmol, 2.5 eq) is added and the resultant mixture is stirred 
for 2 hours at room temperature. The reaction mixture is concentrated in high vacuum and 
flash chromatography on silica gel (ethyl acetate/hexanes 1:9) results in the pure product 
(S,S)-94 as a sticky waxy liquid (64 mg, 90%): TLC analysis (ethyl acetate/hexanes 1:9) 
Rf = 0.5; [α]D20 = +32o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 7.36-7.18 (8H, m, 
aryl), 6.89-6.86 (2H, m, aryl), 5.58 (1H, t, J = 9.0 Hz, NH), 4.86-4.82 (1H, m, d), 4.13 (2H, 
q, J = 7.2 Hz, b), 3.03-2.96 (2H, m, e), 2.05-1.99 (2H, m, i), 1.50 (0.12H, s, h (minor 
diastereomer, 4%)), 1.46 (2.88H, s, h (major diastereomer, 96%)), 1.23 (3H, t, J = 7.2 Hz, 
a), 0.81 (2.89H, t, J = 7.2 Hz, j (major diastereomer, 96%)), 0.70 (0.11H, t, J = 7.2 Hz, j 
(minor diastereomer, 4%)) ppm; 13C NMR (175 MHz, CDCl3) δ 176.56 (f), 171.65 (c), 
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143.73 (aryl), 136.04 (aryl), 129.34 (aryl), 128.83 (aryl), 128.66 (aryl), 127.11 (aryl), 61.55 
(b), 53.06 (d), 50.92 (g), 37.96 (e), 31.42 (i), 23.20 (h), 14.29 (a), 8.93 (j) ppm; IR (neat) 
3359 (amide N-H), 2973 (aromatic C-H), 2879 (aliphatic C-H), 1735 (ester C=O), 1660 
(amide C=O), 1495 (aromatic C=C), 1445 (aromatic C=C) cm-1. The 1H NMR analysis 
provided the dr to be 96:4. 
 
Synthesis of the aryl ketone (S)-66:36 This transformation is carried out with some 
modifications of the original reported procedure37 by Maeda et. al. as follows: To a 
suspension of magnesium turnings (11 mg, 0.46 mmol) in dry THF (1.5 mL) under a 
nitrogen atmosphere was added bromobenzene (47 μL, 0.45 mmol, 3 eq) and the resultant 
mixture was refluxed for a total of 2 hours until the solution turned brown and all of the 
magnesium dissolved. The resultant Grignard reagent is cooled down to room temperature 
and then to -78oC using a dry ice-acetone bath. A solution of acylphosphonate (S)-61 (45 
mg, 0.15 mmol, 1 eq) in dry THF (0.75 mL) is added to the reaction mixture and the 
resultant mixture is stirred at -78oC for 15 minutes. Following this, the reaction mixture is 
acidified to pH 1 using 1N HCl and the resultant mixture is extracted with dichloromethane 
(25 mL x 3). The combined organic extracts are dried over Na2SO4 and concentrated in 
vacuum. The resultant residue is dissolved in THF (1 mL) and a 2N solution of NaOH (0.5 
mL) is added drop-wise. The resultant mixture is stirred for 1 hour. Afterwards, the mixture 
is extracted with diethyl ether (10 mL x 3) and the combined organics were washed with 
brine, dried over Na2SO4 and concentrated in vacuum to afford pure phenyl ketone (S)-66 
(28 mg, 78%): TLC analysis (ethyl acetate/hexanes 1:49) Rf = 0.5; [α]D20 = +37o (c = 1.0, 
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C6H6); 
1H NMR (400 MHz, CDCl3) δ 7.36-7.21 (10H, m, aryl), 2.24-2.05 (2H, m, d), 1.58 
(3H, s, c), 0.77 (3H, t, J = 7.4 Hz, e) ppm; 13C NMR (175 MHz, CDCl3) δ 204.00 (a), 
144.56 (aryl), 137.15 (aryl), 131.72 (aryl), 129.63 (aryl), 129.08 (aryl), 128.10 (aryl), 
126.95 (aryl), 126.48 (aryl), 55.16 (b), 32.27 (d), 23.92 (c), 8.83 (e) ppm; IR (neat) 3059 
(aromatic C-H), 2971 (aliphatic C-H), 1674 (C=O), 1495 (aromatic C=C), 1445 (aromatic 
C=C), 1232, 907 cm-1. 
 
5.10. Total synthesis of (S)-(+)-Bakuchiol Methyl Ether 
 
Step 1: CAHB of the trisubstituted alkene substrate (E)-37x with (S,S)-T2 to prepare chiral 
tertiary boronic ester (S)-38x.   
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The trisubstituted alkene substrate (E)-37x (1.90 g, 4.00 mmol) is subjected to gram-scale 
CAHB with (S,S)-T2 according to GP4. Flash chromatography of the hydroboration 
reaction mass on silica gel yields the tertiary boronic ester (S)-38x (1.93 g, 80%) as a 
colorless viscous oil: TLC analysis (ethyl-acetate/hexanes 1:2) Rf = 0.6; [α]D20 = +2.8o (c 
= 1.0, CHCl3); 
1H NMR (700 MHz; CDCl3) δ 7.66-7.64 (4H, m, aryl), 7.42-7.26 (6H, m, 
aryl), 4.07-4.03 (4H, m, b+b'), 3.61 (2H, t, J = 6.3 Hz, h), 2.04-1.95 (1H, m, c), 1.70-1.65 
(1H, m, c), 1.60-1.47 (3H, m, f+g), 1.40-1.37 (1H, m, f), 1.31-1.28 (6H, m, a+a'), 1.24 
(12H, s, l), 1.10 (3H, s, e), 1.03 (9H, s, j) ppm; 13C NMR (175 MHz; CDCl3) δ 135.57 
(aryl), 134.10 (aryl), 129.50 (aryl), 127.71 (aryl), 127.58 (aryl), 83.44 (k), 64.59 (h), 61.13-
60.86 (m, b+b'), 36.49 (g) , 36.39 (d), 34.29 (d, 1JC-P = 136.5 Hz, c), 28.51 (f), 26.87 (j), 
24.92 (l), 21.88 (d, 3JC-P = 5.25 Hz, e), 19.24 (i), 16.52-16.47 (m, a+a') ppm; 
11B NMR 
(225 MHz, CDCl3) δ 36.75 ppm; 31P NMR (283 MHz, CDCl3) δ 32.34 ppm; IR (neat) 3071 
(aromatic C-H), 2898 (aliphatic C-H), 2359, 2228, 1976, 1589, 1371 (C-O), 1214 (P=O), 
1026, 955 cm-1; HRMS (ESI) calculated for C32H52BNaO6PSi
+ 625.3256, found 625.3271 
m/z. Enantiomer ratio was determined by chiral HPLC analysis of the tertiary alcohol 
derivative 40x. 
  
Step 2: Oxidation of chiral tertiary boronic ester (S)-38x to chiral tertiary alcohol (R)-40x 
to determine enantiomer ratio.   
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The tertiary boronic ester (S)-38x (60 mg, 0.10 mmol) is subjected to oxidation according 
to GP5. Workup of the reaction mass post oxidation yields the chiral tertiary alcohol (R)-
40x (45 mg, 91%) as a colorless viscous oil: TLC analysis (ethyl-acetate/hexanes 1:2) Rf = 
0.4; [α]D20 = +5.1o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.69-7.68 (4H, m, aryl), 
7.46-7.38 (6H, m, aryl), 4.19-4.08 (4H, m, b+b'), 3.99 (1H, s, OH), 3.69 (2H, t, J = 5.6 Hz, 
h), 2.10-1.95 (2H, m, c), 1.73-1.63 (4H, m, f+g), 1.38-1.32 (9H, m, a+a'+e), 1.07 (9H, s, j) 
ppm; 13C NMR (100 MHz, CDCl3) δ 135.68 (aryl), 134.02 (aryl), 129.68 (aryl), 127.73 
(aryl), 70.52 (d, 2JC-P = 5 Hz, d), 64.34 (h), 61.80-61.68 (m, b+b'), 40.01 (d,
 3JC-P = 12 Hz, 
f), 37.48 (d, 1JC-P = 135 Hz, c), 28.10 (d,
 3JC-P = 9 Hz, e), 27.48 (g), 26.98 (j), 19.32 (i), 
16.51 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 30.08 ppm; IR (neat) 
3245 (OH), 3070 (aromatic C-H), 2857 (aliphatic C-H), 1223 (P=O), 1051 (C-O), 1022 
(C-O), 959, 701, 613 cm-1; Enantiomer ratio was determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK IC; Mobile Phase = isopropanol:hexanes 10:90; Flow 
rate = 0.75 mL/min; HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a). R:S = 0.5:99.5; CAHB of 37x with 
(R,R)-T2, then oxidation:  
 
(b). R:S = 99.2:0.8; CAHB of 37x with 
(S,S)-T2, then oxidation:  
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Step 3: Vinylation of chiral tertiary boronic ester (S)-38x. 
 
Following the general procedure for vinylation of chiral tertiary boronic esters (GP9), the 
chiral tertiary boronic ester (S)-38x (1.8 g, 3.0 mmol) yields the chiral vinyl phosphonate 
(S)-74x (1.4 g, 93%) as a colorless viscous oil: TLC analysis (ethyl-acetate/hexanes 1:1) 
Rf = 0.5; [α]D20 = +1.1o (c = 1.0, CHCl3); 1H NMR (700 MHz; CDCl3) δ 7.68-7.67 (4H, m, 
aryl),  7.43-7.37 (6H, m, aryl), 5.85 (1H, dd, J = 11.2, 6.3 Hz, k), 5.04-4.97 (2H, m, l), 
4.10-4.03 (4H, m, b+b'), 3.65 (2H, t, J = 6.3 Hz, h), 1.86 (2H, d, J = 18.9 Hz, c), 1.58-1.49 
(4H, m, h+i), 1.31 (6H, t, J = 7 Hz, a+a'), 1.22 (3H, s, e), 1.07 (9H, s, j) ppm; 13C NMR 
(175 MHz; CDCl3) δ 146.06 (d, 3JC-P = 8.75 Hz, k), 135.57 (aryl), 134.01 (aryl), 129.55 
(aryl), 127.62 (aryl), 111.89 (l), 64.31 (h), 61.25-61.08 (m, b+b'), 37.95 (d), 37.77 (d, 3JC-
P = 10.5 Hz, f), 36.96 (d, 
1JC-P = 138.25 Hz, c), 27.47 (g), 26.89 (j), 23.89 (d, 
3JC-P = 5.25 
Hz, e), 19.23 (i), 16.46 (d, 3JC-P = 7 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) ) δ 29.50 
ppm; IR (neat) 2977 (aromatic C-H), 2859 (aliphatic C-H), 1589 (C=C), 1471, 1240 (P=O), 
1026 (C-O), 730, 701, 613 cm-1.  
 
Step 4: Silyl ether deprotection of chiral vinyl posphonate (S)-74x.  
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Tetrabutylammonium fluoride (TBAF; 1M solution in THF, 5 mL, 5 mmol, 2 equiv.) is 
added to a solution of (S)-74x (1.26 g, 2.50 mmol, 1.00 eq) in THF (25 mL) at 0 oC. The 
reaction mixture is allowed to warm up to room temperature and stirred overnight. 
Afterwards, the reaction mass is concentrated in vacuum and is purified by flash 
chromatography on silica gel (methanol/ethyl-acetate 1:20) afforded the desired product 
(S)-80 as a colorless viscous oil (630 mg, 2.38 mmol, 95%): TLC analysis (methanol/ethyl-
acetate 1:20) Rf = 0.4; [α]D20 = –1.23o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 5.78 
(1H, dd, J = 10.5, 7 Hz, j), 4.96-4.90 (2H, m, k), 4.03-4.96 (4H, m, b+b'), 3.52 (2H, t, J = 
6.3 Hz, h), 3.17 (1H, broad s, i), 1.84-1.76 (2H, m, c), 1.56-1.42 (4H, m, f+g), 1.24 (3H, t, 
J = 7 Hz, a+a'), 1.14 (3H, s, e); 13C NMR (175 MHz, CDCl3) δ 146.14 (d, 3JC-P = 10.5 Hz, 
j), 111.73 (k), 62.67 (h), 61.31-61.24 (m, b+b'), 37.86 (d, 2JC-P = 1.75 Hz, d), 37.17 (d, 
3JC-
P = 8.75 Hz, f), 36.14 (d, 
1JC-P = 138.25 Hz, c), 27.43 (g), 24.48 (d, 
3JC-P = 5.25 Hz, e), 
16.35 (d, 3JC-P = 7 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 29.48 ppm; IR (neat) 
3379 (O-H), 2979 (C-H), 1740, 1638, 1224 (P=O), 1026, 1024, 951, 831, 703, 607 cm-1; 
HRMS (ESI) calculated for C12H25NaO4P
+ 287.1383, found 287.1385 m/z.  
 
Step 5: Parikh-Doering oxidation38 of alcohol (S)-80 to yield phosphono-aldehyde (S)-
81.  
406 
 
 
DMSO (0.80 mL, 14 mmol, 5.0 eq), Hunig’s base (1.57 mL, 9.08 mmol, 4.00 eq) and sulfur 
trioxide pyridine complex (750 mg, 4.76 mmol, 2.10 eq) are added sequentially to a 
solution of the alcohol (S)-80 (600 mg, 2.27 mmol, 1.00 eq) in dry CH2Cl2 (20 mL) at 0 
oC. The resulting solution is allowed to warm up to room temperature and stirred for a total 
of 3 hours. Afterwards, the reaction is quenched with brine (10 mL) and the organic layer 
separated. The aqueous layer is extracted with EtOAc (20 mL x 3) and the combined 
organic layers are concentrated under reduced pressure. The concentrate is  purified by 
flash chromatography on silica gel (ethyl acetate) to yield the final product (S)-81 as a 
colorless oil (507 mg, 1.93 mmol, 85%): TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = –
2.9o (c = 2.0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 9.74 (1H, s, h), 5.79 (1H, dd, J = 10.8, 
6.6 Hz, j), 5.08-4.95 (2H, m, k), 4.12-4.00 (4H, m, b+b'), 2.38 (2H, m, g), 1.95-1.76 (4H, 
m, c+h), 1.32-1.27 (6H, m, a+a'), 1.21 (3H, s, e) ppm;13C NMR (75 MHz, CDCl3) δ  202.23 
(h), 145.21 (d, 3JC-P = 10.5 Hz, j), 112.88 (k), 61.43-61.26 (m, b+b'), 39.48 (g), 37.74 (d, 
2JC-P = 3 Hz, d), 36.57 (d, 
1JC-P = 138.75 Hz, c), 32.72 (d, 
3JC-P = 9 Hz, f), 23.95 (d, 
3JC-P 
= 6 Hz, e), 16.41 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz, CDCl3) δ 28.76 ppm; 
IR (neat) 2981 (aliphatic C-H), 2722 (sp2 C-H), 1722 (C=O), 1637, 1238 (P=O), 1023, 955, 
831, 781 cm-1. 
 
Step 6: Wittig olefination of aldehyde (S)-81 to form the diene intermediate (S)-82.    
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A 2.5 M solution of nBuLi in hexanes (0.87 mL, 2.18 mmol, 1.30 eq) is added dropwise to 
a stirred suspension of isopropyltriphenylphosphonium iodide (1.00 g, 2.35 mmol, 1.40 eq) 
in dry THF (16 mL) at 0oC. The resulting orange-brown solution is allowed to stir for 1 
hour at room temperature and then the reaction mixture is cooled to –78oC using a dry ice-
acetone bath. A solution of the aldehyde (S)-81 (400 mg, 1.52 mmol, 1.00 eq) in THF (8 
mL) is added dropwise to the reaction mixture and the resultant mass is allowed to warm 
up to room temperature and stirred for a total of 24 hours. The reaction is quenched with 
10 mL of saturated ammonium chloride solution and the phases are separated. The aqueous 
phase is extracted twice with 20 mL portions of ethyl acetate. The combined organic layers 
are washed with brine, dried over anhydrous sodium sulfate and concentrated in vacuum. 
Flash chromatography on silica gel (ethyl-acetate/hexanes 1:1) yields the pure product (S)-
82 (408 mg, 1.42 mmol, 93%) as a colorless oil: TLC analysis (ethyl-acetate/hexanes 1:1) 
Rf = 0.5; [α]D20 = +8.1o (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ 5.85 (1H, dd, J = 
10.83, 6.6 Hz, j), 5.09-4.94 (3H, m, k+h), 4.12-4.00 (4H, m, b+b'), 1.92-1.82 (4H, m, c+g), 
1.65 (3H, s, i'), 1.57 (3H, s, i), 1.52-1.45 (2H, m, f), 1.32-1.28 (6H, t, J = 7.05, a+a'), 1.21 
(3H, s, e) ppm; 13C NMR (75 MHz, CDCl3) δ 146.10 (d, 3JC-P = 9.75 Hz, j), 131.12 (l), 
124.41 (h), 111.78 (k), 61.25-61.06 (m, b+b'), 41.69 (d, 3JC-P = 10.5 Hz, f), 38.18 (d, 
2JC-P 
= 3 Hz, d), 36.68 (d, 1JC-P = 137.25 Hz, c), 25.67 (i'), 23.85 (d, 
3JC-P = 6 Hz, e), 22.92 (g), 
17.62 (i), 16.41 (d, 3JC-P = 6 Hz, a+a') ppm; 
31P NMR (121 MHz) δ 29.71 ppm; IR (neat) 
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2977 (sp2 C-H), 2909 (sp3 C-H), 1660 (C=C), 1243 (P=O), 1024, 954, 828 cm-1; HRMS 
(ESI) calculated for C15H29NaO3P
+ 311.1747, found 311.1755 m/z.  
 
Step 7: Thionylation of the phosphonate (S)-82 using Lawesson’s reagent39 to yield 
thiophosphonate (S)-83.  
 
A mixture of phosphonate functionalized chiral diene (S)-82 (87 mg, 0.30 mmol, 1.0 eq) 
and Lawesson’s reagent (242 mg, 0.60 mmol, 2.0 eq) in dry toluene (3 mL) is heated at 
reflux for 6 hours. The solution turns homogenous after heat is applied. At this point, 31P-
NMR analysis of the crude reaction mixture showed the disappearance of the phosphonate 
starting material peak at ~30 ppm and the appearance of a new peak at ~95 ppm which 
corresponds to the thiophosphonate product. The mixture is cooled to room temperature 
and filtered over a bed of celite to get rid of insoluble materials and the combined filtrates 
are concentrated under reduced pressure. Flash chromatography on silica gel (ethyl-
acetate/hexanes 1:50) yields the chiral thiophosphonate (S)-83 as a light yellow oil (69 mg, 
76%): TLC analysis (ethyl-acetate.hexanes 1:50) Rf = 0.5; [α]D20 = +5.1o (c = 1.0, CHCl3); 
1H NMR (300 MHz, CDCl3) δ 5.90 (1H, dd, J = 10.8, 6.6 Hz, j), 5.11-4.95 (3H, m, k+h), 
4.22-4.00 (4H, m, b+b'), 2.17 (2H, d, J = 16.2 Hz, c), 1.99-1.88 (2H, m, g), 1.69 (3H, s, i'), 
1.60 (3H, s, i), 1.57-1.48 (2H, m, f), 1.31 (6H, t, J = 7.1 Hz, a+a'), 1.26 (3H, s, e) ppm; 13C 
NMR (75 MHz, CDCl3) δ 146.29 (d, 3JC-P = 9 Hz, j), 131.51 (l), 124.55 (h), 111.78 (k), 
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62.13 (dd, 2JC-P = 7.5, 6.75 Hz, b+b'), 45.40 (d, 
1JC-P = 108.75 Hz, c), 41.87 (d, 
3JC-P = 9.75 
Hz, f), 39.26 (d, 2JC-P = 3.75 Hz, d), 25.81 (i'), 23.89 (d, 
3JC-P = 6 Hz, e), 22.86 (g), 17.68 
(i), 16.16 (d, 3JC-P = 6.75 Hz, a+a') ppm; 
31P NMR (121 MHz) δ 95.29 ppm; IR (neat) 3082 
(sp2 C-H), 2976 (sp3 C-H), 1638, 1443, 1261, 1024 (P-O), 950 (P-O), 650 (P=S) cm-1.  
 
Step 8: Alkene synthesis from the α-lithiothionophosphonate ester: Synthesis of bakuchiol 
methyl ether.  
 
This transformation is carried out with some modifications of the original procedure40 
described by E. J. Corey et. al. as follows: A solution of nBuLi in hexanes (1.6M solution 
in hexanes; 0.2 mL, 0.315 mmol, 2.1 eq) is added dropwise to a solution of the 
thiophosphonate (S)-83 (46 mg, 0.15 mmol) in dry tetrahydrofuran (1.5 mL) under nitrogen 
at –78oC. The cooling bath is removed, and the mixture is allowed to warm to room 
temperature and stirred for 1 hour. The mixture is re-cooled to –78oC and 4-methoxy-
benzaldehyde (40 μL, 0.33 mmol, 2.2 eq) is added dropwise to the reaction mixture. The 
mixture is stirred at –78oC for 30 minutes and then allowed to warm up to room temperature 
and stirred for a total of 9 hours. The reaction is quenched with the addition of saturated 
aq. NH4Cl and is extracted with diethyl ether (5 mL x 3). The combined organics are 
washed with brine, dried over Na2SO4 and concentrated in vacuum. Flash chromatography 
on silica gel (ethyl-acetate/hexanes 1:50) yields the desired product (S)-84 as a light yellow 
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oil (31 mg, 77%): TLC analysis (ethyl-acetate/hexanes 1:50) Rf = 0.5; [α]D20 = +19.1o (c = 
1.0, CHCl3); 
1H NMR (700 MHz, CDCl3) δ 7.30 (2H, d, J = 8.7 Hz, d), 6.84 (2H, d, J = 
8.7 Hz, c), 6.26 (1H, d, J = 16.4 Hz, f), 6.07 (1H, d, J = 16.4 Hz, g), 5.88 (1H, dd, J = 17.5, 
10.5 Hz, j), 5.11 (1H, t, J = 7 Hz, n), 5.04-5.00 (2H, m, k), 3.80 (3H, s, a), 1.96 (2H, dt, J 
= 8.4, 7.7 Hz, m), 1.68 (3H, s, q), 1.58 (3H, s, p), 1.51-1.48 (2H, m, l), 1.20 (3H, s, i) ppm; 
13C NMR (175 MHz, CDCl3) δ 158.88 (b), 146.15 (j), 135.95 (g), 131.45 (e), 130.85 (o), 
127.30 (d), 126.67 (f), 124.96 (n), 114.05 (c), 112.00 (k), 55.45 (a), 42.68 (h), 41.45 (l), 
25.85 (q), 23.50 (e), 23.38 (m), 17.78 (p) ppm; IR (neat) 2961 (sp2 C-H), 2857 (sp3 C-H), 
1607 (C=C), 1510, 1455, 1247, 1173, 1034, 970, 910, 815, 732 cm-1.  
 
5.11. Absolute Configuration Assignments 
5.11.1 CAHB of conjugated methylidene substrate 5a 
5.11.1.1 Absolute configuration assignment of the major regioisomer: tertiary boronic 
ester 6a: 
 
The configurations of all other chiral tertiary benzylic boronic esters derived from 
conjugated methylidene substrates are assigned based on the following. CAHB of phenyl-
substituted methylidene substrate 5a with (R,R)-T2 results in the formation of chiral 
tertiary benzylic boronic ester 6a as the major product. The latter is protodeboronated to 
6a" (see GP7) using conditions reported by Aggarwal8 giving the corresponding chiral 
reduced product whose configuration is assigned “R” based on the positive value of its 
optical rotation for this previously reported compound.41 Since protodeboronation of chiral 
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tertiary benzylic boronic esters proceeds with retention of stereochemistry, the chiral 
boronic ester 6a derived from CAHB with (R,R)-T2 is assigned as “R”, the result of B-H 
addition to the top-face of the alkene in the perspective drawn.  
The assigned absolute configuration is further supported by conversion of (R)-6a 
to (S)-57 setting the all-carbon quaternary carbon stereocenter with retention of 
stereochemistry; the details are described above. [Note: Aggarwal11 has shown that chiral 
tertiary boronic esters undergo vinylation reaction with stereoretention]. Hydrogenation to 
(S)-58 sets the stage for conversions to the known alcohol (S)-(+)-62, carboxylic acid (S)-
(+)-65, and ketone (S)-(+)-66, each of which gives the expected (+) sign of optical rotation. 
However, the literature indicates that aldehyde (S)-60 and amide (S)-64 should have the (-
) sign of rotation which we believe is incorrect. We find (+)-rotations for each, and 
furthermore, NaBH4 reduction of our (+)-60 affords (S)-(+)-62.  
 
5.11.1.2 Absolute configuration assignment of minor regioisomer: primary boronic 
ester 6a': 
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CAHB of the conjugated methylidene substrate 5a also gives a small amount of the chiral 
primary boronic ester 6a' as a minor product. For mechanistic interest and to compare to 
other directed-CAHBs, we proved the stereochemistry of the major enantiomer of 6a' that 
is formed. Oxidation of 6a' resulted in the formation of chiral γ-hydroxy phosphonate 13a'; 
(R,R)-T2 gives the S-isomer and (S,S)-T2 gives the R-isomer. To establish those 
assignments, (R)-13a' was synthesized using the Evans’ chiral auxiliary for asymmetric 
alkylation to establish the stereochemistry. The oxazolidinone derivative 95 was prepared 
according to literature procedure.42 Reduction of the oxazolidinone derivative 95 using 
LiAlH4 in THF afforded the chiral alcohol (S)-96; the negative value of its optical rotation 
confirms the absolute configuration.18 Sequential bromination (PPh3/NBS), Michaelis-
Arbuzov rearrangement (GP1) and benzyl-ether cleavage (H2/Pd-C) afforded the 
enantiopure chiral γ-hydroxy phosphonate (R)-13a'. As illustrated above, analysis of the 
chiral HPLC traces and optical rotations revealed that the chiral γ-hydroxy phosphonate  
(R)-13a' obtained via asymmetric alkylation is the enantiomer of the minor product 
obtained from CAHB of 5a using (R,R)-T2 followed by oxidation. (S)-13a' arises from the 
B-H addition to the “top-face” of the alkene 5a in the perspective drawn. 
Characterization Data: 
 
To a solution of oxazolidinone derivative 95 (623 mg, 1.50 mmol, 1.00 eq) in dry THF (15 
mL) at 0oC is added LiAlH4 (230 mg, 6.00 mmol, 4.00 eq) slowly and the resultant mixture 
stirred vigorously for 1 hour. Afterwards, the reaction mixture is carefully quenched with 
the addition of ethyl acetate (20 mL) and water (2 mL) and the resultant mixture was 
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filtered over a small pad of silica gel and the silica pad was washed with ethyl acetate (20 
mL). The combined filtrates are concentrated under reduced pressure. Flash 
chromatography over silica gel (ethyl acetate/hexanes 1:3) affords the alcohol (S)-96 (309 
mg, 85%) as a colorless oil: TLC analysis (ethyl acetate/hexanes 1:3) Rf = 0.5; [α]D20 = -
35o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.38-7.24 (10H, m), 4.59 (2H, s), 4.07-
4.02 (1H, m), 3.93-3.79 (3H, m), 3.28-3.22 (1H, m), 2.47 (1H, br d, J = 9.6 Hz) ppm; 13C 
NMR (100 MHz, CDCl3) δ 139.77, 138.05, 128.86, 128.69, 128.20, 127.99, 127.87, 
127.28, 73.88, 73.66, 66.75, 48.01 ppm; IR (neat) 3396 (O-H), 3028 (sp2 C-H), 2863 (sp3 
C-H), 1495 (aromatic C=C), 1452 (aromatic C=C), 1363, 1075 (C-O), 1027 (C-O), 735, 
696 cm-1.  
 
To a solution of the alcohol (S)-96 (242 mg, 1.00 mmol, 1.00 eq) in dry dichloromethane 
(10 mL) at 0oC is added PPh3 (393 mg, 1.50 mmol, 1.5 eq) and NBS (267 mg, 1.50 mmol, 
1.5 eq). The resultant mixture is stirred for 1 hour when TLC (ethyl acetate/hexanes 1:3) 
indicates complete consumption of starting material. The solvent is evaporated under 
reduced pressure and 20% ethyl acetate in hexanes is added to the residue. The resultant 
mixture was filtered over a small bed of silica gel and the bed was further washed with 
more 20% ethyl acetate in hexanes (40 mL total). The combined filtrates were concentrated 
under reduced pressure. The resultant residue was refluxed with triethylphosphite (0.51 
mL) under a nitrogen atmosphere for 6 hours. Following the Arbuzov rearrangement (crude 
NMR analysis: appearance of a phosphonate peak at ~31 ppm), excess triethylphosphite 
was distilled off using bulb-to-bulb distillation. A mixture of the resultant residue and 10% 
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Pd on activated carbon (40 mg, 4.0 mol% Pd-loading) in ethanol (10 mL) is stirred under 
a hydrogen atmosphere (balloon pressure) for 6 hours. Afterwards, the mixture is filtered 
and concentrated under reduced pressure. Flash chromatography over silica gel (ethyl 
acetate/methanol 24:1) affords the phosphonate (R)-13a' as a colorless viscous oil (169 
mg, 62% overall): TLC analysis (ethyl acetate/methanol 24:1) Rf = 0.5; [α]D20 = -22o (c = 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.33-7.21 (5H, m, aryl), 4.06-3.88 (4H, m, 
b+b'), 3.82-3.73 (2H, m, e), 3.48 (1H, br s, OH), 3.27-3.18 (1H, m, d), 2.38-2.28 (1H, m, 
c(1H)), 2.14-2.00 (1H, m, c(1H)), 1.23 (3H, t, J = 7.0 Hz, a or a'), 1.21 (3H, t, J = 7.0 Hz, 
a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 142.34 (d, 3JC-P = 11 Hz, f), 128.75 (g or h), 
127.73 (g or h), 127.10 (i), 67.65 (d, 3JC-P = 10.25 Hz, e), 61.91 (d, 
2JC-P = 6.5 Hz, b or b'), 
61.79 (d, 2JC-P = 6.5 Hz, b or b'), 43.12 (d, 
2JC-P = 3.0 Hz, d), 29.36 (d, 
1JC-P = 140 Hz, c), 
16.42 (d, 3JC-P = 6.0 Hz, a+a') ppm; 
31P NMR (162 MHz, CDCl3) δ 31.38 ppm; IR (neat) 
3372 (O-H), 2981 (sp2 C-H), 2906 (sp3 C-H), 1453 (aromatic C=C), 1391 (aromatic C=C), 
1222 (P=O), 1051 (C-O), 1019 (C-O), 957 (P-O), 699 cm-1.  
Obtaining γ-hydroxyphosphonate 13a' from alkene substrate 5a: Substrate 5a (1.02 g, 
4.00 mmol) is subjected to CAHB according to GP4. After purification of the major 
product (tertiary boronic ester 6a), the minor regioisomer 6a' and the reduced product 6a'' 
are flushed out of the silica packed column with methanol, the mixture is concentrated 
under reduced pressure and is subjected to oxidation following GP5. Afterwards, the 
mixture is extracted with ethyl acetate (20 mL x 5) and the combined extracts are 
concentrated under reduced pressure. Flash chromatography over silica gel (ethyl 
acetate/methanol 24:1) affords the hydroxy phosphonate 13a' as a colorless viscous oil 
(109 mg, 10% overall from the hydroboration/oxidation sequence). Enantiomer ratio is 
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determined by chiral HPLC analysis: Stationary phase = CHIRALPAK AD; Mobile Phase 
= 90:10 Hexanes:Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ = 210 nm, rt. 
HPLC traces: 
(a) R:S = 11:89, CAHB of 5a with (R,R)-
T2 to form (R)-6a', then oxidation to yield 
13a': 
 
(b) R:S = 87:13, CAHB of 5a with (S,S)-
T2 to form (S)-6a', then oxidation to yield 
13a': 
 
(c) R:S = 93:7, 13a' (enriched with “R” 
enantiomer) obtained via chiral auxiliary 
sequence. 
 
 
 
 
5.11.2 CAHB of conjugated methylidene substrate 5b bearing an ortho-
methylphenyl group: 
416 
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CAHB of conjugated methylidene substrate 5b bearing an ortho-methyl phenyl group at 
the beta position resulted in an inseparable mixture of primary boronic ester 6b (major 
product) along with the reduction side product. Oxidation of this CAHB mixture after 
partial purification (ref. GP5) allowed for the separation of the chiral γ-hydroxy 
phosphonate 13b from other products. (R)-13b was independently synthesized via 
asymmetric alkylation using the Evans’ chiral auxiliary to set the required stereochemistry. 
The chiral oxazolidinone auxiliary (S)-97 (derived from L-phenylalanine) was treated with 
nBuLi, followed by 2-(o-tolyl)acetyl chloride to obtain intermediate 98. Alkylation of 98 
with benzyl-chloromethyl ether under standard conditions affords the oxazolidinone 
derivative 99. Reduction of the oxazolidinone derivative 99 using NaBH4 results in the 
chiral alcohol (S)-100. Sequential bromination (PPh3/NBS), Michaelis-Arbuzov 
Rearrangement (P(OEt)3 reflux) and benzyl-ether cleavage (H2/Pd-C) affords the 
enantiopure chiral primary alcohol (R)-13b. Chiral HPLC analysis and optical rotation 
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measurements show that (R)-13b obtained via asymmetric synthesis is the minor 
enantiomer obtained via CAHB of 5b using (R,R)-T2 followed by oxidation. The latter 
(i.e., (S)-13b) arise B-H addition to the “top-face” of the alkene 5b in the perspective 
drawn. The absolute configuration of chiral primary boronic ester derived from ortho-
methoxy substituted substrate 5c is assigned based on analogy.  
Characterization Data: 
 
A solution of nBuLi in hexanes (2.5M; 4.0 mL, 10 mmol, 1.0 equiv.) is added dropwise to 
a solution of the oxazolidinone auxiliary (S)-97 (1.77 g, 10.0 mmol, 1 eq) in THF (20 mL) 
at -78oC. The resultant mixture was stirred for 30 minutes, following which, a solution of 
2-(o-tolyl)acetyl chloride (1.68 g, 10.0 mmol, 1.00 mmol) in THF (10 mL) is added 
dropwise to the reaction mixture. The resultant mixture is stirred for 1 hour at -78oC, 
warmed up to room temperature and stirred for an additional 1 hour and then quenched 
with the addition of saturated aqueous NH4Cl. The resultant mixture is extracted with ethyl 
acetate (20 mL x 3) and the combined organics are washed with brine, dried over anhydrous 
sodium sulfate and concentrated in vacuum. Flash chromatography on silica gel 
(dichloromethane/ethyl-acetate/hexanes 1:2:17) affords the desired oxazolidinone 
derivative 98 as a light yellow solid (2.56 g, 83%): TLC analysis (ethyl acetate/hexanes 
1:4) Rf = 0.5; [α]D20 = +68o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.36-7.22 (9H, 
m), 4.76-4.70 (1H, m), 4.42-4.22 (4H, m), 3.36 (1H, dd, J = 13.0, 3.0 Hz), 2.82 (1H, dd, J 
= 13.0, 10.0 Hz), 2.35 (3H, s) ppm; 13C NMR (100 MHz, CDCl3) δ 171.14, 153.75, 137.28, 
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135.38, 132.55, 130.54, 130.37, 129.57, 129.13, 127.71, 127.53, 126.29, 66.47, 55.62, 
40.11, 38.04, 19.81 ppm; IR (neat) 3060 (sp2 C-H), 2921 (sp3 C-H), 1771 (C=O), 1697 
(C=O), 1387, 1357, 1249, 1210, 1104, 741, 695 cm-1. 
 
A 1M solution of TiCl4 in dichloromethane (6.00 mL, 6.00 mmol, 1.50 equiv.) is added 
drop-wise to a solution of the oxazolidinone derivative 98 (1.24 g, 4.00 mmol, 1.00 mmol) 
in dry dichloromethane (8 mL) at 0oC. Diisopropylamine (1.4 mL, 8.0 mmol, 2.0 equiv.) 
is added to the resultant solution and the dark blue solution was stirred for 1 hour at 0oC. 
Following this, benzyl chloromethyl ether (1.14 mL, 8.00 mmol, 2.00 eq) is added 
dropwise and the resultant mixture is stirred at room temperature for 12 hours. (Note: 
Commercial benzylchloromethyl ether is contaminated with ~25% benzyl chloride, which 
can be removed via Kugelrohr distillation at 2 mmHg vacuum at 60oC. After distillation of 
benzyl chloride, about 90% clean benzyl chloromethyl ether is obtained which is 
contaminated with ~10% of formaldehyde dibenzyl acetal: this is used for synthesis). 
Afterwards, saturated aqueous NH4Cl is added to quench the reaction and the resultant 
mixture is extracted with ethyl acetate (25 mL x 3). The combined organics are washed 
with brine, dried over sodium sulfate and concentrated under reduced pressure. Flash 
chromatography over silica gel (ethyl acetate/hexanes 15:85) affords 99 as a viscous light-
yellow liquid (1.39 g, 81%): TLC analysis (ethyl acetate/hexanes 1:3) Rf = 0.6; [α]D20 = 
+220o (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.39-7.14 (14 H, m), 5.61-5.57 (1H, 
m), 4.74-4.59 (3H, m), 4.19-4.09 (3H, m), 3.59-3.55 (1H, m), 3.37-3.33 (1H, m), 2.96-2.90 
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(1H, m), 2.49 (3H, s) ppm; 13C NMR (100 MHz, CDCl3) δ 172.72, 152.97, 138.39, 137.95, 
135.41, 133.43, 131.14, 129.78, 129.12, 128.57, 127.86, 127.82, 127.51, 126.70, 126.29, 
73.46, 71.65, 65.92, 55.82, 46.76, 37.91, 19.64 ppm; IR (neat) 3063 (sp2 C-H), 2941 (sp3 
C-H), 1769 (C=O), 1691 (C=O), 1391, 1357, 1212, 1099, 743, 6951 cm-1.  
 
The oxazolidinone derivative 99 is cleaved to afford the chiral alcohol (S)-100 according 
to literature procedure as follows: A solution of oxazolidinone 99 (859 mg, 2.00 mmol, 
1.00 eq) in 1:1 THF: H2O mixture (40 mL) is cooled in an ice-bath to 0
oC. To this, NaBH4 
(302 mg, 8.00 mmol, 4.00 eq) is added portion-wise and the resultant mixture is stirred 
vigorously for 9 hours. Afterwards, the reaction mixture is cooled down to 0oC and was 
quenched with saturated aqueous NH4Cl (Caution: careful addition is required, quenching 
is exothermic). The resultant mixture is extracted with ethyl acetate (3 x 30 mL) and the 
combined organics are washed with brine, dried over anhydrous sodium sulfate and 
concentrated under reduced pressure. Flash chromatography over silica gel (ethyl 
acetate/hexanes 1:3) affords the alcohol (S)-100 as a colorless liquid (456 mg, 89%): TLC 
analysis (ethyl acetate/hexanes 1:3) Rf = 0.5; [α]D20 = -25o (c = 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.41-7.31 (5H, m), 7.22-7.12 (4H, m), 4.60 (2H, s), 4.08-4.00 (1H, m), 
3.92-3.82 (2H, m), 3.76 (1H, dd, J = 9.0, 4.5 Hz), 3.57-3.50 (1H, m), 2.62 (1H, br s), 2.40 
(3H, s) ppm; 13C NMR (100 MHz, CDCl3) δ 138.01, 137.76, 136.65, 130.89, 128.71, 
128.02, 127.87, 126.99, 126.42, 74.05, 73.69, 66.66, 43.08, 19.87 ppm; IR (neat) 3425 (O-
H), 3027 (sp2 C-H), 2861 (sp3 C-H), 1493, 1453, 1362, 1093, 1067, 1027, 727, 696 cm-1.  
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To a solution of the alcohol (S)-100 (256 mg, 1.00 mmol, 1.00 eq) in dry dichloromethane 
(10 mL) at 0oC is added PPh3 (393 mg, 1.50 mmol, 1.5 eq) and NBS (267 mg, 1.50 mmol, 
1.5 eq) sequentially. The resultant mixture is stirred for 1 hour when TLC (ethyl 
acetate/hexanes 1:3) indicated complete consumption of starting material. The solvent is 
evaporated under reduced pressure and 20% ethyl acetate in hexanes is added to the 
residue. The resultant mixture is filtered over a small bed of silica gel and the bed is further 
washed with more 20% ethyl acetate in hexanes (40 mL total). The combined filtrates are 
concentrated under reduced pressure. The resultant residue is refluxed with 
triethylphosphite (0.51 mL) under a nitrogen atmosphere for 6 hours. Following the 
Arbuzov rearrangement (crude NMR analysis: appearance of a phosphonate peak at ~31 
ppm), excess triethylphosphite is distilled off via bulb-to-bulb distillation. A mixture of the 
resultant residue and 10% Pd on activated carbon (80 mg, 8.0 mol% Pd-loading) in ethanol 
(10 mL) is stirred under a hydrogen atmosphere (balloon pressure) for 12 hours. 
Afterwards, the mixture is filtered and concentrated under reduced pressure. Flash 
chromatography over silica gel (ethyl acetate/methanol 49:1) affords the phosphonate (R)-
13b as a colorless viscous oil (146 mg, 51% overall): TLC analysis (ethyl acetate/methanol 
49:1) Rf = 0.5; [α]D20 = -16.9o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.23-7.13 
(4H, m, aryl), 4.11-3.97 (4H, m, b+b'), 3.85-3.77 (2H, m, e), 3.60-3.50 (1H, m, d), 2.41 
(3H, s, l), 2.29 (1H, ddd, J = 18.0, 15.0, 8.5 Hz, c(1H)), 2.09 (1H, ddd, J = 19.0, 18.0, 5.5 
Hz, c(1H)), 1.28 (3H, t, J = 7.0 Hz, a or a'), 1.28 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR 
(100 MHz, CDCl3) δ 140.79 (d, 3JC-P = 12.0 Hz, f), 136.13 (k), 130.86 (aryl), 126.92 (aryl), 
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126.61 (aryl), 126.05 (aryl), 67.63 (d, 3JC-P = 8.0 Hz, e), 62.11 (d, 
2JC-P = 7.0 Hz, b or b'), 
62.01 (d, 2JC-P = 6.5 Hz, b or b'), 38.00 (d, 
2JC-P = 3.0 Hz, d), 29.94 (d, 
1JC-P = 139 Hz, c), 
19.85 (l), 16.57 (d, 3JC-P = 6.0 Hz, a or a'), 16.54 (d, 
3JC-P = 6.0 Hz, a or a') ppm; 
31P NMR 
(162 MHz, CDCl3) δ 31.90 ppm; IR (neat) 3364 (O-H), 2980 (sp2 C-H), 2914 (sp3 C-H), 
1456 (aromatic C=C), 1391 (aromatic C=C), 1218 (P=O), 1019 (C-O), 961 (P-O), 757 cm-
1. HRMS (ESI) calculated for C14H23O4P+Na
+ = 309.1232, found 309.1228 m/z. 
Obtaining γ-hydroxyphosphonate 13b from alkene substrate 5b: Following the general 
procedure for CAHB (GP4), the substrate 5b (54 mg, 0.2 mmol) yields a mixture of boronic 
esters and reduced products that were not separable via silica gel chromatography. The 
crude CAHB mixture is chromatographed (ethyl acetate/hexanes 3:1) over silica gel to get 
rid of the non-polar colored complex and the polar metal residues. The crude mixture 
obtained after this partial purification is subjected to oxidation following GP5 to obtain the 
γ-hydroxyphosphonate 13b (47 mg, 82% overall from the hydroboration/oxidation 
sequence) as a colorless oil. Enantiomer ratio is determined by chiral HPLC analysis: 
Stationary phase = CHIRALPAK AS-H; Mobile Phase = 90:10 Hexanes:Isopropanol; 
Flow rate = 1.25 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces: 
(a) R:S = 24:76, CAHB of 5b with (R,R)-
T2, followed by oxidation to yield (S)-13b: 
 
(b) R:S = 78:22, CAHB of 5b with (S,S)-
T2, followed by oxidation to yield (R)-
13b:  
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(c) R:S = 99:1, 13b (enantioenriched “R”) 
obtained via chiral auxiliary sequence: 
 
 
 
 
5.11.3 CAHB of non-conjugated methylidene substrate 7: 
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CAHB of the non-conjugated methylidene substrate 7 resulted in an inseparable mixture 
of primary boronic ester 8 (major product) along with the tertiary boronic ester 9 (minor 
product) along with some of the reduction product. Oxidation of the mixture after partial 
purification (ref. GP5) allowed for the separation of the chiral γ-hydroxy phosphonate 101 
from the other products. (R)-101 was independently synthesized via asymmetric alkylation 
using the Evans’ chiral auxiliary. Oxazolidinone derivative 102 was prepared according to 
its literature report.43 Reduction of the oxazolidinone derivative using NaBH4 resulted in 
the chiral alcohol (S)-103 whose absolute configuration was verified by the observed strong 
negative optical rotation.44 Sequential bromination (PPh3/NBS), Michaelis-Arbuzov 
rearrangement (P(OEt)3 reflux) and benzyl-ether cleavage (H2/Pd-C) affords primary 
alcohol (R)-101. Chiral HPLC analysis reveals that the product obtained via asymmetric 
synthesis and that of CAHB (using (S,S)-T2) and oxidation sequence from substrate 7 are 
enriched with the same configuration (i.e., “R”). The alcohol obtained from substrate 7 
after CAHB (using (R,R)-T2) followed by oxidation is enriched with “S” configuration, 
which comes from the precursor boronic ester 8 enriched with the “R” configuration: 
which resulted from the B-H addition to the “top-face” of the alkene 7 in the perspective 
drawn.  
Characterization Data: 
 
The oxazolidinone derivative is cleaved to afford the chiral alcohol (S)-103 according to 
the procedure outlined for the reduction of oxazolidinone derivative 100 in Sec. 5.11.2: 
The oxazolidinone derivative 102 (859 mg, 2.00 mmol, 1.00 eq) affords the chiral alcohol 
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(S)-103 (471 mg, 92%) as a colorless oil: TLC analysis (ethyl acetate/hexanes 1:3) Rf = 
0.5; [α]D20 = -34.5o (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42-7.21 (10H, m), 
4.54 (2H, dd, J = 18.0, 12.0 Hz), 3.80-3.62 (3H, m), 3.53 (1H, dd, J = 9.0, 6.5 Hz), 2.76-
2.67 (2H, m), 2.61 (1H, t, J = 5.0 Hz), 2.23-2.16 (1H, m) ppm; 13C NMR (100 MHz, CDCl3) 
δ 140.15, 138.16, 129.22, 128.62, 128.53, 127.91, 127.81, 126.21, 73.59, 72.86, 65.35, 
42.76, 34.64 ppm; IR (neat) 3378 (O-H), 3027 (aromatic C-H), 2857 (aliphatic C-H), 1494 
(aromatic C=C), 1453 (aromatic C=C), 1362 (aromatic C=C), 1027 (C-O), 735, 696 cm-1.  
 
The chiral alcohol (S)-103 is transformed to the chiral γ-hydroxyphosphonate (R)-101 
according to the procedure detailed out in Sec. 5.11.2. The chiral alcohol (S)-103 (256 mg, 
1.00 mmol) underwent bromination, Arbuzov rearrangement and benzyl ether cleavage to 
afford (R)-101 (175 mg, 61%) as a colorless viscous liquid: TLC analysis (ethyl 
acetate/methanol 49:1) Rf = 0.5; [α]D20 = +15o (c = 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.33-7.19 (5H, m, aryl), 4.16-3.98 (4H, m, b+b'), 3.77 (1H, dd, J = 12.0, 4.0 Hz, 
e(1H)), 3.59 (1H, dd, J = 12.0, 6.0 Hz, e(1H)), 2.79 (1H, ddd, J = 13.5, 7.0, 2.5 Hz, f(1H)), 
2.64 (1H, dd, J = 13.0, 8.0 Hz, f(1H)), 2.33-2.20 (1H, m, d), 1.89-1.73 (2H, m, c), 1.33 
(3H, t, J = 7.0 Hz, a or a'), 1.32 (3H, t, J = 7.0 Hz, a or a') ppm; 31P NMR (162 MHz, 
CDCl3) δ 32.86 ppm; IR (neat) 3378 (O-H), 2981 (aromatic C-H), 2909 (aliphatic C-H), 
1453 (aromatic C=C), 1391 (aromatic C=C), 1216 (P=O), 1049 (C-O), 1021 (C-O), 959 
(P-O), 700 cm-1; HRMS (ESI) calculated for C14H23O4P+Na
+ = 309.1232, found 309.1230 
m/z.  
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Obtaining γ-hydroxyphosphonate 101 from alkene substrate 7: Following the general 
procedure for CAHB (GP4; 6 h total reaction time), the substrate 7 (54 mg, 0.2 mmol) 
yields a mixture of boronic ester regioisomers and reduced products that are not separable 
via silica gel chromatography. The crude CAHB mixture is chromatographed (ethyl 
acetate/hexanes 1:1) over silica gel to get rid of the non-polar colored complex and the 
polar metal residues. The crude mixture obtained after this partial purification is subjected 
to oxidation following GP5 to obtain the γ-hydroxyphosphonate 101 (47 mg, 71% overall 
from the hydroboration/oxidation sequence) as a colorless oil. Enantiomer ratio is 
determined by chiral HPLC analysis: Stationary phase = CHIRALPAK IC 3 micron; 
Mobile Phase = 80:20 Hexanes: Isopropanol; Flow rate = 1.25 mL/min. HPLC UV detector 
λ = 210 nm, rt. HPLC traces: 
(a) R:S = 12:88, CAHB of 7 with (R,R)-T2, 
followed by oxidation to yield (S)-101: 
 
(b) R:S = 89:11, CAHB of 7 with (S,S)-T2, 
followed by oxidation to yield (R)-101: 
 
(c) R:S = 98:2, (R)-101 (enantioenriched 
“R”) obtained via chiral auxiliary 
sequence: 
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5.11.4 CAHB of β-aryl trisubstituted alkene substrate (E)-41a: 
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CAHB of the conjugated (β-aryl) trisubstituted substrate (E)-41a with (R,R)-T2 results in 
the formation of chiral tertiary benzylic boronic ester product 42a. The latter is 
protodeboronated (GP7) using conditions reported by Aggarwal to the corresponding 
chiral reduced product 104. The (S)-enantiomer of the chiral reduced product (104) is 
obtained via asymmetric alkylation using the Evans chiral auxiliary. Chiral HPLC analysis 
establishes that the protodeborylated product from the chiral boronic ester is (R)-104. Since 
protodeborylation of chiral boronic esters proceed with retention of configuration, the 
configuration of the chiral boronic ester 42a obtained from (E)-41a using (R,R)-T2 is also 
assigned as “R”. The configurations of all other chiral tertiary benzylic boronic esters 
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derived from conjugated (β-aryl) trisubstituted substrates using (R,R)-T2 are assigned as 
“R” by analogy.  
Characterization data: 
 
Compound 105 is prepared according to literature procedure.45 The oxazolidinone 
derivative is cleaved to afford the chiral alcohol (S)-106 according to the procedure 
outlined for the reduction of oxazolidinone derivative 99 in Sec. 5.11.2. The oxazolidinone 
derivative 105 (410 mg, 1.00 mmol, 1.00 eq) affords the chiral alcohol (S)-106 (203 mg, 
85%) as a colorless oil: TLC analysis (ethyl acetate/hexanes 1:3) Rf = 0.5; [α]D20 = +41o (c 
= 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.40-7.20 (10H, m), 6.44 (1H, d, J = 16.0 
Hz), 6.20-6.12 (2H, m), 3.90-3.81 (2H, m), 3.03 (1H, quin, J = 7.0 Hz), 2.72-2.55 (2H, m), 
1.46 (br s) ppm; 13C NMR (100 MHz, CDCl3) δ 141.99, 137.62, 131.79, 128.85, 128.60, 
128.21, 128.17, 127.18, 127.02, 126.16, 66.99, 48.70, 35.99 ppm; IR (neat) 3397 (O-H), 
3025 (sp2 C-H), 2926 (sp3 C-H), 1599 (C=C), 1493 (aromatic C=C), 1451 (aromatic C=C), 
1026 (C-O), 964, 746, 692 cm-1.  
 
A mixture of (S)-106 (191 mg, 0.80 mmol, 1.00 eq) and 10% Pd over activated carbon (10 
mg) in ethanol (10 mL) is stirred under hydrogen atmosphere (balloon pressure) for 6 
hours. Following this, the reaction mixture is filtered over a bed of celite to get rid of the 
insoluble catalyst particles. The celite bed is washed with ethanol (10 mL) and the 
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combined organics were concentrated under reduced pressure. To the resultant residue in 
dry dichloromethane (16 mL) at 0 oC, PPh3 (315 mg, 1.20 mmol, 1.5 eq) and NBS (214 
mg, 0.12 mmol, 1.5 eq) are sequentially added portion-wise and the resultant mixture is 
allowed to warm up to room temperature and stir for a total of 2 hours. Afterwards, the 
reaction mixture is concentrated under reduced pressure and 15 mL of 10% ethyl acetate 
in hexanes is added. The resultant mixture is filtered over a small pad of silica gel to get 
rid of the insoluble components. The silica pad is washed with 2 more portions of 15 mL 
of 10% ethyl acetate in hexanes and the combined organics are concentrated under reduced 
pressure. Triethylphosphite (0.27 mL, 1.6 mmol, 2.0 eq) is added to the resultant residue 
in a 10 mL round bottomed flask charged with a stirbar and the resultant mixture was 
refluxed vigorously under nitrogen for 1 hour. Afterwards, the volatiles are removed under 
reduced pressure and the residue is purified by flash chromatography over silica gel (ethyl 
acetate) to afford the desired chiral phosphonate product (S)-104 (187 mg, 65%) as a 
colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +9.3o (c = 0.5, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 7.32-7.09 (10H, m, aryl), 4.02-3.74 (4H, m, b+b'), 3.11-3.01 
(1H, m, d), 2.65-2.50 (2H, m, h), 2.13-2.07 (2H, m, c), 1.93-1.84 (1H, m, e(1H)), 1.73-1.64 
(1H, m, e(1H)), 1.57-1.38 (2H, m, f), 1.21 (3H, t, J = 7.0 Hz, a or a'), 1.15 (3H, t, J = 7.0 
Hz, a or a') ppm; 13C NMR (100 MHz, CDCl3) δ 144.57 (d, 3JC-P = 8.5 Hz, l), 142.38 (h), 
128.55 (aryl), 128.48 (aryl), 128.36 (aryl), 127.66 (aryl), 126.61 (aryl), 125.79 (aryl), 61.43 
(d, 2JC-P = 7.0 Hz, b or b'), 61.26 (d, 
2JC-P = 6.5 Hz, b or b'), 40.29 (d, 
2JC-P = 3.5 Hz, d), 
37.45 (d, 3JC-P = 12.0 Hz, e), 35.79 (g), 33.39 (d, 
1JC-P = 139 Hz, c), 29.15 (f), 16.43 (d, 
3JC-
P = 7.0 Hz, a or a'), 16.41 (d, 
3JC-P = 7.0 Hz, a or a') ppm; 
31P NMR (162 MHz, CDCl3) δ 
30.18 ppm; IR (neat) 3026 (sp2 C-H), 2933 (sp3 C-H), 1495 (aromatic C=C), 1453 
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(aromatic C=C), 1241 (P=O), 1053 (C-O), 1024 (C-O), 955 (P-O), 697 cm-1. HRMS (EI) 
calculated for C21H29O3P = 360.1854, found 360.1843 m/z.  Enantiomer ratio is determined 
by chiral HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 20:80 
Hexanes:Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC 
traces: 
(a) R:S = 12:88, 104 synthesized via 
chiral auxiliary synthesis:  
 
 
(b) R:S = 83:17, CAHB of (E)-41a with 
(R,R)-T2 to form 42a and then 
protodeboronation to form 104: 
 
(c) Racemic mixture of 104 obtained by 
hydrogenation of (E)-41a with H2 over 
Pd/C: 
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5.11.5 CAHB of β,γ-diaryl trisubstituted alkene substrate (E)-41d: 
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CAHB of the β,γ-diphenyl trisubstituted substrate (E)-41d with (R,R)-T2 results in β-
borylation with the formation of chiral tertiary benzylic boronic ester product 42d. The 
latter is protodeboronated using GP7 to afford the corresponding chiral reduced product 
with the retention of configuration at the chiral carbon.8 Enantioenriched (S)-107 is 
obtained via asymmetric alkylation using the Evans chiral auxiliary to give the known 
chiral alcohol (S)-109.46 Chiral HPLC analysis shows that the protodeborylated product 
obtained from the chiral tertiary boronic ester 42d is (R)-107.  
Characterization Data: 
 
Compound 108 is prepared as previously reported.47 The oxazolidinone derivative 108 is 
cleaved to afford the chiral alcohol (S)-109 according to the procedure outlined for the 
reduction of oxazolidinone derivative 99 in Sec. 5.11.2. The oxazolidinone derivative 108 
(385 mg, 1.00 mmol, 1.00 eq) affords the chiral alcohol (S)-109 (174 mg, 82%) as a 
colorless oil: TLC analysis (ethyl acetate/hexanes 1:3) Rf = 0.5; [α]D20 = +49o (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.26-7.11 (10H, m), 3.86-3.77 (2H, m), 3.16-2.92 
(3H, m), 1.34 (1H, t, J = 6.0 Hz) ppm; 13C NMR (100 MHz, CDCl3) δ 142.11, 140.12, 
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129.26, 128.84, 128.45, 128.30, 127.06, 126.23, 66.57, 50.39, 38.91 ppm; IR (neat) 3320 
(O-H), 3025 (sp2 C-H), 2920 (sp3 C-H), 1601, 1494 (aromatic C=C), 1451 (aromatic C=C), 
1060 (C-O), 1028 (C-O), 757, 695 cm-1.  
 
To a solution of the chiral alcohol (S)-109 (106 mg, 0.5 mmol, 1.0 eq) in dry 
dichloromethane (10 mL) is added PPh3 (197 mg, 0.75 mmol, 1.50 eq) and the resultant 
solution is cooled down to 0oC. To the resultant solution NBS (134 mg, 0.75 mmol, 1.50 
eq) is added portion wise and the resultant mixture is allowed to warm up to room 
temperature and stirred for a total of 2 hours. Afterwards, the reaction mixture is 
concentrated under reduced pressure and 10 mL of 15% ethyl acetate in hexanes is added. 
The resultant mixture is filtered over a small pad of silica gel to get rid of the insoluble 
components. The silica pad is washed with 2 more portions of 10 mL of 10% ethyl acetate 
in hexanes and the combined organics are concentrated under reduced pressure. To the 
resultant residue triethylphosphite (0.17 mL, 1.0 mmol, 2.0 eq) is added and the resultant 
mixture refluxed vigorously under nitrogen atmosphere for 2 hours. Afterwards, the 
volatiles were removed under reduced pressure and the residue is purified by flash 
chromatography over silica gel (ethyl acetate) to afford the desired chiral phosphonate 
product (S)-107 (116 mg, 70%) as a colorless oil: TLC analysis (ethyl acetate) Rf = 0.5; 
[α]D20 = +34o (c = 1.0, CHCl3); 1H NMR (700 MHz, CDCl3) δ 7.28-7.26 (2H, m, aryl), 
7.23-7.15 (6H, m, aryl), 7.03 (2H, d, J = 7.0 Hz, aryl), 3.97-3.91 (1H, m, b or b'), 3.90-3.84 
(2H, m, b or b'), 3.74-3.68 (1H, m, b or b'), 3.35-3.29 (1H, m, d), 3.05 (1H, dd, J = 13.5, 
7.5 Hz, e (1H)), 2.94 (1H, ddd, J = 13.5, 7.5, 1.5 Hz, e (1H)), 2.22-2.11 (2H, m, c), 1.18 
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(3H, t, J = 7.0 Hz, a or a'), 1.13 (3H, t, J = 7.0 Hz, a or a') ppm; 13C NMR (175 MHz, 
CDCl3) δ 143.99 (d, 3JC-P = 7.0 Hz, j), 139.56 (f), 129.51 (aryl), 128.46 (aryl), 128.36 (aryl), 
127.91 (aryl), 126.75 (aryl), 126.35 (aryl), 61.56 (d, 2JC-P = 6.5 Hz, b or b'), 61.34 (d, 
2JC-P 
= 6.5 Hz, b or b'), 44.70 (d, 3JC-P = 14.0 Hz, e), 42.46 (d, 
2JC-P = 3.5 Hz, d), 31.75 (d, 
1JC-P 
= 139 Hz, c), 16.44 (d, 3JC-P = 6.5 Hz, a+a') ppm; 
31P NMR (283 MHz, CDCl3) δ 30.09 
ppm; IR (neat) 3018 (sp2 C-H), 2943 (sp3 C-H), 1496 (aromatic C=C), 1451 (aromatic 
C=C), 1239 (P=O), 1051 (C-O), 1025 (C-O), 955 (P-O), 698 cm-1. HRMS (EI) calculated 
for C19H25O3P = 332.1541, found = 332.1538 m/z. Enantiomer ratio is determined by chiral 
HPLC analysis: Stationary phase = CHIRALPAK IC; Mobile Phase = 20:80 Hexanes: 
Isopropanol; Flow rate = 1 mL/min. HPLC UV detector λ = 210 nm, rt. HPLC traces: 
 
(a) R:S = 9:91, 107 synthesized via chiral 
auxiliary synthesis: 
 
 
(b) R:S = 88:12, CAHB of (E)-41d with 
(R,R)-T2 to form 42d which 
protodeboronates to form 107. 
 
(c) Racemic mixture of 107 obtained by 
hydrogenation of (E)-41d with H2 over 
Pd/C: 
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5.11.6. Kinetic Acylation of Chiral Secondary Benzylic Alcohols using 
Benzotetramisole (BTM) 
Benzotetramisole is prepared according to Birman’s previously reported procedure.48 For 
carrying out enantioselectivity tests, the general guided reaction of kinetic acylation using 
Benzotetramisole (BTM) for a racemic mixture of chiral secondary benzyl alcohol 22a is 
shown below. (R)-BTM catalyzes the esterification reaction of (R)-enantiomer of the chiral 
secondary benzylic alcohol with isobutyric anhydride faster than the (S)-enantiomer and 
vice-versa.  
 
General Procedure for Absolute Configuration Assignment via Enantioselectivity 
Test (GP18): The absolute configuration assignments based on enantioselectivity tests 
were carried out according to the procedure reported by Birman and coworkers as follows. 
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The stock solution of the kinetic acylation catalyst is prepared by dissolving 0.05 mmol of 
BTM and 0.75 mmol of Hunig’s base in 1 mL CDCl3 (dried over activated molecular 
sieves). The racemic mixture of the chiral secondary benzylic alcohol (0.25 mmol) is taken 
in an oven dried glass vial and to this, 0.5 mL of the stock solution of the catalyst is added. 
To this, propionic anhydride (0.15 mmol, 0.6 eq) is added (stopwatch started at this point), 
the contents were mixed and transferred to an NMR tube. The reaction is monitored by 31P 
NMR by comparing the integration values of the peak corresponding to the starting alcohol 
and the new peak appearing upfield (corresponding to the anhydride). When the relative 
ratios of the two species are about 1:1, the reaction mixture is quenched by pouring the 
contents into a vial containing MeOH. Standard workup and HPLC analysis were carried 
out afterwards. 
 
Absolute configuration assignment of alcohol 22a obtained from (E)-18a following 
GP4 using (R)-B2 followed by oxidation (GP5): Rac-22a is subjected to kinetic acylation 
according to GP18 using (R)-BTM. Matching the HPLC traces of unreacted 22a after 
kinetic acylation with that of 22a obtained from (E/Z)-5a after CAHB/Oxidation sequence 
(GP4 using (R)-B2) suggests that (S)-22a is forming in the CAHB/Oxidation sequence of 
18a with (R)-B2.   
Alcohol 22a is also a previously reported compound in the literature. Negative value of 
optical rotation obtained for 22a (obtained via CAHB/Oxidation sequence of (E/Z)-18a 
(GP4) using (R)-B2) is also in lines with what would be expected for the (S)-enantiomer.12  
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HPLC traces are shown below: 
(a) Racemate 
  
 
(b) After kinetic resolution of rac-22a using (R)-BTM. Major peak corresponds to (S)-22a.  
 
 
  
(c) 22a formed via CAHB of (E/Z)-18a using (R)-B2 followed by oxidation (R:S = 4:96). 
Major peak corresponds to (S)-22a.  
  
 
 
Absolute configuration assignment of alcohol 22n obtained from (E)-18n following 
GP4 using (R)-B2 followed by oxidation (GP5): Rac-22n is subjected to kinetic acylation 
according to GP18 using (R)-BTM. Matching the HPLC traces of unreacted 22n after 
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kinetic acylation with that of 22n obtained from (E)-18n after CAHB/Oxidation sequence 
(GP4 using (R)-B2) suggests that (S)-22n is forming in the CAHB/Oxidation sequence of 
(E)-18n with (R)-B2. HPLC traces are shown below: 
(a) Racemate 
 
 
 
(b) After kinetic resolution of rac-22n using (R)-BTM. Major peak corresponds to (S)-22n  
 
 
  
(c) 22n formed via CAHB of (E)-18n using (R)-B2 followed by oxidation (R:S = 1:99). 
Major peak corresponds to (S)-22n.  
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Absolute configuration assignment of alcohol 22q obtained from (E)-18q following 
GP4 using (R)-B2 followed by oxidation (GP5): Rac-22q is subjected to kinetic acylation 
according to GP18 using (R)-BTM. Matching the HPLC traces of unreacted 22q after 
kinetic acylation with that of 22q obtained from (E)-18q after CAHB/Oxidation sequence 
(GP4 using (R)-B2) suggests that (S)-22q is forming in the CAHB/Oxidation sequence of 
18q with (R)-B2. HPLC traces are shown below: 
(a) Racemate 
 
 
 
(b) After kinetic resolution of rac-22q using (R)-BTM. Major peak corresponds to (S)-22q.   
 
 
  
(c) 22q formed via CAHB of (E)-18q using (R)-B2 followed by oxidation (R:S = 5:95). 
Major peak corresponds to (S)-22q.  
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Absolute configuration assignment of alcohol 22x obtained from (E)-18x following 
GP4 using (R)-B2 followed by oxidation (GP5): Rac-22x is subjected to kinetic acylation 
according to GP18 using (R)-BTM. Matching the HPLC traces of unreacted 22x after 
kinetic acylation with that of 22x obtained from (E)-18x after CAHB/Oxidation sequence 
(GP4 using (R)-B2) suggests that (S)-22x is forming in the CAHB/Oxidation sequence of 
(E)-18x with (R)-B2. HPLC traces are shown below: 
(a) Racemate 
 
 
 
(b) After kinetic resolution of rac-22x using (R)-BTM. Major peak corresponds to (S)-22x  
 
 
 
(c) 22x formed via CAHB of (E)-18x using (R)-B2 followed by oxidation (R:S = 12:88). 
Major peak corresponds to (S)-22x. 
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Absolute configuration assignment of alcohol 25 obtained from (E/Z)-23 following 
GP4 using (R)-B2 followed by oxidation (GP5): Rac-25 is subjected to kinetic acylation 
according to GP18 using (R)-BTM. Matching the HPLC traces of unreacted 25 after kinetic 
acylation with that of 25 obtained from (E/Z)-23 after CAHB/Oxidation sequence (GP4 
using (R)-B2) confirmed that (S)-25 is forming in the CAHB/Oxidation sequence of (E/Z)-
23 with (R)-B2. HPLC traces are shown below: 
(a) Racemate 
 
 
 
(b) After kinetic resolution of rac-25 using (R)-BTM. Major peak corresponds to (S)-25  
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(c) 25 formed via CAHB of (E/Z)-23 using (R)-B2 followed by oxidation (R:S = 5:95). 
Major peak corresponds to (S)-25. 
 
 
 
For the above 5 cases, absolute configuration is assigned based on enantioselectivity tests. 
The conversion (c) is estimated via NMR analysis. The selectivity factor (s)49 is calculated 
using the following formula: 
s = ln[(1-c)(1-ee)]/ln[(1-c)(1+ee)] 
Entry Substrate 
ee of recovered 
alcohol 
Conversion 
(via NMR) 
Selectivity 
factor (s) 
1 
 
84.45% 49% 41.45 
2 
 
49.80% 46% 6.15 
3 
 
75.81% 47% 29.08 
4 
 
58.58% 40% 28.00 
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5 
 
66.32% 40% 45.38 
 
General Procedure for Absolute Configuration Assignment based on the Relative 
Speed of Ester Formation from Chiral Secondary Benzylic Alcohol (Obtained via 
CAHB/Oxidation sequence) using (R)- and (S)- BTM (GP19): Two separate stock 
solutions of (R)- and (S)-BTM were prepared as follows. 25 μmol of BTM and 0.4 mmol 
of Hunig’s base are taken up in 1 mL CDCl3 (dried over activated molecular sieves). The 
chiral secondary benzylic alcohol (0.25 mmol; Obtained using GP4 with (R)-B2 followed 
by oxidation (GP5)) is weighed in two separate labelled oven dried glass vials and in one 
vial 0.5 mL of the stock solution of (R)-BTM is added. In the second vial, 0.5 mL of the 
stock solution of (S)-BTM is added. To each vial propionic anhydride (0.15 mmol, 0.6 eq) 
is added and (timer started at this point), the contents were mixed and transferred to an 
NMR tube. The reactions are monitored by 31P NMR spectroscopy for the appearance of 
an upfield peak corresponding to the ester. Since (R)-BTM catalyzes reaction of (R)-
enantiomer of a chiral secondary benzylic alcohol with propionic anhydride faster than the 
(S)-enantiomer and vice-versa, the absolute configuration is assigned based on which 
configuration of BTM leads to the faster formation of the anhydride.  
Entry 
Alcohol obtained via GP4 
(Using (R)-B2) followed by 
oxidation (GP5) 
% Ester 
formation 
using (R)-
BTM 
% Ester 
formation 
using (S)-
BTM 
Absolute 
Configuration 
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1 
 
5% in 30 
minutes 
50% in 30 
minutes 
“S” 
2 
 
3% in 30 
minutes 
45% in 30 
minutes 
“S” 
3 
 
5% in 30 
minutes 
47% in 30 
minutes 
“S” 
4 
 
2% in 12 
hours 
27% in 12 
hours 
“S” 
5 
 
21% in 12 
hours 
3% in 12 
hours 
“R” 
6 
 
4% in 1 hour 30% in 1 hour “S” 
7 
 
2% in 1 hour 31% in 1 hour “S” 
8 
 
6% in 12 
hours 
41% in 12 
hours 
“S” 
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9 
 
3% in 12 
hours 
14% in 12 
hours 
“S” 
 
 
Characterization data of (R)-26a: TLC analysis (ethyl acetate) Rf = 0.5; [α]D20 = +47o (c = 
1.0, CHCl3; Optical rotation of “R” enantiomer); 1H NMR (400 MHz, CDCl3) δ 7.35-7.25 
(5H, m, aryl), 5.76 (1H, dd, J = 7.0, 6.0 Hz, e), 4.13-4.00 (4H, m, b+b'), 2.58 (1H, sept, J 
= 7.0 Hz, k), 2.23-2.02 (2H, m, d), 1.82-1.62 (2H, m, c), 1.30 (6H, t, J = 7.0 Hz, a+a'), 1.18 
(3H, d, J = 7.0 Hz, l or l'), 1.15 (3H, d, J = 7.0 Hz, l or l') ppm; 13C NMR (100 MHz, CDCl3) 
δ 176.08 (l), 139.99 (f), 128.69 (h), 128.19 (i), 126.42 (g), 75.26 (d, 3JC-P = 19 Hz, e), 61.75 
(d, 2JC-P = 6.5 Hz, b+b'), 34.27 (k), 29.61 (d, 
2JC-P = 4.25 Hz, d), 22.11 (d, 
1JC-P = 143 Hz, 
c), 19.05 (l or l'), 19.00 (l or l'), 16.54 (d, 3JC-P = 5.9 Hz, a+a') ppm; 
31P NMR (162 MHz, 
CDCl3) δ 30.95 ppm; IR (neat) 2976 (C-H), 1732 (C=O), 1470 (aromatic C=C), 1455 
(aromatic C=C), 1387 (aromatic C=C), 1244 (P=O), 1053 (C-O), 1022 (C-O), 955 (P-O), 
699 cm-1. Enantiomer ratio = 99:1, determined by chiral HPLC analysis: Stationary phase 
= CHIRALPAK IC; Mobile Phase = 50:50 Isopropanol:Hexanes; Flow rate = 1 mL/min; 
HPLC UV Detector λ = 210 nm, 25 oC. HPLC traces: 
(a) R:S = 96:4, Reaction of rac-22a with 0.6 eq. isobutyric anhydride with (R)-BTM. Ester 
26a formed is enriched in “R” enantiomer. 
444 
 
 
 
 
(b) R:S = 1:99, Reaction of rac-22a with 0.6 eq. isobutyric anhydride with (S)-BTM. Ester 
26a formed is enriched in “S” enantiomer. 
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